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Foreword    
2020 will forever be remembered as the year of the COVID-19 pandemic. For the first time since 
1972, the 49th Annual Scientific Meeting of the SAPC, due to be held in Leeds in July 2020, could not 
take place. The cancellation occurred after the submission deadline for abstracts, and, as there was 
no capacity for a ‘virtual’ meeting, these abstracts could not be presented. We thank all of the 
authors, from around the world, for their submissions, which were, as ever, of high quality, 
importance, and impact, reflecting the state of our discipline.   
We have great pleasure in publishing the abstracts in this document. A total of 281 abstracts were 
submitted, 205 for consideration as ‘long orals’, and 76 as ‘short orals’.  A couple of ‘technical’ points 
to note: 
 The theme of the meeting was ‘Living and Dying Well’. This has become more poignant as 
the events of 2020 sadly unfold. 
 They are published ‘as submitted’ with no edits or updates from authors 
 There has been no selection of abstracts – all are included, except those where authors have 
declined the option of publication 
  
The ASM in Leeds has been rescheduled for 30th  June – 2nd July 2021, and we look forward to 
hosting a successful meeting. We hope that many people who submitted in 2020 will also do so in 
2021. 
  
Richard Neal & Suzanne Richards 
On behalf of the Scientific and Organising Committees 
University of Leeds 
May 2020 
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Distinguished papers 
A.0a 
Australasian Association of Academic Primary Care 
Conference (AAAPC) – winning presentation 2019 
The Australian Contraceptive ChOice pRoject 
(ACCORd): Results of a cluster randomised controlled 
trial aimed at increasing Long Acting Reversible 
Contraceptive (LARC) uptake 
Professor Danielle Mazza 
Professor Danielle Mazza (1). Dr Cathy Watson (1), 
Professor Kirsten Black (2). Professor Jayne Lucke (3). 
Professor Angela Taft (4), Dr Kevin McGeechan (5), 
Professor Marion Haas (6), Dr Kathleen McNamee (7), 
Professor Jeffrey Peipert (8) 
1) Department of General Practice Monash 
University 
2) Obstetrics, Gynaecology and Neonatology, 
University of Sydney 
3) Australian Research Centre for Sex, Health 
and Society (ARCSHS). La Trobe University 
4) Judith Lumley Centre, La Trobe University 
5) School of Public Health, University of Sydney 
6) Centre for Health Economics Research and 
Evaluation, University of Technology Sydney 
7) Family Planning Victoria 
8) Obstetrics and Gynecology, Indiana University 
School of Medicine 
Context 
LARCs reduce unintended pregnancy and abortion 
rates but Australian uptake is low. General 
practitioners (GPs) are ideally placed to promote 
LARCs.   
Objective 
The Australian Contraceptive ChOice pRoject 
(ACCORd), adapted from the US Contraceptive 
CHOICE study, evaluated whether a complex primary 
care intervention increased LARC uptake.  
Study Design 
Cluster randomised controlled trial in general 
practices in Melbourne, Australia. Intervention GPs 
received training to deliver structured contraceptive 
counselling with contraceptive effectiveness emphasis 
and access to rapid referral to LARC insertion clinics. 
Control GPs had access to neither. Primary outcome: 
number of LARCs inserted. Data collected from 
women at baseline (telephone interview), six months 
(online survey) and from GPs and gynaecologists 
during contraceptive consultation and at time of 
contraception uptake.  
Participants 
GPs: worked 3+ sessions weekly, computerised 
practice and supportive reception staff. Women: 
attended GP, English speaking, sexually active, not 
pregnant, not planning pregnancy in following year, 
16–45 years, interested in contraceptive counselling.  
Findings 
Twenty-five intervention GPs and 32 control GPs 
recruited 307 and 433 women (N=740). Referral for 
LARC insertion within 4 weeks of initial consultation - 
Intervention: 37%; Control: 18% (RR 1.98, 95% CI 1.39-
2.8; p<0.001). LARC inserted by 4 weeks - 
Intervention: 19%; Control: 12% (RR 2.03, CI 1.06-
3.89; p=0.033). Using LARC at 6 months - Intervention: 
45%; Control: 29% (RR1.66, 95%CI 1.28-2.16; 
p<0.001). No difference in age nor parity with LARC 
uptake across groups.  
Implications for practice 
ACCORd intervention resulted in significantly more 
LARC uptake at 4 weeks and 6 months and has 
potential to reduce unintended pregnancies. 
 
A.0b 
North American Primary Care Group Annual Meeting 
– winning presentation 2019 
“Nosotros” Approach:  Community health workers as 
trust builders and community healers 
 
Dr Robert L Ferrer 
Authors: 
RL Ferrer, CG Schlenker, RS Poursani, I Cruz, P Noel, R 
Palmer, CR Jaén 
Department of Family and Community Medicine, UT 
Health San Antonio, Texas, USA 
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Context: Promoting patients’ commitment to engage 
in self-care is a core goal of primary care, yet often 
elusive in the context of social deprivation. 
 
Objective: To report on an innovative, practice-
integrated, community health worker 
(CHW) intervention designed to promote trusting 
relationships and effective self-care in patients with 
type 2 diabetes. 
 
Study Design: Retrospective cohort study. 
 
Setting: Family medicine practice in a safety-net 
county health care system in San Antonio, Texas, USA. 
 
Population studied: Predominantly Hispanic, low-
income primary care patients with uncontrolled type 2 
diabetes, and significant psychosocial risk factors. 
 
Intervention: Clinicians identified eligible patients 
through a diabetes registry and at point of care. 
Patients were assigned CHWs, who engaged 
them in trust-building and relationship-based sense 
making to understand their social context, 
collaboratively identify goals, navigate the health care 
system, and connect them to community resources. 
 
Outcome Measures: Primary outcome was patient 
progress through three prospectively defined stages 
of self-care: a) Outreach (patient responds to CHW’s 
invitation to meet face-to-face); b) Stabilization 
(patient and CHW build trust and create an alliance to 
address pressing problems within the patient's 
life circumstances); and c) Self-Care Generativity 
(patient commits to self-care. Secondary outcome was 
repeated measures analysis of glycosylated 
hemoglobin (A1c). 
 
Results: From a population of 8,647 patients with 
diabetes, 986 were referred to the Nosotros Approach 
over 4 years. Of those, 267 (27.1%) remained in 
Outreach; 399 (40.5%) progressed to Stabilization; 
while 320 (32.5%) achieved Self-Care Generativity. 
Repeated measures ANOVA demonstrates an overall 
decline in A1c, without group differences, through the 
4th A1c measurement occasion (mean follow-up 704 
days). Beginning at the 5th A1c measurement 
occasion (mean 860 days), the self-care generativity 
group achieved greater declines in A1c (p<.05). The 
relative advantage of the self-care generatively group 
grew through the 10th measurement occasion (mean 
follow up 1367 days) when it attained an average A1c 
of 8.26% vs 9.29% in the engagement group and 
9.17% in the stabilization group (p<.003). 
 
Conclusions: Community health workers can 
sustainably engage vulnerable patients, helping them 
identify and advance long-term self-management 
goals in the context of formidable social disadvantage. 
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A.1 
Spatial clusters for potentially preventable 
hospitalisations (PPHs) for chronic conditions and 
access to allied health in South Western Sydney 
Presenter: Sarah Dennis 
Authors:  Janelle Gifford, Soumya Mazumdar, Luke 
Arnold, Matthew Jennings, Bin Jalaluddin, Sarah 
Dennis 
Institutions 
University of Sydney, Ingham Institute of Applied 
Medical Research, South Western Sydney Local Health 
District,  South Western Sydney Primary Health 
Network, UNSW 
Abstract 
Problem 
A key role of primary care is to support patients to live 
well with their chronic condition in the community. 
Potentially preventable hospitalisations (PPHs) for 
chronic conditions are increasing in Australia. A recent 
study in South Western Sydney Local Health District 
(SWLHD) found six hotspots of PPHs which were 
associated with socioeconomic disadvantage but also 
higher access to primary care (general practice) 
services.  These services were largely bulk-billing 
general practices .  Many PPHs for chronic conditions 
may be amenable to allied health interventions and 
yet access to affordable allied health professionals in 
SWSLHD is lower than for more affluent areas in 
Sydney.  The aim of this study is to use geospatial 
analysis techniques to determine whether there is an 
association between access to primary and 
community allied health services and hotspots of 
PPHs for chronic conditions in the SWSLHD area. 
Approach 
The main study involves the comparison of two sets of 
data: 
1. Hospital admission data for PPHs for chronic 
conditions for all age groups from all public hospitals 
in SWSLHD for a 12-month period (2018) available 
from NSW Health. 
2. The location and availability of allied health 
services (dietetics, exercise physiology, occupational 
therapy, physiotherapy, psychology, social work and 
speech pathology) in primary and community health 
in SWSLHD and South Western Sydney Primary Health 
Network (SWSPHN).  The following data is required for 
all services: geographic location (suburb & postcode), 
opening hours, out of pocket cost of services (private 
or community health), and languages spoken by allied 
health professionals.The allied health service data for 
2019 was obtained from National Health Services 
Directory.  The data accuracy and completeness 
checked against the directory at SWSPHN and 
community health services (SWSLHD) publically 
available information.The data will be cleaned and 
coded. Summary statistics will be produced for all 
variables in the data. Inferential or regression models 
will be implemented to investigate relationships. 
Findings 
Cross checking of the allied health service data for 
data accuracy and completeness is underway.  
Summary data for PPHs and allied health services will 
be presented. 
Consequences 
Cross checking of the allied health service data has 
revealed some challenges.  This has implications for 
patients and providers trying to access allied health 
services to support people to live well with chronic 
disease. 
 
A.2 
What are the barriers and facilitators to access to 
care for people with co-morbid severe mental illness 
and obstructive airways disease (Asthma and 
COPD)?: a qualitative study of patient perspectives 
and stakeholder feedback 
Presenter: Caroline Mitchell 
Authors:  Nicholas Zuraw, Brigitte Delaney, Neil Dolan, 
Helen Twohig, Elizabeth Walton, Kirsty Payne, Joe 
Hulin 
Institutions 
University of Sheffield 
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Abstract 
Problem 
People with a serious mental illness (SMI- 
schizophrenia, bipolar disorder, related psychoses) 
experience premature multi-morbidity and mortality. 
Research suggests systemic barriers to access and 
overshadowing by the SMI of physical health needs 
contribute to health inequalities. Compared to the 
general population, people with a SMI have a 
significantly higher prevalence of COPD and Asthma. 
In 2014, the  UK ‘Asthma Deaths Report’ found that 
18% of those who died also had mental illness. The UK 
General Practice Quality and Outcomes Framework 
(QOF) incentivises an annual health-check (cardio-
metabolic/ lifestyle risk factors) for patients with a 
SMI, and separate structured primary care reviews for 
people with Asthma and COPD. Our novel research 
aimed to explore the perspectives of patients with 
both a SMI and obstructive airways disease (OAD- 
Asthma or COPD) on access to respiratory care and to 
discuss the implications with stakeholders. 
Approach 
Patients with a SMI and with either co-morbid Asthma 
or COPD were identified by eight practices using QOF 
registers and invited by letter to participate in a 
qualitative interview study. A topic guide was 
informed by a literature review and feedback from 
patient groups (x2) . Semi-structured interviews were 
recorded, transcribed and independently analysed 
(interpretive phenomenological analysis) and 
continued to data saturation in a purposive sample by 
patient and practice setting. Results were fed back to 
a stakeholder group of 18 participants (service users, 
a charitable service provider, a social prescriber, GPs, 
nurses, commissioners, researchers) and implications 
discussed using real-time infographics. 
Findings 
We interviewed 16 people (seven male, nine female, 
aged 45-75yrs). The majority lived alone, (10/16), had 
left school with no formal qualifications (12/16), were 
unemployed/ retired (15/16) and were current (6/16) 
or ex-smokers (6/16). Participants described 
significant disability and poor access to routine 
primary care. Social capital determined ease of access. 
Self-management was challenged by poor health 
literacy and poverty. Smoking cessation was perceived 
as impossible without psychological support. Service 
level factors could facilitate access to timely primary 
care and also continuity. However, there was a lack of 
proactive self-management and over-reliance on 
urgent care if service factors were lacking. Physical-
mental multimorbidity led to fragmentation of care in 
speciality silos.The stakeholder group expressed 
similar concerns and in addition, ‘fear of loss of 
benefits’ and the 'insecure funding of community 
organisations'. Potential solutions focused on 
adequate resources, supported navigation of complex 
care pathways, relational continuity, individual and 
community asset-building and the evolving ‘social 
prescriber’ role. 
Consequences 
This study suggests that despite UK guidelines and 
incentives to optimise physical healthcare, primary 
care fails to consistently deliver integrated 
biopsychosocial care for patients with SMI and OAD. 
Collaborative, personalised care which builds social 
capital and tailors support for self-management is 
needed, alongside enhanced access to primary care 
for patients with SMI and OAD. 
Funding Acknowledgement 
Patient recruitment was supported by adoption of the 
study by  the Deep End  Yorkshire and Humber NIHR 
Clinical Cluster Research  Network (CRN) and the 
Sheffield-Ten NIHR CRN  A Grant from the Clare Wand 
Fund (BMA) supported project costs Researcher time 
was part-funded by the NIHR CLAHRC Yorkshire and 
Humber. www.clahrc-yh.nihr.ac.uk.  The views 
expressed are those of the author(s), and not 
necessarily those of the NIHR or the Department of 
Health and Social Care 
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B.1 
Differences in family carer’s awareness of dementia 
caring support between Scotland and Japan 
Presenter: Daiki Ando 
Authors:  Mina Suematsu(1), Noriyuki Takahashi(1), 
Kentaro Okazaki(1), Etsuko Fuchita(2), Manako 
Hanya(3), Keiko Abe(4), Yusuke Suzuki(5), Masafumi 
Kuzuya(1), Morag McFadyen(6), Sundari Joseph(7), 
Lesley Diack(6) 
Institutions 
1) Nagoya University Graduate School of Medicine, 
Japan,  
2) Nagoya University School of Health Science, Japan, 
3) Department of Pharmacy, Meijo University, Japan, 
4) Critical Care Nursing, Aichi Medical University, 
Japan,  
5) Center for Community Liaison and Patient 
Consulations, Nagoya University Hospital,  
6) School of Pharmacy Sciences, Robert Gordon 
University, Aberdeen, UK,  
7) Learning and Deve 
Abstract 
Problem 
Family carers suffer from their caring burden, 
especially in dementia care. In Japan, family carers 
tend to shoulder most of the caring burden because 
of cultural norms, such as the expectation of providing 
family care at home. Although the Japanese 
government established new strategies to provide 
support for both people with dementia and family 
carers, the burden on family carers has been 
increasing because of shortened length of hospital 
stays and promotion of home caring. Like Japan, 
Scotland is also an ageing society, and it supports 
family carers for people with dementia as a national 
strategy. Although care for dementia has been 
adequately provided and become widespread 
according to the national strategy, there has been 
little research on family carers’ recognition of 
available caring support.This study aimed to clarify 
how family carers for people with dementia at home 
perceive caring support in Scotland and Japan. 
Approach 
This was a qualitative study which interviewed the key 
family carers in dementia home-caring environments 
in Scotland and Japan. Participants were recruited 
through convenience purposive sampling. We asked 
family carers how they felt about dementia care and 
the formal and informal care they received. The 
transcripts were analysed using ‘Steps for Coding and 
Theorisation’, a qualitative data analysis method. This 
study was approved by the Ethics Committee of 
Nagoya University School of Medicine. 
Findings 
Common perceptions of family carers for dementia in 
Scotland and Japan were 1) difficulty accepting 
dementia, 2) feeling a caring burden due to difficult 
dementia care, 3) hope for escaping from the caring 
responsibility and 4) interrole conflict among family 
carers. Family carers’ perceptions of each support 
were different and categorized into 3 types of 
providers: 1) subcarers, 2) community and 3) 
providers of care supports. In Scotland, support from 
the subcarers decreased the burden on the main 
carers because care roles were equal, clearly divided 
and cooperative. Family carers assumed a ‘Let it be’ 
attitude in announcing the dementia to the 
community, and they were satisfied with and trusted 
the providers of care support. In Japan, there was a 
difference in the awareness of dementia care among 
the family members because the care roles were 
ambiguous, sometimes uncooperative and unequal. 
Family carers were reluctant to let their community 
know about the dementia, and there was insufficient 
support for main carers from providers of care 
supports. 
Consequences 
Compared with Scotland, Japanese family carers are 
more frequently isolated. Thus, they tend to disclose 
their care experience to groups with similar care 
experience and peer support is more effective. It is 
expected that the comparison of two diverse 
countries’ awareness about dementia caring support 
can inform the development of quality dementia care 
worldwide. 
Funding Acknowledgement 
Grant-in-Aid for Scientific Research(C) Funded from 
JSPS (Japan Society for Promotion for Science) 2018  
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B.2 
Managing older people’s perceptions of alcohol-
related risk in primary care: Qualitative exploration   
Presenter: Bethany Bareham 
Co-authors:  Professor Eileen Kaner, Professor Barbara 
Hanratty 
Institutions 
Newcastle Univesity Population Health Sciences 
Institute 
Abstract 
Problem 
Risks of harm from drinking increase with age, as 
alcohol affects health conditions and medications that 
are common in later life. Different types of 
information and experiences affect older people’s 
perceptions of effects of alcohol on their bodies, 
which must be navigated when supporting healthier 
decisions for drinking. This study aimed to explore 
how older people understand effects of alcohol on 
their health; and how these perspectives are 
navigated in supportive discussions in primary care to 
promote healthier alcohol use.  
Approach 
A qualitative study was conducted, consisting of semi-
structured interviews and focus groups with older 
(≥65 years) non-dependent drinkers and primary care 
practitioners in Northern England. Twenty-four older 
adults and 35 primary care practitioners participated 
in interviews and focus groups. Data were analysed 
thematically, applying principles of constant 
comparison.  
Findings 
Older adults were motivated to make changes to their 
alcohol use when they experienced symptoms, and if 
they felt that limiting consumption would enable 
them to maintain their quality of life. The results of 
alcohol-related screening were useful to provide 
insights into the potential effects for individuals. 
Primary care practitioners motivated older people to 
make healthier decisions by highlighting individual 
risks of drinking, and potential gains of limiting intake.  
 
Consequences 
Later life is a time when older people may be open to 
making changes to their alcohol use, particularly when 
suggested by practitioners. Older people can struggle 
to recognise potential risks, or perceive little gain in 
acting upon perceived risks. Such perceptions may be 
challenging to navigate in supportive discussions.  
Funding Acknowledgement 
This study/project is funded by the National Institute 
for Health Research (NIHR) School for Primary Care 
Research (project reference BH152196).  The views 
expressed are those of the author(s) and not 
necessarily those of the NIHR or the Department of 
Health and Social Care. 
 
B.3 
Development and feasibility testing of a new person 
centred care intervention ‘VOLITION’: an 
Intervention Mapping approach.   
Presenter: Jo Butterworth 
Co-authors:  Professor Suzanne Richards (1), Dr Emma 
Pitchforth, Professor John Campbell 
Institutions 
University of Exeter Medical School,  
(1)University of Leeds Faculty of Medicine and Health 
Abstract 
Problem 
The population is ageing and two thirds of those in the 
UK have multimorbidity. These patients consult 
frequently and live with a heavy burden of illness, 
associated with poor quality of life and increased 
mortality, along with a high treatment burden and 
associated healthcare costs. Ensuring the provision of 
high quality person-centred care for these patients 
poses a real challenge for primary care clinicians, 
researchers and policy-makers alike. There are few 
existing interventions in this emerging field.Recently, 
the potential benefits to older patients with 
multimorbidity, from participating in decision-making 
about their healthcare, have been acknowledged in 
UK health policy. The aim of VOLITION is to facilitate 
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the involvement of older people with multimorbidity 
in decision-making about their healthcare during 
general practice consultations.  
Approach 
An Intervention Mapping (IM) framework was 
followed as a means of systematically applying 
existing literature, new data and relevant theory to six 
iterative steps in the development, refinement and 
feasibility testing of VOLITION. Patient and public 
involvement (PPI) was central. We also sought expert 
stakeholder opinion e.g. through the international 
symposium on multimorbidity and the RCGP’s 
Network of Champions for patient centred care. We 
published a Cochrane systematic review of similar 
interventions. A qualitative focus group study 
validated our proposed ‘performance’ and ‘change’ 
objectives e.g. by asking patients whether objectives 
matched their preferences for GP consultations, and 
asking GPs how they might perform changed 
behaviours.  VOLITION is to be feasibility tested, with 
process evaluation, in March-July 2020. The feasibility 
trial was designed using IM and integrates 
implementation theory, stakeholder opinion and 
existing literature.  
Findings 
Whilst patient involvement is advocated by experts 
and recent guidelines on multimorbidity, few studies 
exist that evaluate interventions to facilitate the 
involvement of older patients with multimorbidity in 
primary care. Additionally, potential barriers are 
perceived by GPs and patients when considering 
patient involvement in this context.Our IM approach 
to development ensured that VOLITION took into 
account all of the above. VOLITION consists of a 
handout to prompt patients to express their 
preference for involvement; and a GP training 
workshop in shared decision-making, tackling the 
perceived challenges of applying these skills when 
consulting with this patient group.  
Consequences 
VOLITION adheres to core components of NHS 
England’s current universal personalised care plan; to 
empower patients in the management of their own 
healthcare and to train more clinicians in patient-
centred skills. The stakeholder involvement, 
established through our IM approach, provides a 
platform for dissemination of our findings. A full, 
definitive trial of VOLITION is planned. An effective 
intervention in this area, designed and refined using 
end-user perspectives, has the potential to influence 
policy makers as well as clinicians towards ensuring 
high quality patient-centred care for older people with 
multimorbidity. 
Funding Acknowledgement 
National Institute for Health Research (NIHR) Doctoral 
Research Fellowship 
 
B.4 
Does method of frailty measurement affect 
prevalence or associations with health-related 
outcomes in those affected by stroke?   
Presenter: Katie Gallacher 
Co-authors:  Peter Hanlon, Terry Quinn, Jenni K 
Burton, Frances S Mair 
Institutions 
Institute of Health and Wellbeing, University of 
Glasgow  
Institute of Cardiovascular and Medical Sciences, 
University of Glasgow 
Abstract 
Problem 
There has been recent interest in the measurement of 
frailty to enable identification of those at risk of 
adverse health-related outcomes.  There is a scarcity 
of research on frailty after stroke, with no consensus 
on method of measurement. This study aims to 
examine the prevalence of frailty in stroke survivors 
and associations with health-related outcomes using 
differing methods of measurement.  
Approach 
A pooled cohort was created of participants with self-
reported stroke aged >50 years from three datasets: 
the USA Health and Retirement Survey (HRS), the 
Survey for Health, Ageing and Retirement in Europe 
(SHARE) and the English Longitudinal Study of Ageing 
(ELSA). Frailty was assessed at baseline using: 1) frailty 
phenotype (low grip strength, unintentional weight 
loss, slow walking speed, exhaustion, low physical 
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activity; 1-2 = pre-frail, 3 or more = frail); 2) the frailty 
index (a cumulative total of age-related deficits, 
divided by the total number of possible deficits; <0.12 
= robust , 0.12-0.24 = mild, 0.24-0.36 = moderate, 
>0.36 = severe frailty); 3) the frailty index with an 
additional six cognitive measures (e.g. immediate and 
delayed recall, naming current date). Outcomes were 
assessed at the first data collection point following 
baseline (approximately 2 years follow-up) and 
included mortality/hospital admission in the 
preceding 2 years, and recurrent stroke. Logistic 
regression models were adjusted for age and sex.  
Findings 
Pooled cohort data included 12,422 participants with 
stroke (HRS: n=3164; SHARE: n=8179; ELSA: n=1079). 
Mean age (sd): 71.9 (10.8), 50.4% female. Frailty 
phenotype: robust 1925 (28.8%); pre-frail 3406 
(50.9%); frail 1355 (20.3%). Frailty index without 
cognitive variables: robust 1454 (13.7%), mild 3049 
(28.7%), moderate 2352 (22.2%), severe 3758 (35.4%). 
Frailty index with cognitive variables: robust 1447 
(14.6%); mild 3107 (31.3%); moderate 2064 (20.8%); 
severe 3320 (33.4%). When measuring frailty with the 
frailty index (without cognitive measures), stroke 
survivors with moderate frailty had nearly triple the 
mortality risk compared to those who were robust (RR 
2.80; CI 1.9-4.2) and stroke survivors with severe 
frailty had six times the mortality risk (6.2;4.4-9.1). 
Compared to robust stroke survivors, risk of hospital 
admission was double in the moderate frailty group 
(2.3;1.9-2.9) and triple in the severe frailty group (3.1; 
2.52-3.84). There were no associations found between 
frailty and recurrent stroke, even when comparing 
those with severe frailty to those who were robust 
(0.9; 0.66-1.24). Results for health-related outcomes 
were similar when using all three methods of frailty 
measurement. ConsequencesUse of the frailty index 
found a higher prevalence of post-stroke frailty than 
the frailty phenotype, however adding cognitive 
variables to the frailty index did not alter findings. All 
measurements gave similar results when examining 
frailty and health-related outcomes. Building an 
international consensus and harmonising measures 
across registries/trials would facilitate future 
comparative research.  
Funding Acknowledgement 
The Stroke Association TSA LECT 2017/01, MRC 
Clinical Research Training Fellowship 
B.5 
Would legislating through  a Human Rights Lens 
promote a fair and effective long term care system?   
Presenter: Louisa Harding-Edgar 
Co-authors:  Allyson Pollock, Luke Clements, Julie 
Froud, Barbara Hanratty, Charlene Harrington, Katie 
Boyle 
Institutions 
University of Glasgow, Newcastle University, 
University of Leeds, University of Manchester, 
University of California, University of Stirling 
Abstract 
Problem 
The system for long term care in England is 
inequitable and unfit for purpose. Long term care 
charging is a complex, confusing and fragmented mix 
of funding streams, with various statutory bodies 
commissioning services from multiple providers. This 
analysis piece aims to explore the flaws in the current 
long term care system and also examines whether 
legislating for a ‘human right to health’ would 
promote the development of a fair and effective long 
term care system.  
Approach 
This analysis describes the history of long term care in 
the UK, then examines data from a number of reports 
including from the Office of National Statistics, 
National Audit Office, Care Quality Commission, 
Department for Work and Pensions and the Kings 
Fund, using this to identify problems in the current 
system. We especially scrutinised data related to 
funding, workforce factors and quality of care. 
Research from the US was also included to show the 
effects of marketisation on long term care.  
Findings 
An examination of the history of long term care in the 
UK shows how gradual divergence from the NHS led 
to the current, fragmented system. The extent of 
market involvement and privatisation in today’s 
system and inadequate funding and poor working 
conditions have clearly had a negative effect. As local 
authority funding has fallen from 2010 to 2017, the 
workforce has continued to shift away from local 
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authority jobs toward independent sector jobs. 
Reduced funding has been accompanied by tightening 
of eligibility criteria for long term care, delays in 
assessing eligibility and inconsistent and inequitable 
application of criteria. 24% of the workforce is on zero 
hour contracts, with many paid the National Living 
Wage or less. Data on quality of care is scarce, with 
little information available about the quality of 
accommodation or the extent to which needs are 
met.  
Consequences 
Our findings suggest that a human rights approach 
could counter many of the problems we have 
identified in the current long term care system. A 
national strategy for long term care would be 
required, devised through a participatory and 
transparent process, giving particular attention to 
vulnerable groups. The legally mandated system 
would integrate funding and require the creation of 
unified statutory bodies with clear duties to avoid 
unnecessary fragmentation. Data collection would be 
routine to ensure accountability and transparency. 
This approach would lead to the reorientation of 
services away from the profit driven market towards 
participator model consistent with progressive human 
rights obligations. It would also make regression in 
funding and delivery of services challengeable in the 
courts.  
 
B.6 
Development of a framework to support the design 
and evaluation of Pharmacist led medicines 
optimisation in Care Homes – a local validation   
Presenter: Dr Andrea Hilton 
Co-authors:  Ian Maidment, Nichola Seare, Hemant 
Patel 
Institutions 
University of Hull, Aston University, Wolverhampton 
CCG 
 
 
 
Abstract 
Problem 
Older people are the major users of medication. In the 
last 20 years there has been a dramatic increase in the 
prevalence of polypharmacy with the number of older 
people taking five or more medicines increasing from 
12% to nearly 50%. Medicines optimisation is thus 
challenging in older people and can be particularly 
challenging in older people in Care Homes where 
there is a high prevalence of 
dementia.Wolverhampton CCG has been supporting 
medicines optimisation in Care Homes for a number 
of years via a series of initiatives all of which aim to 
reduce the problems associated with inappropriate 
polypharmacy, reducing medication errors, adverse 
drug interactions, difficulty in taking medications as 
directed and supporting medicines management 
within care homes.The aim of this service evaluation 
project was to develop a framework to support the 
design and evaluation of Pharmacist led medicines 
optimisation in Care Homes.  
Approach 
The framework, for pharmacist-led medicines 
optimisation, was developed in a four-stage process: 
Stage 1: Establishment of a Core Project Team and a 
Consultative GroupN= 11 (local clinicians (doctors, 
pharmacists/pharmacy technicians, nurses) and a care 
home manager) to support evaluation of the 
framework during its development 
Stage 2: Development of a first draft of the 
frameworkKey elements for the framework were 
developed by the Core Team (AH, NS, IM) from 
current literature, previous research and service 
evaluations undertaken by the CCG and Aston 
University. Several iterations were developed  
Stage 3: Evaluation of the first draft of the framework 
by the Consultative GroupThe Consultative Group 
evaluated every element of the draft framework 
providing quantitative data and free-text qualitative 
comments. Elements of the framework were rated 
using a six-point scale of (5) Essential (4) Highly 
recommended, (3) Recommended (2) Desirable, (1) 
Desirable if possible (0) Remove.  
Stage 4: Analysis of the data from the evaluation by 
the Consultative Group  
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Findings 
Elements with a mean rating of two or less (N = 12) 
were reviewed by the Core Team. Along with the 
qualitative comments. Qualitative comments on the 
framework were analysed. Key amendments were 
made: Using full Primary Care record rather than a 
summaryRemoval of any duplication notificationsTo 
include information on vital physical signs and other 
clinical assessmentsFurther to this, other general 
themes included the need to involve A) GP’s B) care 
home staff C) residents/family carers at key stages  
Consequences 
We have evaluated/validated a local framework to 
support a pharmacist led model for medicines 
optimisation in care homes.  The next steps include 
validating the framework to reflect different models 
across the UK with a national survey of health 
professionals and a qualitative study investigating the 
engagement of residents and family carers.  
Funding Acknowledgement 
Wolverhampton CCG 
 
B.7 
Challenges for rural primary care teams in providing 
care for patients with dementia   
Presenter: Lucy Hodkinson 
Co-authors:  Dr Nigel Hart, Dr Bernadette McGuinness 
Institutions 
Queen's University Belast 
Abstract 
Problem 
Concerns about managing the healthcare needs of an 
aging population are growing. Predictions shows the 
number of people over 65 years old will grow by 
around 7% by 2025. With more people living longer 
there is a higher prevalence of chronic diseases. 
Significant amongst these related to dementia and its 
impact on the individual, caregivers and healthcare 
system.  Currently 850,000 people in the UK have 
dementia with this expected to grow by 140% by 
2050. Health and socialcare expenditure on people 
with dementia is expected to double within 20 years. 
Over the next decade the rural population is set to 
increase by 6 percent- with an upwards trend in 
deurbinsation- people moving from urban areas to the 
countryside as they get older. This will lead to an 
increase in elderly people in rural areas, and an 
increase therefore in chronic conditions such as 
dementia.  Challenges of rural healthcare include 
distance to services, isolation, lack of internet/phone 
connectivity. These compounded with a diagnosis of 
dementia can result in a negative quality of life. Often 
the first point of contact for these patients, who could 
be living alone with no support, is their General 
Practitioner and Primary Healthcare Team. 
(PCT)General literature review suggests that some 
work has been done looking at challenges for carers of 
patients with dementia in rural areas but little 
specifically looking at the challenegs facing the 
multidisciplinary PCT.  
Approach 
The aim of this study is to identify the challenges, for 
the rural primary care team in providing care for 
patients with dementia and to identify ways in which 
care might be improved. 1. To identify challenges for 
the rural PCT in providing care for patients with 
dementia 2. To establish degrees of concordance and 
difference of challenges faced by rural PCTs providing 
care for patients with dementia in Northern Ireland 
and that revealed in the literature  3. To identify ways 
in which the rural PCT could improve care for patients 
with dementia  
Findings 
I have carried out a scoping review with the question - 
what is known about the challenges for rural primary 
care teams in providing care for patients with 
dementia. Results of this have shown a small number 
of studies mainly based in the USA and Australia. The 
challenges of geography, distance and access to 
specialist services, lack of community resources, 
stigma and lack of training for rural physicians were 
amongst the main findings. More detailed findings 
would be presented at the conference if successful.I 
am in the process of conducting focus groups in rural 
Northern Ireland. Results of these would be presented 
at the conference.  
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Consequences 
I feel the findings will be pivotal in addressing future 
healthcare needs for patients with dementia living in 
rural and remote areas of northern Ireland and 
further afield.  
 
B.8 
Exploring GPs’ experience of difficult decisions in 
dementia patients with an acute illness   
Presenter: Samuel Lassa 
Co-authors:  Chris Burton, Jon M Dickson 
Institutions 
University of Sheffield 
Abstract 
Problem 
Dementia is a brain disease which causes disturbance 
in higher cortical functions such as learning capacity, 
memory, thinking, orientation, comprehension, 
calculation, language and judgement leading to a 
decline in their cognitive function which affects their 
social and occupational functioning, hence impairing 
their independent functioning. Although dementia is 
not, in itself an acute medical condition, it accounts 
for a large number of emergency hospital admission in 
older persons with a majority of these patients 
referred to hospital from home with acute illnesses 
such as respiratory and urinary tract infections. These 
account for 42% of all unplanned hospital admissions 
and recent studies show that acute hospital care is 
often not the most appropriate place for people with 
dementia and acute illness. In primary care there are 
guidelines for most health conditions but most 
guidelines do not give GPs enough guidance on how 
to make decisions for dementia patients with co-
morbidities or acute illnesses. As GP assessment and 
admission is one of the pathways to acute hospital 
care, it is important to understand how GPs make 
decisions about acute care for people with dementia 
and intercurrent acute illness. This study aims to 
understand how these decisions are made, between 
GP, patient, family and carers and other health & 
social care providers in the presence or absence of 
advanced care plans.  
Approach 
This study will be a qualitative study carried out in a 
community setting, conducting approximately 15 
semi-structured interviews with GPs who have 
managed dementia patients with acute illnesses. Our 
sample will be aimed at GPs who are experienced in 
caring for dementia patients who have acute illness 
including at home and in social care and both in and 
out of normal working hours. This diverse sample of in 
hours GPs and Out of hours GPs will facilitate a 
comparative analysis during data synthesis. The study 
will frame the analysis within a model of micro-politics 
– in which actions about a specific issue arise from 
discussion and negotiation between different agents 
during which trade-offs and compromises may be 
made in search of a solution. In this case the focus of 
the micro-politics will be decisions between GP, 
patient, family and carers and other health and social 
care providers about the management of acute illness 
in a person with dementia.  
Findings 
Results of this study will give more insight into 
Continuity of care (in hours service) versus 
Transactional care (Out of hours service) as it relates 
to dementia care in acute situations and the barriers 
GPs overcome when while making decisions for 
dementia patients in shared-care.  
Consequences 
Understanding more about decision making for 
dementia patients has implications for both equitable 
care for patients and helps to inform interventions 
and policies to optimise acute illness care for people 
with dementia.  
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B.9 
What is the role of primary care in reducing the 
decline in physical function and physical activity in 
people with long-term conditions? Findings from a 
realist evidence synthesis with intervention co-
design.   
Presenter: Rebecca-Jane Law or Nefyn Williams 
Co-authors:  Rebecca-Jane Law, Joe Langley, Chris 
Burton, Beth Hall, Julia Hiscock, Lynne Williams, Val 
Morrison, Andrew Lemmey, Jennifer Cooney, Rebecca 
Partridge, John Gallanders, Candida Lovell-Smith, 
Nefyn Williams 
Institutions 
Bangor University, University of Liverpool, Sheffield 
Hallam University, Canterbury Christchurch University, 
Public Involvement 
Abstract 
Problem 
Approximately 25% of people with one long-term 
condition report ‘problems performing usual 
activities’, rising to over 60% with three or more long-
term conditions. As people age and accumulate more 
long-term conditions, physical activity typically 
declines, contributing further to disability and reduced 
independence. Primary care is well placed to 
empower individuals and communities to address this 
problem; however, the best approach is uncertain. 
This study aims to develop a primary care intervention 
to promote physical activity and physical function for 
people with long-term conditions.  
Approach 
A realist synthesis was conducted, incorporating 
systematic and purposive searches of relevant 
literature, two theory-building workshops (n=25) and 
ten theory-refining interviews with stakeholders. The 
emerging evidence-based programme theories 
informed three co-design workshops (n=23) and a 
knowledge mobilisation event (n=14) to develop a 
primary care service innovation.  
Findings 
Five context (C), mechanism (M), and outcome (O) 
statements were developed: 
1. Primary care settings are characterised by 
competing demands, and improving physical activity 
and physical function is not prioritised in a busy 
practice (C). If the practice team culture is aligned to 
promote and support the elements of physical literacy 
(M), then physical activity promotion will become 
more routine and embedded in usual care (O).    
2. Physical activity promotion in primary care is 
inconsistent and uncoordinated (C). If specific 
resources are allocated to physical activity promotion 
(in combination with an aligned practice culture) (M), 
then this will improve opportunities to change 
behaviour (O). 
3. People with long-term conditions have 
varying levels of physical function and physical 
activity, different attitudes to physical activity and 
differing access to local resources that enable physical 
activity (C). If physical activity promotion is adapted to 
individual needs, priorities and preferences, and 
considers local resource availability (M), then this will 
facilitate a sustained improvement in physical activity 
(O). 
4. Many primary care practice staff have a lack 
of knowledge and confidence to promote physical 
activity (C). If staff develop an improved sense of 
capability through education and training (M), then 
they will increase their engagement in physical activity 
promotion (O). 
5. There have been many initiatives to 
encourage physical activity with varying degrees of 
success (C). If a programme is credible to patients and 
professionals, trust and confidence in the programme 
will develop (M) and more patients and professionals 
engage with the programme (O).A prototype 
intervention has been co-designed, embodying the 
emerging programme theories and developing 
resources to promote physical activity and physical 
function for people with long-term conditions.  
Consequences 
This work addresses the need to determine ways of 
promoting physical activity that can improve health 
and independence for people with long-term 
conditions, and are adaptable to varying and 
pressurised primary care contexts. A future research 
programme will develop further the intervention 
elements and assess acceptability.  
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Funding Acknowledgement 
This project is funded by the National Institute for 
Health Research (NIHR) Health Services and Delivery 
Research programme (17/45/22). The views 
expressed are those of the author(s) and not 
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B.10 
Treatment access and self-management support for 
migraine in primary care: development of a 
feasibility study proposal for group consultations   
Presenter: Anne-Marie Logan 
Co-authors:  Nan Greenwood, Mark Edwards 
Institutions 
St George's University of London, Faculty of Health, 
Social Care and Education and St George's University 
of London and Kingston University 
Abstract 
ProblemMigraine is ranked as the most disabling 
health condition under the age of 50 years, affecting 1 
in 7 people. Access to effective treatment of episodic 
migraine (EM) in primary care is important as 
inadequate acute treatment is a predictor of chronic 
migraine (CM).  Emergency hospital admissions for 
headache have increased by 15% in England since 
2012/2013 despite recommendations that migraine is 
treated in primary care.  Waiting lists for neurology 
continue to grow. Group self-management 
interventions have been shown to be effective in 
patients with CM but the evidence in EM is less clear. 
This project aimed to identify patients’ priorities for 
research through patient and public involvement 
(PPI).  
Approach 
One to one discussions with migraine patients were 
held in a specialist headache clinic and a national 
migraine charity clinic. A discussion framework, 
developed previously with patients, guided 
discussions about patient and healthcare provider 
roles. Handwritten transcripts were typed by the 
author and analysed using an inductive approach to 
identify codes and these codes were grouped into 
themes. The themes then informed development of 
an online social media survey which asked patients to 
rate the importance of different types, providers and 
locations of support.  The survey was publicised by 
national migraine charities through Twitter and 
Facebook after piloting. Findings were then discussed 
with the PPI group.  
Findings 
Discussions with 21 consecutive patients from the two 
settings were analysed. Four themes were identified: 
access to care, collaboration, prevention and 
treatment. Patients thought they had an important 
self-management role that centred on migraine attack 
prevention through leading “the right lifestyle”. They 
described what support was needed and was missing. 
Access to care was highlighted in most discussions as 
a problem. Collaboration between patients and 
clinicians was important: "have to use medical side 
and your side together”. The survey, completed by 
221 respondents, rated decision making support, 
education and side effect knowledge as extremely 
important in > 80% of responses.  The majority 
responded that self-management support should be 
provided by the NHS, located in the community and 
provided through group plus one to one support. 
Subsequent discussions with the PPI group have 
identified that evidence is needed as to whether 
group consultations for migraine address the 
problems identified.  
Consequences 
Patients’ identified support for their role along with 
better access to treatment as priorities for research. 
This has led to the development of a feasibility study 
proposal of group consultations for migraine.  The 
expected outcome will be a manualised group 
consultation programme, a process evaluation and co-
creation of video and written resources for use in 
primary care.  
Funding Acknowledgement 
Anne-Marie Logan is funded by a National Institute for 
Health Research (NIHR) Pre-doctoral Clinical Academic 
Fellowship (PCAF) for this research project 
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B.11 
Developing a Culturally Adapted Intervention to 
Improve Cognitive Functioning in British South 
Asians with Dementia: A Protocol   
Presenter: Sarah McMullen 
Co-authors:  Dr Waquas Waheed, Prof Peter Bower 
Institutions 
University of Manchester 
Abstract 
Problem 
The WHO states, ‘Dementia is a global public health 
challenge.’ Non-pharmacological interventions such as 
Cognitive Stimulation Therapy and Reminiscence 
Therapy are recommended by NICE to support 
individuals living with dementia. However the ‘one 
size fits all’ approach does not allow all individuals 
living with dementia to benefit from these 
interventions. The proposed project will be focused 
on the Urdu speaking British South Asian population. 
According to the ONS, Urdu is the fourth most spoken 
language in the UK, with 269,000 Urdu speaking 
individuals in residing in England and Wales.  The aim 
of the project is to select and culturally adapt the 
appropriate treatment (Cognitive Stimulation Therapy 
or Reminiscence Therapy) for Urdu speaking British 
South Asians with dementia using previously 
conducted systematic reviews and qualitative 
methods. 
Approach 
The study will be based on the MRC (2008) guidelines 
on developing and evaluating complex interventions. 
This project will be based on the first phase of the 
MRC guidelines which is the development stage. The 
study is based on qualitative research methods. The 
research methods will include background research 
using previously conducted systematic reviews, focus 
groups, a consensus process meeting and a PPIE 
group. The first step of the project is to conduct 
background research on both therapies. This will 
include systematic reviews on the recommended 
interventions, literature on patient priorities and 
patient preferences. The second step is to conduct a 
focus group. Focus group 1 will aim to select the 
appropriate therapy.  The third step is the cultural 
adaptation of the manual for the appropriate therapy 
using results from the first focus group and 
background research. The fourth step is the consensus 
process meeting and PPIE Group. The aim of the 
meeting is to finalise the changes and solutions for 
the culturally adapted manual. The PPIE group will be 
asked to give their opinion on the activities, format 
and translations of the culturally adapted manual. 
Lastly, another focus group will be conducted that will 
aim to evaluate the appropriateness, deliverability 
and acceptability of the culturally adapted 
intervention for Urdu speaking British South Asians 
with dementia.  
Findings 
Background research has shown that Cognitive 
Stimulation Therapy provides improvement in 
cognition and Reminiscence Therapy provides 
improvement in psychological and behavioural 
symptoms, quality of life and depression.  
Consequences 
There is a need for culturally appropriate and 
acceptable interventions for the ethnic minority 
community in the UK. The top five spoken languages 
in England and Wales are dominated by South Asian 
languages. Important risk factors for dementia such as 
stroke, diabetes, heart disease (including blood 
pressure, hypertension) are more prevalent in the 
South Asian community in comparison with the white 
population. These risk factors increase the 
susceptibility of South Asians developing dementia 
however South Asians have been neglected in 
dementia research.  
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B.12 
GP views on the routine identification and 
management of frailty in primary care   
Presenter: Ebrahim Mulla 
Co-authors:  Elizabeth Orton, Denise Kendrick 
Institutions 
University of Nottingham 
Abstract 
Problem 
The 2017/18 General Medical Services (GMS) contract 
requires primary care providers to use electronic tools 
to risk-stratify for frailty all patients over 65 years of 
age. Those patients flagged as moderately or severely 
frail should be clinically reviewed and if severe frailty 
is confirmed, providers have been asked to offer 
relevant interventions.  These include an annual 
medication review, sharing of the summary care 
record and if applicable referral to a falls prevention 
scheme.  However, little is known about how this is 
being operationalised.  The aim of this study was to 
improve our understanding of the ways in which the 
frailty contractual requirement is being implemented 
in primary care and the barriers and facilitators GPs 
encounter when routinely identifying, risk-stratifying 
and providing interventions for people living with 
frailty in primary care. 
Approach 
This was a 2-part study- a survey via online 
questionnaire to recruit participants, selected by 
maximum variation sampling, for a follow-up semi-
structured telephone interview.  All GPs working in 
the East Midlands region (Derbyshire, Leicestershire, 
Lincolnshire Nottinghamshire, Northamptonshire) 
were eligible to take part.  A written invitation to 
participate in the survey was circulated electronically 
through primary care newsletters and direct GP email.  
The questionnaire and interview schedule were 
developed following a review of the literature, peer-
reviewed by an expert advisory group from NHS 
England’s Older People team and piloted with 8 and 3 
GPs respectively.  The questionnaire collected 
demographic information, responses to a series of 
Likert-type statements assessing GPs' knowledge and 
attitudes and provided an opportunity for the GP to 
volunteer for a follow-up interview.  The interview 
schedule consisted of 3 stem questions exploring 
practice systems to identify patients living with frailty, 
subsequent actions and how it was implemented.  The 
online questionnaire was analysed using descriptive 
statistics.  Interview recordings were transcribed 
verbatim and transcripts were analysed using 
framework analysis.  
Findings 
188 GPs responded to the survey from a possible 
3,058 GPs (response rate 6%) and 18 GPs were 
interviewed.  GPs held mixed attitudes towards 
stratification and pro-active identification of people 
living with frailty, underpinned by a lack of 
understanding about frailty and frailty stratification.  
GPs found an increase in workload from both 
undertaking reviews and uncovering unmet need.  
Many GPs found the usefulness of electronic tools 
hampered by a lack of sensitivity and specificity.  
Consequences 
The study has highlighted a range of factors which 
influence the ability of primary care services to 
proactively identify and manage older people living 
with frailty.  The findings will inform the ongoing 
development of NHS England policy on the GMS frailty 
contractual requirement for primary care providers, 
development of frailty educational interventions for 
primary care healthcare professionals and further 
research about appropriate service configuration.  
Funding Acknowledgement 
RCGP Scientific Foundation Board Practitioners 
Allowance Grant 
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B.13 
Living and dying well with dementia: Investigating a 
Dementia Nurse Specialist role in primary care   
Presenter: Louise Robinson 
Co-authors:  Marie Poole, Emma McLennan, Dorothy 
Coe, Kate Rennie, Louise Robinson on behalf of the 
SEED team 
Institutions 
Newcastle University 
Abstract 
Problem 
Dementia is a leading cause of death in older people 
in the UK. Research shows that people with dementia 
receive poorer end of life care (EOLC) than to those 
with cancer. Supporting Excellence in End of Life Care 
in Dementia (SEED) was a 5-year NIHR-funded 
programme which aimed to support professionals to 
deliver good quality, community-based care towards, 
and at, the EOL for people living with dementia and 
their families.  
Approach 
We drew on existing literature, qualitative research 
and co-design workshops with key stakeholders to 
develop an intervention comprising a primary care 
based, dementia nurse specialist (DNS) and associated 
resources. The DNS provided direct care to people 
with dementia and their families, supported 
professionals and promoted systems change. We 
assessed the feasibility and acceptability of the 
intervention through a pilot study with a cluster 
design. Two GP practices were allocated a DNS for 12 
months, two further practice acted as controls, 
providing usual care. Eligible patients were identified 
using the practice dementia register and a family 
member and, for those in care homes, a key 
informant, were also recruited. Numerical data on 
recruitment and retention and completion of 
outcome measures were supplemented with 
qualitative data on the acceptability of study 
procedures and outcome assessment. Data on 
intervention fidelity and the acceptability of the 
intervention were captured through activity logs, 
observation of intervention delivery and interviews 
with people with dementia, family carers, a broad 
range of health and social care professionals, and the 
DNS. 
Findings 
We achieved our recruitment target of 11 people with 
dementia per practice; although identifying patients 
thought to be approaching end of life was challenging 
and time consuming. Only 12 patients died during the 
study period. The SEED intervention proved feasible 
and acceptable to all stakeholders; key components of 
the role were providing proactive care, continuity and 
co-ordination. Improving the local context for EOLC 
was achieved through development of training for 
care home staff and implementing a template for 
annual dementia reviews. None of our outcome 
measures were suitable as the primary outcome 
measure for a future trial.  
Consequences 
Our DNS intervention was acceptable, feasible and 
integrated well with existing care; importantly it was 
highly valued by all stakeholders. Extending the 
intervention to all people with dementia was widely 
recommended; this offers a possible solution to 
delivering the single, named care co-ordinator role 
recommended in NICE dementia guidance.  
Funding Acknowledgement 
This presentation reports independent research 
funded by the National Institute for Health Research 
(NIHR) under its Programme Grants for Applied 
Research programme (Grant Reference Number RP-
PG-0611-20005). The views expressed are those of the 
authors and not necessarily those of the NHS, the 
NIHR or the Department of Health. 
 
B.14 
Pilot study of a mobile phone app and health coach 
intervention for dementia prevention in socially and 
economically deprived communities in the UK.   
Presenter: Shanu Sadhwani 
Co-authors:  Shanu Sadhwani, Harm van Marwijk, Edo 
Richard, Eric Moll Van Charante, Marieke Hoevenaar-
Blom,  Melanie Hafdi, Esme Eggink and the 
PRODEMOS consortium 
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Institutions 
Brighton and Sussex Medical School, Academic 
Medical Centre Amsterdam 
Abstract 
Problem 
Dementia is a pressing public health concern and the 
burden of NHS care for dementia largely falls within 
primary care. The projected steep rise in global 
dementia prevalence will largely occur in low and 
middle-income countries and vulnerable populations 
in high-income countries. Up to 30% of all dementia is 
attributable to potentially modifiable risk factors. 
Innovative strategies are needed to bridge the gap 
between the theoretical benefits of effective 
dementia risk factor control and what is in fact 
achieved in practice. Mobile Health (mHealth) 
technology allows for scalable and widely 
implementable prevention programs using self-
management for improvement of dementia risk 
factors such as smoking, diet and physical activity.  
Approach 
Here, we report a pilot study of a mobile phone 
application enabling goal-setting and behaviour 
change, and supported by a health coach. We 
included 20 participants aged 55-75, who had two 
CVD risk factors, lived in economically deprived areas 
in Sussex, and who were recruited through two 
general practices. We assessed the success of our 
methods and procedures for: recruiting participants, 
screening them for eligibility, installing the app on 
their mobile phones, randomising them, and starting 
the health coaching both face to face and through the 
app. Participants were followed up for 8 weeks. 
Participants were invited to a focus group to give 
feedback on the app and the study procedures.  
Findings 
Participants were invited to participate using a 
mailshot sent out from their GP surgery, only 3% of 
invited participants responded. A text-message 
follow-up was effective at reminding potential 
participants to call the study team. Many participants 
needed support in installing the app on their phones 
as well as ongoing technical support throughout the 
pilot. We identified that robust tracking systems 
needed to be in place to support participants through 
the study protocol. GP sites and health coaches 
needed study specific training and ongoing technical 
support. Focus groups found that participants are 
keen to reduce their risk of dementia, and like the 
concept of doing this through technology.  
Consequences 
Rolling out mobile phone technologies for dementia 
prevention in economically deprived and older 
populations comes with a host of challenges. 
Following lower than expected recruitment, our 
participants liked the idea of the app, but we found 
delivering an m-Health intervention required 
significant and ongoing technical support and robust 
resources for participants and staff involved. Although 
some clinical time could be saved using m-Health 
interventions, significant time was required from 
technical staff in order to support both patients and 
health coaches for the duration of the pilot. Learning 
from the pilot will inform the roll out of our large 
randomised controlled trial on the efficacy of the app, 
which will start later this year.  
 
Funding Acknowledgement 
This project has received funding from the European 
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B.15 
A psychosocial intervention for older adults with 
depression and multiple long-term conditions: 
Development utilising qualitative and co-design 
methods.   
Presenter: Dr Claire Sloan 
Co-authors:  Claire Sloan(2), Dean McMillan(2), David 
Ekers(1&2), Della Bailey(2), Elizabeth Littlewood(2), 
Suzanne Crosland(2), Eloise Ryde(1&2), Andrew 
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Institutions 
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Abstract 
Problem 
Long-term conditions (LTCs) are prevalent amongst 
older adults: 60% of people aged 70-79 years and 70% 
of people aged 80+ years report one or more LTCs. 
Demographic changes mean that LTC management is 
an increasing health priority. Depression is 2 to 3 
times more common in people with LTCs, resulting in 
poorer health outcomes and increased mortality, 
increased treatment costs and a significant 
contribution to health inequalities. The study aimed to 
iteratively develop and refine a psychosocial 
intervention (Behavioural Activation within a 
collaborative care framework) for older adults with 
comorbid depression and LTCs to improve physical 
and psychological functioning.   The effectiveness of 
this intervention will be tested as part of a larger 
programme of research: the Multimorbidity in Older 
Adults with Depression Study (MODS).  
 
 
Approach 
An iterative process of intervention development and 
refinement using interview and co-design methods 
was adopted, following O’Cathain et al’s., (2019) 
recommendations for developing interventions to 
improve health (1 Partnership; 2 Target population-
centred; 3 Theory and evidence-based; and 4 
Implementation-based).  Semi-structured interviews 
were conducted with physical and mental healthcare 
professionals (HCPs), older adults (OAs) who had 
experienced low mood/depression and/or had two or 
more LTCs, and people who provided informal care to 
this OA population (Caregivers, CGs).  Interviews 
explored OAs’ and CGs’ experiences of mental-
physical multimorbidity, access to and experiences of 
care for physical and mental health symptoms, views 
on the proposed intervention; and, for HCPs, 
experiences of providing care for OAs with depression 
and/or LTCs.   Data analysis utilised thematic analysis 
(TA) and Framework Analysis (FWA). Key questions 
generated from data analysis were presented and 
discussed at 3 stakeholder co-design workshops. The 
prototype intervention and OA materials were tested 
with two small samples of OA participants (“case 
series”), who were then interviewed to explore their 
experiences of the intervention.Ethical and regulatory 
approvals were obtained.  
Findings 
Practical features of the intervention, including 
number of sessions, mode of delivery, how to include 
a caregiver, liaison with other HCPs, who should 
deliver the intervention and methods of signposting 
to other services were agreed during the co-design 
process. The co-design workshops also contributed to 
the development of a self-help booklet for OAs which 
included patient diaries, goal setting, and ‘patient 
stories’; which were all further refined following the 
case series. Key features of the intervention, including 
the support worker training programme and 
accompanying intervention manual, were also agreed 
during the co-design process.  
Consequences 
The value of co-design to develop a psychosocial 
intervention which aims to improve the mental and 
physical well-being of OAs with comorbid depression 
and LTCs will be discussed. The intervention is due to 
be tested in a future trial and, if acceptable and 
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effective, can be applied across a range of healthcare 
settings.  
Funding Acknowledgement 
This work presents independent research funded by 
the National Institute for Health Research (NIHR) 
Programme Grants for Applied Research programme 
[RP-PG-0217-20006]. The views expressed in this work 
are those of the author(s) and not necessarily those of 
the NIHR or the Department of Health and Social Care. 
 
B.16 
What are the consequences of caring for older 
people and what interventions work best to promote 
caregivers’ health and wellbeing? A rapid review of 
reviews   
Presenter: Gemma Spiers 
Co-authors:  Jennifer Liddle; Patience Kunonga; 
Sheena Ramsay; Daniel Stow; Orla Whitehead; Claire 
Welsh; Fiona Beyer; Dawn Craig; Barbara Hanratty 
Institutions 
Population & Health Sciences Institute, Newcastle 
University 
Abstract 
Problem 
Approximately 6.5 million adults provide unpaid care 
in England, with risks to their own health, social and 
financial wellbeing.  Supporting unpaid carers of older 
people is a high priority for current policy. To support 
policymaking for this population a clear picture is 
needed, of what is known and where there are gaps in 
the current evidence. A rapid review of systematic 
reviews was undertaken to map current evidence 
about a) the consequences of caring for older people 
and b) effective interventions for this group of 
caregivers.  
Approach 
Searches were conducted in Medline, PsychInfo and 
Epistemonikos (January 2020). Systematic reviews 
published in English after 2000 were included if they 
reported evidence about a) the impact of caregiving 
on carers’ health, social and financial wellbeing, 
and/or b) the effectiveness of caregiver interventions. 
Caregiver populations were those of any age and sex, 
whilst care recipients were older people (as defined in 
the review). Reviews must have met three out of five 
DARE criteria to be considered for inclusion. Titles and 
abstracts were screened: 20% by two researchers 
independently and the remainder by a single 
researcher. Full texts were screened against review 
criteria. Review risk of bias was appraised and a 
narrative synthesis undertaken by a single researcher.  
Findings 
Sixty-nine systematic reviews were eligible for 
inclusion. Fifty-seven of these were specific to 
dementia caregivers. To avoid duplication of existing 
umbrella reviews for this population, the synthesis 
focused on systematic reviews that reported evidence 
about those caring for non-dementia older 
populations (n=12). Systematic reviews about the 
consequences of caregiving (n=6) typically focused on 
carers’ mental health, quality of life and burden. Few 
systematic reviews (n=1) included evidence about the 
impact on carers’ physical health, and none reported 
the social and financial impact of caregiving. There 
was a consensus across systematic reviews that 
caregivers experienced poor mental health, quality of 
life and burden. However, estimates of prevalence 
and severity were either very variable or not reported 
at all.  Limited evidence from these systematic 
reviews also indicated that carers experienced poorer 
mental health compared to that of the general 
population. Six systematic reviews reported evidence 
about interventions to support carers of older people. 
Interventions included respite, psychosocial, 
educational, cognitive and multicomponent.  Evidence 
suggested that respite care, cognitive, and 
educational interventions were not beneficial to 
caregivers. Some psychosocial and multicomponent 
interventions were promising, with positive outcomes 
for carers. However, evidence for these was limited in 
quantity and from reviews with moderate and high 
risk of bias.  
Consequences 
This rapid review of reviews highlights a need for a 
robust synthesis of primary studies focusing on 
physical health, social and financial wellbeing 
outcomes for carers of older people. Further evidence 
is also required to ascertain the benefits of some 
psychosocial and multicomponent interventions.  
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B.17 
Ultrasound-assisted Refill of Continuous Intrathecal 
Drug Delivery System as part of Management of 
Spasticity in the Community   
Presenter: Mostyn Yong 
Co-authors:  Meredith Ogilvie – Brown, Saul Geffen 
Institutions 
Mater Private Hospital Brisbane Rehabilitation Unit 
Brisbane Australia, Rehab + Fitness Brisbane Australia 
Abstract 
Problem 
Management of spasticity with via Baclofen 
Continuous Intrathecal Drug Delivery (CIDD) is a well-
established technique (Saulino 2013, Godeld 2011).  
One component of this therapy is a regular scheduled 
refill of the system’s Baclofen (Bacthecal Medicianz 
Healthcare Pty Limited) reservoir. During this refill 
procedure, it is paramount to have an accurate 
placement of the needle into the drug reservoir to 
aspirate residual contents of the reservoir and refill of 
new Baclofen within the reservoir. We propose 
several advantages of an ultrasound guided refill 
procedure over conventional use of a template for 
this refilling process. Firstly, it would be possible to 
exclude any subcutaneous collections overlying the 
device therefore avoiding the potential to seeding 
unwanted fluid or material in the pump. Secondly, this 
provides the operator a visual appreciation of the port 
access and accurate marking of this site. In addition to 
these, the ultrasound image allows for the altered 
external shape to the device as a result of a mobile 
pocket therefore improving the trajectory of the 
refilling needle. This day-therapy technique has been 
adopted for patients with varied long-term 
neurological conditions such as Stiff Person Syndrome, 
Spastic Cerebral Palsy and Spinal Cord Injury.  
Approach 
With the patient lying supine, the pump residual 
volume along with device details is established with 
the use of a pump interrogator (Medtronic 
SynchroMed II, Minneaopolis, MN).Ultrasonography is 
performed by a suitably experienced operator (SG, 
MO-B) using a portable ultrasound machine (GE 
Healthcare Venue 40 Ultrasound). The injection port 
site is identified as a hypoechoic rectangle structure 
and image centred. This step is followed by gentle 
external skin markings with the use of a sterile 
surgical marker. A sterile field centred on the port site 
is prepared with aqueous chlorhexidine and draped 
with a pre-cut out sterile paper cloth. Sterile gloves 
and strict aseptic technique is maintained throughout 
the procedure. A standard non-coring Huber 22-guage 
needle (Refill Kit, Medtronic, Minneapolis, MN) is 
used. Utilising the external skin markings, the needle 
is placed perpendicular to the plane of the pump and 
gentle pressure applied until a ‘give’ is felt. At this 
stage, the accurate needle placement within the 
pump reservoir is further checked by drawing back on 
the syringe and cross-checking volumes aspirated 
against device data obtained at the start with the 
pump interrogator.  
Findings 
Since the adoption of these technique for CIDD 
Baclofen refilling at this establishment, there has been 
no complications and deemed to be the standard 
operating protocol for this procedure and has proven 
to be reliable.  
Consequences 
With the adoption of these techniques for CIDD 
Baclofen refilling, a more accurate and safer 
procedure can be carried out within an outpatient 
setting. This potentially reduces the rates of 
complications associated with inaccurate needle 
placement and failed filling procedure.  
Funding Acknowledgement 
There are no financial conflicts of interest to disclose 
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C.1 
Guideline discordant diagnostic care: when do 
primary care referrals not reflect guidelines for 
suspected cancer?   
Presenter: Gary Abel 
Co-authors:  Bianca Wiering, Georgios Lyratzopoulos, 
John Campbell, William Hamilton 
Institutions 
University of Exeter Medical School, University College 
London 
Abstract 
Problem 
Survival of patients with cancer in the United Kingdom 
lags behind that of patients in many similar countries 
around the world. A key service aimed at improving 
UK cancer survival rates (through improved diagnostic 
timeliness) is the fast-track referral system known as 
the two-week wait pathway. Guidelines advise 
general practitioners which patients warrant a two-
week wait referral. However, guidelines are only 
effective to the degree that they are implemented. 
This study aims to investigate how often GPs follow 
the guidelines and whether certain types of patients 
are more or less likely to be referred. 
Approach 
We used linked primary care (Clinical Practice 
Research Datalink) and secondary care (Hospital 
Episode Statistics) data. Patients presenting with 
haematuria, rectal bleeding, breast lump, post-
menopausal bleeding, dysphagia or iron-deficiency 
anaemia for the first time during 2014-2015 were 
included (for patients of those ages where NICE 
guidelines recommend two-week wait referral). For 
patients presenting with haematuria, either the 
second or third GP visit was defined as the index 
consultation where patients had received treatment 
for urinary tract infection during earlier visits. A 
composite outcome reflecting whether a two-week 
wait referral or an urgent referral had taken place was 
used since both reflect the need for an urgent clinical 
assessment. Multilevel logistic regression was used to 
investigate whether the referral composite outcome 
was associated with symptoms and patient 
characteristics (age, gender, comorbidities and 
deprivation level). 
Findings 
Considering referrals made within 14 days of first 
presentation with a recorded symptom indicate a high 
percentage of patients do not receive a two-week 
wait or urgent referral, varying from 81.8% (rectal 
bleeding) to 33.3% (breast lump). There is evidence 
that referrals are associated with age (p<0.001), and 
comorbidities (p<0.05), with young patients and 
patients with comorbidities less likely to receive a 
referral. Associations between patient characteristics 
and referrals differ by symptom. More deprived 
patients with breast lumps, female patients with 
haematuria and anaemia patients with multi-
morbidity were less likely to receive a referral. 
Furthermore, early evidence suggests that around 
4.0% of patients not receiving a referral were 
diagnosed with cancer in the next year. 
Consequences   
Actions recommended in authoritative guidelines 
often do not occur for patients presenting with 
common possible cancer symptoms. Appreciating 
those patient groups which are at greater risk of non-
referral when compared with guideline 
recommendations may help target improvement 
efforts in cancer diagnosis in primary care. For 
example, these findings may be used alongside 
schemes such as CRUK’s cancer facilitators and 
Macmillan GPs to directly influence practice. 
Alternatively, they could inform educational materials 
and novel interventions targeting early diagnosis.  
Funding Acknowledgement 
This work was funded by Cancer Research UK 
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Faculty. GL is supported by a Cancer Research UK 
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C.2 
Exploring the feasibility of gathering economic data 
for ThinkCancer!: supporting the early diagnosis of 
cancer in primary care   
Presenter: Bethany F Anthony 
Co-authors:  Bethany F Anthony(1),  Professor Richard 
Neal(2),  Professor Clare Wilkinson(3), Professor 
Rhiannon T Edwards(1),  on behalf of the WICKED 
team 
Institutions 
1) Centre for Health Economics and Medicines 
Evaluation (CHEME), Bangor University,  
2) Leeds Institute of Health Sciences, Leeds 
University,  
3) North Wales Centre for Primary Care 
Research, Bangor University, 
Abstract 
Problem 
Invaluable progress has been made in improving 
cancer outcomes in the UK, with approximately 1 in 2 
patients living with cancer in England and Wales now 
surviving for 10 years or more. Despite this progress, 
cancer survival in the UK continues to be lower 
compared to other Westernised countries including 
Australia, Canada and a number of other European 
countries. Welsh Government outline a number of 
challenges with respect to earlier cancer diagnosis 
including a lack of awareness of ‘red flag’ symptoms 
and difficulties among GPs and other healthcare 
professionals in identifying cancers that present with 
vague or non-specific symptoms. For some cancers, 
earlier diagnosis is associated with greater survival 
and better patient quality of life and experience. The 
aim of this current study was to conduct a feasibility 
economic analysis of the ThinkCancer! intervention to 
improve earlier cancer diagnosis in primary care.  
Approach 
The ThinkCancer! intervention is a complex behaviour 
change intervention, which aims to change the 
behaviours of primary care practice teams, when 
thinking of and acting on clinical symptoms that could 
be cancer. From an NHS perspective, we will conduct 
a feasibility economic analysis of the ThinkCancer! 
intervention. We will use micro-costing to determine 
whether it is feasible to gather sufficient economic 
data to cost the ThinkCancer! intervention. 
Researchers delivering the intervention will complete 
cost diaries, which will include staff costs, travel and 
subsistence costs for delivering the workshops 
throughout Wales, material costs and overheads. In 
order to understand the current evidence base on the 
topic of earlier cancer diagnosis with economic 
elements, we undertook a rapid scoping review of the 
literature.  
Findings 
Scoping searches identified eight published papers. 
Most of the studies identified (n=5) were costing 
studies and did not explore both costs and 
outcome/effects. Three of the studies were screening 
studies that seek to identify unrecognised cancer, 
which differ from studies exploring earlier cancer 
diagnosis that seeks to identify cancer in patients who 
present with symptoms of the disease. Studies (n=5) 
were predominately conducted outside of the UK, 
making comparisons to the NHS difficult. Searches did 
not identify any published feasibility economic 
analyses of interventions to expedite earlier cancer 
diagnosis in primary care.  
Consequences 
Results of this feasibility study will be used to inform a 
future definitive economic evaluation alongside a 
pragmatic randomised controlled trial (RCT). Primary 
care interventions to expedite the diagnosis of 
symptomatic cancer have the potential to reduce 
large costs to the NHS and improve patient and carer 
outcomes; as later stage cancer treatments are often 
longer, more aggressive to patients, with larger 
associated healthcare costs, compared to earlier stage 
treatment.  
Funding Acknowledgement 
Cancer Research Wales 
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C.3 
Can a targeted intervention improve cancer 
symptom awareness and help-seeking among adults 
living in socioeconomically deprived communities? 
The Awareness and Beliefs About Cancer (ABACus) 
randomised controlled trial.   
Presenter: Kate Brain 
Co-authors:  Y Moriarty, P Buckle, P Dimitropoulou, A 
Edwards, S Gilbert, J Hepburn, V Kolovou, M Lau, M 
Matthews, C Mitchell, R Neal, S Owen, L Padgett, R 
Playle, H Quinn-Scoggins, M Robling, B Sewell, S Smits, 
J Townson, R Trubey, F Wood 
Institutions 
Cardiff University School of Medicine, Cardiff 
University Centre for Trials Research, Swansea 
University, University of Leeds, University of Sheffield, 
Tenovus Cancer Care 
Abstract 
Problem 
Cancer outcomes are poor in the UK’s 
socioeconomically deprived communities, with low 
symptom awareness and fatalistic beliefs about 
cancer contributing to prolonged help-seeking and 
advanced stage disease. We conducted the first trial 
of a facilitated cancer awareness intervention 
designed to improve cancer symptom knowledge, 
encourage positive beliefs about early cancer 
detection, and increase motivation to seek help 
among adults living in deprived communities. The 
theory-grounded intervention entails completion of a 
touchscreen questionnaire (cancer symptoms, 
screening, risk factors), with personalised results 
delivered by a trained lay advisor. We report the main 
trial findings for the primary and secondary 
quantitative outcomes. 
Approach 
Adults aged over 40 were recruited opportunistically 
in community and primary healthcare settings in 
socioeconomically deprived areas of Yorkshire and 
South Wales. Participants were randomised in a 1:1 
ratio to the health check intervention or usual care 
control, and completed self-report measures at 
baseline, 2-weeks and 6-months. Cancer symptom 
recognition (primary outcome at 2-weeks, total score 
range 0-12), anticipated symptom presentation, 
barriers to presentation and beliefs about cancer 
were measured using the adapted Awareness and 
Beliefs about Cancer (Simon et al., 2012) at baseline, 
2-weeks and 6-months post randomisation. State 
anxiety was assessed using the short-form State Trait 
Anxiety Inventory (Marteau and Bekker, 1992). 
Intervention effects were tested using multilevel 
linear regression adjusted for baseline score. Health 
economic data (implementation costs and healthcare 
resource use data) were also evaluated.  
Findings 
A total 234 participants were randomised, with high 
retention at 2-weeks (90%) and 6-months (85%). 
Participants were predominantly resident in areas of 
high deprivation (66% in 0-20% most deprived areas). 
There was no significant difference in total symptom 
recognition at 2-weeks [difference 0.57, 95% CI -0.03-
1.17, p=0.06]. Intervention participants reported 
increased symptom recognition (difference 0.78, 95% 
CI 0.18-1.37, p<0.01) and earlier intended 
presentation (difference -1.96, 95% CI -3.02--0.91, 
p<0.001) at 6-months. Baseline ceiling effects in the 
primary outcome were observed across arms 
[intervention baseline mean=8.8, control mean=9.0]. 
Recognition of less well-known cancer symptoms (e.g. 
persistent tiredness, unexplained weight loss) was 
higher in the intervention group [2-weeks p<0.05, 6-
months p<0.01]. Differences in perceived barriers, 
beliefs and state anxiety were not significant. Health 
economic outcomes are currently being analysed.  
Consequences 
The ABACus health check improved recognition of 
potential cancer symptoms, especially those that are 
less well-known, and did not cause unintended harm. 
Symptom knowledge was retained and earlier 
anticipated presentation occurred at longer-term 
follow-up. Effects on perceived barriers and beliefs 
about cancer were not observed, partly due to 
measurement problems. The health check 
intervention has the potential to achieve significant 
public health benefits by encouraging cancer 
symptom awareness and earlier help-seeking in 
deprived communities, especially for vague, common 
cancer symptoms that require expedited routes to 
diagnosis.  
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C.4 
What is the prevalence of incidental findings found 
during lung cancer screening using low dose CT?   
Presenter: Dr Thomas Cassidy 
Co-authors:   
Institutions 
University of York 
Abstract 
Problem 
The NHS plan to expand lung cancer screening using 
low dose computed tomography (LDCT) is likely to 
reduce deaths from lung cancer. However, it remains 
unclear whether incidental findings will have a 
beneficial or detrimental effect upon the screened 
individual. Coronary artery calcification found 
incidentally might be used to stratify cardiovascular 
risk and increase adherence to preventative 
strategies. Extra-pulmonary malignancy found 
incidentally might provide an early life-saving 
diagnosis, while large numbers of false positive 
findings or over-diagnosis may cause anxiety and 
harm through investigation and over-treatment. What 
is the possible effect upon primary and secondary 
care services? It is not clear from the current 
literature how many and what type of incidental 
findings are to be expected from widespread 
screening. This study intends to estimate the 
prevalence and type of incidental findings found 
during LDCT screening for lung cancer using 
systematic review methodology. This subject is 
original, with only a single similar review published in 
2008, and timely due to the planned expansion of 
screening in the 2019 NHS long term plan.  
Approach 
A systematic review of the literature is intended, 
including all primary lung cancer screening studies 
that report sufficiently upon the nature and 
prevalence of the incidental findings found. A full 
protocol is available on PROSPERO. Two reviewers will 
independently screen abstracts, full papers for 
inclusion and quality assess. Data will be extracted 
using an extraction tool by one reviewer and cross 
checked. A narrative synthesis will explore themes 
and heterogeneity. Permitting adequate clinical and 
methodological homogeneity, fixed and random-
effects meta-analysis will be performed to provide 
pooled estimates with corresponding 95% CIs. 
Heterogeneity will be assessed by Cochran’s Q test 
and I2 statistic. Publication bias will be considered 
using a funnel plot. 
Findings 
Interim findings suggest significant heterogeneity in 
the definition of and reporting of incidental findings 
across studies. It is also clear that incidental findings 
are numerous. An aggregate of the prevalence for 
common incidental findings such as coronary artery 
calcification is expected to show these to be highly 
prevalent. The prevalence of findings that require 
further investigation or follow up is expected to be 
around 10-15% of scans (previously estimated as 
14.2%) while the reports of confirmed extra-
pulmonary malignancy is generally less than 1%.  
Consequences 
Estimates of the nature and prevalence of incidental 
findings can be used to council patients undergoing 
screening. They can inform further research, guideline 
development, and policy makers upon the potential 
benefits and challenges incidental findings pose for 
primary and secondary care services. The cost of 
incidental findings has also been omitted from 
economic modelling and estimates can allow for their 
inclusion within prevalence-based economic 
modelling, which might in turn have a significant 
impact upon overall cost-effectiveness of lung cancer 
screening.  
Funding Acknowledgement 
The projects is part of a self funded masters in public 
health, supervised and supported by Professor Rhian 
Gabe and Alison Booth from the University of York. 
The second reviewer is Ann Cochrane from the Clinical 
trials unit at the University of York. 
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C.5 
What are the associations between multimorbidity 
or individual long-term conditions and colorectal 
cancer risk?   
Presenter: Dr Neave Corcoran 
Co-authors:  Dr Bhautesh Jani, Professor Frances Mair 
Institutions 
General Practice & Primary Care, 1 Horselethill Road, 
Glasgow, G12 9LX 
Abstract 
Problem 
Early identification of cancer and specifically 
colorectal cancer (CRC) is a major international focus 
in current primary care. CRC survival is improving and 
early diagnosis has major benefits. Multimorbidity 
(the presence of ≥2 long-term conditions (LTCs)) is 
another growing public health problem but the 
interaction between CRC and multimorbidity is 
complex and poorly-understood.Understanding the 
interplay between multimorbidity and CRC outcomes 
is important to enhance understanding of implications 
for screening or points for future intervention.This 
work explores the relationship between CRC and 
multimorbidity by examining associations between 
multimorbidity and particular LTCs, and CRC incidence 
and mortality. 
Approach 
Prospective population-based study using UK Biobank. 
Demographic characteristics (age/sex/socioeconomic 
status), lifestyle factors (BMI/physical 
activity/smoking/alcohol use), multimorbidity 
(measured by LTC count, of a possible 42) were 
recorded at baseline. Outcomes: CRC diagnosis and 
CRC-specific mortality, determined from linked 
cancer/mortality registry data.Cox regression models 
analysed associations between multimorbidity and 
CRC outcomes, adjusting for demographic/lifestyle 
factors. F-test variable selection modelling identified 
LTCs that were potential significant predictors of CRC 
outcomes. Predictor LTCs were tested for significance 
in fully adjusted Cox regression models.  
 
 
Findings 
The sample included 500,222 participants, aged 37–73 
(mean age 56.5; 54.5% female), recruited between 
2006-10. CRC was diagnosed in 3669 (0.73%) 
participants and 876 (0.18%) died of CRC during 
follow-up (median follow-up duration 7 years). CRC 
incidence increased with age; those aged 60-73 had 
higher CRC incidence (hazard ratio (HR) 5.00, 95% 
confidence interval (CI) 4.36-5.72) and higher CRC 
mortality (HR 4.69 95% CI 3.66-6.02) compared to 
those aged 37-49. Multivariate analysis demonstrated 
male sex (HR 1.43, CI 1.33-1.54), BMI >40 (HR 1.30, CI 
1.02-1.66), previous smoking history (HR 1.21 CI 1.13-
1.30), and higher alcohol intake (HR 1.42, CI 1.26-1.61) 
were significantly associated with CRC incidence. 
Having ≥2 LTCs did not show a statistically significant 
association with CRC incidence. CRC mortality was 
significantly more likely in males (HR 1.62, CI 1.42-
1.86), BMI >40 (HR 1.54, CI 1.05-2.27), ex-smokers (HR 
1.17, CI 1.03-1.34), high alcohol intake (HR 1.54, CI 
1.33-2.03), no physical activity (HR 1.55, CI 1.12-2.13) 
and multimorbidity, HR of 1.71 (CI 1.38-2.12) in 
participants with ≥4 LTCs.F-test logistic regression 
identified hypertension as a potentially significant 
predictor of CRC incidence and diabetes of CRC 
mortality. Adjusted HR for CRC incidence in 
participants with hypertension compared to those 
without was 1.1 (CI 1.03-1.19); for CRC mortality in 
those with diabetes adjusted HR = 1.3 (CI 1.08-1.69) 
compared to those without.  
Consequences 
This work demonstrates higher mortality from CRC in 
those with multimorbidity and identifies hypertension 
as a potential predictor of CRC incidence and diabetes 
of CRC mortality.These results will guide further 
research on relationships between CRC risk, other 
LTCs and multimorbidity that should include exploring 
causative mechanisms and patient perspectives.  
Funding Acknowledgement 
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C.6 
The GLANCE study: Exploring the role, use, and utility 
of General Practitioners’ gut feelings for cancer and 
serious disease in primary care.   
Presenter: Claire Friedemann Smith 
Co-authors:  Jason Oke, Benedikte Moller Kristensen, 
Rikke Sand Andersen, Julie-Ann Moreland, Fergus 
Gleeson, Sue Ziebland, Brian D Nicholson 
Institutions 
University of Oxford 
Abstract 
Problem 
Gut feelings (GFs), often described as a sense of alarm 
or reassurance for a patient’s health are increasingly 
accepted as a component of clinical reasoning in 
primary care. They remain contentious, however, due 
to concerns over their subjectivity and difficulties in 
rationalising, articulating, and incorporating them into 
clinical guidance. Our objective was to summarise the 
literature on GF, explore the views of GPs and patients 
about GF in primary care, and establish their 
diagnostic utility. 
Approach 
GLANCE is a mixed methods study incorporating three 
sub-studies: a systematic review and meta-analysis of 
literature published to July 2019; qualitative 
interviews with 40 GPs and patients who had used an 
urgent referral pathway for non-specific symptoms 
that includes the option to refer based on GP GF; and 
a quantitative analysis assessing the diagnostic utility 
of GPs’ GFs for cancer and serious disease.  
Findings 
Twelve papers and four web resources were included 
in the systematic review. GPs conceptualised GF as 
suspicion that grew out of unease not necessarily 
based on clinical evidence which could lead to 
difficulties acting on them. GFs were often related to 
the patient being “unwell” and rarely experienced in 
the absence of symptoms or non-verbal cues. The 
pooled odds of cancer diagnosis were four times 
higher when GFs were recorded (OR 4.24 (95% CI 2.26 
to 7.94)), and GFs became more predictive with 
increasing clinical experience and familiarity with the 
patient. Results from the interviews suggest GPs and 
patients support the use of GFs in primary care and 
see them as a manifestation of clinician expertise 
combined with patient knowledge. GPs described that 
GFs arise when there is a lack of fit between the 
clinical scenario and the diagnostic ‘box’ that they 
would usually place a similar set of signs and 
symptoms. Patients acknowledged the uncertainty of 
clinical practice in primary care and felt that GFs are 
an important diagnostic tool. When experiencing their 
own GFs, patients made them more ‘doctorable’ by 
focusing on clinical aspects of their ailment rather 
than relying on their own judgement of their illness. 
Quantitative analysis of the diagnostic value of GFs is 
underway and will be complete by the conference.  
Consequences 
This is the first study that has discussed GFs with both 
clinicians and patients, and in which participants have 
either been referred, or made a referral, based on a 
GP's GF. What seems clear is that GFs provide a way 
for patients to be referred who do not meet strict 
referral criteria, perhaps highlighting the limits of the 
evidence base informing current clinical guidance. The 
completion of the quantitative analysis will provide 
further insight into the predictive value of GFs for 
cancer and serious disease in primary care.  
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Abstract 
Problem 
Dementia and cancer are both associated with older 
age. The National Cancer Data Audit in England found 
that 4.4% of people diagnosed with cancer also had 
cognitive impairment. Decisions about cancer 
treatment can be very complex when someone 
already has dementia. Often someone's closest 
relative is asked to make decisions on their behalf. 
Research examining the impact that making life-
altering decisions by proxy has on family carers shows 
that it can be highly distressing. The specific 
experience of proxy decision-making regarding cancer 
treatment for someone with dementia is almost 
wholly unresearched. This study aimed to explore the 
experiences of family carers who have been involved 
in making cancer treatment decisions on behalf of a 
relative with dementia, in particular identifying 
challenges and support needs.  
Approach 
Semi-structured interviews were conducted with adult 
carers of people with dementia who had made 
decisions about cancer treatment on their behalf 
within the last two years. A purposive sampling 
strategy recruited participants via CRN-portfolio GP 
practices and the Join Dementia Research database. 
Two researchers separately undertook analysis on 
Nvivo using an inductive, grounded-theory approach 
to identify themes. A third researcher independently 
verified these themes to provide a rigorous thematic 
framework. 
Findings 
Interviews were conducted with 16 carers (husbands, 
wives, sons, daughters and grandchildren). Cancer 
diagnoses included prostate, breast, bowel, renal, 
melanoma and lung. We identified four main themes. 
TranslatorsDecisions about cancer treatment were 
relatively straightforward for carers. They were 
usually strongly influenced by the medical team who 
gave a clear best option. Carers viewed their role as 
translating a frightening situation for their relative and 
representing their wishes to healthcare professionals. 
Cancer services ill-equipped for people with 
dementiaThe biggest challenge for carers was having 
to navigate healthcare services which are not 
prepared for people with dementia. Poor 
communication, lack of person-centred care and 
inexperienced staff caused carer stress throughout all 
stages of the cancer journey.LPAs hinder, not 
helpLasting Power of Attorney should simplify making 
healthcare decisions on someone’s behalf, but 
medical staff have a poor understanding of the 
authority it grants. It was frequently one of the 
biggest causes of conflict between carers and 
healthcare professionals. Cancer preferable to 
dementiaFor most carers managing the person’s 
dementia remained the biggest challenge and caused 
the most emotional distress. Many viewed their loved 
one’s cancer as a possible escape from dementia.  
Consequences 
Ultimately there remains a huge lack of practical and 
emotional support for dementia carers, who remain 
isolated and exhausted. The addition of serious 
comorbidity in their relative only compounds this and 
makes it worse. Services across the NHS need to be 
better equipped to care for people with dementia. 
Healthcare staff require greater understanding of the 
authority granted by LPA.  
Funding Acknowledgement 
Project funded by RCGP Scientific Foundation Board 
Annual Research Grant 2018 PPI support provided by 
the Alzheimer's Society 
 
C.8 
What chronic diseases are associated with increased 
lung cancer incidence?   
Presenter: Bhautesh Jani 
Co-authors:  Sara Macdonald, Barbara Nicholl, Craig 
Anderson, Frances S Mair 
Institutions 
University of Glasgow 
Abstract 
Problem 
The relationship between chronic diseases and new 
cancer incidence remains unclear. We studied the 
association between existing long-term conditions 
(LTCs) and lung cancer incidence in a general 
population sample using different data science 
methods and explored the validity of a lung cancer 
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incidence prediction model, using information on 
existing LTCs. 
Approach 
Data: We used UK Biobank with a sample size of 
N=502536, aged between 37-73 years. The sample 
size used for analysis N=488085, after excluding 
missing values, participants with previous lung cancer 
and those lost to follow-up.  A comprehensive 
phenotype description was obtained from participants 
at recruitment; including information on 
demographics, lifestyle including smoking 
consumption, family history of lung cancer, previous 
history of cancer (other than lung), and N=42  health 
conditions which included chronic diseases and a 
history of previous lung infections. Record linkage 
with the cancer registry was used to capture lung 
cancer incidence. Statistical Models: Five different 
variable selection methods (Automated likelihood-
ratio- F test-based backward selection, Akaike 
information criterion backward selection, Lasso 
regression, Elastic net regression and Xtreme gradient 
boosting) were used to reduce data dimension and 
select candidate variables from a list of demographic/ 
lifestyle/health conditions as lung cancer risk factors. 
Cox's proportional hazards regression was used to 
build a final lung cancer risk prediction model.  
Findings 
At the end of seven year median follow-up, lung 
cancer incidence was 2541 (0.5%) of total sample. In 
total, N=15 variables including five LTCs were chosen 
as significant predictors using variable selection 
methods. Four out of five LTCs were found to have a 
significant association with higher lung cancer risk-
Chronic Obstructive Pulmonary Disease (COPD) 
(Hazard Ratio-HR 1.92; 95% Confidence intervals-CI 
1.67-2.20) , Coronary Heart Disease-(CHD) (HR 1.24; 
95% CI 1.10-1.41), Peripheral Vascular Disease-(PVD) 
(HR 1.83; 95% CI 1.25-2.68), Dementia (HR 6.90; 95% 
CI 2.59-18.43), while Hypertension did not have a 
significant association (HR 1.09; 95% CI 0.99-1.18), in 
the fully adjusted model. In mediation analysis, 
smoking variables could explain only a small 
proportion of the observed association between 
chronic diseases and lung cancer association (15% for 
CHD, 6.2% for PVD, 1.4% for Dementia).  
 
 
Consequences 
• Four chronic diseases, COPD, CHD, PVD and 
Dementia, were found to have a significant 
association with the risk of lung cancer incidence, in 
addition to ten previously validated  demographic and 
lifestyle risk factors. 
• Associations were robust in mediation 
analysis with smoking variables.  
• Association between vascular diseases and 
lung cancer incidence needs further research. This 
association may have a role in lung cancer screening 
as well as lung cancer symptom assessment in primary 
care. 
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Abstract 
Problem 
Approximately 360,000 people in the United Kingdom 
are diagnosed with cancer each year and 
approximately 160,000 people die of the disease. 
Most people diagnosed with cancer in the UK first 
present in primary care, where General Practitioners 
will evaluate (often vague) presenting symptoms and 
decide on an appropriate management strategy. More 
accurate triage of these presenting symptoms could 
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lead to earlier diagnosis of cancer, and improved 
outcomes for patients, including improved survival 
rates. There has recently been huge interest in the 
application of AI technologies, including machine 
learning, to medical diagnosis. However, there are 
currently no AI technologies that are established in 
routine clinical care.  
Approach 
We performed a scoping review, aiming to explore 
and map the research landscape for AI technologies 
designed to aid the early detection of cancer, focusing 
on technologies which would be suitable for 
implementation in primary care settings. We searched 
Medline, EMBASE, SCOPUS and Web of Science 
bibliographic databases from the 1st January 2000 to 
11th June 2019 for relevant published studies. We 
identified 10,456 relevant studies after removing 
duplicates, and subsequently assessed 793 full text 
articles. This led to 250 studies included in the 
quantitative synthesis.  
Findings 
The AI technologies we identified fell into three main 
categories:  
(1) applied to electronic health records and routine 
blood results, 
(2) applied to superficial digital imaging, such as 
lesions on the skin, buccal cavity or cervix, and 
(3) applied to subsurface digital images, such as 
ultrasound and thermography.  
We found a diverse range of AI techniques used in the 
studies, although neural networks and support vector 
machines were by far the most common. We also 
identified a range of outcomes measures used across 
the studies. Most studies represented very early stage 
translational research, using various AI techniques to 
address clinical problems using freely available online 
datasets. However, there appeared to be a paucity of 
clinical input into the design of these AI-technologies, 
and they were rarely validated in independent 
datasets or prospectively tested in clinical settings.  
Consequences 
Many of the AI-technologies we identified could 
potentially aid the early detection of cancer and other 
serious conditions in primary care settings. However, 
the research is currently at an early stage, and there 
are a number of further steps needed before the 
technologies can be safely and effectively 
implemented into routine primary care. One key step 
will be validation of the AI-technologies in 
independent datasets and prospective clinical studies 
set among the intended population. Health economic 
assessments, and research involving patients and 
clinicians are further important steps, to identify their 
opinions on AI technologies and potential 
implementation barriers.  
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Abstract 
Problem 
Lung cancer screening can reduce lung cancer 
mortality by 20% and is currently recommended in the 
USA, but not the UK. Ensuring any potential 
psychological harm is minimised is important. Current 
evidence is limited to the psychological impact of CT 
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lung cancer screening. This study assesses 
psychological responses to screening using a novel 
tumour antibody blood test (Early CDT®-Lung test) 
within The Early Cancer Detection Test - Lung Cancer 
Scotland Study (ECLS) to aid the early detection of 
lung cancer.  
Approach 
ECLS study participants (n=12,208) were randomised 
to an Early CDT®-Lung test group or a control group. 
Test-positive participants also had CT scans 6-monthly 
for 2 years. A sample (n=1,032) of test-positive and 
test-negative participants completed questionnaires 
measuring psychological responses (positive and 
negative affect schedule, lung cancer worry scale and 
impact of events scale (IES)) at baseline and 1, 3, 6 
and 12 months post-trial recruitment. Random effects 
linear and logistic regression compared psychological 
responses over time between controls, test-positive 
and test-negative participants.  
Findings 
Compared to controls, test-positive participants were 
significantly more likely to worry about developing 
lung cancer at 1 month (OR: 3.30 [95%CI: 1.73, 
6.34]).Compared to controls, test-negative 
participants had significantly higher levels of positive 
affect at 1, 3 and 6 months (difference between 
means (DBM): 1.45 [0.44, 2.47], 1.46 [0.42, 2.49], 1.35 
[0.32, 2.38] respectively) and at 3 months were 
significantly less likely to worry about developing lung 
cancer (OR: 0.53 [0.30, 0.93]), reported lower impact 
of worries (DBM -0.26 [-0.45, -.07]), and lower levels 
of negative affect (DBM -1.46 [-2.57, -0.35]). 
Compared to test-positive participants, test-negative 
participants were significantly less likely to worry 
about developing lung cancer at 1, 3 and 6 months 
(OR: 0.42 [0.24, 0.74], 0.43 [0.25, 0.76], 0.36 [0.20, 
0.64] respectively) or be anxious about future 
treatment at 1 and 3 months (OR: 0.19, [0.09, 0.37], 
0.49 [0.25, 0.99] respectively). Test-negative 
participants also reported significantly lower impact 
of lung cancer worry at 1 and 3 months (DBM -0.26 [-
0.45, -0.06], -0.29 [-0.49, -0.09] respectively), higher 
positive affect at 3 months (DBM 1.58 [0.50, 2.67]), 
and lower IES scores at 1 month (avoidance DBM: -
2.04 [-2.80, -1.27], intrusion DBM: -1.54 [-2.14, -
0.95]), 3 months (avoidance DBM: -1.18 [-1.95, -0.41], 
intrusion DBM: -1.07 [-1.67, -0.48]) and 6 months 
(avoidance DBM: -1.17 [-1.94, -0.40], intrusion DBM: -
0.76 [-1.36, -0.16]). No significant differences between 
groups were evident at 12 months.  
Consequences 
Findings suggest lung cancer screening may initially 
increase worries in those with a positive test and 
reduce worries and distress in those with a negative 
test. However, most differences were short-lived and 
small and may not be clinically important. Lung cancer 
screening using the Early CDT®-Lung test does not 
appear to have a long term negative psychological 
impact.  
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Abstract 
Problem 
Challenges have been identified in delivering 
interventions to deprived populations due to 
knowledge, language and literacy barriers. The phase 
3 ABACus trial (Awareness and Beliefs About Cancer) 
aims to improve cancer symptom awareness and 
help-seeking behaviours among adults living in 
socioeconomically deprived areas in South West 
Yorkshire and South Wales. This trial used four 
adapted scales from an internationally validated scale 
(awareness and beliefs about cancer (ABC) measure) 
to assess cancer knowledge: Cancer symptom 
recognition (primary outcome), Anticipated symptom 
presentation, Barriers to presentation and Beliefs 
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about cancer. Language within the cancer symptom 
recognition scale were simplified to meet the need in 
the targeted population. This presentation describes 
the findings of the psychometric tests on the adapted 
ABC measure.  
Approach 
Language within the cancer symptom recognition 
scale were simplified using feedback from focus 
groups during phase 1 development and tested during 
the phase 2 feasibility study. Changes were made to 
accommodate understanding of those with low 
literacy and health literacy skills through simplification 
of phrasing and terminology used throughout the 
scale. We conducted psychometric testing to validate 
the modified ABC scales using baseline data collected 
from our phase 3 randomised controlled trial. We 
explored scale properties such as item functioning, 
responsiveness, validity and reliability. Factor analysis, 
Cronbach’s alpha, Pearson’s correlations and 
agreement were used to determine item 
correspondence to the underlying constructs of the 
outcome measures and internal consistency. Multiple 
linear regressions were used to explore the 
intervention effect on each scale and the new 
aggregated scores.  
Findings 
The modified 12 item Cancer symptom recognition 
scale had strong internal consistency (Cronbach’s 
Alpha = 0.79) and strong reliability (0.80). Results 
were comparable to the original ABC measures. 
However, a high celling effect was found among five 
well-known cancer symptom items. Principal 
component analysis resulted in a 2-factor solution. 
Well-known cancer symptoms formed the first factor 
and less well-known cancer symptoms the second. 
There was no difference between the intervention 
and control groups for the 12 item Cancer symptom 
recognition score but when the new 2-factor solution 
was explored the intervention had a positive effect on 
the second factor; demonstrating that the ABACus 
intervention improved symptom knowledge on less 
well-known symptoms.  
Consequences 
The ABC is an internationally validated scale. 
However, the 12 items Cancer symptom recognition 
scale does not function well to capture the level of 
awareness in deprived populations in the UK due to a 
high proportion of adults already recognising those 
‘red flag symptoms’. Item selection should be 
carefully considered due to cultural attitudes and 
presence of campaigns about the red flag symptoms.  
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Abstract 
Problem 
Many people living with cancer have additional 
comorbidities (e.g. diabetes, asthma), which may lead 
to treatment and care complexities and poorer 
patient outcomes.  Research on the prevalence and 
healthcare resource use of those with cancer and 
different comorbidities in primary care in England is 
limited. CATCH, funded by Macmillan Cancer Support, 
aims to describe the population size, characteristics 
and healthcare usage of people living with cancer and 
comorbidities. 
Approach 
CATCH is a cross-sectional observational study, 
analysing anonymised electronic patient records from 
391 English GP practices during 2005-2016 for 
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patients aged ≥50 with a cancer diagnosis consistent 
with QOF eligibility. Data were obtained from 
ResearchOne and included socio-demographics, 
presence of comorbidities and primary care 
appointments, prescriptions and referrals, totalling 
37,095,534 records. Summarised comparator data for 
the whole population aged ≥50 was also provided.  
Findings 
Out of 99,188 people living with cancer, 56% had at 
least one other comorbidity diagnosed within the 2 
years prior to cancer.  Of these, 54% had one 
comorbidity, 28% had two, 12% had three and 6% had 
≥4.  People with lung cancer were more likely to have 
other comorbidities (~70% had at least one other 
comorbidity) compared to breast (~50%), prostate 
and bowel cancers (both ~55%).  Hypertension was 
the most common comorbidity (22% of patients), 
followed by Diabetes (11%), Chronic Kidney Disease 
(9%) and Coronary Heart Disease (9%). People with 
two comorbidities were most likely to have 
Hypertension combined with either Chronic Kidney 
Disease, Diabetes or Coronary Heart Disease.  The 
number of primary care appointments in the year 
following cancer increased with the number of 
additional comorbidities. Compared to those with 
cancer alone, people with one comorbidity had 17% 
more appointments (IRR: 1.17, 95% CI: 1.14-1.21) and 
people with >five comorbidities had 59% more 
appointments (IRR: 1.59, 95% CI: 1.3-1.94). Of all 
appointments that had taken place for people with 
cancer alone, 29% were with an Allied Health 
Professional, 22% were with a nurse and 21% were 
with a GP.  This was comparable when compared to 
appointments for people with both cancer and a 
comorbidity.  
Consequences 
This study provides initial estimates of the population 
size, clinical and primary healthcare usage 
characteristics of people living with cancer and 
comorbidities in England.  Results highlight the 
prevalence of additional comorbidities in patients 
living with cancer and suggest a higher demand on 
primary healthcare services, particularly for those 
with >1 additional comorbidity. Future research 
should focus on understanding the additional needs of 
patients with cancer and specific comorbidities which 
could lead to more personalised care for patients in 
the future.  
C.13 
Understanding population demographics and 
primary healthcare resource use for people with 
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Presenter: Ellen Mason 
Co-authors:  Michelle Collinson, Amanda Farrin, Laura 
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Abstract 
Problem 
People with comorbid cancer and dementia are likely 
to have complex care needs, making the provision of 
cancer treatment and care particularly challenging. 
Little is known about this population that could inform 
practice. We undertook two studies: study 1 aimed to 
estimate the prevalence, characteristics and 
healthcare usage of people living with cancer and 
dementia in England; study 2 explored experiences of 
cancer care for those with both conditions.  
Approach 
Study 1 analysed an anonymised database of 
electronic records from 391 English GP practices 
during 2005-2016. Data, obtained from ResearchOne, 
include socio-demographics, clinical characteristics, 
primary care appointments, prescriptions and 
referrals for patients aged ≥50 with a cancer and/or 
dementia diagnosis consistent with QOF eligibility. 
Study 2 used ethnographic methods to explore the 
experiences of patients, their families and hospital 
staff in two NHS trusts. Patient, carer and public 
involvement was embedded throughout.  
Findings 
The most common comorbidities in people with 
comorbid cancer and dementia were mental 
health/psychiatric disorders (24% of patients) and 
stroke (20%). In the year following the first mention of 
cancer/dementia in GP records, people with both 
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conditions had 9% more primary care appointments 
compared to people with cancer alone (IRR: 1.09, 95% 
CI: 1.01-1.17) and 37% more compared to people with 
dementia alone (IRR: 1.37, 95% CI: 1.28-1.47). 162,371 
people aged ≥50 with cancer and/or dementia were 
identified. 7.5% of those aged ≥75 with cancer also 
had dementia and similarly, 7.5% of people with 
dementia also had cancer.  People with cancer and 
dementia differed from people with cancer; they were 
older (mean 83 vs. 69 years), more likely to be living in 
a care home (44% of patients vs. 5%) and more likely 
to have additional comorbidities (70% of patients vs. 
50%).  The most common comorbidities in people 
with both cancer and dementia were mental 
health/psychiatric disorders (24% of patients) and 
stroke (20%). Dementia prevalence amongst people 
with the ten most common cancers ranged from 1.2% 
(brain, other CNS and intracranial tumours) to 5% 
(bladder cancer). People with cancer and dementia 
had 9% more primary care appointments than people 
with cancer alone (IRR:1.09, 95% CI:1.01-1.17). Study 
2 identified many challenges relating to cancer care, 
including recognition of dementia, and difficulties 
around decision-making, care processes and care 
environments. Families played an important and 
difficult to replicate role in relatives care.  
Consequences 
This study provides the best available estimates of the 
size, characteristics and care needs of this comorbid 
patient population. Results highlight the prevalence 
and complexity of this population but indicate a lower 
primary healthcare use than expected for people 
dealing with two complex conditions.  
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Abstract 
Problem 
In the United Kingdom (UK), the National Institute for 
Health and Care Excellence (NICE) recommends 
urgent referral for the investigation of cancer in 
patients with unexplained weight loss in primary care, 
but provide no guidance on the extent or timing of 
weight loss. Weight is not routinely recorded in UK 
primary care and is often missing in primary care 
databases. Consequently, NHS primary care data are 
unlikely to be provide rich enough weight information 
to derive the extent and timing of weight loss that is 
most indicative of an underlying malignancy. Unlike 
the UK, weight is measured routinely in the USA and 
weight data is sufficiently complete to allow detailed 
analysis of weight change. The overall aim is to 
provide the evidence to allow GPs to more effectively 
implement the NICE cancer guidance on the 
management of unexplained weight loss using USA 
primary care data  
Approach 
The study population comprised a dataset of 50,000 
randomly selected US primary care patients aged 
>=40 years who were members of Kaiser Permanente 
Washington (KPW) on their date of birth in 2006 and 
resided in the local cancer registry catchment area. 
We examined associations between measured weight 
loss and a diagnosis of cancer. A multi-variable Cox 
proportional hazard model with time-varying 
covariates for percentage weight change, symptoms, 
and blood test results. The model was used to 
estimate the risk of cancer for combinations of weight 
loss and intervals of weight measurement in order to 
identify thresholds for further investigation.  
Findings 
Of 43,302 patients with measured weight and over 
288,000 person-years of follow-up, 3,352 were 
diagnosed with cancer. The median (IQR) number of 
weight change measures of 13 (6, 24) at a median 
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(IQR) interval of 39 (15, 104) days. Percentage weight 
change has a linear association with the risk of any 
cancer (Hazard ratio of 1.05, 95% CI 1.04 to 1.07 per 
unit % weight loss independent of age, sex, ethnicity, 
haemoglobin and platelets, previous cancer diagnosis, 
the time interval between consecutive weight 
measures and diagnoses of conditions associated with 
weight change. In men aged 60 with no existing 
comorbidities, weight loss of 5% over 6 months is 
associated with a risk of 2.3%, increasing to 3.0% if 
weight loss occured over a 1 month interval.  
Consequences 
Measured weight loss is independently associated 
with an increased risk of cancer. More weight loss 
means a higher risk of cancer independent of the time 
interval between weight measurements and a 
previous diagnosis of cancer. Diagnostic strategies 
necessitating that weight loss is observed over a fixed 
period may delay diagnostic action. Our initial analysis 
will be expanded to explore the utility of diagnostic 
strategies using increasing thresholds of measured 
weight loss and changes in combinations with changes 
in biomarkers for presentation at the conference.  
 
C.15 
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Abstract 
Problem 
The linkage of patient records across different 
healthcare sectors has enhanced research, particularly 
in the area of cancer. Clinical Practice Research 
Datalink (CPRD) provides primary care data linked to 
several National Cancer Registration and Analysis 
Service (NCRAS)) data sets, enabling researchers to 
study the clinical management and treatment of 
cancer patients. However, it is currently unclear how 
these data sources complement each other. 
Understanding this is crucial to determine the 
appropriate combination of data sources when 
planning a study.  
Approach 
This was a cross-sectional study using linked UK data 
from CPRD [CPRD GOLD primary care, NCRAS Cancer 
Registration Data and the recently available NCRAS 
Systemic Anti-Cancer Therapy dataset (SACT)]. Cases 
included women with incident breast cancer 
registered between 2013-2015. Treatment was 
defined as a record of receiving any form of 
chemotherapy drug. Concordance of recording was 
calculated by estimating the proportion of patients 
with (i) the same breast cancer diagnosis code 
recorded in the cancer registry and SACT, (ii) a record 
for systemic treatment in the cancer registry and 
SACT, and (iii) Body mass index (BMI) recorded in 
CPRD GOLD and SACT.  
Findings 
3,579 female patients with incident breast cancer and 
a treatment event recorded in the cancer registry 
data, were included [mean age: 61 years (standard 
deviation: 13.6)]. 990 of these patients also had a 
primary diagnosis recorded in SACT, of which 43% 
were an exact match with the record in the cancer 
registry data. Of 3,579 patients, only 9% had a record 
for receiving a named systemic treatment in the 
cancer registry. Of the 3,579 patients in the cohort, 
894 (25%) had a record of receiving a named systemic 
treatment in the SACT data. Only 17% of patients had 
a record in both data sources. There was lower 
concordance (6%) for records of a specific systemic 
treatment.Of the 894 patients with a complete record 
of treatment in SACT, 86% had the information 
required to calculate BMI in the associated record. 
This data was available for 96% of the same cohort in 
CPRD GOLD. Of the patients with a complete BMI 
record in SACT, 46% of patients had a BMI record in 
CPRD GOLD which was within 1 kg/m2 of their record 
in SACT. For the remaining 54%, most of the recorded 
BMIs were higher in primary care. Outcome of 
treatment was missing for 95% patients with a record 
in SACT. Adjusted analyses and further analysis 
regarding the feasibility of determining outcome of 
treatment in CPRD GOLD (when this information was 
not available in SACT) will be explored.  
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Consequences 
These results demonstrate the limitations of using 
these data sources in isolation and how combined 
they can help bridge data gaps in the individual data 
source.  
Funding Acknowledgement 
This study was funded by the Clinical Practice 
Research Datalink (CPRD) 
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Evidence underpinning benefits and harms of earlier 
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Institutions 
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Abstract 
Problem 
The early diagnosis of cancer has been an area of 
significant investment in recent years, with the 
overarching ambition of detecting cancer at a more 
easily treated stage, thus improving quality of life and 
survival. Economic evaluations of interventions that 
facilitate earlier diagnosis of cancer (e.g. screening, 
novel diagnostics, revised diagnostic pathways, and 
cancer awareness campaigns) require evidence on the 
benefits and harms of detecting cancer earlier to 
estimate health outcomes and costs. This study is a 
systematic review of the evidence used to underpin 
the benefits and harms of earlier cancer diagnosis in 
such studies.  
Approach 
We have searched the following electronic databases: 
Medline, Embase, Web of Science and the CRD HTA 
Database. Titles and abstracts of the studies retrieved 
during the database search are being screened, split 
evenly between two reviewers (LS and BS), with a 
further 10% double screened by each of these 
reviewers. A PRISMA flow chart will be developed to 
show the different stages of the screening process. 
Studies are included if they report an economic 
evaluation of an intervention that facilitates the 
earlier diagnosis of cancer. Studies published prior to 
2015, non-English papers, and conference abstracts 
will be excluded. Data will be extracted on the 
evidence underpinning any assumed benefits or 
harms arising from the earlier diagnosis of cancer. 
Specially, the evidence informing the reduced time to 
diagnosis and the estimated benefits and harms 
resulting from this will be summarised and 
categorised using a hierarchy of evidence framework. 
In the absence of evidence, a summary of the 
methods used to estimate the consequences of early 
diagnosis will be provided e.g. calibration, expert 
elicitation.  The Consolidated Health Economic 
Evaluation Reporting Standards (CHEERS) checklist will 
be used to assess the overall quality of the economic 
evaluations.  
Findings 
The results of the systematic review will be presented 
and the broader implications of the quality of the 
evidence underpinning the early diagnosis will be 
discussed.  
Consequences 
The findings from this study will be relevant for 
primary care and have implications for the 
development of interventions aimed at promoting the 
earlier diagnosis of cancer, of which GPs play a crucial 
role.  
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the GP in supporting patients following major 
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Dr Lara Rimmer, Prof Carolyn A Chew-Graham 
Institutions 
East Lancashire Hospitals NHS Trust, Keele University 
 
Abstract 
Problem 
Pancreatic cancer is the 11th most common cancer in 
the UK. Most are diagnosed at a late stage, but 
around 15% of patients undergo a 
pancreaticoduodenectomy. There is limited research 
focusing on the experiences of patients living with 
pancreatic cancer; most qualitative studies have 
focused on shared decision-making around surgery, 
and secondary care surveillance. The role of the GP 
has thus far been unexplored, yet GPs are key in 
enabling effective coordination of care for people 
living with life-shortening conditions, and unmet 
support needs negatively impact patients’ quality of 
life.Our study aimed to explore patients’ experiences 
of help-seeking before diagnosis and following 
surgery, the impact of living with pancreatic cancer, 
and opportunities to develop improved support 
interventions in primary or secondary care.  
Approach 
Ethical approval was obtained. Semi-structured 
interviews were conducted with patients who had 
undergone a pancreaticoduodenectomy for 
pancreatic or biliary duct cancer at a specialist hepato-
pancreatic-biliary (HPB) centre in Northwest England. 
Interviews explored their experience of the diagnostic 
process and surgery, life after surgery, and sources of 
support including primary care. Data were analysed 
thematically using the principles of constant 
comparison.  
Findings 
Interviews are ongoing, but analysis of 16 interviews 
has yielded several themes. Patients described 
difficulties navigating the healthcare system both 
prior to diagnosis and following surgery, and being 
uncertain of the role of the GP in their ongoing care. 
This was particularly articulated by patients referred 
to the HPB service via other hospitals in the cancer 
alliance. Participants recognized that GPs have little 
contact with patients who have had a 
pancreaticoduodenectomy, but felt that GPs should 
be more proactive in offering support. Participants 
described a significant treatment and monitoring 
burden, which included: difficulties managing 
medications (including creon and insulin), the impact 
of ongoing symptoms on daily activities, and the 
disruption of frequent appointments and 
investigations. Participants gained support from a 
variety of sources including family, friends, and faith 
communities, but rarely their GP. They reported that 
although they wanted more support post-operatively, 
they felt inhibited from asking for help because they 
did not perceive themselves to be unwell. Participants 
felt they would value recognition from GPs of both 
physical and psychological sequelae.  
Consequences 
Patients can feel they are not candidates for an 
increased level of support following surgery because 
they may not consider themselves sufficiently unwell. 
Therefore, an awareness of both physical and 
psychological sequelae is crucial in order for GPs to 
offer appropriate support proactively following 
discharge. Gaining an understanding of the surgical 
and medical treatments offered to patients will 
enable more effective liaison with specialist care 
including surgeons, oncologists and dieticians. 
Understanding the impact of cancer on patients’ 
quality of life is vital in enabling the development of 
improved support interventions across primary and 
secondary care.  
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Abstract 
Problem 
There is a substantial incidence of stroke in patients 
with atrial fibrillation (AF) not receiving 
anticoagulation.  Reasons for patients with AF not 
receiving anticoagulation are generally attributed to 
the clinician decision, however in practice some 
patients refuse anticoagulation. The aim of our study 
was to investigate the rate of refusal of 
anticoagulation in patients with AF and the factors 
associated with patient refusal of anticoagulation.  
Approach 
The Global Anticoagulant Registry in the FIELD 
(GARFIELD-AF) was an international prospective 
observational study of patients≥ 18 years with newly 
diagnosed AF and ≥1 investigator determined risk 
factor for stroke. Participants were consecutively 
enrolled in ≥1000 centres in 35 countries and followed 
up for a minimum of 2 years. A logistic regression was 
developed with predictors of patient anticoagulation 
refusal identified by least absolute shrinkage and 
selection operator (LASSO) methodology. The 
following information were considered as potential 
predictors: demographics (sex, age, ethnicity), medical 
and cardiovascular history, lifestyle factors (smoking 
and alcohol consumption), vital signs (BMI, pulse, 
systolic and diastolic blood pressure), type of AF and 
care setting at diagnosis. Patient refusal of 
anticoagulation was defined as patients with AF at 
high risk of stroke (CHA2DS2VASc ≥2) who refused 
anticoagulation.  
Findings 
Out of 43,154, 13,283 (30.8%) participants at high risk 
of stroke did not receive anticoagulation at baseline. 
The reason for not receiving anticoagulation was 
unavailable for 38.7% (5146/13283); of the patients 
with a known reason for not receiving 
anticoagulation, 12.5% (1014/8137) refused 
anticoagulation. The median (Q1; Q3) age of 
participants who refused anticoagulation was 72 (65; 
78) years, and 48.3% were female. CHA2DS2VASc 
score was 3.0 (3.0; 5.0) in patients who refused 
anticoagulation and HAS-BLED score was 1.0 (1.0; 2.0). 
The strongest determinant of anticoagulation refusal 
was care setting at diagnosis, with patients diagnosed 
in primary care/GP having a higher likelihood of 
refusing anticoagulation compared to patients 
diagnosed in cardiology. After care setting, other 
determinants were ethnicity, vascular disease, type of 
AF, pulse, care setting location, age, diastolic and 
systolic blood pressure, history of venous 
thromboembolism, prior bleeding and prior 
stroke/TIA/systemic embolism.  
Consequences 
In this global real-world prospective study of patients 
with newly diagnosed AF, the overall rate of patient 
refusal of anticoagulation was low (2.3% of patients at 
high risk of stroke), though patient refusal accounted 
for 12.5% of patients at high risk of stroke and not 
receiving anticoagulation. Diagnosis in primary 
care/GP, Asian ethnicity and presence of vascular 
disease were strongly associated with a higher risk of 
patient refusal of anticoagulation. While patient 
refusal of anticoagulation is an acceptable outcome of 
shared decision-making, clinically it is a missed 
opportunity to prevent AF related stroke. Patients’ 
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reasons for refusing anticoagulation need to be 
explored.  
Funding Acknowledgement 
The GARFIELD-AF registry is funded by an unrestricted 
research grant from Bayer AG. 
 
D.2 
Does GP based, cardiac arrest, community first 
response save lives?   
Presenter: Tomas Barry 
Co-authors:  Prof Gerard Bury, Ms Mary Headon 
Institutions 
University College Dublin 
Abstract 
Problem 
CPR and defibrillation are the most important 
interventions following cardiac arrest but are critically 
time sensitive. The mobilization of ‘community first 
responders’ has been shown to shorten the interval 
from out-of-hospital cardiac arrest (OHCA) occurring 
to CPR and defibrillation being performed and is an 
important strategy to improve survival.Irish General 
Practitioners have historically been involved in the 
resuscitation efforts of 10-15% of all patients who 
survive cardiac arrest in Ireland, but have not been 
formally linked with emergency medical services 
dispatch systems. Since 2015 the worlds first GP 
based, ambulance service linked, cardiac arrest first 
response initiative has been operational in Ireland.  
Approach 
GPs volunteer to receive text message alerts to 
instances of cardiac arrest in their local communities 
from emergency services dispatch. Data on alerts, 
responses, OHCA incidents and outcomes are 
gathered prospectively, using ambulance control and 
GP data and with corroborative data from the national 
OHCA registry.  
Findings 
During 2016 to 2018, 190 GPs participated, 146 
received one or more alert(s) and 80 responded. In 
total 228 patients were attended. GPs arrived before 
the emergency services on 83 (36% of) occasions. 196 
patients (86%) had suffered OHCA of whom 138 (70%) 
had resuscitation attempted. The remainder were 
already deceased. GPs initiated CPR on three 
occasions and delivered the first defibrillation on eight 
occasions.  55 patients were transferred to hospital of 
whom 14 (10% of all whom had resuscitation 
attempted) are known to have survived.  
Consequences 
GPs are willing to volunteer to provide OHCA first 
response in their own communities. GPs reached 
patients in advance of the emergency medical services 
in a third of all incidents. A considerable volume of 
alerting activity is required to generate true 
resuscitation opportunities. A considerable 
component of the GP OHCA first responder role 
involves the management of death in the community. 
Opportunities to provide early CPR and defibrillation 
are more limited however likely to contribute to 
additional survival when they occur.  
 
D.3 
Systolic inter-arm blood pressure difference and 
cognitive decline: Findings from the INTERPRESS-IPD 
Collaboration.   
Presenter: Christopher E Clark 
Co-authors:  Christopher E Clark, Kate Boddy, Fiona C 
Warren, Sinead TJ McDonagh, Sarah Moore, Victor 
Aboyans, Lyne Cloutier, Richard J McManus, Angela C 
Shore, Rod S Taylor, John L Campbell 
Institutions 
University of Exeter Medical School, Dupuytren 
University Hospital, Université du Québec à Trois-
Rivières, University of Oxford, Royal Devon and Exeter 
Hospital NHS Foundation Trust, University of Glasgow. 
Abstract 
Problem 
Hypertension and dementia are associated with older 
age and with each other. As the populations age, 
numbers of individuals living with dementia will rise, 
representing substantial costs and care burdens for 
society. Currently, there are no interventions to halt 
established cognitive decline, therefore approaches 
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focus on prevention. Systolic inter-arm difference in 
blood pressure (IAD) and cognitive decline are both 
associated with cardiovascular disease. We therefore 
propose, and recently published initial evidence for, 
associations of IAD with prospective cognitive decline. 
We now present findings from the Inter-arm blood 
pressure difference individual participant data 
(INTERPRESS-IPD) Collaboration, examining 
associations of IAD with development of mild 
cognitive decline (MCI) and dementia.  
Approach 
Individual participant data meta-analyses: we 
examined time to event data for new diagnoses of 
MCI and dementia, according to IAD status in 
univariable and multivariable Cox regression models, 
stratified by study. Multivariable analyses were 
adjusted for systolic blood pressure, age, sex and 
highest educational attainment. We also examined 
changes in Mental State Examination (MSE) scores, 
with adjustment for all of the above and duration of 
follow up.  
Findings 
Mean age was 66.2 (SD 11.9) years, 55% of 
participants were female, 84% were of White ethnicity 
and mean systolic IAD was 7.0 (7.5) mmHg. During 10 
years of follow up, there were 273 (5.9%) new 
diagnoses of MCI among 4,635 participants, from 3 
cohorts. In univariable analyses, MCI was associated 
with a systolic IAD ≥ 5mmHg (Hazard Ratio (HR) 1.34 
(95%CI 1.04 to 1.72); p=0.022) and IAD ≥ 10mmHg (HR 
1.33 (1.03 to 1.73); p=0.032). After adjustment, the 
associations remained: HR 1.31 (1.02 to 1.67; 
p=0.036) for IAD ≥ 5mmHg and HR 1.29 (0.99 to 1.68; 
p =0.056) for IAD ≥ 10mmHg. No significant 
associations were observed above an IAD of 10mmHg. 
There were 95 (2.0%) new diagnoses of dementia 
during follow up; no associations were observed 
between diagnosis of dementia and IAD.MSE scores 
were recorded for 2,709 participants in 3 cohorts; 419 
(15.5%) showed clinically meaningful reductions (i.e. ≥ 
5 points) during follow up. Decreases were associated 
with an IAD ≥ 5mmHg (p=0.004) and IAD ≥ 10mmHg 
(p=0.006) on univariable analyses. After adjustment 
the association with an IAD ≥ 5mmHg remained 
(p=0.033); age and educational attainment attenuated 
the association with an IAD ≥ 10mmHg (p=0.11).  
 
Consequences 
We present the first time-to-event analyses of 
development of MCI with IAD. These data provide 
additional evidence that systolic IADs ≥5mmHg and 
≥10mmHg are associated with development of MCI in 
a pooled cohort of >4,000 participants. Work to 
enlarge the dataset and extend these analyses 
continues. Measurement of blood pressure in both 
arms is recommended and is straightforward; 
confirmation of these findings could inform 
individualised treatment decisions to minimise risk of 
future cognitive decline.  
 
D.4 
Why do people take part in atrial fibrillation 
screening? A longitudinal interview study with SAFER 
trial participants   
Presenter: Sarah Hoare 
Co-authors:  Alison Powell, Jonathan Mant, Jenni Burt 
– on behalf of the SAFER investigators 
Institutions 
University of Cambridge 
Abstract 
ProblemA number of patient groups, charities and 
clinical organisations have championed the practice of 
case finding for atrial fibrillation (AF), arguing that 
early AF diagnosis and treatment may reduce the 
incidence of stroke. Calls for increased AF case-finding 
are ranged against concerns about the potential 
proliferation of unregulated ‘back-door’ screening; 
the UK National Screening Committee currently states 
there is insufficient evidence to support a national AF 
screening programme. Within this debate the attitude 
of the public towards AF screening is unknown. The 
aim of this study was to explore the reasons why 
participants chose to engage in an AF screening trial.  
Approach 
We conducted semi-structured longitudinal interviews 
with participants in the feasibility phase of the SAFER 
trial (Screening for Atrial Fibrillation with ECG to 
Reduce stroke). Interview participants were sampled 
purposively in relation to age and gender. Initial face-
to-face interviews took place shortly after participants 
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accepted an invitation to take part in SAFER; up to 
two follow-up interviews took place via telephone, 
spaced throughout and following the four-week 
screening process. We used a flexible topic guide to 
explore experiences of and attitudes towards 
screening and AF screening. Interviews were analysed 
thematically, using both inductive and deductive 
codes. Themes were synthesised to understand 
shared views of screening participation, aided by 
reference to the social science screening literature.  
Findings 
We interviewed 24 participants, totalling 55 
interviews (interview 1 n=24, interview 2 n=10, 
interview 3 n=21). Participants were highly supportive 
of the AF screening programme, underpinned by the 
belief that screening was a ‘good thing to do’. Whilst 
AF was unfamiliar to most without personal 
experience of the condition, stroke was well-known 
and frightening. For participants, AF screening 
functioned as a way of attenuating the perceived risk 
and anxiety of having a stroke, but also more broadly 
to demonstrate (both to themselves and others) their 
commitment to self-care and being a ‘good patient’. 
Should they be diagnosed with AF, this would offer 
beneficial early diagnosis and treatment, and further 
contribute to the maintenance of their health. 
However, importantly, participants were unlikely to 
consider themselves to be candidates for AF on 
entering the screening programme. Engaging in AF 
screening was therefore thought to be relatively low 
risk, especially as the screening test was seen as non-
invasive. Further, AF screening was commonly 
presumed to offer a wider health check beyond an 
assessment of cardiac arrhythmias.  
Consequences 
Participants in AF screening can have wider 
aspirations for the programme than the identification 
of AF, and the communication of screening results 
needs to manage expectations effectively. Negative 
AF screening results may lead to false reassurance 
concerning wider cardiac risks.  
Funding Acknowledgement 
This research is funded by the National Institute for 
Health Research (NIHR) [Programme Grants for 
Applied Research (grant reference number RP-PG-
0217-20007) and School for Primary Care Research 
(SPCR)] The views expressed are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
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Presenter: Muhammad Hossain 
Co-authors:  Nadia Corp, Carolyn Chew-Graham, 
Stephanie Tierney, Faraz Mughal, Tom Kingstone, 
Emma Sowden, Thomas Blakeman, Faye Forsyth, 
Susana Borja Boluda, Christi Deaton 
Institutions 
Keele University, University of Manchester, University 
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Abstract 
Problem 
An estimated 0.9 million people live with Heart Failure 
(HF) in the United Kingdom (UK), accounting for 5% of 
emergency hospital admissions. Evidence from the UK 
shows young South Asians are at higher risk of 
developing HF than young white Europeans and 
among South Asians, Bangladeshis and Pakistanis are 
thought to be at greater risk of HF. However, research 
examining the views and experiences of HF among 
ethnic minority groups are limited. Previous 
qualitative research has explored attitudes towards 
optimising management of HF, diagnosis and 
treatment, barriers and enablers to service use and 
support. There is a need to synthesise this work to 
provide a coherent critical summary, to improve care 
and service provision for patients, and suggest areas 
for future research. The aim of this systematic review 
is to appraise and synthesise the best available 
qualitative evidence to provide a better 
understanding of the barriers and facilitators to 
optimising HF management in people from ethnic 
minority groups.  
Approach 
A systematic review of qualitative research exploring 
patients’ and carers’ perceptions of HF management 
is being conducted. Seven databases will be searched 
from inception (EMBASE, MEDLINE, AMED, 
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CINHALPlus, PsycINFO, ASSIA and Web of Science). In 
addition, a grey literature search, citation tracking and 
reference checking of included articles will be 
undertaken. Articles will be screened using inclusion 
and exclusion criteria, and full-text articles selected 
for inclusion will undergo data extraction and quality 
appraisal using the Joanna Briggs Institute Qualitative 
Assessment and Review Instrument (JBI QARI). 
Screening, data extraction and quality assessment will 
be performed independently by two reviewers. 
Where there is conflict, this will be resolved through 
discussion, or a third reviewer will be involved when 
an agreement cannot be reached. Findings will be 
synthesised using meta-aggregation guided by the JBI 
QARI.  
Findings 
The review is ongoing and findings from this review 
will be first presented at the SAPC ASM 2020 - Leeds. 
Barriers and facilitators to optimising HF management 
in people from ethnic groups will be presented. 
Preliminary analysis suggests that people from 
minority ethnic groups have different beliefs about HF 
and its treatment which impacts on self-management 
and access to the services. The diverse religious and 
cultural traditions of different ethnic groups may 
affect their knowledge of HF and how they engage 
with self-management.  
Consequences 
The findings will have the potential to inform clinical 
practice and policy that will reflect the views of ethnic 
minority groups, to ensure services are culturally and 
religiously appropriate, accessible and personalised to 
their needs. The results will provide directions for 
healthcare providers to improve supportive strategies 
in the care of HF people from ethnic minority groups.  
Funding Acknowledgement 
This work is independent research funded by the 
National Institute for Health Research School for 
Primary Care Research (NIHR SPCR), Grant reference 
number 384. The views expressed are those of the 
author(s) and not necessarily those of the NIHR, the 
NHS or the Department of Health. 
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Andrea K Roalfe, Saul Myerson, Bernard Prendergast, 
FD Richard Hobbs 
Institutions 
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Care Health Sciences, NIHR Oxford Biomedical 
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Abstract 
Problem 
More than half of all adults aged over 65 years have 
some form of valvular heart disease (VHD). Significant 
VHD, defined as stenosis or regurgitation that impacts 
upon cardiac function, is associated with impaired 
quality of life and increased hospitalisation. However, 
many existing studies of VHD prognosis are 
confounded by being hospital-based, with likely 
greater co-morbidity. In addition, most people with 
VHD have mild disease, which has been linked to 
poorer outcomes in hospital-based studies but is of 
uncertain clinical significance in community 
populations. Furthermore, degenerative valve 
changes are also common findings on echocardiogram 
and have traditionally been deemed of little clinical 
significance as they do not have a functional impact 
on the heart, but their prognostic significance is also 
unclear. In this study we aimed to investigate the 
association between VHD and its subtypes with all-
cause and cause-specific mortality in a community 
population.  
Approach 
We linked data from the OxVALVE study to the Office 
for National Statistics mortality registry. OxVALVE 
used echocardiography to screen over 4,000 
participants aged over 65 years from seven general 
practices in Oxfordshire for presence and severity of 
VHD. We examined the association between VHD and 
mortality alone and in relation to mitral annular 
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calcification and aortic sclerosis. We hypothesized 
that these degenerative forms of valve disease may be 
associated with an adverse prognosis given that they 
are markers of atherosclerosis. Kaplan-Meier curves, 
log rank tests, Cox regression and the Fine-Gray 
competing risks model were used for the analysis.  
Findings 
Mortality data were available for 3,511 participants, 
of whom 361 (10.3%) died (median 6.49 years follow-
up). Most had some form of valve abnormality 
(n=2,645, 70.2%), including either aortic sclerosis or 
mitral annular calcification. VHD without degenerative 
disease was present in 1,760 (50.1%) and 182 (5.2%) 
had significant disease. Mild and significant VHD were 
associated with increased all-cause mortality in the 
unadjusted analysis but not the multivariable model 
(mild VHD: HR 1.20, 95% CI: 0∙96-1.51; significant 
VHD: HR 1.47, 95% CI: 0.94-2.31). Aortic sclerosis and 
mitral annular calcification were common findings and 
both were independently associated with an 
increased risk of death. Mortality was highest for 
people with a combination of significant VHD and 
significant valve degeneration (HR 4.38, 95% CI 1.99-
9.67).  
Consequences 
These results are important in changing the way that 
echocardiogram results are interpreted. Most older 
people detected with VHD (over 90%) will have mild 
disease that it is not associated with increased risk of 
death, and they can be reassured. However, 
degenerative valve changes, particularly in people 
with significant VHD, are associated with increased 
mortality, and represent potentially important 
prognostic indicators, the significance of which may 
currently be overlooked in clinical practice. Their 
presence should prompt clinicians to consider 
intensive treatment of modifiable cardiovascular risk 
factors.  
Funding Acknowledgement 
The OxVALVE study is supported by the National 
Institute of Health Research (NIHR) Oxford Biomedical 
Research Centre (BRC), with initial support from the 
NIHR Thames Valley Comprehensive Local Research 
Network (UKCRN ID 6086), and the NIHR School for 
Primary Care Research. The views expressed are those 
of the authors and not necessarily those of the NHS, 
the NIHR, or the Department of Health and Social 
Care. 
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Familiarity and use of cardiovascular clinical 
prediction rules: A survey of general practitioners   
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University of Oxford 
Abstract 
Problem 
Clinical prediction rules (CPRs) can help general 
practitioners (GPs) address challenges in 
cardiovascular disease. Although many cardiovascular 
CPRs exist, few have been broadly used because of 
inefficiencies in CPR development. It is unknown 
which cardiovascular CPRs are currently recognized 
and used by GPs. Therefore, we aimed to identify 
cardiovascular CPRs recognized and used by GPs, and 
to assess how GPs’ familiarity and use have changed.  
Approach 
An online survey of GPs in the UK was conducted. We 
recruited a geographically representative sample of 
GPs from Doctors.net.uk. We asked participants how 
familiar they were with, how frequently they used, 
and why they used cardiovascular CPRs. We compared 
our results with a survey conducted in 2014.  
Findings 
Most GPs were familiar with QRISK scores, ABCD 
scores, CHADS scores, HAS-BLED score, Wells scores 
for deep vein thrombosis, and Wells scores for 
pulmonary embolism. The proportions of GPs using 
these CPRs were 96.3%, 65.1%, 97.3%, 93.0%, 92.5%, 
and 82.0%, respectively. GPs’ use increased by 31.2% 
for QRISK scores, by 13.5% for ABCD scores, by 54.6% 
for CHADS scores, by 33.2% for Wells scores for deep 
vein thrombosis, and by 43.6% for Wells scores for 
pulmonary embolism; and decreased by 45.9% for JBS 
risk calculator, by 38.7% for Framingham risk scores, 
and by 8.7% for New Zealand tables. GPs most 
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commonly used cardiovascular CPRs to guide therapy 
and referral.  
Consequences 
We found GPs’ familiarity and use of cardiovascular 
CPRs changed substantially in the UK. Integrating 
cardiovascular CPRs into guidelines and EHRs might 
increase familiarity and use.  
Funding Acknowledgement 
This study was funded by the Collaboration for 
Leadership in Applied Health Research and Care 
(CLAHRC) Oxford, the National Institute for Health 
Research (NIHR). 
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Abstract 
Problem 
Musculoskeletal conditions are a common reason for 
consulting primary care and a major cause of years 
lived with disability. Many people with painful 
musculoskeletal conditions have other long-term 
conditions necessitating hospitalisation. 
Musculoskeletal conditions may affect outcomes of 
other conditions managed within hospital through 
pain, restricted functioning and mobility, and sleep 
interference. These factors may hinder or delay 
delivery of appropriate treatment, thereby reducing 
its effectiveness, potentially extending time to 
discharge from hospital, and worsening outcomes of 
hospitalisation. The objective was to determine 
whether people with musculoskeletal pain spend 
longer in hospital and have worse short-term 
outcomes after hospitalisation with acute coronary 
syndrome (ACS).  
Approach 
We used information on patients aged 45 years and 
over newly diagnosed with ACS between 1998-2019 
recorded within a large UK database of general 
practice records (Clinical Practice Research Datalink) 
linked to hospital data. We identified primary care 
consultations by these patients for musculoskeletal 
pain in the 24 months prior to ACS hospitalisation. 
Length of hospital stay and risk of worse hospital 
outcomes including mortality and readmission within 
30 days of discharge were compared between those 
with pre-existing musculoskeletal pain and those 
without. We  assessed whether findings varied by 
time since most recent musculoskeletal pain 
consultation (within 6 months vs 6-24 months before 
hospitalisation date) and severity (using prescription 
of strong opioid analgesics and referral as proxies for 
greater severity).  
Findings 
There were 33,870 patients with a new hospitalisation 
for ACS. Mean age was 70. 12,669 (37%) had 
consulted for a painful musculoskeletal condition in 
the previous 24 months. Patients with a 
musculoskeletal pain consultation had an increased 
risk of readmission for any cause to hospital within 30 
days of discharge after adjustment for comorbidity 
and sociodemographic characteristics (21% vs 19% 
readmitted; adjusted odds ratio 1.08; 95% CI 
1.02,1.14). Risk of readmission was increased further 
in those with a more recent consultation and severe 
musculoskeletal pain (23% readmitted). Length of 
hospital stay was longer in those with a more recent 
consultation and severe musculoskeletal pain (mean 
difference 0.8 days; adjusted incident rate ratio 1.06; 
1.01, 1.11), as was risk of mortality within 30 days 
(although not statistically significant, adjusted odds 
ratio 1.17; 0.98, 1.39).  
Consequences 
Musculoskeletal pain is associated with poorer short-
term outcomes from ACS. Given the high rate of 
musculoskeletal pain in patients with ACS, increased 
awareness of the impact of such pain may in 
particular reduce rates of readmission to hospital 
following ACS. Further work should assess whether 
musculoskeletal pain affects the long-term prognosis 
of cardiovascular conditions, impacts on service 
utilisation and costs after ACS, and whether there are 
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potential interventions to ameliorate these effects at 
either a population level or during inpatient stays.  
Funding Acknowledgement 
This study is funded by the National Institute for 
Health Research (NIHR) School for Primary Care 
Research (project reference 428). JJE is funded by an 
NIHR Academic Clinical Lectureship (reference CL-
2016-10-003). CM is funded by the National Institute 
for Health Research (NIHR) Applied Research 
Collaboration West Midlands and the National 
Institute for Health Research (NIHR) School for 
Primary Care Research  This abstract presents 
independent research funded by the National 
Institute for Health Research (NIHR) and the National 
Institute for Health Research (NIHR) Applied Research 
Collaboration (ARC) West Midlands. The views 
expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. This study is 
based in part on data from the Clinical Practice 
Research Datalink obtained under licence from the UK 
Medicines and Healthcare products Regulatory 
Agency. The data is provided by patients and collected 
by the NHS as part of their care and support. The 
Office for National Statistics (ONS) is the provider of 
the ONS data contained within the linked CPRD data 
used for this study. ONS Data and Hospital Episode 
Statistics (HES) Data: copyright © (2019), re-used with 
the permission of The Health and Social Care 
Information Centre; all rights reserved. The 
interpretation and conclusions contained in this study 
are those of the authors alone. 
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Abstract 
Problem 
Lower extremity peripheral arterial disease (PAD) has 
a global prevalence of 10%. PAD is associated with 
reduced quality of life and physical functioning, and 
may lead to critical limb ischaemia, limb loss or death. 
PAD represents a substantial economic and health 
care burden and is under-diagnosed, perhaps due to 
variability of leg symptoms presented. The EuroPAD 
group comprises PAD guideline authors, vascular and 
primary care experts from 10 European countries. This 
group conceived and developed a survey for a Europe-
wide assessment of current primary care approaches 
to detecting and monitoring PAD.This study seeks to 
understand general practitioners’ (GPs) usual 
approaches to the diagnosis, assessment and follow-
up of PAD in England and the Republic of Ireland 
(ROI), using an online, country-specific, version of the 
EuroPAD survey. We will compare aggregated 
responses with current standards and guidelines, 
explore trends in responses according to practice 
demographics, and link responses to current Quality 
and Outcomes Framework (QOF) indicator 
achievements for PAD, to describe factors associated 
with high or low-level achievement.  
Approach 
The online survey is currently being distributed via 
email to GPs using various means: the local Clinical 
Research Network (CRN), newsletters for Royal 
College of General Practitioners (RCGP) Faculties (in 
England and ROI), Local Medical Committees and the 
RCGP Rural Forum Google Group.Responses will be 
summarised as either mean and standard deviations, 
or median and inter-quartile ranges according to 
normality of the data. Demographic and QOF 
characteristics of responding and non-responding 
practices will be compared using t-tests, Mann-
Whitney or χ2 tests, as appropriate. QOF data will be 
compared with survey responses using Pearson’s 
correlation coefficients or t-tests for unadjusted 
comparisons, and adjusted for practice-level 
demographics using mixed effects logistic 
regression.We aim to obtain 300 responses, which will 
give 90% power (p<0.05) to detect a difference of 
3.5% between QOF reporting of anti-platelet 
prescribing as one indicator of care.  
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Findings 
The survey opened in January 2020. We aim to finish 
data collection by April 2020. The results from this 
ongoing survey will be presented at the conference.  
Consequences 
Our findings will offer insight into current PAD 
management in English and Irish primary care 
settings. These results will be merged with other 
national surveys led by the EuroPAD investigators and 
contribute to a Europe-wide report that can guide 
future policy. The results will provide an evidence 
base to inform the design of future interventions with 
the aim of improving approaches to diagnosing and 
monitoring PAD. We will discuss our findings with our 
Patient Participation (PPI) Group prior to 
dissemination to ensure that interpretation and 
presentation of results are meaningful to service 
users.  
Funding Acknowledgement 
This research was funded by the Scientific Foundation 
Board of the Royal College of General 
Practitioners(Grant No SFB 2019-24). 
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Abstract 
Problem 
Transient ischemic attacks and minor strokes (TIAMS) 
are common and entail risk of subsequent stroke. 
Rapid secondary prevention implementation is vital, 
and most guidelines recommend urgent referral to 
secondary care. There has been a substantial 
improvement in prognosis of TIAMS managed in 
secondary care, coincident with the institution of 
rapid access pathways following the landmark 2007 
EXPRESS and SOS-TIA trials. The overall prognosis for 
TIAMS in contemporary practice, managed across the 
spectrum of primary and secondary care, is less 
certain.We aimed to establish recurrent stroke 
incidence in all patients of 16 general practices, in the 
Newcastle-Hunter Valley-Manning Valley region of 
Australia, who experienced a TIAMS.  
Approach 
We conducted an inception cohort study. Multiple 
overlapping ascertainment methods (the general 
practices; after-hours GP co-operative; hospitals EDs, 
outpatient clinics, and inpatient records) identified 
participating practice’s patients with possible 
TIAMS.Data collection (August 2012-July 2017) was via 
extraction from participant’s clinical notes from all 
above sources and from interviews at baseline, three- 
and 12-months. Adjudication of participant index 
events (and subsequent events) as TIA, minor stroke, 
stroke, or TIAMS-mimic was by a three-member panel 
of senior GPs/stroke physicians.The incidence of 
subsequent stroke in the TIAMS and TIAMS-mimic 
groups was calculated. Time to subsequent event was 
assessed with Kaplan Meier Curves.  
Findings 
Of 613 participants (response rate 49%), 298 (49%) 
were adjudicated to have had a TIAMS (175 TIA, 123 
minor stroke). Of all TIAMS, 26% were managed 
entirely by a GP, 55% were either referred to ED by a 
GP or presented to ED. Of all TIAMS, 9 (3.0%) had a 
subsequent stroke during 12-months follow-up. The 
median time to stroke was 34 days. The Kaplan Meier 
Time to First Recurrent Stroke following a TIAMS 
index event did not display the prominent early 
recurrence (‘front-loaded risk’) of initial 
epidemiological studies.Of 315 mimics, 2 (0.6%) had a 
subsequent stroke.These findings are of considerably 
lower incidence of recurrent stroke than in historical 
TIA cohorts and also lower incidence than in more 
recent (post-EXPRESS/SOS-TIA) secondary care 
cohorts.Possible explanations for this low recurrent 
stroke incidence may include the spectrum of TIAMS 
severity in this community-based study being less 
than that in previous studies of patients reaching 
secondary care. It may also reflect translation to 
practice, including primary care practice, of the need 
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for urgent secondary prevention suggested by the 
findings of EXPRESS/SOS-TIA and subsequent studies.  
Consequences 
The findings have implications for health care systems 
in areas where prompt access to secondary care for 
TIAMS is difficult or not practicable. TIAMS prognosis 
may still generally be good in these settings and 
emphasis may be best directed at referral of highest 
risk patients or of difficult diagnostic scenarios.  
Funding Acknowledgement 
The study was funded by a National Health and 
Medical Research Council (Australia) Project Grant 
(1027794) 
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Abstract 
Problem 
Atrial Fibrillation (AF) is a major risk factor for 
ischaemic stroke unless treated with an anticoagulant. 
Detecting AF can be difficult because it is often 
paroxysmal and asymptomatic. Many clinicians 
support AF screening. The UK National Screening 
Committee and the US Preventive Services Task Force 
have highlighted a lack of evidence that screening for 
AF is beneficial. Informing a large (n=126,000) cluster 
randomised controlled trial in UK general practice, this 
feasibility study aimed to quantify: participation rates, 
screening uptake, AF detection rate, and 
anticoagulation uptake.  
Approach 
8,000 people aged ≥65 registered with a participating 
practice (n=10) were invited to the study. Those that 
consented to take part were invited to a practice AF 
screening appointment, and instructed how to use a 
handheld single-lead ECG device (Zenicor). They 
continued screening at home (1-4 weeks). ECGs were 
reviewed by a computer algorithm, a technician and 
(if potentially ‘positive’) a cardiologist. Treatment for 
AF followed national guidelines.  
Findings 
Results from practices 1-5 (full results will be 
presented):1,644/4,000 (41%) of people consented to 
take part in the study. 1,375/1,512 (91%) of people 
invited for screening accepted. To date, AF was 
detected in 3.1% (4-week screen, 31/987), and in 0.9% 
(1-week screen, 3/347). 17 people with ‘positive’ 
results are still under review, and 19 had 
indeterminate results. Anticoagulation commenced in 
27/34 (79%) people.  
Consequences 
It is feasible to screen for AF in general practice. We 
will modify the screening process in the trial; raising 
the lower age limit to 70 years and screening for three 
weeks per participant.  
Funding Acknowledgement 
This project is funded by the National Institute for 
Health Research (NIHR) School for Primary Care 
Research and Programme Grant for Applied Research 
(Grant Reference Number RP-PG-0217-20007). The 
views expressed are those of the author(s) and not 
necessarily those of the NIHR or the Department of 
Health and Social Care. 
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Abstract 
Problem 
Atrial Fibrillation (AF) is a major risk factor for 
ischaemic stroke unless treated with an anticoagulant. 
Detecting AF can be difficult because it is often 
paroxysmal and asymptomatic. Many clinicians 
support AF screening. The UK National Screening 
Committee and the US Preventive Services Task Force 
have highlighted a lack of evidence that screening for 
AF is beneficial. The 8-year NIHR-funded SAFER 
Programme aims to identify the benefits and harms of 
screening for AF in people ≥70yrs and estimate the 
overall cost-effectiveness. Following a successful 
feasibility study the cluster randomised trial internal 
pilot started in 2020.  
Approach 
Patients will attend their GP practice for instruction in 
the use of a handheld single-lead ECG device. They 
will continue screening at home over a 3 week period. 
Treatment for AF will follow national guidelines.  
1. Internal pilot trial - ongoingCluster randomising 
practices (12 screening, 24 control) to determine AF 
detection rate and inform power calculation for main 
trial.  
2. Main trial – 2021Cluster randomising practices (120 
screening, 240 control; 126,000 patients). 5-year 
follow-up of electronic medical records will determine 
if screening leads to fewer strokes, heart attacks and 
deaths, and whether it increases the risk of serious 
bleeding. 
3. QualitativeInterviews and observations with 
patients and staff to clarify how to best carry out 
screening.  
4. Health economicsA within trial analysis and 
decision modelling analysis to determine whether 
screening is cost effective.  
Findings 
The trial is due to report in 2027.  
Consequences 
This will be the world’s largest planned AF screening 
trial to date and will inform the decision to implement 
a national AF screening programme.  
Funding Acknowledgement 
This project is funded by the National Institute for 
Health Research (NIHR) School for Primary Care 
Research and Programme Grant for Applied Research 
(Grant Reference Number RP-PG-0217-20007). The 
views expressed are those of the author(s) and not 
necessarily those of the NIHR or the Department of 
Health and Social Care. 
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Abstract 
Problem 
National and international guidelines advocate 
advance care planning (ACP) to improve end-of-life 
care for patients with heart failure. ACP improves 
quality of life and patient satisfaction with care but 
clinicians are hesitant to engage with ACP. Only 8% of 
eligible patients have an advance care plan and 
patient care is affected.Behaviour change techniques 
(BCTs) have been used in the past to change clinicians’ 
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practice pattern. But there is no systematic evaluation 
of the evidence base for effective behaviour change 
techniques to support clinicians with ACP in heart 
failure. Our aim was to identify interventions with the 
greatest potential to engage clinicians.  
Approach 
We conducted a systematic review and meta-analysis 
and searched CINAHL, Cochrane Central Register of 
Controlled Trials, Database of Systematic Reviews, 
Embase, ERIC, Ovid MEDLINE, Science Citation Index, 
PsycINFO for randomised controlled trials (RCTs) from 
inception to August 2019. Three reviewers 
independently extracted data, assessed risk of bias 
(Cochrane risk of bias tool), the quality of evidence 
(GRADE) and intervention synergy according to the 
Behaviour Change Wheel and Behaviour Change 
Techniques (BCTs). Odds ratios (ORs) were calculated 
for pooled effects. 
Findings 
We conducted a systematic review and meta-analysis 
and searched CINAHL, Cochrane Central Register of 
Controlled Trials, Database of Systematic Reviews, 
Embase, ERIC, Ovid MEDLINE, Science Citation Index, 
PsycINFO for randomised controlled trials (RCTs) from 
inception to August 2019. Three reviewers 
independently extracted data, assessed risk of bias 
(Cochrane risk of bias tool), the quality of evidence 
(GRADE) and intervention synergy according to the 
Behaviour Change Wheel and Behaviour Change 
Techniques (BCTs). Odds ratios (ORs) were calculated 
for pooled effects.Of 14483 articles screened, we 
assessed the full text of 131 studies. 13 RCTs including 
3709 participants met all of the inclusion criteria. The 
BCTs of prompts/ cues (OR, 4.18; 95% CI [2.03 - 8.59]), 
credible source (OR, 3.24; 95% CI [1.44 - 7.28]), goal 
setting (outcome) (OR, 2.67; 95% CI [1.56 - 4.57]), 
behavioural practice/ rehearsal (OR, 2.64; 95% CI 
[1.50 - 4.67]); instruction on behaviour performance 
(OR, 2.49; 95% CI [1.63 - 3.79]), goal setting 
(behaviour) (OR, 2.12; 95% CI [1.57 - 2.87]), and 
information about consequences (OR, 2.06; 95% CI 
[1.40 - 3.05]) showed statistically significant effects to 
engage clinicians with ACP.  
Consequences 
BCTs that simultaneously involved prompts, goal 
setting (outcome), patients and credible source were 
among the most effective interventions to improve 
clinicians’ practice with ACP in heart failure.  Heart 
failure services should consider these components for 
implementation into routine clinical practice.  
Funding Acknowledgement 
No funding was involved.  We acknowledge and thank 
Nia Roberts, health science librarian, Bodleian Library, 
University of Oxford, for running the literature data 
base searches. 
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Abstract 
Problem 
Evidence in favour of using financial rewards for 
quality improvement in primary care is generally 
inconsistent, often short-lived, and arose from data 
with confounded control groups. The biggest and 
best-known reward scheme is QOF, which has proved 
unpopular with surgeries, and has some negative 
effects on care. East Lancashire CCG has run a local 
quality framework for general practice since 2016/7 
designed to improve standards and diagnosis in AF 
and hypertension, for a fixed amount per head of 
population, rather than the sliding remuneration scale 
used by QOF. Participating surgeries appointed 
surgery leads for AF and hypertension, produced their 
own protocols, and reflected with peer groups on 
protocols and data at quarterly workshops. At SAPC 
ASM, we have previously demonstrated that this 
improves diagnosis rates of hypertension and 
management of AF, after 1 and 2 years, although 
benefits in AF diagnosis seen in year 1 were short 
lived. With latest data available for year 3, we aimed 
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to analyse long-term effects of this continuing 
intervention.  
Approach 
This study used published QOF data to compare those 
surgeries taking part in the intervention (n=57) to 
controls in the rest of England (n=7243). It adopted a 
controlled before-after approach, using the primary 
outcome measure for AF and hypertension of change 
from baseline in mean recorded prevalence per 
surgery. Secondary outcome measures looked at 
indicators of quality of management. Time-series 
analyses at CCG and surgery level were used to 
determine whether the effects of the intervention 
appeared to be uniform with time or peaked then 
waned.  
Findings 
Welch’s t test showed a significantly higher mean 
increase in recorded hypertension prevalence over 36 
months for the intervention group (0.82%) versus 
controls (0.26%), p=0.006, although the mean 
increase in AF prevalence (0.33%) compared to 
controls (0.29%) was non-significant, p=0.305. Time 
series analysis showed that there was a significant 
increase in recorded hypertension and AF prevalence 
in the first year (p=0.033 and 0.006 respectively) and 
in hypertension prevalence in the second year 
(p=0.011) but not in either in the third year. 
Opportunistic BP checks were higher in the second 
year (p<0.001) and AF management in the first year 
(p=0.001) but not in any other year.  
Consequences 
Earlier data demonstrated that this funded quality 
framework designed to meet local needs, could 
engage local primary care providers and improve 
patient outcome measures, without the need for 
target incentivisation. Potentially, it offers an 
alternative method for funding quality improvement 
within existing services. Similar to findings of some 
earlier quality-improvement schemes that 
demonstrated only short-lived benefits, we found that 
acceleration in already improving standards may be 
limited to one or two years, although the overall 
benefit gained during this time is maintained for 
longer. This has implications for the optimum length 
for improvement schemes.  
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Abstract 
Problem 
Approximately 26 million people worldwide are living 
with heart failure (HF) – a serious life-threatening 
disease for which the outlook is often poor. Primary 
care has a crucial role in the management of this 
patient population, yet the optimal structure of care 
remains unclear. About half of patients with HF have 
heart failure with preserved ejection fraction (HFpEF). 
HFpEF is more common in older adults with 
multimorbidity. Compared to HF with reduced 
ejection fraction (HFrEF), there is a limited evidence-
base for management, making the need to establish 
models of care more pressing. This study aims to 
identify key barriers to the optimal care of patients 
with HFpEF.  
Approach 
This study formed part of the NIHR School for Primary 
Care Research funded programme of work aimed at  
Optimising management of patients with HFpEF  
(OPTIMISE HFpEF). A Patient Advisory Group and a 
multidisciplinary team of experts have been involved 
in the development and implementation of the study. 
The research adopted a qualitative multi-perspective 
approach in which findings across key stakeholder 
groups were triangulated using Framework analysis to 
identify key barriers to the optimal care for this 
patient population.  
Findings 
This study entailed 106 interviews and two focus 
groups with key stakeholders. Participants included 50 
patients with diagnosed or suspected HFpEF, nine 
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carers, and 73 clinicians (including 35 GPs, 8 Practices 
nurses, 14 HF Specialist nurses, six Cardiologists and 
ten other Health professionals). Limited 
understanding of the syndrome and associated roles 
and responsibilities were widespread across patients’ 
and primary care clinicians’ accounts, indicating an 
unmet educational need. Respondents described a 
precarious starting point associated with HFpEF in 
terms of lack of awareness, failure to diagnose, and a 
poor evidence-base, from which other problems 
appeared to stem. Some providers, particularly 
specialists, expressed concern that HFpEF patients 
may be missed as the system is attuned to identifying 
reduced ejection fraction, ignoring other parameters. 
GPs conveyed uncertainty about interpreting reports, 
with many relying on summaries or conclusions of 
variable quality. Patients’ descriptions of their journey 
to diagnosis contrasted with linear referral pathways 
of protocols and guidelines, conveying a convoluted, 
protracted series of hospital admissions or specialist 
appointments. The data suggest that amidst 
uncertainty and variability as to how HFpEF was 
identified and understood, and care organised, 
optimal management was problematic leading to 
unclear treatment, diminished possibilities of self-
management and limited access to specialist care.  
Consequences 
Findings suggest that the current approach to the 
management of people with HFpEF in primary and 
secondary care may miss opportunities to optimise 
the care of this patient population owing to limited 
understanding of the condition. Findings are being 
used to inform consensus work leading to the 
development of an optimised programme of 
management in primary care for this patient group.  
Funding Acknowledgement 
The study was funded by the National Institute for 
Health Research, School for Primary Care Research 
(NIHR SPCR). Grant reference number 384. 
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Abstract 
Problem 
The Risk Assessment and Management Programme - 
Hypertension (RAMP-HT) is a territory-wide, multi-
disciplinary, multi-component intervention added 
onto usual primary care that provides total 
cardiovascular disease risk management of 
hypertensive patients. It has proven effectiveness in 
reducing hypertension-related complications and 
mortality among hypertensive patients after 5 years, 
thus potentially lessening healthcare burden. 
However, the sustainability of programme benefit 
remains unknown. This study aims to evaluate the 
cost-effectiveness of the RAMP-HT over lifetime.  
Approach 
A lifetime cost-effectiveness analysis from health 
service provider’s perspective was conducted using 
Markov modelling. Empirical data from a propensity-
score-matched cohort of 79,161 RAMP-HT 
participants and 79,161 usual primary care patients 
with hypertension was used to estimate public direct 
medical costs and gender-specific annual transition 
probabilities of developing hypertension-related 
complications, including coronary heart disease, 
stroke, heart failure and end stage renal disease. The 
mortality of patients with specific hypertension-
related complications was estimated from a cohort of 
327,842 primary care patients with hypertension. 
Private direct medical costs and health preference of 
hypertensive patients with different complication 
status were collected through structured 
questionnaire survey of 486 and 873  patients, 
respectively. Incremental cost‐effectiveness ratios 
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(ICER) was calculated by the ratio difference of direct 
medical cost to difference of quality-adjusted-life-year 
(QALY) gained between RAMP-HT participants and 
usual care patients. Probabilistic sensitivity analysis 
was conducted with results presented as a cost‐
effectiveness acceptability curve.  
Findings 
A RAMP-HT participant was estimated to save US$714 
(US$43,340 vs. US$44,054), gain 0.20 QALYs (12.49 
QALYs vs 12.29 QALYs) and 0.19 life years (LYs) (14.64 
LYs vs. 14.45 LYs), compared to a patient received 
usual care on average. The probabilistic sensitivity 
analysis found that RAMP-HT had 100% chance of 
being cost-saving compared to usual care under the 
assumptions and estimates used in the model. Hence, 
RAMP-HT was proved to be a cost-saving intervention 
dominating usual care, regardless of the willingness-
to-pay threshold. The positive effect of RAMP-HT was 
shown to be greater if the duration of the 
intervention lasted longer.  
Consequences 
RAMP-HT was projected to be a cost-saving 
intervention compared to usual care in preventing 
hypertension-related complications and mortality 
over the lifespan of a hypertensive patient. The 
significant reduction in mortalities, complications and 
resultant direct medical costs could be attributed to 
the team-based approach facilitated by an improved 
electronic information-relay system, which ensured 
delivery of holistic cardiovascular disease risk 
management, enhanced coordination of allied health 
services and maximized use of doctor consultation 
time. In view of the clinical and financial benefits, 
RAMP-HT should be integrated into usual primary 
care to enhance management of hypertensive 
patients. Further study should be conducted to inform 
who will benefit most from and the optimal frequency 
of repeating the RAMP-HT intervention.  
Funding Acknowledgement 
This study was funded by the Health and Medical 
Research Fund, Food and Health Bureau, HKSAR 
(Project no: 13142471). 
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Abstract 
Problem 
Coronary heart disease (CHD) is the most common 
cardiovascular (CV) disease (CVD) and was responsible 
for nearly 9.5m deaths worldwide in 2016. In the UK, 
nearly 2.3m people have CHD. Despite the importance 
of assessing CV severity, however, no established CVD 
severity scores for primary care patients with CHD 
exist. Past studies examining CVD severity in patients 
with CHD are limited, with most currently available CV 
risk stratification tools are for people without 
prevalent CVD.Our study aims:  
1) develop and validate CV severity score in people 
with CHD using routinely-collected clinical data;  
2) evaluate its association with risks of all-cause and 
cause-specific hospitalisation and mortality.  
Approach 
A retrospective cohort study using Clinical Practice 
Research Data link (CPRD) GOLD data between 2007-
2017. People with CHD aged ≥35years and registered 
in English general practices were included. The study 
population was randomly divided into 80% and 20% 
parts as the training and validation datasets, 
respectively. Baseline and longitudinal severity scores 
were developed based on 20 relevant severity 
domains. Cox regression models and competing risk 
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regressions were used to evaluate the association 
between severity and 1-year all-cause mortality 
(primary outcome), 1-year hospitalisations (secondary 
outcomes) after controlling for age, gender, ethnicity, 
and deprivation.Patient and public involvement and 
Engagement (PPIE): we invited people with CHD to a 
PPIE meeting to obtain their opinions on the included 
severity domains and the readability of our lay 
summary. All participants agreed on the importance 
of grading disease severity and their perceptions 
about the domains varied. 
Findings 
A cohort of 213,088 people with CHD (170,395 in the 
training dataset and 42,693 in the validation dataset) 
from 398 general practices was identified. Mean (±SD) 
age was 64.5 (±12.7) years, 98,041 (46%) were 
women, 189,272 (89%) White, and 45,719 (22%) and 
34,412 (16%) from least and most deprived areas, 
respectively.Overall, 49,918 (23%) patients died, and 
173,204 (81%) patients had ≥1 hospitalisation during 
9.4 (±6.0) years of follow-up. A 1-unit increase in 
baseline severity score was associated with 
significantly 41% increased risk for all-cause mortality 
(95%CI: 37%-45%, AUROC=0.83). In the competing risk 
regressions, a 1-unit increase in score was associated 
with 28% increased risk for any-cause hospitalisation 
(27%-29%, AIC=992,096), and 39% risk for 
CV/diabetes hospitalisation (37%-40%, AIC=699,635). 
The new score improved the models' predictive value 
for all outcomes when added to socio-demographic 
variables. The findings were consistent in the 
validation dataset.Conclusions: A higher CV severity 
score in people with CHD is associated with increased 
risks for any cause and CV-related hospital admissions 
and mortality. 
Consequences 
This reproducible scoring tool based on routinely-
collected data can support practitioners to provide 
better clinical management of CHD in primary care 
with wider implications on public health programmes 
for people with CHD and informing commissioning.  
Funding Acknowledgement 
This study is funded by the National Institute for 
Health Research School for Primary Care Research 
(NIHR SPCR), grant number 331. 
 
E.1 
What contribution do the parents of children with 
long term conditions make to their NHS care? A 
qualitative study of lived experience.   
Presenter: Emily Devoy 
Co-authors:  Jennifer Swann, Joanne Thompson 
Institutions 
Academic Unit of Primary Medical Care, The 
University of Sheffield 
Abstract 
Problem 
There is a dearth of literature concerning how parents 
of children with long term conditions (LTCs) 
experience and manage their child’s care and how 
they provide feedback to NHS services. Research has 
shown GPs are often the coordinators of care, but 
very often parents tend to bridge the gap in 
communication between primary and secondary 
healthcare. Therefore, having effective channels for 
parents to provide feedback is an important factor for 
improving experience of both primary and secondary 
care. Parents develop expertise in the management of 
their child’s condition so there is a lot we can learn 
from their experiences to better improve the services 
provided. The literature also shows, having a child 
with a LTC has a broader psychosocial impact on the 
lives of the parents and siblings, including 
employment, support and the financial impact, which 
will be further explored in this research. The aim is to 
understand what contribution parents of children 
with LTCs can make to their NHS care based on their 
lived experience. Our objective is to identify the ways 
in which parents provide feedback to the NHS about 
their child’s care.  
Approach 
This is a qualitative interview study in South Yorkshire. 
A literature review was carried out to identify the 
gaps in the literature. From this the research question 
was formed in an attempt to fill these gaps. A method 
of co-production is being used to ensure public 
involvement and authenticity of the research. Semi-
structured interviews are currently being carried out, 
with six already completed and five more scheduled. 
Recruitment is ongoing and the aim is to interview 15-
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20 parents of children with physical LTCs until data 
saturation. The topic guide is being developed 
iteratively to incorporate emerging themes. The 
interviews are being audiotaped, transcribed verbatim 
and analysis of the results using the Framework 
approach is ongoing and due for completion in April.  
Findings 
Interviews are being conducted between February 
and April and analysis is ongoing. This forms part of an 
educational degree (BMedSci) due for submission in 
May 2020.  This method of co-production allows 
experts in this area to contribute and shape the 
research as it progresses. Our findings will provide a 
greater understanding of parents’ experiences of 
having a child with a LTC and their perspective on 
providing feedback to the NHS.  
Consequences 
This study will show what methods parents use, or 
know about, to provide feedback to NHS services. This 
will allow us to understand where potential 
improvements can be made.  
 
E.2 
Exploring Online Forums to Understand Parents’ and 
Families’ Views about Resources and Sources of 
Support for the Management of Children’s Chronic 
Insomnia in the Community and Primary Care.   
Presenter: Samantha Hornsey 
Co-authors:  Samantha Hornsey [1], Catherine Hill 
[1,2], Ingrid Muller [1], Beth Stuart [1] and Hazel 
Everitt [1] 
Institutions 
[1] University of Southampton, [2] University Hospital 
Southampton NHS Foundation Trust 
Abstract 
Problem 
Poor sleep can affect children’s development in a 
range of ways such as in behavioural, academic, 
cognitive, emotional and physiological domains. A 
common sleep disorder in children is Behavioural 
Insomnia (BI, a form of Chronic Insomnia) and it 
presents as problems initiating and/or maintaining 
sleep. Research indicates that behavioural and sleep 
hygiene interventions are effective for BI (Mindell et 
al, 2006; Allen et al 2016). Within primary care, BI 
could not only be addressed early, but it could also be 
prevented. However, research on the management of 
sleep in paediatric primary care (Honaker and Meltzer, 
2016), though limited, suggests that sleep is not 
regularly discussed in paediatric consultations and 
that formal professional training on the topic is 
lacking. UK research (Hatton and Gardani, 2018) 
suggested that the internet is used as an information 
source by parents or carers of children with sleep 
problems. Other research (Porter and Ispa, 2012) also 
indicated that mothers discuss childrearing concerns 
on online message boards. However, there is no 
published research to date, which analyses online 
discussion forums to specifically explore parent’s 
perceptions of how children’s sleep problems are 
managed in primary care. Therefore, this study aims 
to explore what parents post in discussion forums 
about their concerns and expectations regarding 
children’s sleep problems, and how they perceive 
these sleep problems to be addressed during GP 
consultations. It also aims to explore whether the 
parents are aware of any resources (online, in the 
community or in primary care).  
Approach 
This study takes an exploratory qualitative approach 
by analysing posts from parents/carers in public 
online discussion forums, which are about children’s 
sleep problems in primary care or the community. 
Scoping searches have been conducted to inform a 
systematic search for each online forum included in 
this study. Final searches are being conducted in the 
three active online discussion forums using terms for 
sleep and terms for various primary care practitioners 
(e.g. ‘GP and ‘doctor’). Data is being collected by 
downloading the first 300 relevant discussion threads 
in total and data will be coded in Nvivo. Qualitative 
analysis of the threads will be based on inductive 
thematic analysis, involving reading and rereading the 
data, generating and reviewing a coding schedule and 
by refining the themes and subthemes that emerge.  
Findings 
Data is currently being collected. However, the results 
will be presented at the conference.  
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Consequences 
Parents’ and carers’ perspectives about the available 
support for children’s sleep problems in primary care 
and the community will be highlighted by this study. 
This will therefore highlight areas for improvement 
which can be addressed by future research. It will also 
inform the development of possible support tools (to 
be used by families and primary care providers).  
Funding Acknowledgement 
This project is funded by the National Institute for 
Health Research (NIHR) School for Primary Care 
Research.  The views expressed are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
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Everitt [1] 
Institutions 
[1] University of Southampton [2] University Hospital 
Southampton NHS Foundation Trust 
Abstract 
Problem 
Poor sleep in children can have both physiological and 
psychological consequences on their development. A 
form of Chronic Insomnia, Behavioural Insomnia in 
children (BI) is common and is typically discussed as 
problems with limit setting and/or with sleep-onset 
associations. Research indicates that behavioural 
interventions (e.g. extinction methods, parental 
education, stimulus control methods) and sleep 
hygiene interventions are effective treatment 
strategies (Mindell et al 2006; Allen et al 2016). 
Primary care offers potential to help families prevent 
BI or address it early (reducing the risk of 
consequences of persisting sleep problems). Research 
on this topic is limited, however, a review (Honaker 
and Meltzer 2016) suggested that for general sleep 
problems in paediatric primary care, professionals’ 
formal training about sleep is limited and that sleep is 
rarely discussed in appointments. Our review further 
explores primary care professionals’ (PCPs) current 
practice, knowledge, and perceptions of role, 
regarding management specific to BI.  
Approach 
A systematic search strategy consisting of various 
terms for ‘sleep’, ‘child’ and ‘primary care’ was 
conducted in six electronic databases (CINAHL, 
EMBASE, MEDLINE, PsycINFO, Web of Science and 
Cochrane Library CENTRAL). Studies were selected if 
they included PCPs seeing families about BI (or 
parents/children presenting to PCPs with sleep 
problems) and if they looked at PCPs knowledge, role 
perceptions or current practice regarding 
management of BI in primary care. SH lead initial / full 
text screening and many of the potentially eligible full 
texts have been screened for full eligibility. SH is 
leading data extraction and data from included 
studies to date have been extracted. Further data is 
being extracted accordingly, as further articles are 
included from the remaining full texts. Twenty 
percent of initial results were also screened by BS who 
will also screen 20% of full texts and check data 
extraction. Quantitative and qualitative papers will be 
synthesised with a narrative synthesis and thematic 
synthesis, respectively. Quality appraisal will be 
assessed using the Mixed Methods Appraisal Tool.  
Findings 
There were 7578 results from the databases searches 
(de-duplicated to 5505). Title and abstract screening 
resulted in 499 potentially eligible full texts to read. 
To date, 11 papers have been included for analysis, 
from which data have been extracted. To date, UK 
research is lacking. Preliminary synthesis is being 
conducted whilst the final full texts are being 
screened. Full results will be presented at the 
conference.  
Consequences 
Findings will highlight what PCPs currently know, 
practice and perceive their role to be, regarding the 
management of children’s BI.  Findings will direct 
future research which aims to further explore, or 
improve, particular areas of management of BI within 
primary care.  The lack of UK based studies is notable, 
indicating that further UK research is warranted.  
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Health Research (NIHR) School for Primary Care 
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E.4 
What is a most important measure for food allergy in 
nursery?   
Presenter: Mitsunobu Kaneko 
Co-authors:  Tomoko Miyoshi, Yoshihiro Miyashita, 
Riku Hayashi, Yuji Okano 
Institutions 
The Department of Nursery Health Administration, 
Kawasaki Branch of Japan Medical Association 
Abstract 
Problem 
As food allergy potentially can induce life-threatening 
anaphylaxis, measures for food allergy are required at 
nurseries caring for food allergy children, but a large-
scale factual investigation has not been carried out.  
Approach 
We evaluated measures for food allergy and 
emergency cases of food allergy children in nurseries. 
A questionnaire survey regarding emergency 
measures in all authorized nurseries (411 facilities 
including 20586 children) was conducted in Kawasaki 
city, Japan.  
Findings 
The recovery rate of the questionnaire was 46.5%, 
which include 14343 children of 191 facilities in total. 
A total of 637 children (4.4%) in 157 facilities (82.2%) 
requires elimination diets that were suggested by 
physicians. Among them, 22 children had been 
suggested to undergo the use of epinephrine auto-
injection kit for emergency. 161 facilities (84.3%) had 
set a specific manual for emergency of food 
allergy.Emergency cases over the past one year were 
four cases and there was no case that had been 
suggested to use epinephrine auto-injection kit. All 
were anaphylaxis and the causes of it included two 
accidental digestion of culprit foods and the causes of 
other two cases were unknown. A case who required 
no elimination diet showed first episode of 
anaphylaxis. All cases were recovered.High 
percentage of nurseries in Kawasaki city has cared for 
food allergy children. While many children with food 
allergy have been in nurseries, only several cases of 
anaphylaxis has been reported for a one year. Among 
four cases of anaphylaxis, no specific cause has not be 
recognized in two cases and one case has been the 
first episode of anaphylaxis.  
Consequences 
While most of nurseries have set specific measures for 
emergency of food allergy, there is certain possibility 
that nursery staffs can encounter the first episode of 
anaphylaxis even if there is no food allergy child. For 
all nurseries, emergency measures for food allergy is 
vital.  
Funding Acknowledgement 
The authors declare no conflicts of interest associated 
with this study. 
 
E.5 
Helping parents of children with respiratory 
infections decide when to seek medical help: an 
appropriateness study   
Presenter: Louise Newbould 
Co-authors:  Newbould L, Campbell S, Edwards, Morris 
RL, Hughes E, Hayward G, Hay AD 
Institutions 
Social Policy Research Unit, University of York; NIHR 
Greater Manchester Patient Safety Translational 
Research Centre, University of Manchester, UK.; 
Nuffield Department of Primary Care Health Sciences, 
University of Oxford; Manchester University NHS 
Foundation Trust; Centre of Academic Primary Care, 
University of Bristol. 
Abstract 
Problem 
Meeting demand for care is a challenge for primary 
care services internationally. Respiratory tract 
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infections (RTI’s) in children are the most common 
problem managed, and the most frequent reason for 
antibiotics to be prescribed. Parents report they are 
often unsure if and when to seek help, and that 
existing guidance is unclear. Our research addresses 
this key issue, as far as we are aware, for the first time 
worldwide.AimTo develop appropriateness criteria to 
support parental decision making regarding the 
appropriate next step and when to consult 
GP/A&E/999 and when to self-care  
Approach 
The UCLA/RAND method was applied in two-stages. A 
panel of experts (pharmacists, NHS 111 nurses, GPs 
and Children’s A&E Consultants) rated 1,134, first on 
their own and then as part of an expert workshop, to 
see if a consensus could be achieved on the 
appropriate ‘next step’ 
Findings 
Panellists reached a consensus in 755 (66.58%) 
scenarios. Of these 6 (0.53%) were rated with 
disagreement and 383 (33.77%) with an equivocal 
rating. Of those where agreement was obtained, an 
appropriate next step was identified in 449 (39.59 %) 
scenarios. Increasing numbers of symptoms were 
generally associated with escalation of care from self-
care to NHS111/GP to ED/999. In addition, past 
medical history of hospital admission for asthma, 
bronchiolitis or other respiratory condition had a 
nominal impact on panel ratings, though the 
threshold for the appropriateness of accessing 
services generally increased with a child aged over 12 
years. Informed use of self-care including, pharmacy 
services, is often appropriate for normal symptoms of 
RTI of several days duration in children, with guidance 
for parents on when to consider using primary care or 
emergency services having the potential to optimise 
appropriate care options.  
Consequences 
Clinicians and policy makers may wish to use promote 
these criteria to parents to help inform healthcare 
seeking decision making. In an age where any 
symptom may be regarded as abnormal and therefore 
requiring treatment, perhaps in part explaining the 
rising demand for care, these criteria could be 
considered useful to distinguish ‘normal’ from 
‘abnormal’ infections.  
Funding Acknowledgement 
NIHR School of Primary Care Research grant number 
417  GH and GE are funded by the NIHR Community 
Healthcare Medtech and IVD Cooperative. The views 
expressed are of the authors and not of the 
Department of Health and Social Care 
 
F.1 
Ethical and feasibility challenges in scaling up to a 
randomised trial of a complex intervention tackling 
problematic primary care prescribing: a consensus 
process   
Presenter: Sarah Alderson 
Co-authors:  Amanda Farrin, Alexander Bald, Paul 
Carder, Robbie Foy 
Institutions 
Leeds Institute of Health Sciences, Leeds Institute for 
Clinical Trials Research, University of Leeds Medical 
School, West Yorkshire Research and Development 
Abstract 
Problem 
Cumulative meta-analysis of ‘Audit and Feedback’ 
(A&F) trials have shown no improvement in effect 
sizes, suggesting a lack of learning on how to improve 
effectiveness. The Campaign to Reduce Opioid 
Prescribing (CROP) provided 316 practices in West 
Yorkshire, UK (population 2.24 million) with bimonthly 
evidence-based enhanced A&F reports on their opioid 
prescribing for one year. The CROP intervention 
reduced predicted opioid prescription spending by 
£900,000 in West Yorkshire.We explored feasibility 
and ethical challenges of scaling up the CROP 
intervention for a primary care randomised controlled 
trial to reduce harmful opioid prescribing whilst 
adding significantly to the wider evidence base on 
A&F.  
Approach 
A structured Delphi consensus panel of A&F experts, 
primary care medicines optimisation leads and 
members of our existing Patient and Public 
Involvement Panel identified solutions to the ethical 
and feasibility issues of scaling up the CROP 
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intervention to a trial, drawing upon a state-of-the-
science summary of recommendations, on-going 
research and medicines optimisation expertise.The 
consensus process had two rounds and participants 
were presented with a range of trial feasibility issues 
to be considered (e.g. randomisation, ethical and 
governance issues). Participants rated characteristics 
for each recommendation on a 1-9 scale, where 
scores of ‘1’ indicates the strongest disagreement and 
scores of ‘9’ indicate strongest agreement.  
Findings 
Consensus was reached for 36 key conclusions. An 
opt-out approach to practice consent for a trial was 
the most acceptable approach to recruitment, 
however waiving consent completely was considered 
the most ideal. Randomisation at practice or primary 
care network level was preferred to higher level 
randomisation (e.g. by Clinical Commissioning Group). 
Participants rated detailed prescribing information 
highly, such as high-risk sub-groups of patients and 
excluding those not targeted by the feedback, such as 
those with palliative care patients, rather than total 
number of prescriptions.  
Consequences 
Waiving consent is the ideal option for primary care 
A&F studies using aggregated practice data, as 
obtaining consent may undermine results and create a 
greater burden than the A&F intervention, however 
this may be complicated by data protection. 
Randomisation at primary care network level is 
acceptable and may reduce the risk of trial arm 
contamination, although there are inherent risks of 
organisational instability which may threaten future 
randomisation. A key factor to the successful planning 
and delivery of a primary care A&F intervention trial 
will be how well ethical and feasibility issues relating 
to trial consent (waive consent, practice or Clinical 
Commissioning Group consent), unit of randomisation 
(practices, Clinical Commissioning Groups or regional), 
and the source of primary care data (nationally 
gathered databases or electronic health records) are 
resolved. We will present the panel's 36 key 
conclusions for scaling up a primary care intervention 
into a randomised controlled trial.  
 
 
Funding Acknowledgement 
This work was supported by the Wellcome Trust 
Institutional Strategic Support Fund (grant no. 
204825/Z/16/Z). 
 
F.2 
Trial based cost-effectiveness evaluation of Link-me: 
A systematic approach to stepped mental health care 
in primary care   
Presenter: Mary Lou Chatterton 
Co-authors:  Cathrine Mihalopolous, Jan Faller, Susan 
Fletcher, Matthew Spittal, Meredith Harris, Philip 
Burgess, Patty Chondros, Victoria Palmer, Bridget 
Bassilios, Jane Pirkis, Jane Gunn 
Institutions 
Deakin University, The University of Melbourne, The 
University of Queensland 
Abstract 
Problem 
Stepped care has been promoted to reduce health 
care costs without compromising outcomes in the 
management of mental health. However, there is 
limited empirical evidence to support the cost-
effectiveness of stepped care for mental health 
treatment in primary care. One challenge to its 
implementation is the identification of patient need to 
allow timely matching to appropriate interventions. 
Link-me is a multifaceted, digitally supported, 
systematic approach to stepped care beginning with a 
patient-completed Decision Support Tool (DST) 
allocating patients into two treatment pathways (low 
intensity services, care navigation) based on predicted 
depressive and anxiety symptom severity 
(minimal/mild, severe) in 3 months. We conducted an 
economic evaluation within a parallel, stratified 
individually randomised controlled trial (RCT) to 
evaluate the costs and outcomes of Link-me 
compared to usual care for patients in the 
minimal/mild and severe groups.  
Approach 
The RCT screened 15,474 adults attending general 
practices in 3 Australian states. Health sector costs 
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included the DST, care navigation and other health 
care services used by participants during the trial. 
Societal costs included health sector costs plus lost 
productivity. DST and care navigation cost were 
determined through provider records. Other health 
care service use (i.e. hospitalisations) and lost 
productivity were captured through a self-report 
resource use questionnaire at 6-month follow-up. 
Standard Australian unit costs were applied 
(2018/2019 AUD). Outcomes included psychological 
distress [Kessler Psychological Distress Scale (K10)] 
and quality adjusted life years [EQ-5D-5L, Australian 
value set]. Incremental cost-effectiveness ratios were 
calculated as the difference in average costs between 
the Link-me and usual care groups, divided by the 
difference in average outcome with nonparametric 
bootstrapping to calculate 95% confidence intervals.  
Findings 
Among 1,671 participants (830 minimal/mild and 841 
severe), Link-me resulted in greater reductions in 
psychological distress at 6 months than usual care 
(standardised mean difference -0.10 (95% CI: -0.18 to 
-0.01). Link-me was associated with higher mean 
health sector costs than usual care of $24 (95% CI $8.3 
to $43.8) per person across all participants, and $333 
(95% CI $125 to $623) per person for the severe 
symptom group. Across all participants, we observed 
an incremental cost per 1-point decrease in K10 score 
of $1,018 (95% CI $259 to $10,471) from the health 
sector perspective and $1,282 (95% CI Dominant to 
$21,964) from the societal perspective. For the severe 
symptom group the incremental cost per 1-point 
decrease in K10 score was $896 (95% CI 234 to 3,978) 
from the health sector perspective and $1,359 (95% CI 
Dominant to 8,677) from the societal perspective.  
Consequences 
These preliminary findings suggest the Link-me 
approach led to improvements in clinical outcomes 
with higher costs. A planned longer-term follow up 
evaluation will examine whether improvements in 
outcomes and trends in cost differences are 
maintained.  
Funding Acknowledgement 
Link-me was funded by the Australian Government 
Department of Health 
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Bowel Syndrome as Second-line Treatment (The 
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Co-authors:  Heather Cook, Matthew Ridd, Robbie 
Foy, Sarah Alderson, Felicity Bishop, Elspeth Guthrie, 
Matthew Chaddock, Delia Muir, Richard Brindle, 
Christopher Taylor, Daniel Howdon, Roberta Longo, 
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Institutions 
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Abstract 
Problem 
Irritable Bowel syndrome (IBS) is common, causing 
abdominal pain, bloating and changes in bowel habit 
that can significantly affect quality of life. Many 
people suffer ongoing troublesome symptoms despite 
having been offered first line treatments. NICE IBS 
guidelines recommend low dose amitriptyline as a 
potential second-line treatment option but evidence 
for its use is limited and it is infrequently prescribed 
for IBS in primary care.The aim of this NIHR HTA 
funded ATLANTIS trial is to determine the clinical and 
cost-effectiveness of low-dose amitriptyline as a 
second-line treatment for IBS in primary care.  
Approach 
ATLANTIS is a randomised, multi-centre, parallel-
group, two-arm, double-blind, placebo-controlled trial 
of low-dose amitriptyline as a second-line treatment 
for people with irritable bowel syndrome (IBS) in 
primary care. It includes an internal pilot and a 
nested, qualitative study. The aim is to recruit 518 
participants from approximately 75 GP surgeries in 3 
geographical areas: West Yorkshire, Wessex and, 
West of England, with the support of local Clinical 
Research Networks. Participants will be identified by 
searching GP lists for people with a diagnosis of IBS 
and sending of invite letters or by opportunistic 
recruitment when people present to the GP surgery. 
Those eligible after screening will be randomised to 
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receive 6 months of trial treatment, taking either 1 to 
3 tablets (10-30 mg) of amitriptyline or placebo once-
daily. Participants will be able to titrate their dose 
(between 1 and 3 tablets) depending on symptoms 
and side effects. At 6 months participants will have 
the option to continue treatment for an additional 6 
months (12 months total treatment).Outcome 
measures will be self-completed online or on paper 
(participant preference) at 3, 6, and 12 months 
following randomisation and a weekly question about 
relief of IBS symptoms. The primary outcome is IBS 
symptom severity score at 6 months. Secondary 
outcomes include the work and social adjustment 
scale, hospital anxiety and depression score (HADs), 
subjects global assessment of relief of IBS symptoms , 
quality of life using EQ-5D-3L and costs using a health 
care resource use questionnaire. A sub-sample of 
participants and recruiting GPs will undertake two 
semi-structured telephone interviews at 6 and 12 
months to identify factors affecting the prescribing, 
acceptability and adherence of low-dose amitriptyline, 
and explore factors that might shape wider use of 
amitriptyline for IBS.  
Findings 
Trial set up and ethical approval has been completed 
and recruitment has begun. Reflections on the 
challenges of setting up this large RCT and initial 
recruitment figures will be presented at the 
conference  
Consequences 
This large RCT will provide robust evidence on the 
clinical and cost effectiveness of amitriptyline for IBS 
in the primary care population and enable patients 
and clinicians to make better informed treatment 
decisions.  
Funding Acknowledgement 
The ATLANTIS trial is funded by the NIHR, HTA Project: 
16/162/01, with additional support from the NIHR 
Clinical Research Network. The views expressed are 
those of the author(s) and not necessarily those of the 
NHS, the NIHR, or the Department of Health and 
Social Care. 
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Palmer, Rosemary Knight, Lauren Jerome, Kimberley 
Potter, Megan Knight, Faran Dhaliwal, Zahra Jamal, 
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Institutions 
London School of Hygiene and Tropical Medicine 
Abstract 
Problem 
The number of sexually transmitted infection (STI) 
diagnoses in the United Kingdom (UK) is rising, with 
the biggest increase in chlamydia and gonorrhoea 
diagnoses. Young people aged 16-24 have the highest 
prevalence of genital chlamydia and gonorrhoea 
compared to other age groups and re-infection rates 
following treatment are high. The risk of adverse 
health effects increases with repeated infections, 
including long-term adverse health effects such as 
sub-fertility and ectopic pregnancy. There is some 
evidence that existing interventions delivered face-to-
face may be effective, but are limited in their reach or 
too costly for widespread application. Phone 
ownership in the UK is high, and young people in 
particular tend to constantly interact with their 
mobile phones. An intervention delivered by mobile 
phone message therefore has the potential to be a 
widely accessible and inexpensive health behaviour 
support. Previous research has found support for 
sexual health via mobile phone messaging to be 
acceptable, and the ability to receive support 
anywhere and anytime facilitated confidentiality and 
privacy. However, no trials to date provide conclusive 
evidence of their effectiveness as support for safer sex 
behaviours. We developed the safetxt intervention 
delivered by mobile phone message to reduce STI by 
increasing partner notification, condom use and STI 
testing among young people in the UK.  
Approach 
We conducted a single blind randomised controlled 
trial to reliably establish the effect of the safetxt 
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intervention delivered by mobile phone messaging on 
chlamydia or gonorrhoea infection at one year. We 
recruited 6250 people aged 16-24 years who had 
recently been diagnosed with chlamydia, gonorrhoea 
or non-specific urethritis from 52 sexual health 
services in the UK. Participants were allocated to 
receive either the safetxt intervention (text messages 
designed to promote safer sexual health behaviours) 
or to receive the control text messages (monthly 
messages asking participants for contact detail 
updates). The primary outcome is the cumulative 
incidence of chlamydia and gonorrhoea infection at 
one year. Secondary outcomes include partner 
notification, correct treatment of infection, condom 
use, and STI testing prior to sex with new partners.  
Findings 
Follow up for the safetxt trial will be complete in 
March 2020. We will present preliminary findings 
from the trial.  
Consequences 
If effective, a safer sex intervention delivered by 
mobile phone messaging has the potential to increase 
safer sex behaviours in young people, and reduce the 
number of chlamydia or gonorrhoea infections. This 
would be an important impact on the sexual health of 
young people in the UK.  The intervention would likely 
have a global impact, as short written messages 
delivered via mobile phones are increasingly used for 
behavioural support worldwide and STIs remain an 
important cause of morbidity and mortality. 
Identifying which intervention components are 
effective has the potential to inform similar 
interventions in the future.  
Funding Acknowledgement 
NIHR 
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Abstract 
Problem 
Over- and under-treatment of mental health problems 
in primary care is common. Stepped care aims address 
this by matching patients to the least intensive 
intervention effective for their level of need. 
However, tools to easily match patients to an 
appropriate intervention in real-time are required. 
Link-me is a multifaceted, digitally supported, and 
systematic approach to stepped care. A patient-
completed Decision Support Tool (DST) allocates 
patients according to their predicted depressive and 
anxiety symptom severity (minimal/mild, moderate, 
severe) in three months’ time, and provides treatment 
pathways matched to group allocation. This 
randomised controlled trial (RCT), examined whether 
Link-me improved psychological distress at 6 months, 
relative to usual care plus attention control, for the 
minimal/mild or severe groups.  
Approach 
Adult patients (18-75) attending 23 general practices 
in 3 Australian states were invited to complete the 
Link-me DST on a purpose-built online platform which 
included a randomisation function. The comparison 
arm received usual care plus attention control 
(information on community-based resources). The 
intervention arm received feedback on Link-me DST 
responses, treatment priority-setting, reflection on 
their motivation to change, and an evidence-based 
treatment recommendation (low intensity service 
options for the minimal/mild group and a 
collaborative care-based, motivational-interviewing 
informed intervention referred to as care navigation 
for the severe group). This presentation reports on 
patient-reported outcome measures completed 
online at 6 months. The primary outcome was 
psychological distress (Kessler Psychological Distress 
Scale [K10]). Secondary outcomes included 
depression, anxiety, and quality of life.  
Findings 
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Of 15,474 patients screened, 7,985 were eligible; of 
those, 1,671 were allocated into the minimal/mild (n = 
830) or severe symptom groups (n = 841) and 
randomised. Intention to treat analyses found that 
overall, Link-me resulted in greater reductions in 
psychological distress at 6 months than usual care, 
with a standardised mean difference (effect size) of -
0.09 (95 % CI: -0.17 to -0.01). The intervention effect 
differed for the two symptom severity groups: 0.04 
(95% CI: -0.17 to 0.24) for the minimal/mild symptom 
group and -0.26 (95% CI: -0.43 to -0.09) for the severe 
symptom group. Supplementary analyses showed 
increasingly large and more clinically meaningful 
effect sizes associated with delivery of additional 
elements of the intervention in the severe group.  
Consequences 
These preliminary findings suggest that the Link-me 
approach to matching interventions to patient need is 
feasible in primary care and can improve mental 
health outcomes, particularly amongst those with 
severe symptoms. Implementation of Link-me into 
routine practice could reduce unnecessary treatment 
burden and improve allocation of treatment 
resources. Future analysis will examine the longer-
term effect of the intervention.  
Funding Acknowledgement 
Link-me was funded by the Australian Government 
Department of Health. 
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Abstract 
Problem 
Frailty is common in clinical practice. Many clinical 
guidelines warn that clinical trial findings may not be 
applicable to frail patients. However, few trials 
explicitly quantify or report frailty. In this study we 
quantified frailty using individual patient data from 
industry-sponsored clinical trials of pharmacological 
interventions. We included three exemplar 
conditions: type 2 diabetes mellitus (T2DM), chronic 
obstructive pulmonary disease (COPD), and 
rheumatoid arthritis (RA).  
Approach 
Trials were identified from the Clinical Study Data 
Request repository. Frailty index (FI) was calculated 
using a previously published standard method. Forty 
deficits (comorbidities, laboratory deficits, functional 
limitations and symptoms) meeting standard FI 
criteria were identified from baseline data. The FI was 
calculated for each participant as the total number of 
deficits present, divided by the total number of 
possible deficits. Participants with an FI >0.24 were 
considered ‘frail’. FI 0.12-0.24 was considered ‘pre-
frailty’. Baseline disease severity was assessed using 
HbA1c for T2DM, % predicted FEV1 for COPD, and 
Disease Activity Score-28 (DAS-28) for RA. Using 
generalised gamma regression, we modelled FI on 
age, sex and disease severity. In negative binomial 
regression we modelled serious adverse event rates 
on FI.  
Findings 
26 studies were identified from the CSDR repository, 
of which 13 contained sufficient data to calculate a 
40-item FI (5 T2DM, 4 COPD, 4 RA). The remaining 
trials redacted or did not record individual-level 
participant data (IPD) on baseline functional 
measures, medical history and/or laboratory deficits. 
The prevalence of frailty ranged from 7-22% in T2DM 
trials, 15-21% in COPD trials, and 32-46% in RA trials. 
Increased disease severity (HbA1c, FEV1 or DAS-28, 
respectively) and female sex were associated with 
higher FI in all trials. Older participants had a higher FI 
in T2DM and RA trials, however there was no 
significant association with age in the COPD trials. 
After adjusting for age, sex and disease severity, in 10 
out of the 13 trials, a higher FI was associated with a 
higher rate of serious adverse events (e.g. incidence 
rate ratio 1.56 (95% confidence interval 1.05-2.40) per 
0.1-point increase in FI).  
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Consequences 
Using a standard method, frailty among clinical trial 
participants was quantifiable, and generally showed 
the expected associations with age, sex, disease 
severity and serious adverse event rates. The 
prevalence of frailty varied between trials and 
between index conditions, but all trials included some 
frail participants. Clinical trials therefore appear to be 
an underused resource for determining treatment 
effects in people with frailty. Understanding 
treatment effects in people with frailty is essential to 
inform decision making and maximise wellness across 
the life course.  
Funding Acknowledgement 
Peter Hanlon is funded by a Medical Research Council 
Clinical Research Training Fellowship. 
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Abstract 
Problem 
22% of women report smoking in the year before 
pregnancy. Around half quit smoking during 
pregnancy, but up to 76% return to smoking within 6 
months. There is currently no routine support 
preventing relapse. Sustained smoking abstinence has 
significant health benefits for mothers, minimising 
long-term smoking harm. Furthermore, maternal 
smoking is the primary source of infant/child second 
hand smoke exposure and a substantial cause of child 
morbidity and mortality. “BabyBreathe” successfully 
developed by our team through an MRC PHIND 
project, is a novel, complex intervention, offering a 
combination of face-to-face, digital and tailored 
support to postpartum women. Study aim: to 
undertake a randomised controlled trial (RCT) with 
internal pilot, comparing BabyBreathe with usual care, 
assessing long-term smoking abstinence for mothers 
who have recently given birth and have stopped 
smoking during pregnancy, or during the 12 months 
prior to pregnancy.  
Approach 
The study design is an RCT with internal pilot trial, 
including economic evaluation and process 
evaluation. We will recruit 880 pregnant women who 
quit smoking for or during pregnancy identified 
through their routine midwife or health visitor 
appointments across four areas of the UK (Norfolk, 
London, Scotland, the North East). We will run an 
internal pilot study, with clear stop/go criteria, to test 
recruitment systems. We will definitively test the real-
world effectiveness of BabyBreathe intervention in 
comparison with usual care, by comparing smoking 
abstinence at 12-month follow-up between trial 
groups. We will undertake a cost-effectiveness 
analysis of BabyBreathe in comparison with usual 
care, based on healthcare resource use of mother and 
infant (from NHS, social care and broader family 
perspectives) and health related quality of life. We will 
undertake a mixed-methods process evaluation to 
assess delivery, implementation, fidelity and 
contamination and to identify mechanisms of action, 
by exploring which intervention components may be 
particularly effective, for which women, in which 
contexts.  
Findings 
Trial start date Spring / Summer 2020, total duration 
39 month: 3m study set up, 15m recruitment, 12-15m 
follow-up; 6m analysis and dissemination. Details 
around planned recruitment strategies and 
intervention delivery will be shared.  
Consequences 
As a definitive trial, the short-term anticipated impact 
if the intervention is found to be effective and cost-
effective, will be recommendations for change in 
healthcare policy and practice for supporting 
postpartum relapse prevention. The anticipated 
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impact of our intervention will be significant 
improvements in smoking relapse rates, resulting in 
improved health outcomes for mothers, increased 
smoking cessation for partners and reduced second-
hand smoke for babies and families.  
Funding Acknowledgement 
Public Health Research Programme, National Institute 
for Health Research 
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Abstract 
Problem 
Supporting prescribing in older patients with 
multimorbidity in Irish primary care (SPPiRE) is an 
ongoing cluster randomised controlled trial that was 
designed to evaluate the effectiveness of an 
individualised web guided medication review in 
reducing potentially inappropriate prescribing and 
polypharmacy. The population under investigation are 
adults in primary care aged ≥ 65 years who are 
prescribed ≥ 15 medicines. This cohort was targeted 
as a national Irish dispensing database indicated that 
approximately 5% of Irish adults aged 65 years and 
older are on ≥15 medicines and the first nationally 
published multimorbidity guidelines in the UK 
recommended targeting patients on ≥15 medicines as 
they are at particular risk of adverse medication 
related events. The aim of this study is to describe 
patient uptake rates for the SPPiRE trial and to 
describe baseline characteristics of this population.  
 
 
Approach 
Quantitative data collected for the purpose of the 
trial’s CONSORT participant flow is summarised using 
descriptive statistics. Patient characteristics including 
demographics and patient reported outcome 
measures (PROMs) obtained from baseline 
questionnaires are presented using descriptive 
statistics.  
Findings 
Between April 2017 and December 2019, 3,113 
patients from 74 practices were identified by running 
a patient finder tool; 1,790 of these were deemed 
eligible to participate giving an eligibility fraction of 
57.5%. The most common exclusion criteria were 
nursing home residents and those cognitively unable 
to participate. Of the 1790 eligible patients, 422 were 
ultimately recruited and randomised, giving an 
enrolment fraction of 23.6%. Fifty-two patients from 
23 different practices were excluded prior to 
randomisation as the practices failed to recruit a 
sufficient number of participants. The mean age of 
recruited patients was 76.5 years (SD 6.8 years) and 
58.4% were female. The average number of self-
reported GP visits over the previous year was 8.5 visits 
per person (SD 7.1) and 22% of patients reported 
seeing their GP at least once per month. With respect 
to health related quality of life (EQ-5D) scores a 
sizeable proportion reported scores in the severe or 
extreme impairment domains for mobility (27%), 
activities of daily living (25%) and pain (29%). The 
median score on a multimorbidity treatment burden 
questionnaire was 16 (IQR 8) which represents a 
medium treatment burden.  
Consequences 
Providing evidence based care for patients with 
multimorbidity is challenging, given their 
heterogeneity but also given that they are frequently 
excluded from clinical trials, however recruitment in 
this population who have complex multimorbidity has 
particular challenges. The process was slow and 
involved significant time input from recruited GPs and 
study personnel and almost a third of these practices 
were ultimately excluded as they failed to recruit a 
sufficient number of patients. Baseline data suggests 
that recruited patients have a significant disease and 
treatment burden.  
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Abstract 
Problem 
Multimorbidity guidelines recommend tailoring care 
to the individual and eliciting treatment priorities but 
specific recommendations are often missing. 
Developing and evaluating a complex intervention 
takes a considerable period of time, often by the time 
an intervention is ready for evaluation in a definitive 
randomised controlled trial (RCT) the context of the 
evidence base may have evolved. To avoid research 
waste, it is imperative that intervention design and 
evaluation is an iterative and adaptive process 
incorporating emerging evidence and novel concepts. 
The aim of this study is to describe the evolution of a 
multimorbidity intervention in this context of a rapidly 
evolving evidence.  
Approach 
The core components of the original effective 
intervention were identified and maintained and 
following an overview of the literature, novel 
components were added and modifications made to 
discretionary components. A framework that was 
developed to describe intervention modification was 
employed to describe the key features of the 
intervention and its evaluation that were modified. 
These are: 
• The context in which the intervention is 
delivered. 
• The content of the intervention. 
• The evaluation of the intervention.  
Findings 
Supporting prescribing in older adults with 
multimorbidity (SPPiRE) is a cluster RCT that was 
designed to evaluate the effectiveness of a complex 
intervention comprising a web guided medication 
review and professional training in reducing 
polypharmacy and potentially inappropriate 
prescribing (PIP) in older adults on 15 or more regular 
medicines in Irish primary care. SPPiRE built on a 
previous trial, Optimising prescribing for older people 
in primary care (OPTI-SCRIPT), which was an 
exploratory cluster RCT that demonstrated that a web 
guided medication review was effective in reducing 
PIP in older adults in primary care. Due to the evolving 
evidence base and the results of another RCT looking 
at a similar problem, the research question was 
reconsidered and the population under investigation 
changed from older people with an identified PIP to 
older people with significant polypharmacy, a proxy 
marker for complex multimorbidity. The core 
component of the OPTI-SCRIPT intervention, a GP 
delivered web-guided medication review, was 
maintained and additional components including an 
assessment of patient treatment priorities. To assess 
the effect of these new components, an additional 
primary outcome measure, the number of repeat 
medicines was included as were additional patient 
reported secondary outcome measures including a 
multimorbidity treatment burden score.  
Consequences 
Intervention modification is different from 
“intervention drift” or unplanned changes that are 
assessed in a trial’s process evaluation. A framework 
that has been implemented in public health research 
was adapted and used to systematically describe how 
and why the original OPTI-SCRIPT intervention was 
modified, allowing SPPiRE to build upon an effective 
and robustly developed intervention but also to be 
relevant in the context of the current literature and 
evidence base.  
Funding Acknowledgement 
Funded by the HRB Primary Care Clinical Trials 
Network in Ireland 
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Abstract 
Problem 
Eczema is a common inflammatory skin disorder 
characterised by red itchy skin and dryness. Eczema 
can lead to poor quality of life due to itching or 
bleeding skin and broken sleep. A common cause of 
poor control of eczema is the underuse of effective 
treatments. Reasons for underuse include concerns 
about safety of treatments, time consuming 
treatments, and insufficient or conflicting advice 
about how to use treatments.  
Approach 
We have developed two online interventions to 
support self-care for people with eczema; one for 
young people aged 13-25 years and one for parents 
and carers of children aged 0-12 years. The 
interventions support self-management of eczema 
using tailored content delivered in a series of 
modules, accessible from mobile devices and 
computers.  Interventions have been iteratively 
developed following evidence, theory and the Person-
Based Approach. We are currently carrying out two 
randomised controlled trials to assess the 
effectiveness of: 
1. the ECO intervention in young people with 
eczema aged 13-25 years 
2. the ECO intervention in parents and carers of 
children with eczema aged 0-12 years Both trials will 
include an internal pilot phase and nested health 
economic and process evaluation studies. 
Findings 
200 participants will be recruited into each trial from 
UK Primary Care. Participants will be invited to 
participate if they are: 
•  a young person aged 13-25 years or a 
parent/carer of a child aged 0-12  years 
• AND they have a recorded diagnosis of 
eczema in their records and  have obtained a 
prescription for this in the past 12 monthsPotential 
participants with a Patient-Oriented Eczema Measure 
score less than 5 will be excluded as having very mild 
or quiescent eczema. 
Participants will be randomised to one of two groups: 
1. Usual care (with access to the online 
intervention after 52 weeks of follow-up) 
2. Usual care plus immediate access to the 
online intervention  
The primary outcome for both trials will be eczema 
severity over 24 weeks measured by 4-weekly Patient-
Oriented Eczema Measure (POEM) which measures 
frequency of symptoms. Secondary outcomes include: 
Quality of Life, long-term eczema control, itch 
intensity measure, enablement, service use and 
medication use.  
Consequences 
If these interventions prove to be effective, health 
professionals would be encouraged to recommend 
their use as part of standard care. Improved self-care 
has the potential to benefit patients and carers 
through improved control of eczema.  
Funding Acknowledgement 
This study is funded by the NIHR Programme Grants 
for Applied Research (RP-PG-0216-20007). Data 
collection for Healthtalk.org was funded by National 
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Abstract 
Problem 
We developed a complex intervention called DECIDE 
(ComputeriseD dECisIonal support for suboptimally 
controlleD typE 2 Diabetes mellitus in Irish General 
Practice) which used a clinical decision support system 
to address clinical inertia and support GP 
intensification of treatment for adults with 
suboptimally controlled T2DM.  
Approach 
The current study explored the feasibility and 
potential impact of DECIDE, through a pilot cluster 
randomised controlled trial (RCT). Conducted in 14 
practices in Irish General Practice, the DECIDE 
intervention was targeted at GPs. They applied 
DECIDE to patients with suboptimally controlled 
T2DM, defined as a HbA1c ≥ 70mmol/mol and /or BP 
≥ 150/95 mmHg. The intervention incorporated 
training and a web-based clinical decision support 
system which supported; i) medication intensification 
actions; and ii) non-pharmacological actions to 
support care.  Control practices delivered usual care.  
Feasibility and acceptability was determined using 
thematic analysis of semi-structured interviews with 
GPs, combined with data from the DECIDE website. 
Clinical outcomes included HbA1c, medication 
intensification, blood pressure and lipids.  
Findings 
We recruited 14 practices and 134 patients. At 4-
month follow-up, all practices and 114 patients were 
followed up. GPs reported finding decision support 
helpful navigating increasingly complex medication 
algorithms. However, the majority of GPs believed 
that the target patient group had poor engagement 
with GP and hospital services for a range of reasons. 
At follow-up, there was no difference in glycaemic 
control (-3.6mmol/mol (95% CI; -11.2, 4.0)) between 
intervention and control groups or in secondary 
outcomes including, blood pressure, total cholesterol, 
medication intensification or utilisation of services. 
Continuation criteria supported proceeding to a 
definitive randomised trial with some modifications.  
Consequences 
The DECIDE study was feasible and acceptable to GPs 
but wider impacts on glycaemic and blood pressure 
control need to be considered for this patient 
population going forward.  
Funding Acknowledgement 
This work was supported by the Health Research 
Board (HRB) Centre for Primary Care Research grant 
number: HRC-2014-1. The authors would also like to 
acknowledge support from the HRB-funded SPHeRE 
PhD Programme (Grant code: 1598), a research grant 
from the Irish College of General Practitioners, the 
WestREN Research Network and the HRB Primary 
Care Clinical Trials Network Ireland (Grant Code: CTN-
2014-011). 
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Abstract 
Problem 
Care navigation has been identified as effective to 
support patients to navigate complex health systems, 
treatment pathways, reduce barriers to accessing 
services and, to attend to social and health needs. 
Literature indicates however that diversity in care 
navigation models does exist and there is no 
consensus on the ingredients of such models for 
primary care. There is some literature on positive 
experiences for patients and for supporting 
coordination of care across sectors (e.g. from hospital 
to primary care). However, the evidence for whether 
care navigation results in improved mental health 
outcomes is limited; particularly for complex mental 
health needs in the primary care setting. In the Link-
me randomised controlled trial we tested whether 
care navigation would improve mental health 
outcomes for people with severe mental health 
symptoms.  
Approach 
Link-me was a multifaceted, digitally supported, and 
systematic approach to stepped care for mental 
health. A patient completed Decision Support Tool 
(DST) allocated people to minimal/mild, moderate or 
severe groups based on predicted depressive and 
anxiety symptom severity in three months’ time. 
Treatment pathways were matched to group 
allocation. Those with severe symptoms were 
randomized to receive usual care or care navigation. 
Care navigation comprised a non-mental health 
professional delivering care planning, coordination, 
and funding to support individuals to find and access 
services to improve mental health for up to eight 
structured contacts. The care navigation model 
delivered in Link-me was informed by collaborative 
care and motivational interviewing. As part of the 
process evaluation for the trial 32 semi-structured 
interviews were conducted with eligible participants 
who took part in care navigation. Thematic analysis 
was conducted to identify critical elements of patient 
experiences shared across all 32 interviews and a 
patient reported experiential model of care navigation 
was developed.  
Findings 
There were 420 patients randomized to care 
navigation and 216 engaged in the intervention across 
the 23 participating general practices. Interview 
analysis identified shared positive experiences across 
the group in terms of setting priorities, developing 
plans for actions, and receiving support and linkages 
to services. For some patients this led to greater self-
confidence and the ability to take ownership of their 
own health beyond care navigation. Based on these 
shared experiences we developed a patient-reported 
experiential model of care navigation for mental 
health in primary care. Six interrelated mechanisms of 
action were also identified: dialogue and affirmation, 
insight and self-reflection, self-responsibility and self-
confidence.  
Consequences 
Care navigation can improve care experiences and 
mental health outcomes amongst those with more 
severe symptoms. Identification of the mechanisms of 
action for care navigation is essential for future 
implementation in primary care.  
Funding Acknowledgement 
Link-me was funded by the Australian Government 
Department of Health. 
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Abstract 
Problem 
Cancer outcomes are poor in the UK’s 
socioeconomically deprived communities, with low 
symptom awareness and fatalistic beliefs contributing 
to delayed help-seeking and advanced stage disease. 
The ABACus 3 trial tested the effectiveness of a 
theory-grounded lay advisor-facilitated cancer 
awareness intervention for adults (aged 40+) living in 
deprived communities in healthcare and community 
settings. The intervention entails completion of a 
touchscreen questionnaire (cancer symptoms, 
screening, risk factors), with personalised behavioural 
advice delivered by a trained lay advisor through 
specified behaviour change techniques (BCTs). In 
parallel to the trial, the process evaluation was 
conducted to assess intervention fidelity, dose, 
contamination and reach and to identify key 
mechanisms of change and contextual influences at 
the social and environmental level.  
Approach 
Semi-structured interviews were conducted with lay 
advisors post-training and post-intervention delivery 
to explore resource use, engagement, barriers and 
enablers, delivery of BCTs and perceived social and 
contextual influences. Purposefully sampled semi-
structured participant interviews were conducted 2-4 
weeks and 6 months post-randomisation to explore 
influences on knowledge, beliefs and behaviours, 
contamination, reach, actual and perceived barriers to 
behaviour change and contextual factors (10% across 
time-points and arms). Interviews were transcribed 
verbatim and analysed thematically supported by 
NVivo, 20% independently dual-coded. A purposive 
sample of intervention delivery sessions (20%; based 
on lay advisor, setting type, participant age and 
gender) were audio-recorded with 50% of these 
additionally observed. Audio-recordings and 
observations were used to quantitatively assess BCT 
delivery against a pre-defined coding matrix for 
personalised results to assess fidelity and dose using 
content analysis.  
Findings 
Six lay advisor (n=3) and 37 participant interviews 
were conducted (n=15 at 2-4 weeks, n=22 at 6 
months). Twelve intervention delivery sessions were 
audio-recorded (7 observed) with an average of 68% 
of the theoretical maximum BCTs being delivered 
across the three lay advisors (range 23.7% - 94.9%).  
Personalisation was recognised as key to successful 
engagement; however, advisors were concerned that 
tailoring delivery to the participant’s interest may 
have diluted symptom awareness messages, 
highlighted in the range of BCTs delivered. 
Participants reported high symptom knowledge 
(across both arms) associated with prior experience 
and awareness of mass-media cancer awareness 
campaigns. Contamination occurred between trial 
arms, especially within community settings where 
participants discussed taking part and their results 
within their social networks. Fidelity and dose of the 
intervention were high even though the content of 
discussions, including providing additional information 
and signposting to resources, differed by session and 
advisor.  
Consequences 
High self-reported knowledge is consistent with 
baseline ceiling effects in the main trial primary 
outcome. Whilst personalisation increases participant 
engagement, it may dilute core intervention 
messages. Findings highlight critical learning about 
effective methods of engaging deprived populations in 
research and reinforce the importance of conducting 
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robust process evaluations of cancer awareness 
interventions due to complexities in evaluation.  
Funding Acknowledgement 
This work was supported by Yorkshire Cancer 
Research grant number C402. 
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Abstract 
Problem 
In England there are estimated to be over 100,000 
individuals with chronic Hepatitis C Virus (HCV) 
infection. Since 2016 over 10,000 people per year 
have been treated for HCV and an estimated 50,000 
people have been diagnosed, though many of the 
latter may not have been assessed or currently under 
management by HCV services.  Primary care is the 
largest source of HCV testing, comprising of nearly 
30% of all HCV antibody positive tests in laboratory 
surveillance. Thus, there is a significant number of 
infected individuals in whom the diagnosis has not 
been made and a large number of people who have 
not been treated. Targeted case finding in primary 
care is estimated to be cost-effective, but there is no 
robust RCT evidence of specific interventions.  
Approach 
The objective of the study was to evaluate the 
effectiveness and cost effectiveness of a complex 
intervention in primary care that aims to increase 
uptake of HCV case-finding and treatment.A 
pragmatic, two-armed, practice level, cluster 
controlled randomised trial included 45 general 
practices in the south west England. The intervention 
included: An offer of educational training on HCV for 
practice staff; poster and leaflets displayed in the 
waiting room; electronic algorithm to flag patients 
with HCV risk markers and invite them for an HCV 
test. Control practices followed usual care. The 
effectiveness of the intervention was measured by 
comparing uptake of HCV testing. Intervention costs 
and health service utilisation were recorded to 
estimate the NHS cost per new HCV diagnosis and 
new HCV patient initiating treatment.  
Findings 
The total number of flagged patients was 24 473 
(about 5% of practice list). 2071 (16%) flagged 
patients in the intervention practices and 1163 (10%) 
in control practices were tested for HCV (adjusted rate 
ratio 1.59, 95% confidence interval 1.21 to 2.08; 
P<0.001). The “number needed to help” was 792 (558 
to 1883) patients flagged for one extra HCV diagnosis, 
referral, and assessment. The average cost of HCV 
case finding was £4.03 (£2.27 to £5.80) per at risk 
patient, £3165 per additional patient assessed at 
hepatology, and £6212 per quality adjusted life year 
(QALY) (with 92.5% probability of being below £20 000 
per QALY).  
Consequences 
A complex intervention based around an electronic 
algorithm integrated with primary care practice 
systems can increase HCV case finding by a modest 
amount and be cost effective. The intervention would 
benefit from being optimised before implementation.  
Funding Acknowledgement 
The trial was funded by the NIHR and Department of 
Health Policy Research Programme (PRP) (Grant Code 
015/0309) and trials registration number: 
ISRCTN61788850. 
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Abstract 
Problem 
Five-year lung cancer (LC) mortality rates remain 
unacceptably high, and the UK’s survival rate is poor 
by international comparisons. To improve the poor 
prognosis, methods that detect lung cancer at an 
earlier stage, when it is more likely to be treated with 
curative intent, are needed. Several clinical trials have 
reported that low-dose CT (LDCT) screening can 
detect lung cancer earlier and reduce lung cancer 
mortality by around 20%. Most recently, the NELSON 
trial reported a 24% reduction in lung cancer mortality 
from screening after 10-years of follow-up of 13,131 
men. These findings provide impetus to consider 
National screening programmes for the early 
detection of lung cancer. However, the widespread 
adoption of LDCT screening will likely remain limited 
by resource constraints, high false positive rates and 
concerns about overdiagnosis. Less resource-intensive 
investigations, such as a biomarker test, continue to 
provide a feasible alternative as a first-line screening 
test by contributing to more precise, risk-based 
targeting strategies for LDCT screening.  
Approach 
ECLS was a pragmatic randomised controlled trial 
involving 12,208 high-risk participants recruited 
through General Practices and community-based 
recruitment strategies in Scotland. The trial addressed 
whether the EarlyCDT-Lung test and subsequent 
imaging can reduce the incidence of patients with 
late-stage lung cancer at diagnosis compared to 
standard clinical practice. The EarlyCDT-Lung blood 
test is a biomarker panel that measures seven 
autoantibodies that can be found in patients with lung 
cancer up to four years before symptomatic 
presentation. The intervention arm received the 
EarlyCDT-Lung blood test and, if test-positive, LDCT 
scanning 6-monthly for up to two years. The control 
arm received standard clinical care.  
Findings 
The trial met its primary endpoint by demonstrating a 
significant reduction in late-stage lung cancer 
presentation in the intervention arm compared to the 
control arm at two years. The trial also demonstrated 
a reduction in lung cancer and all-cause mortality 
between arms, albeit not yet statistically significant at 
two years.  
Consequences 
ECLS demonstrates that blood-based biomarker 
panels, such as the EarlyCDT-Lung test, may have an 
important role in the early diagnosis of lung cancer: 
whether in clinical care or screening. This trial 
provides proof of concept and clinical utility that 
blood testing in combination with optimal selection of 
high-risk people and imaging can find cancers at the 
earliest stages when they are most amenable to cure. 
Further investigation in large, community-based 
phase V studies are needed to determine the long-
term impact of performing the EarlyCDT-Lung test on 
mortality, cost-effectiveness, the level of risk that 
should be targeted, the time interval between tests, 
and how to improve the engagement of people at the 
highest risk.  
Funding Acknowledgement 
Scottish Government Health and Social Care 
Directorate, and Oncimmune Ltd. 
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Abstract 
Problem 
Higher-dose inhaled corticosteroids (ICS) are 
prescribed frequently by GPs, outside COPD 
guidelines, to patients with mild or moderate airflow 
limitation. Evidence suggests these are rarely 
indicated and risk important side-effects. We assessed 
the implications and opportunities of withdrawal by 
GPs of ICS prescribed outside guidelines in COPD 
patients with mild or moderate airflow limitation.  
Approach 
COPD patients with mild or moderate airflow 
limitation, with no history of ≥ 2 moderate or ≥ 1 
severe COPD exacerbations or of asthma, and using 
ICS (dose >400mcg beclomethasone diproprionate - 
BDP/day equivalent), were recruited by their GPs to 
undergo ICS withdrawal. The electronic records of 
potential participants, identified by algorithm 
assessment, were reviewed followed by clinical 
assessment of those eligible. Participants were 
randomised to withdrawal from higher-dose ICS. 
Impact of withdrawal was assessed through measures 
of lung function (forced expiratory volume in the first 
second – FEV1), quality of life (COPD Assessment Test 
– CAT), exacerbations, and cellular and molecular 
biomarkers. Measures were repeated at 3 and 6 
months.  
Findings 
392 (13%) patients with mild or moderate airflow 
limitation were identified for higher-dose ICS 
withdrawal from a COPD population of 2967. On 
individual record review, 15 (5%) of those identified 
had prior evidence of asthma. A further 228 (58%) 
were excluded for other reasons. 149 eligible patients 
were invited for clinical assessment. 61 attended. All 
agreed to randomisation for ICS withdrawal. Eleven 
(18%) had new evidence of asthma on assessment 
(FEV1 variability > 12% and >200ml). 40 were 
randomised to ICS withdrawal or maintenance of 
whom 18 (45%) had new evidence of asthma after 
repeated spirometric assessment over six months; 10 
(25%) were in the withdrawal group and 8 (20%) in 
the maintenance group. Worsening symptom burden 
(increase of ≥+2 in CAT score) was seen after 
withdrawal of ICS in those with FEV1 variability 
consistent with a diagnosis of asthma. The presence 
of a Th2 (asthma-like) inflammatory response in the 
patients with FEV1 variability was seen in: significant 
association between FEV1 variability and raised 
fractional exhaled nitric oxide (FENO) levels (p=0.009); 
significant association between FEV1 variability and a 
combination of raised FENO and symptom burden 
(p=0.005); and significant association between FEV1 
variability and a combination of blood eosinophil 
count and symptom burden (0.005).  
Consequences 
Withdrawal of higher-dose ICS prescribed outside 
guidelines for COPD is feasible and acceptable. A high 
proportion of these patients had features consistent 
with a diagnosis of asthma. We recommend that 
general practices actively assess patients with COPD 
with mild or moderate airflow limitation on higher-
dose ICS (dose >400mcg BDP equivalent) to identify 
those with airflow variability suggestive of asthma. 
Adoption of an asthma treatment strategy 
recommended by the asthma guidelines should be 
considered in these patients.  
Funding Acknowledgement 
This paper presents independent research funded by 
the NIHR under its Research for Patient Benefit (RfPB) 
Programme (Grant Reference Number PB-PG-0214-
33060). The views expressed are those of the authors 
and not necessarily those of the NHS, the NIHR or the 
Department of Health. THH is in receipt of an NIHR 
Doctoral Research Fellowship. 
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Abstract 
Problem 
We face a growing challenge of tackling problematic 
polypharmacy; where the benefits of long-term use of 
multiple medications is often outweighed by the 
burden and potential harm. There has been a call for 
more tailoring of medication in people with 
polypharmacy. However, in 2017 there were over 800 
million repeat prescriptions issued, so the problem 
faced is designing repeat prescribing systems that 
allow for patient-specific tailoring. We seek to 
describe/deliver a new complex intervention to 
address polypharmacy that actively builds person-
centred medication reviews into the model. We have 
started by assessing the current evidence base on 
how this can be/is being achieved in practice. The aim 
of this scoping literature review is to describe 
currently the key components of person-centred 
medication reviews in repeat prescribing.  
Approach 
A scoping literature review was undertaken with an 
information specialist. We conducted a systematic 
search of key databases: CINAHL complete, Embase, 
Academic Search Premier, Medline, PsycINFO, HMIC 
using piloted search terms. Searches were restricted 
to the UK. Our wide-lens inclusion and exclusion 
criteria included: repeat prescribing AND Patient 
centred; holistic; multimorbities/multi-morbid/long 
term condition/co-morbidities; medication review or 
annual review; system/task/safety; 
attitudes/behaviours; how do repeat prescribing 
systems work – logistics/mechanisms/processes; 
prescribing decisions (clinical). Any non-UK or papers 
before 2000 were excluded. We screened 415 articles 
following duplication removal. Abstracts were 
screened by AH, JB and KH against inclusion/exclusion 
criteria. Discrepancies were discussed within the 
team. Full text articles were all double screened to 
confirm inclusion. A standard data extraction tool was 
used to identify details from the included studies on 
setting, intervention, study methods, study quality. 
Thematic analysis will be used on the final data set 
through constant comparison to describe the core 
components of patient centred medication reviews. 
The review process was supported by the use of 
Rayyan software.  
Findings 
Data Extraction and analysis is ongoing. Emerging 
findings suggest a focus on safe repeat prescribing 
systems, receptionist’s roles and practice based 
pharmacists but there appears to be a paucity on 
patient centered repeat prescribing.  There appears to 
be limited research in the context of repeat 
prescribing systems.  
Consequences 
The findings will feed in to our work to describe a new 
complex intervention to embed patient centred 
reviews in repeat prescribing systems. Medication 
optimisation needs to be patient centred. The findings 
from this systematic review will help to identify any 
current patient centredness within repeat prescribing 
systems in primary care. From this, we plan to identify 
possible changes that need to be made to the repeat 
prescribing systems to ensure they are tailored to 
patients with multimorbidities. Overall, this 
systematic review aims to explore and help us 
develop patient centred systems in primary care to 
deliver better outcomes for our patients.  
Funding Acknowledgement 
Non-Funded Pre Grant application 
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Abstract 
Problem 
Our understanding of the relationship between 
ethnicity and multimorbidity lags behind that of 
multimorbidity and socioeconomic status. Ethnicity, 
however, is likely to be as important a contributor to 
multimorbidity-related health inequalities as 
deprivation. To date, the evidence base for 
multimorbidity in minority ethnic populations is small. 
However, with increasing ethnic diversity and long-
established ethnic populations ageing, we need 
evidence to ensure primary care services are 
appropriate to need.  
Approach 
We searched Medline and EMBASE, from 1996 to 
October 2019. Search terms included ethnicity, 
minority ethnic groups, multimorbidity. We also 
searched the reference lists of two previous reviews 
and the Academy of Medical Sciences multimorbidity 
report. A total of 531 papers were identified. These 
were double-screened and included if their principal 
focus was reporting on multimorbidity in ethnic/racial 
populations. Data extraction focused on: year of 
study; country of study; study design; number of 
participants; aim; key findings; definitions used for 
ethnicity/race; definitions for multimorbidity.  
Findings 
We identified 18 papers, all published since 2011. Of 
these, 12 were located in the US, 3 in the UK, 2 in 
Europe, 1 in New Zealand. In general, ethnicity/race 
was self-reported, although some US studies used 
computer algorithms to assign race. Multimorbidity 
was usually based on a count of conditions and 
defined as ≥2 long-term conditions, usually taken 
from a longer list of physical and mental health 
conditions. Most focused on multimorbidity 
prevalence in ethnic/racial populations, with little or 
no attention to condition clusters or health-related 
outcomes. US-based studies also focused on different 
communities to that in the UK, in particular Hispanic 
and Latino populations. Compared to the White 
majority population, the adjusted prevalence of 
multimorbidity was higher for Black populations and, 
in US studies, lower for Hispanic populations. In the 
US, the prevalence tended to be lower for Asian 
populations. In the UK, compared to the White 
population, multimorbidity prevalence was higher for 
South Asians. Two related US studies reported that 
multimorbidity starts earlier in minority ethnic groups 
than in White groups. One UK study suggested that 
disease clusters were different for White and non-
White populations, with diabetes the most dominant 
condition in clusters in the White population, whereas 
depression and cancer dominated the cluster in the 
non-White population.  
Consequences 
There is little literature to draw on to understand the 
impact of multimorbidity in ethnic minority 
populations. Most of the published papers reported 
on prevalence, comparing it to the majority White 
population. Populations were often reported as a 
homogenous entity, e.g South Asians. There is almost 
no literature on onset or disease clusters, nor the 
impact on ethnic minority populations. In an 
increasingly diverse UK, primary care practitioners 
need much more information about multimorbidity in 
their minority ethnic patient populations.  
Funding Acknowledgement 
Unfunded study. 
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Abstract 
Problem 
Multimorbidity prevalence is rising and people with 
multimorbidity often require significant interaction 
with health and care systems. Treatment guidelines 
emphasise reducing treatment burden and improving 
coordination of care across services. Yet recent large-
scale studies of care for people with multimorbidity 
have not shown immediate success and so more is 
needed to understand how to improve their care.As 
the daily responsibility for managing and coordinating 
their health conditions commonly falls primarily on 
the individuals themselves and on their informal 
carers (who are often in the same household), we set 
out to test whether the household health context 
matters for the use and cost of care for people with 
multimorbidity.  
Approach 
Difficulty in identifying households within electronic 
health records (EHRs) likely contributes to the lack of 
research in this area. To address this, we used a local 
sample of EHRs linked to detailed household 
composition data from local authority records and 
then replicated the analysis in a national study where 
co-residence was inferred from anonymised address 
data.  Linked data from health providers and local 
government in Barking and Dagenham provided a 
retrospective cohort of people aged 50+ in two-
person households between April 2016 and March 
2018. Two-part regression models were applied to 
estimate annualised use and cost of hospital, primary, 
community, mental health and social care by 
multimorbidity status of individuals and co-residents, 
adjusted for age, sex and deprivation. Applicability at 
the national level was tested using the Clinical 
Practice Research Datalink.  
Findings 
In our sample of two-person households, over 45% of 
multimorbid people were co-resident with another 
multimorbid person. They were 1·14 (95% CI 1·00, 
1·30) times as likely to have any community care 
activity and 1·24 (95% CI 0·99,1·54) times as likely to 
have any mental health care activity than those co-
resident with a healthy person. They had more 
primary care visits (8·5 (95% CI 8·2,8·8) vs 7·9 (95% CI 
7·7,8·2)) and higher primary care costs. Outpatient 
care and elective admissions did not differ between 
these groups. Findings in the national data were 
similar.  
Consequences 
The study provides early evidence that some forms of 
care utilisation among people with multimorbidity 
varies by their household health context. The findings 
raise questions about how to deliver health and social 
care that acknowledges the household context for 
people with multimorbidity. For example, this could 
include scheduling community care to households or 
developing health care initiatives to households based 
on the principles of the group care approach.  
Funding Acknowledgement 
This study was funded by The Health Foundation as 
part of core activity of Health Foundation members of 
staff. 
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Abstract 
Problem 
Hearing loss (HL) constitutes a major public health 
challenge, affecting over 12 million people in the UK. 
The help-seeking behaviour for HL starts with the self-
diagnosis and the initiation of contact with a health 
provider in primary care. However, little is known 
about the patterns of diagnosis of HL in primary care 
and referral to secondary care. Also, the 
consequences of HL in older adults’ mental health are 
relatively unknown. We aimed to examine: (a) the 
accuracy of self-reported measures of hearing 
difficulty in comparison to objective hearing data, and 
(b) the relationship between HL and depressive 
symptoms in later life.  
Approach 
We used data from the English Longitudinal Study of 
Ageing (ELSA), which is a large population-based 
prospective cohort study. We examined cross-
sectionally 8,529 individuals that had an assessment 
in their hearing by both self-reported measures and 
consented for assessment via a handheld audiometric 
screening device (HearCheck™ Screener). Multiple 
logistic regression models examined the validity of 
self-reported measures of hearing and their potential 
drivers across different population subgroups. Also, 
we applied a novel structural equation modelling 
(SEM) approach to examine the longitudinal 
association between the HL and clinically significant 
depressive symptoms of participants (CES Depression 
Scale), across the 8 Waves of ELSA Dataset.  
Findings 
A large percentage (30.2%) of individuals with HL 
were not detected by the self-report measure. 
Statistically significant predictors of misreporting 
hearing difficulties (while they had objectively 
measured HL >35dBHL at 3.0kHz, in the better-hearing 
ear) were: female gender (OR 1.97, 95%CI 1.18-3.28), 
no educational qualifications (OR 1.37, 95%CI 1.26-
2.55), routine/manual occupation (OR 1.43, 95%CI 
1.28-2.61), tobacco consumption (OR 1.14, 95%CI 
1.08-1.90),  harmful use of alcohol (OR 1.13, 95%CI 
1.11-2.34), and lack of moderate physical activity (OR 
1.25, 95%CI 1.03-1.42). The relative risk for depressive 
symptoms was higher for those who had reported HL 
than for those who had not reported HL, ranging from 
1.40 (Wave 1) to 1.58 (Wave 8).  
Consequences 
Up to one-third of adults with HL in England may 
remain undiagnosed and therefore not referred to ear 
specialists or given access to hearing aids. People 
belonging in high-risk groups for HL, such as older and 
less educated people that face socioeconomic 
inequalities and adopt an unhealthy lifestyle, are the 
least likely to be accurately identified. These findings 
provide novel insights into clinical practice and 
reinforce the importance of an effective and 
sustainable HL screening strategy in primary care, for 
the early detection and intervention for HL in older 
adults. Importantly, as our findings are consistent with 
the hypothesis that the early detection of HL could 
largely prevent or delay the onset of depression, a 
Primary Health Care approach for hearing health is 
crucial in maximising wellbeing for people across their 
life course.  
Funding Acknowledgement 
This research was funded by the NIHR Manchester 
Biomedical Research Centre (PhD Studentship). The 
views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the 
Department of Health. 
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Abstract 
Problem 
Eligibility for antihypertensive treatment is 
determined from blood pressure (BP) and predicted 
ten-year risk of cardiovascular disease (CVD). 
Currently, patients without pre-existing cardiovascular 
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disease are eligible for BP treatment if their BP is 
≥160/100 mm Hg or 140/90 to 159/99 and at ≥20% 
ten-year CVD risk. We investigated initiations of 
antihypertensive drugs in young adults aged 18-40 
years to determine the proportion who were eligible 
for treatment.  
Approach 
A retrospective cohort study using an anonymised 
electronic primary care health record database.Setting 
Electronic health records using The Health 
Improvement Network (THIN). This included individual 
health records of approximately 4 million patients 
uploaded from general practices using Vision primary 
care records software.Participants Included patients 
were aged 18 to 40 years, registered in a THIN 
practice for at least one year between 1st January 
2005 and 1st January 2018, free from cardiovascular 
disease and previously not treated with 
antihypertensives. A total of 19,006 patients were 
eligible for inclusion (initiated n=1357 vs. not-initiated 
on antihypertensive medication n=17649), with 
142,238 person-years of follow-up. Main outcome 
measuresPatients were categorised into BP and ten-
year CVD risk bands based on a rolling yearly average 
of their BP and calculated CVD risk (QRisk). Because 
average BP could change over time, each patient 
could have periods of exposure in more than one 
blood pressure category and ten-year CVD risk band. 
Initiation rates of antihypertensive medication were 
reported as patient years of follow-up and annual 
initiation rates. We also used a multivariable cox 
proportional hazards model to observe factors 
predicting initiation of antihypertensive medication 
reported as HR and CI. 
Findings 
Of 19,006 patients with 142,238 person-years of 
follow-up, 7.1% (1357) were prescribed 
antihypertensive medication: Of these 52.1% 
(707/1357) (95% CI 49.4% to 54.8%) of patients had a 
mean blood pressure <140/90 mm Hg and 32.0% 
(434/1357) (95% CI 29.5% to 34.6%) had blood 
pressure 140/90 to 159/99 mm Hg but were at <20% 
ten-year CVD risk and thus not eligible for treatment. 
Therefore, only 15.9% (216/1357) (95% CI 14.0% to 
18.0%) were eligible for treatment who were initiated 
on antihypertensive medication. Under updated NICE 
guidelines (≥10% ten-year CVD risk) eligibility for 
treatment would rise to 21.8% (95% CI 19.7% to 
24.2%). Furthermore, rates of antihypertensive drug 
initiation were lower in patients in lower blood 
pressure and lower ten-year CVD risk categories.  
Consequences 
The great majority of young adults initiated on 
antihypertensive treatment are not eligible (even 
when adjusting for updated guidelines of <10% ten-
year CVD) resulting in further management, 
unnecessary treatment and cost to healthcare 
services. Novel strategies are needed to prevent 
overtreatment and stratify antihypertensive initiation 
in young adults.  
Funding Acknowledgement 
Tom Marshall is supported by the National Institute 
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Abstract 
Problem 
According to the Scottish Public Health Observatory, 
in 2016 the proportion of adults who drink alcohol 
beyond 14 units per week were 30% of men and 16% 
of women. Evidence suggests that even low-level 
regular alcohol use could harm. Reliable estimates of 
health-related behaviours are required to formulate 
and evaluate policies, and for alcohol research. One of 
the main problems when evaluating the effects of 
alcohol is accurately measuring how much people 
drink. The use of routinely collected data (RCD) and its 
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linkage from different sources, such as health and 
administrative, are increasingly used in different fields 
and offer an unrivalled opportunity for research in 
biomedical sciences. In Scotland GPs often ask 
patients about their alcohol consumption. Plus, it has 
been one of the Quality and Outcome Framework 
(QoF) indicators from 2004-16.  Although there are 
numerous codes in GP databases indicating alcohol 
consumption and multiple records per individual, this 
information is difficult to use for research or quality 
purposes and has not been validated.  
Approach 
From the UKBiobank cohort we selected and 
extracted those who answered to alcohol 
consumption question. We recoded these variables to 
establish, amount of alcohol drunk per week and then 
stratified these participants in four consumption 
categories. This dataset was linked to their GP’s 
records. GP data were processed using Read Codes V2 
and V3 identification, using UKB guidance and 
compiling a list of all codes related to alcohol 
consumption. We performed the analysis only in 
participants from Scotland.  
Findings 
We included 35,769 participants in our analysis (those 
who had a recorded alcohol status in UKB 
questionnaire (99.7% of Scottish participants). After 
reclassification of the weekly alcohol consumption 
variables, we detected 8.38% of Non-drinkers 
,56.74%Sensible drinkers (less than 14 Units per week) 
,13.56% of Moderate drinkers (between 15 and 21 
Units/week), 12.33% of Hazardous drinkers (between 
22 and 35 Units/week and 8.99% of Harmful drinkers 
(more than 35 Units). GP data preliminary analysis 
detected alcohol records for 24,409(68.08%) distinct 
participants. Those participants included 133,726 
coded records related to alcohol consumption (136.) 
with 93,057 associated recorded values.  
Consequences 
We found that 68.1% of Scottish UKB participants had 
recorded alcohol consumption in Primary Care data, 
considering that UKB had only released GP data for 
half of the cohort.Preliminary results show a poor 
correlation between UKB questionnaires and GP 
records. It is difficult to assess how it is related to real 
changes in alcohol consumption and if it is associated 
with underreportingIt’s crucial to improve data 
collection and proper codification for effective data 
research and epidemiologic surveillance. If properly 
validated, GP records could represent a great 
opportunity to have populational data on alcohol 
consumption.  
Funding Acknowledgement 
This project was funded/supported by a research 
bursary from NHS Fife R&D department. The views 
and opinions expressed are those of the authors and 
do not necessarily reflect those of NHS Fife. 
 
H.3 
Linking CPRD Primary Care Data to HES Diagnostic 
Imaging Data; A Data Resource Profile   
Presenter: Jennifer Campbell 
Co-authors:  Jessie Oyinlola 
Institutions 
Clinical Practice Research Datalink 
Abstract 
Problem 
When using electronic health data to study patient 
care pathways it is often useful to see beyond that 
which is administered and recorded in primary care. 
The Clinical Practice Research Datalink (CPRD) links 
primary care data to secondary care data sources 
including the Hospital Episode Statistics Diagnostic 
Imaging Dataset (HES DID). HES DID is a collection of 
detailed information about diagnostic imaging tests 
carried out on NHS patients in England since April 
2012. HES DID contains information about referral 
source and patient type, details of the test, plus items 
about waiting times for each diagnostic imaging 
event, from time of test request through to time of 
reporting. HES DID does not contain the images 
produced or the results of the test.Whilst linkage 
between these two data sets has been in place for a 
few years to date nobody has attempted to describe 
what it offers. The aim of this study is to profile the 
linkage between HES DID and CPRD data in terms of 
content, coverage, completeness and concordance in 
order to define information that can be gained from 
the linkage.  
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Approach 
The HES DID linked data will be described in terms of 
coverage of the data source over time and by 
geography. We will also investigate how complete 
individual scan records are.  Analysis will look at the 
type of scans recorded in HES DID, which are the most 
frequently recorded imaging scans and how does that 
compare with records of scans in primary care 
data.We will look at the concordance between scans 
being recorded in CPRD data (both as referral records 
and scan outcomes) and the record of a scan taking 
place in HES DID. We will explore whether the linkage 
between these two data sets and other HES datasets 
linked to CPRD allows researchers to follow a patient 
journey from referral for an imaging test through to 
diagnosis and treatment. We will also carry out a 
descriptive analysis of the average waiting times 
between each stage of the patient’s care.  
Findings 
The latest release of HES DID data linked to CPRD 
covers the period April 2007 – June 2019. Initial 
exploratory findings have shown that there were ~15 
million CPRD patients who had at least one scan 
recorded in HES DID during this period with the 
number of scans recorded in the data increasing 
slightly year on year. The most frequently recorded 
scan type was chest x-ray with over 5 million records.  
Consequences 
The linkage between CPRD primary care data and HES 
DID has the potential to provide a valuable resource 
for researchers wishing to study treatment pathways. 
This descriptive analysis will allow researchers to 
assess the value that linked HES DID data could add to 
their study.  
 
H.4 
Can early markers of poor long-term outcomes in 
dementia be identified from primary care electronic 
health records?   
Presenter: Kelvin Jordan 
Co-authors:  Trishna Rathod-Mistry, Michelle 
Marshall, Paul Campbell, James Bailey, Carolyn A. 
Chew-Graham, Martin Frisher, Richard Hayward, Rashi 
Negi, Swaran Singh, Athula Sumathipala, Nwe Thein, 
Kate Walters, Scott Weich 
Institutions 
Keele University, Midlands Partnership NHS 
Foundation Trust, University of Warwick, University 
College London, University of Sheffield 
Abstract 
Problem 
The prevalence of dementia is rising. The UK 
government has prioritised early recognition and 
treatment to prolong independence, reduce hospital 
admissions, and delay nursing home admission and 
mortality. Advances have been made in “case finding” 
and identifying risk factors for dementia using primary 
care Electronic Health Records (EHR). “Hard” long 
term outcomes such as hospital admissions and 
mortality are obtainable from EHR but less is known 
about the early course of the disease. This 
information could help clinicians spot patients at risk 
of quicker progression and enable shorter term 
research outcomes to be assessed. The objective was 
to assess whether early markers of dementia 
progression can be identified within information 
routinely recorded in primary care EHR.  
Approach 
Through reviewing research studies, consensus 
meetings with experts in dementia and EHR research, 
and analysis of a North Staffordshire EHR database, 
we have established a list of potential markers of 
dementia-related health that are feasible to assess in 
primary care EHR. Markers were grouped into 
domains. We analysed records of patients newly 
diagnosed with dementia between 1998-2017 from a 
UK-wide primary care EHR database (Clinical Practice 
Research Datalink). The incidence of recording of 
markers from domains up to three years after 
diagnosis were determined. We tested the validity of 
the domains as measures of dementia progression 
with the hypothesis that early recording of the 
domains should be associated with increased risk of 
long-term hospital admission, palliative care, and 
mortality.  
Findings 
Sixty-three markers were mapped within thirteen 
domains. The domains included severe 
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neuropsychiatric (example marker: psychosis), other 
neuropsychiatric (e.g. depression), cognition (e.g. 
memory loss), daily functioning (e.g. walking 
limitation), selected other illnesses (e.g. heart 
problem), symptoms (e.g. hearing loss), increased 
polypharmacy. There were 30,463 people with newly 
diagnosed dementia. Common first recorded markers 
after diagnosis included those in the comorbidity 
(incidence 300/1000 person-years), symptoms 
(230/1000), and other neuropsychiatric (186/1000) 
domains. Increased polypharmacy was also common 
(469/1000). Risk of long-term outcomes increased 
with increasing number of new markers recorded in 
the first year after diagnosis. For example, patients 
with four or more domains in which a new marker 
was recorded (18% of patients) had greater risk of 
long term hospital admission (adjusted hazard ratio 
1.24 versus no domains; 95% CI 1.16, 1.32), palliative 
care (1.86; 1.61, 2.16), and mortality (1.57; 95% CI 
1.47, 1.67). The individual domains were also 
associated with long term outcomes, with the 
neuropsychiatric domains and increased 
polypharmacy, in particular, having stronger 
associations.  
Consequences 
Primary care EHR capture measures of dementia-
related health associated with long-term outcomes. 
These may facilitate better understanding of 
progression, make it easier for GPs to recognise 
people on a more severe course of dementia, and 
provide early outcome measures for research studies 
including clinical trials.  
Funding Acknowledgement 
This work is supported by a grant from the Dunhill 
Medical Trust (RPGF 1711/11). The views and opinions 
expressed within this abstract are those of the 
authors and not necessarily the views of the Dunhill 
Medical Trust.  This study is based in part on data 
from the Clinical Practice Research Datalink obtained 
under licence from the UK Medicines and Healthcare 
products Regulatory Agency. The data is provided by 
patients and collected by the NHS as part of their care 
and support. The Office for National Statistics (ONS) is 
the provider of the ONS data contained within the 
linked CPRD data used for this study. ONS Data and 
Hospital Episode Statistics (HES) Data: copyright © 
(2019), re-used with the permission of The Health and 
Social Care Information Centre; all rights reserved. 
The interpretation and conclusions contained in this 
study are those of the authors alone. 
 
H.5 
Primary care mortality and the impact of funding: a 
national longitudinal study 2013 -2016   
Presenter: Veline L’Esperance 
Co-authors:  Veline L’Esperance1, Hugh Gravelle2, 
Peter Schofield1, Mark Ashworth1 
 
Institutions 
1. School of Population Health & Environmental 
Sciences, King’s College London, 2. Centre for Health 
Economics, University of York 
Abstract 
Problem 
Previous studies reporting an association between 
primary care investment and practice-level mortality 
have relied on estimates of mortality or been confined 
to small geographical areas. We investigated the 
relationship between funding and actual mortality 
rates, both at practice-level, in a national sample of 
practices in England.  
Approach 
We combined seven datasets for all general practices 
in England (n=7310), 2013-2016:  
(i) General and Personal Medical Services 
database , providing workforce and 
patient data; 
(ii) NHS payments to General Practice,  which 
records payments to practices; 
(iii) Quality and Outcomes Framework  
describing performance on clinical 
achievement indicators in LTCs,  
(iv) deprivation data for each practice;  
(v) neighbourhood ethnicity for each 
practice;  
(vi) patient experience scores from the 
General Practice Patient Survey; and  
(vii) practice-level mortality. We estimated a 
variety of count data models using 
longitudinal practice-level data to 
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examine the association between general 
practice funding and practice-level 
mortality. These included  
(a)pooled models;  
(b) practice fixed effect models;  
(c) random effects models; and 
(d) Mundlak specification.  
 
We used the Poisson specification for models with 
practice fixed effects and allowed for over-dispersion 
of errors by using robust standard errors. Practice-
year observations with <5 deaths/year were 
truncated. We entered the number of general 
practitioners, nurses and administrative staff in four 
different ways in the exponential mean function. The 
goodness of fit for each model was explored using the 
Akaike Information Criterion (AIC) and the Bayesian 
Information Criterion (BIC), both of which penalise the 
number of coefficients estimated; smaller AIC and BIC 
scores indicate better fitting models.  
Findings 
The inflation adjusted mean total funding per patient 
across the study period was £133.66 (standard 
deviation £39.46), adjusted to 2016 costs. The mean 
total deaths per practice increased from 61.23 (SD 
46.15) in 2013/14 to 65.78 (SD 50.52) in 2016/17. 
Premature mortality (deaths in those <75 years) also 
increased from 19.22(SD 13.09) in 2013/14 to 20.86 
(SD14.45) in 2016/17. Reduced practice mortality 
rates were significantly associated with increased 
total funding (B coefficient -0.003; %95CI: -0.0004, -
0.0001). Other characteristics associated with reduced 
mortality included: practices in receipt of the 
capitation supplement, (MPIG) (B coefficient -0.02; 
%95CI: -0.04, -0.01); practices with less deprived 
populations (B coefficient 0.011; %95CI: 0.010, 0.011); 
and practices with increased overall patient 
experience scores (B coefficient -0.001; %95CI: -0.001, 
-0.0001). The relationship between mortality and 
patient age was U-shaped, with extremes of age 0- 4 
years (B coefficient 0.03; %95CI: 0.03, 0.04) and ≥75 
years (B coefficient 0.10; %95CI:0.10, 0.11) 
significantly associated with practice mortality.  
Consequences 
This is the first study to examine general practice 
funding and practice-level mortality rates in England. 
We found that practice mortality rates are inversely 
related to the underlying funding allocated to each 
general practice. Further work is needed to determine 
the likely mechanism of any causal relationship 
between funding and mortality.  
Funding Acknowledgement 
The work was funded by the National Institute for 
Health Research (NIHR) who funded a Doctoral 
Research Fellowship for VL (reference, DRF-2017-10-
132). HG was funded by the UK NIHR Policy Research 
Programme (Policy Research Unit in the Economics of 
Health and Social Care Systems: Ref 103/0001). 
 
H.6 
Reducing DNAs in general practice: evaluating 
methods of change.   
Presenter: Tom Margham 
Co-authors:  Crystal Williams, Jack Steadman, Sally 
Hull 
Institutions 
Queen Mary University of London, Tower Hamlets 
CCG 
Abstract 
Problem 
Non-attendance or Did Not Attend (DNA) is common 
UK in primary care,  reducing clinical capacity. 
Nationally it is estimated that 5% of appointments in 
primary care are missed, of which 7.2 million are GP 
appointments, which equates to a waste of £216 
million every year. Reducing DNAs is also important 
for effective primary care clinical delivery. Missed 
appointments may translate to patient presentations 
at less appropriate care settings with additional health 
and financial implications.The study aimed to:a) 
Evaluate the impact on practice DNA appointment 
rates of a system-wide quality improvement (QI) 
programme which included sharing data on 
appointment systems and DNA rates.b) Compare the 
effectiveness of different practice interventions to 
reduce DNA rates.  
Approach 
Based in a clinical commissioning group (CCG) in east 
London, with a mobile, ethnically diverse and socially 
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deprived population; 25 of the 32 practices voluntarily 
engaged with the  programme. Following the generic 
QI intervention,14  practices undertook further work 
on DNA reduction projects, supported by practice 
based coaching.CCG wide monthly appointment data 
was collected from the electronic health record (EHR) 
of each practice between April 2014 and June 2019. 
An interrupted time series analysis was used to 
compare DNA rates pre and post the generic 
intervention; and following specific project work on 
DNA reduction.  
Findings 
Appointment data from all 32 practices in the CCG were 
available for analysis, comprising more than 4 million 
booked appointments over the study period. Before the 
intervention (April 2017) the average DNA rate across 
the CCG was 7.6% with a practice range of 2-12%. 
Practice DNA rate was not associated with list size. For 
all practices combined 80% of DNAs were associated 
with a wait time of >2 days. Two years following the 
generic QI intervention the DNA rates for the 25 study 
practices fell to 5.2%. This equates to an absolute 
reduction of 4,031 DNAs among the study practices and 
a potential saving of £120,930. Trend in DNA rates: 
comparison of 25 Project practices* with 7 control 
practices 2014-2019 Monthly change in DNA rates p 
value for monthly change PROJECT practices (25) 0.990 
(0.989 to 0.991) P<0.001(post intervention) Control 
practices (7) 0.996 (0.995 to 0.997) P<0.001 * Adjusted 
for the different intervention start date of each study 
practice. 13 practices which implemented patient 
behaviour change projects showed a modest additional 
drop in DNAs compared to the generic intervention. One 
practice introduced a system change to the appointment 
system, resulting in a sustained drop in DNAs. 
Consequences 
The number of days between booking a GP 
appointment and seeing the doctor is the best 
predictor of practice DNA rates. Sharing appointment 
data, combined with QI coaching, produced a 
significant reduction in missed appointments. 
Behaviour change interventions had a modest 
additional impact. In contrast introducing structural 
change to the appointment system effectively 
reduced DNA rates. To reduce non-attendance the 
appointment system needs to change – not the 
patient.  
 
Funding Acknowledgement 
This project was supported by an Innovating for 
Improvement grant from the Health Foundation 
 
H.7 
Development of a dementia risk detection tool using 
primary care electronic health records   
Presenter: David Reeves 
Co-authors:  Catharine Morgan, Darren M Ashcroft, 
Evan Kontopantelis, Daniel Stamate, John Langham, 
Brian Mcmillan 
Institutions 
University of Manchester, Goldsmiths University of 
London, Brighton and Sussex Medical School 
Abstract 
Problem 
Increasing prevalence of dementia, related to an 
ageing population, is a major healthcare challenge.  
Primary care is the main route through which 
individuals are identified or subsequently diagnosed 
with dementia by a GP or specialist referral services. 
Evidence suggests numerous risk factors are 
associated with development of Dementia and many 
multi-factorial dementia risk models have been 
proposed. However, predictive ability has generally 
been quite limited, few have exploited routinely 
collected general practice data or focused on early 
detection, none incorporate longitudinal trends in 
health, and only one has utilised the potential of 
Machine Learning (ML) methods. We aim to develop 
an improved healthcare record-based tool for 
estimating patient risk of developing dementia with a 
focus on earlier identification of those at risk.  
Approach 
The Clinical Practice Research Datalink (CPRD) is an 
anonymised primary care electronic patient record 
database capturing events from healthcare 
interactions. We identified patients aged 60-95 years 
contributing to CPRD between 01/01/2005 and 
31/12/2017 along with data on a diagnosis of 
dementia over the period.  A set of more than 150 
potential predictors were identified from published 
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systematic reviews, relevant individual research 
studies, and advice from dementia experts, Model 
building is using both traditional logistic regression 
analysis and machine learning (ML) techniques. ML is 
being carried out by co-investigators at the University 
of London in parallel to the traditional modelling 
approach based at the University of Manchester.  
Findings 
Between 01/01/2005 and 31/12/2007, 2,005,756 
adults aged ≥60 years contributed to CPRD and 
fulfilled inclusion criteria. Of this cohort, 7,621 (3.4%) 
were identified as having a dementia diagnosis. After 
assessment for feasibility and reliability, we 
developed and implemented Clinical Readcode lists 
for 60 risk factors, broadly classified into demographic 
and social factors, physical and mental health status, 
consulting patterns, and treatments received. 
Additional variables were constructed for many 
factors to capture longitudinal trends alongside 
current status. Under univariate analysis, the great 
majority of factors have demonstrated an association 
with progression to a dementia diagnosis within a 5 or 
10 year period, including most classes of prescribed 
drugs. Multivariate analysis and full predictive 
modelling using regression and ML methods is 
underway and will be presented.  
Consequences 
Tools to aid in the early identification of people at 
high risk of dementia are urgently needed. Screening 
in primary care on the basis of information in the 
electronic health record has great potential, provided 
a sufficiently accurate tool can be developed. Such a 
tool is also greatly needed to identify high-risk 
individuals for invitation into clinical trials of 
promising treatments. Success in developing a 
markedly improved tool for the prediction of 
dementia may also lead to utilising the same 
techniques to develop improved risk tools for many 
other health conditions.  
Funding Acknowledgement 
This study is funded by Alzheimer's Research UK 
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Improving treatment adherence in people with 
diabetes mellitus (INTENSE)   
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Abstract 
Problem 
Medication adherence is a common problem among 
people with type 2 diabetes mellitus (T2DM), and is 
associated with increased hospitalisation and 
healthcare costs. Interventions developed to enhance 
medication adherence rarely allow for significant 
tailoring to individual need. This study aims to 
investigate the effectiveness and cost effectiveness of 
a personalised intervention program to improve 
medication adherence in people who are non-
adherent to oral antidiabetic and/or antihypertensive 
medicines. 
Approach 
The study was designed for the Netherlands and 
adapted for a UK audience through working with a 
patient and public involvement (PPI) group and other 
relevant stakeholders including the local 
pharmaceutical committee. The one to one parallel-
group, cluster randomised controlled trial will be 
conducted in community pharmacies in the 
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Netherlands and the UK. A total of 300 participants 
will be recruited (n=150 per country) and followed-up 
for six months. Eligible patients are smartphone users 
aged 35 to 75 years with T2DM. They must be non-
adherent to oral antidiabetic and/or antihypertensive 
medicines and able to read and write in English.   
Screening and recruitment will be undertaken in two 
stages: 1. Potentially eligible patients will be identified 
by medical practice database searches. The results will 
be screened by a GP and a letter posted to potentially 
eligible patients inviting them to contact their 
community pharmacy team for recruitment. 2. 
Patients expressing interest in participation will be 
screened by a member of the pharmacy team to 
confirm eligibility.   Electronic 1:1 block randomisation 
per pharmacy will be used to randomise patients to 
intervention or control. Patients will complete an 
adherence profiling questionnaire to inform 
generation of a personalised intervention program for 
intervention participants. This may comprise a 
selection from text messages, medication dispensing 
systems and referral to a prescriber. The control 
group will receive usual care plus access to a general 
T2DM website.   The primary outcome is change in 
medication adherence measured by telephone pill 
count. Secondary outcomes include change at six 
months in blood pressure, HbA1c, quality of life and 
healthcare costs. A process evaluation including 
interviews and focus groups with patients, 
pharmacists and prescribers will be used to 
understand the trial findings. NHS ethical approval has 
been secured. 
Findings 
Three medical practices and their most proximal 
community pharmacies have expressed an interest in 
participating in participant identification and 
recruitment. Two meetings with PPI members were 
conducted, and patient-facing supporting programs 
were adapted to suit the UK population. Participant 
recruitment is expected to start in April 2020. 
Consequences   
The study is expected to demonstrate the impact of a 
personalised adherence intervention on diabetes-
related health, health-related quality of life and 
healthcare costs.  
 
 
Funding Acknowledgement 
We would like to thank the European Foundation for 
the Study of Diabetes for funding this study 
 
I.2 
What is the prevalence and implications of frailty in 
diabetes? A systematic review   
Presenter: Isabella Fauré 
Co-authors:  Peter Hanlon, Isabella Fauré, Neave 
Corcoran, Elaine Butterly, David McAllister, Frances S 
Mair 
Institutions 
University of Glasgow 
Abstract 
Problem 
With rising life expectancy, the average age of people 
with diabetes mellitus is increasing. Diabetes is known 
to be associated with frailty. Frailty describes an age-
related decline in physiological reserves leading to 
increased vulnerability to decompensation and poor 
health outcomes. Diabetes guidelines recommend 
relaxing glycaemic targets in people with frailty, citing 
increased risks from hypoglycaemia. However, there is 
no consensus on how frailty should be measured nor 
the effects of frailty on health outcomes in diabetes. 
We performed a systematic review of studies 
assessing the prevalence of frailty in people with 
diabetes and the association between frailty and 
clinical outcomes.  
Approach 
We searched three electronic databases: Medline, 
Embase and Web of Science. Abstracts and full texts 
were screened to identify studies meeting the 
following inclusion criteria: (i) include people with 
diabetes (type 1, type 2, or unspecified); (ii) assess 
frailty status using a recognized frailty measure; (iii) 
report the prevalence of frailty in people with 
diabetes and/or the association between frailty and 
clinical outcomes in the context of diabetes. We 
included observational studies in any setting 
(community, hospital, institutional care). Quality was 
assessed using the Newcastle Ottawa Scale.  
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Findings 
We screened 3,007 abstracts and 267 full texts, from 
which 74 studies were identified as eligible for 
inclusion. Studies were heterogenous in the type of 
diabetes studied (n=28 type 2, n=46 unspecified), 
setting, age of participants, and frailty measure used. 
Median sample size was 189 (IQR 95-534). Twenty-
one different frailty scales were used. The frailty 
phenotype was the most frequently used measure 
(n=29 studies) followed by the frailty index (n=11), 
FRAIL scale (n=5), clinical frailty scale (n=3), Edmonton 
frailty scale (n=3), comprehensive geriatric 
assessment (n=3). Fourteen other scales were used in 
one or two studies each. The median prevalence of 
frailty in community studies was 9% (IQR 4%-17%). 
Prevalence was higher in inpatient settings (median 
36%, IQR 22%-48%). Frailty was associated with 
mortality (9/9 studies), hospitalization (5/6 studies), 
cardiovascular events (3/4), hypoglycaemia (2/2), 
neuropathy (1/1), depression (1/1) lower quality of 
life (1/1) and incident disability (1/1). Frailty was 
associated with higher HbA1c in 3/6 studies, with 3 
studies also showing that a high proportion of frail 
people had HbA1c levels below target range. No 
studies assessed if the impact of glycaemic control 
varied by frailty status.  
Consequences 
Frailty is common in diabetes and associated with a 
range of adverse outcomes. There is little consensus 
over how best to measure frailty, and no studies 
exploring how the choice of measure impacts on the 
estimated prevalence and the relationship with 
outcomes. Few studies in diabetes have assessed 
frailty measures designed for clinical practice. Future 
work should clarify the impact of choice of measure as 
well as the implications of glycaemic control to help 
guide treatment recommendations.  
Funding Acknowledgement 
Peter Hanlon is funded by a Medical Research Council 
Clinical Research Training Fellowship 
 
 
 
 
I.3 
Experiences of Doctors and Patients in the 
implementation of Indonesia’s diabetes 
management model, Prolanis   
Presenter: Aghnaa Gayatri 
Co-authors:  Barbara Nicholl, Stewart Mercer, Sara 
Macdonald 
Institutions 
University of Glasgow, University of Edinburgh 
Abstract 
Problem 
Indonesia have been implementing a nationwide 
diabetes management model through the newly 
established universal health coverage scheme since 
2014. The model has similarities with the Chronic Care 
Model that originated in the United States. It consists 
of monthly consultations, medication dispensing, 
laboratory checks, with an optional addition of group 
exercise and education classes. There are three 
distinct types of primary care practices in Indonesia 
implementing this model (government-run 
community health centre, private primary care clinic, 
individual doctor practice).  No study to date has 
assessed how Prolanis is being implemented across 
the different types of primary care. We aimed to 
explore the experiences of primary care doctors and 
patients in the implementation of Prolanis. Specifically 
to address the questions: 1) How is Prolanis 
implemented in different primary care settings?; 2) 
What are the factors influencing the implementation 
of Prolanis?; 3) What are the perceived effects of 
implementing Prolanis in diabetes care provision?  
Approach 
A qualitative approach used in-depth interviews to 
explore the experiences of doctors and patients in the 
implementation of Prolanis. We carried out a 
purposive sampling on the basis of maximum 
variation to include doctors and patients from the 
three types of primary care and from both urban and 
rural settings. Themes and sub-themes were 
identified from interview transcripts using a thematic 
approach in order to answer the research questions.  
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Findings 
A total of 36 participants were interviewed for this 
study, 18 doctors and 18 patients. An overlap of 
themes was found from the doctor and patient 
interviews, resulting in four main themes influencing 
the implementation of Prolanis for all participants: 
contextual factors, system factors, process factors, 
and outcome factors. Prolanis was found to be 
implemented differently across types of primary care. 
One example was whether patient group sessions 
were provided. The decision to run group sessions 
was influenced by the setting of the practice, the 
social nature of their patient group, and the available 
human resources. Having group sessions was highly 
regarded as an effective approach to achieve good 
clinical outcomes in diabetes management with 
Prolanis, with both patients and doctors expressing its 
effectiveness in the actual increase of diabetes self-
management.  
Consequences 
The relatively short period of Prolanis implementation 
(5 years) may be reflected in the different approaches 
to Prolanis implementation, with practices still finding 
their way to implement the model according to their 
circumstances (e.g. size, urban/rural). The highly 
appreciated group sessions should be considered 
across all primary care types as they have been 
viewed as an effective approach to management. 
Improvements are still needed to effectively 
implement Prolanis nationally and the findings from 
this study will provide recommendations on how best 
to achieve optimum diabetes self-management 
provision in primary care in Indonesia.  
Funding Acknowledgement 
This study is part of a PhD fully funded by the 
Indonesian Endowment Fund for Education, Ministry 
of Finance, Republic of Indonesia. 
 
 
 
 
 
I.4 
What is the risk of adverse clinical outcomes in 
middle-aged and older adults with Type 2 Diabetes 
and Frailty?   
Presenter: Peter Hanlon 
Co-authors:  Peter Hanlon, Jim Lewsey, Bhautesh Jani, 
Barbara Nicholl, David McAllister, Frances S Mair 
Institutions 
University of Glasgow 
Abstract 
Problem 
The prevalence of type 2 diabetes (T2D) is growing 
worldwide, and the average age of people with T2D is 
rising. Frailty, a state of increased vulnerability to 
adverse health outcomes, is an important factor in 
T2D. Clinical guidelines recommend less stringent 
glycated haemoglobin (HbA1c) targets for older frail 
people with T2D.  The implications for relatively 
younger people meeting criteria for frailty are less 
clear. We aim to assess the association between 
frailty and clinical outcomes in T2D and explore if 
frailty modifies the association between HbA1c and 
mortality and hypoglycaemia.  
Approach 
We identified people with T2D form the UK Biobank 
cohort. We assessed baseline frailty using the Frailty 
Phenotype model, comprising five characteristics (low 
grip strength, weight loss, slow walking speed, 
exhaustion, and low physical activity). People with 1-2 
of these features are considered pre-frail. People with 
3 or more considered frail. Clinical outcomes were 
identified from linkage to national mortality registers 
and hospital episode statistics over a median 75 
months follow-up. Outcomes included all-cause 
mortality, cardiovascular mortality, cancer mortality, 
major adverse cardiovascular event (MACE), 
hypoglycaemia, and fall/fracture. Cox-proportional 
hazards models assessed the association between 
frailty and each outcome, adjusted for age, sex, body 
mass index, socioeconomic status, smoking and 
alcohol. We then assessed the association between 
HbA1c and both all-cause mortality and 
hypoglycaemia at different levels of frailty.  
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Findings 
Among 20,569 people with T2D (mean age 60.2, 
36.8% female) 2,506 (12.7%) met the criteria for 
frailty and 11,026 (55.7%) were pre-frail. Frailty was 
associated with older age, female sex, higher 
socioeconomic deprivation, higher body mass index, 
current smoking, and no alcohol drinking. Compared 
with participants with no frailty characteristics, frailty 
was associated with all-cause mortality (hazard ratio 
2.23, 95% confidence intervals 1.92-2.60), 
cardiovascular mortality (3.65, 2.16-5.12), cancer 
mortality (1.75, 1.31-2.35), MACE (1.75, 1.31-2.35), 
hypoglycaemia (3.21, 2.29-4.49) and fall/fracture 
(2.22, 1.85-2.67). Pre-frailty was also associated with 
each of these outcomes, with smaller effect sizes. 
HbA1c showed a J-shaped relationship with all-cause 
mortality, with increased risk below 45 mmol/mol and 
above 55mmol/mol. This relationship was consistent 
at all levels of frailty (p for interaction = 0.196). Higher 
HbA1c was associated with greater risk of 
hypoglycaemia at all levels of frailty.  
Consequences 
Frailty is identifiable and common among middle-aged 
as well as older adults with T2D. It is associated with a 
range of adverse outcomes, with particularly strong 
associations with cardiovascular mortality and 
hypoglycaemia. Low and high HbA1c are associated 
with mortality, with similar hazard ratios at all levels 
of frailty. Consequently, the absolute risks of low and 
high HbA1c are necessarily larger in people who are 
frail.  
Funding Acknowledgement 
Peter Hanlon is funded by a Medical Research Council 
Clinical Research Training Fellowship 
 
 
 
 
 
 
 
I.5 
Are different phenotypes of type 2 diabetes 
associated with different risks of vascular outcomes? 
A cohort study in east London   
Presenter: Rohini Mathur 
Co-authors:  Sarah Finer, Sally Hull 
Institutions 
Insitute of Population Health Sciences, Queen Mary, 
University of London 
Abstract 
Problem 
Background: Recent studies have identified distinct 
subtypes of type 2 diabetes (T2DM). Characterizing 
diabetes phenotypes in a young, ethnically diverse 
inner-city population and their associations with 
vascular risk is an essential step towards tailoring 
diabetes management for high-risk groups. The aim of 
this study was to identify and characterize subtypes of 
type 2 diabetes based on clinical characteristics at 
diagnosis and determine associations with vascular 
outcomes.  
Approach 
An observational cohort study using data from the 
east London Database was conducted using 30,000 
adults aged 18 and over diagnosed with T2DM 
between 2008 and 2018. Latent class analysis was 
used to identify distinct subgroups of type 2 diabetes 
using baseline data on HbA1c, age at diagnosis and 
BMI. The ideal number of classes was selected based 
on model fit criteria and clinical relevance. 
Multinomial logistic regression was used to identify 
demographic and baseline characteristics associated 
with class membership.  Amongst those free from 
prevalent vascular disease, multivariable cox-
proportional hazards regression was used to compare 
risk of incident cardio- and micro-vascular disease 
between classes.  
Findings 
Three clinically meaningful T2DM classes were 
identified; 70% of the population were classified as 
having ‘Typical diabetes’; 22.8% were classed as 
having ‘Age-related diabetes’ (mean age at diagnosis 
72.7), while 8.1% were classed as having ‘Severe 
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hyperglycaemia related diabetes’ (mean HbA1c at 
diagnosis 12.1%/108.7 mmol/L. The majority of 
individuals in the age-related group were of white 
ethnicity (42.9%), while the other two classes were 
largely south Asian (43.2% severe hyperglycaemia, 
56.8% typical onset).  Compared to those with typical 
onset, risk of macrovascular disease was 2.75 times 
higher in the age-related diabetes group (95%CI 2.42-
3.14). Risk of microvascular disease was 29% higher in 
the age-related diabetes group (95%CI 1.21-1.36) and 
41% higher in the severe hyperglycaemia group 
(95%CI 1.30-1.52) relative to those with typical onset.  
Consequences 
We characterized differences between individuals 
belonging to three distinct classes of type 2 diabetes 
and identified strong associations between some 
diabetes subtypes and vascular risk.  Further 
exploration into the clustering and trajectories of 
cardio-metabolic risk factors, both around the time of 
diagnosis and over the longer term will be key to 
developing targeted strategies to identify and manage 
those at highest risk of poor outcomes.  
 
I.6 
What is the utility of the COM-B model in identifying 
facilitators and barriers to maintaining a healthy 
postnatal lifestyle following a diagnosis of 
gestational diabetes: a qualitative study?   
Presenter: Caroline Mitchell 
Co-authors:  Jennifer Boyd, Brian McMillan, Katherine 
Easton, Brigitte Delaney 
Institutions 
Academic Unit of Primary Medical Care, University of 
Sheffield, School of Health and Related Research, 
University of Sheffield;  Centre for Primary Care and 
Health Services Research, University of Manchester; 
School of Education, University of Sheffield. Sheffield. 
Abstract 
Problem 
One in twenty pregnant women in the UK develop 
Gestational Diabetes (GD) and prevalence is 
increasing. Women who have had GD are over seven 
times more likely to be diagnosed with type 2 
diabetes mellitus (T2DM) in their lifetime. The adverse 
health outcomes associated with T2DM include a 
reduction in average life expectancy by 10 years. 
Although women with GD are generally satisfied with 
antenatal care, many feel abandoned postnatally and 
are uncertain about what to expect from their GP 
regarding follow-up. There is a need to develop 
innovative postnatal lifestyle interventions to reduce 
the risk of T2DM amongst women who have had GD. 
Previous qualitative research investigating the 
experiences of women diagnosed with gestational 
diabetes (GD) has provided important insights for 
intervention development but often lack a theoretical 
underpinning. This study explores the use of the COM-
B framework (Michie et al) to code and the socio-
ecological model (Dahlgreen & Whitehead) to 
contextualise participant responses in order to inform 
intervention development.  
Approach 
Qualitative semi-structured interviews post-natally 
were undertaken with women who had received a 
diagnosis of GD in the preceding six months. 
Invitations to participate were sent out with 
appointment letters from Sheffield University 
Teaching Hospital NHS Trust for a postnatal oral 
glucose tolerance test (OGTT). A purposive approach 
was used to achieve a maximum-variety sample (age, 
parity, socioeconomic status, ethnicity). OGTT non-
attenders were targeted, by further study invitations 
offering a home visit or telephone interview. 
Interviews were audio-recorded, transcribed and 
independently coded using the COM-B framework. A 
socio-ecological approach was adopted to understand 
the context of intervention facets. The final model 
was developed within the research team.  
Findings 
We interviewed 27 women diverse in age and parity, 
most were White-British (20/27). Applying the COM-B 
framework, we identified sixteen key subthemes 
which reflected either: capability, opportunity, or 
motivation components of the model. Four domains 
adapted from the socio-ecological model: ‘individual’, 
family life’, ‘community and healthcare provision’, 
contextualised factors important for these women in 
terms of behaviour change. ‘Emotional response’ at 
the individual level was highly motivating or 
demotivating. Factors related to ‘Family life ‘and 
‘Community’ were particularly dominant and could 
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either facilitate or impede change. Many participants 
relied on ‘Healthcare provision’ during the postnatal 
periods with timing and positive relationships key to 
good care.  
Consequences 
The application of the COM-B framework in a socio-
ecological context provides novel insight into the 
factors crucial for postnatal behaviour change in 
women with GD. Intervention facets need to target 
the micro through to macro-levels to prove effective 
in this population. Future research should consider 
family rather than individual level interventions as this 
could enable sustained behaviour change and 
consequently prevent the development of T2DM.  
Funding Acknowledgement 
This work was supported by the Royal College of 
General Practitioners Scientific Foundation Board, 
grant number SFB 2015-04. The interviews were 
completed while Brian McMillan was employed as an 
NIHR Academic Clinical Fellow (award ref: 1897). The 
views expressed are those of the authors and not 
necessarily those of the NHS, the National Institute for 
Health Research (NIHR), or the Department of Health. 
 
I.7 
SuMMiT-D - Formative development of a mobile-
health based system to support type 2 diabetes 
medication adherence in primary care: qualitative 
study with British South Asian patients   
Presenter: Nikki Newhouse 
Co-authors:  Suman Prinjha, Ignacio Ricci-Cabello, 
Andrew Farmer 
Institutions 
University of Oxford, Balearic Islands Health Research 
Institute (IdISBa) 
Abstract 
Problem 
Type 2 diabetes is a lifelong condition affecting four 
million people in the UK. Alongside lifestyle change, 
medicines are used to lower blood glucose, blood 
pressure and lipids. However, up to half of these 
medicines are not taken as prescribed and many 
interventions for improving medicine use are 
ineffective.  British South Asians are up to six times 
more likely to have type 2 diabetes than the general 
population, to develop the condition at a younger age, 
and to experience related complications.  Evidence to 
support the use of mobile phones in type 2 diabetes 
management has shown positive impacts on 
glycaemic control. The Support through Mobile 
Messaging and digital health Technology for Diabetes 
(SuMMiT-D) project is developing and testing a 
mobile-device based system delivering short 
automated messages to offer support for medicine 
use alongside usual care to people with type 2 
diabetes in primary care. This qualitative study 
explored the views of British South Asian patients with 
type 2 diabetes on the feasibility of such a system.  
Approach 
Sixty-seven adults took part in eight focus groups from 
the Punjabi Sikh, Pakistani Muslim, Gujarati Hindu, 
Bangladeshi Muslim and Gujarati Muslim 
communities. Purposive sampling reflected 
community diversity in terms of age group, 
educational and occupational background, fluency in 
English, place of birth, time since diagnosis and self-
reported use of digital devices. Participants were 
recruited by the Centre for BME Health through local 
community organisations in Leicester, and discussions 
were conducted in Punjabi, Bengali, Sylheti, Urdu, 
Hindi and English.  
Findings 
Users and non-users of digital devices discussed a 
range of self-management challenges and suggested 
ways that a messaging system could help. Five themes 
were identified: message content and design; 
language preferences; family involvement; different 
digital formats for different groups; face-to-face 
groups for those who do not use digital devices. 
Participants found messages supporting medication 
adherence to be acceptable and relevant, but they 
also wanted more information on topics including 
South Asian foods and religious fasting. Other 
information needs included messages about diet, 
physical activity, stress management, natural and 
complementary approaches, and current research. 
Brief messages delivered in English were perceived to 
be acceptable.  
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Consequences 
It is recognised that health interventions that are 
culturally adapted to the needs of specific groups are 
more likely to be acceptable, but evidence to support 
the effectiveness of adapted interventions is limited.  
A messaging intervention that addresses holistic self-
management of type 2 diabetes is more acceptable to 
British South Asian people with type 2 diabetes than 
one that focuses only on medication adherence. 
However, for such an intervention to meet specific 
needs, encourage uptake and credibility, it would also 
have to include a range of culturally-relevant 
messages and consider the needs of those who do not 
routinely use digital devices.  
Funding Acknowledgement 
This study was funded by the National Institute for 
Health Research (NIHR; Programme Grants for Applied 
Research programme [RP-PG-1214-20003]). The views 
expressed are those of the authors and not 
necessarily those of the NIHR or the Department of 
Health and Social Care. 
 
I.8 
People with NAFLD also drink alcohol - how should 
we advise and manage this expanding group in 
primary care? A systematic review.   
Presenter: Hannah O'Keefe 
Co-authors:  Hannah O'Keefe, Dawn Craig, Daniel 
Stow, Quentin M Anstee, Barbara Hanratty 
Institutions 
Population Health Sciences Institute, Newcastle 
University 
Abstract 
Problem 
Liver disease incidence, morbidity and mortality is 
increasing in the UK. Most liver disease is lifestyle 
related with alcohol related liver disease and non-
alcoholic fatty liver disease (NAFLD) accounting for 
the majority of chronic liver disease in the UK.  
Traditionally, little attention has been paid to people 
drinking alcohol at above modest recommended limits 
who also have NAFLD. The incidence of obesity and 
diabetes is rising  and the percentage of the 
population drinking at above recommended limits is 
significant.There is little guidance available on how to 
advise patients with a diagnosis of NAFLD around safe 
alcohol consumption. Interest in the relevance and 
implications of this ‘dual’ pathology has led to the 
publication of several recent  reviews, each with 
different questions, remit and methodology, but all 
looking to elucidate the role of moderate alcohol 
consumption in the NAFLD disease process. The 
purpose of this systematic review is to synthesise the 
evidence around the role of moderate alcohol 
consumption in influencing progression to severe liver 
disease in those with NAFLD.  This will help guide 
those working in primary care to advise and manage 
patients with NAFLD who also drink alcohol.  
Approach 
Studies were included if they were looking at the role 
of moderate alcohol in influencing progression to 
severe liver disease in those with diagnosed 
NAFLD.We searched the following electronic 
bibliographic databases: MEDLINE, EMBASE and The 
Cochrane Library and clinical trials.gov. We also 
searched for additional grey literature on CPCI-S 
(Conference Proceedings Citation Index – Science, 
Web of Knowledge) and OpenGrey 
(http://www.opengrey.eu/). There were no language 
restrictions. Titles and/or abstracts of studies were 
screened independently by two review authors to 
identify studies that potentially met the inclusion 
criteria outlined above. The full text of these 
potentially eligible studies were retrieved and 
independently assessed for eligibility by two review 
team members.  
Findings 
The searches identified 3780 unique references.  Of 
the titles and abstracts screened 85 were selected for 
full text screening. At the time of abstract submission 
full texts were being assessed for inclusion in the 
systematic review. From screening and early full text 
assessment it appears there are conflicting results 
regarding the role of alcohol consumption in NAFLD 
progression. Some studies report a protective effect 
and other studies suggest that any level of alcohol 
consumption is harmful in those with diagnosed 
NAFLD. The systematic review and conclusions will be 
completed and presented at the SAPC annual 
conference.  
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Consequences 
With increasing levels of obesity and Type 2 Diabetes 
we are going to be diagnosing an increasing number 
of individuals with NAFLD. These people will be 
drinking alcohol in varying amounts and looking for 
advice from primary care practitioners. This 
systematic review will allow GPs to give evidence 
based advice to this increasing population.  
Funding Acknowledgement 
This review is independent research supported by the 
National Institute for Health Research (NIHR In 
Practice Fellowship, Dr Helen Jarvis, NIHR IPF-2018-
12-008). The views expressed in this publication are 
those of the author(s) and not necessarily those of the 
NHS, the National Institute for Health Research or the 
Department of Health and Social Care. 
 
I.9 
How common is antidepressant use in people with 
type 2 diabetes and who is  at risk?   
Presenter: Kingshuk Pal 
Co-authors:  Manuj Sharma, Naaheed Mukadam, 
Irene Petersen 
Institutions 
UCL 
Abstract 
Problem 
Diabetes is the third most common long-term 
condition in England after hypertension and 
depression, and it affects around six percent of the 
population. People with type 2 diabetes (T2D) appear 
to be more at risk of developing depression and have 
poorer outcomes if they are depressed. However 
estimates of the prevalence of depression in people 
with type 2 diabetes vary widely, ranging from 0-39%. 
However, here is very little information  on 
populations within the UK. This study examines 
antidepressant treatment  in people with type 2 
diabetes and identify those most at risk.  
Approach 
This was a retrospective cohort study using data from 
The Health Improvement Network (THIN) primary 
care database.  THIN contains electronic primary care 
health records for approximately 12 million patients in 
the UK. The majority of diabetes and depression is 
usually treated and managed in primary care hence 
diagnoses, monitoring and treatments is captured by 
THIN. We  calculated the number of new and 
prevalent users  antidepressant treatment in people 
with type 2 diabetes compared to the general 
population. We used a Poisson regression to examine 
initiation of antidepressant treatment in people with 
and without type 2 diabetes and the relationship 
between initiation and gender, age and deprivation 
(quintiles of Townsend scores).  
Findings 
There were 466,399 people with a diagnosis of T2D, of 
which 328,277 (70%) were newly diagnosed between 
2000 and 2016. The total follow up time was 
1,199,362 years. The hazard ratio for initiation 
antidepressant medication was 1.18 (95% CI 1.17 to 
1.20) in people with type 2 diabetes compared people 
of similar age and gender, but without type 2 
diabetes.  Women with type 2 diabetes were about 
50% more likely than men to initiate antidepressants  
(HR 1.53, 95% CI 1.17 to 1.20). Antidepressant 
treatment in people with type 2 diabetes increased 
with social deprivation and rates of anti-depressant 
prescribing were 62% higher in the most deprived 
quintile (95% CI 1.59 to 1.65) compared to the least 
deprived. People who were prescribed insulin were 
50%  more likely to be on antidepressant treatment 
than individuals not on insulin (HR 1.51 95% CI 1.46 to 
1.57).  
Consequences 
Patients with type 2 diabetes are at increased risk of 
developing diabetes, but the risks vary by age, gender, 
treatment and deprivation. Targeting screening at 
higher risk patients may help clinicians to identify, 
treat and improve outcomes for patients with 
comorbid common mental health problems and type 
2 diabetes.  
Funding Acknowledgement 
Kingshuk Pal holds a clinical research post funded by 
the NIHR SPCR. 
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I.10 
Costing the participation of general practice in a pilot 
randomised controlled trial to increase attendance at 
diabetic retinopathy screening   
Presenter: Fiona Riordan 
Co-authors:  Susan Ahern, Susan Smith, Aileen 
Murphy, John Browne, Patricia M Kearney, Sheena M 
McHugh 
Institutions 
School of Public Health, University College Cork, Royal 
College of Surgeons in Ireland, Department of 
Economics, Cork University Business School, 
University College Cork 
Abstract 
Problem 
Research participation by healthcare providers is 
critical to the conduct of research and translation of 
evidence into practice. However, GPs report lack of 
time, capacity, and the risk of hindering patient flow 
as inhibiting factors. Nonetheless, the economic cost 
to general practice of participating in research is 
rarely investigated or reported.  
Approach 
We have estimated the economic cost of participating 
in the development and implementation of an 
intervention to increase attendance at diabetic 
retinopathy screening from a general practice 
perspective. In a pilot RCT, eight practices were 
randomly assigned to either intervention or waitlist 
control. The intervention, delivered over 6 months, 
comprised (i) audit of patients with diabetes to 
identify non-attenders of DRS, (ii) addition of 
electronic prompts to patient records, (iii) delivery of 
GP-endorsed reminders and information leaflets to 
eligible patients. Four intervention components were 
costed: participation in intervention briefing (human 
resources), intervention delivery (human resources), 
intervention delivery (consumables), and contact with 
the research team (human resources). Data were 
collected at intervention briefing and during research 
phone calls with practices to establish the number of 
eligible patients, profession of staff delivering the 
intervention, time taken to deliver, and consumables 
required. Resources were valued in line with the 
Health Information and Quality Authority’s (HIQA) 
guidelines for the Economic Evaluation of Health 
Technologies in Ireland 2019.  
Findings 
Preliminary analysis is based on two practices that 
have completed intervention delivery. Following the 
audit, 19 patients were eligible to receive the 
intervention in Practice A and 30 patients in Practice 
B. The total cost of participation was €632 and €598 
for practices A and B respectively. Intervention 
delivery (human resources) comprised 73% and 75% 
respectively of total cost, with delivery of reminders 
and information leaflets to eligible patients 
comprising 50% and 75% respectively of this cost. 
Variation in cost between practices was largely due to 
the number and profession of staff involved in 
intervention delivery.  
Consequences 
Economic costs should be captured and analysed 
routinely from the early stages of intervention 
development and piloting to inform efficient resource 
allocation for ongoing programme development and 
public health policy investment decisions. These costs 
will be used to inform economic analysis of a 
definitive trial of this intervention.  
Funding Acknowledgement 
Definitive Interventions and Feasibility Awards 
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Feasibility of a theory-based implementation 
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retinopathy screening:  a cluster randomised pilot 
trial   
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Abstract 
Problem 
Although diabetic retinopathy screening (DRS) can 
prevent blindness, uptake remains sub-optimal in 
many countries, including Ireland.  Routine 
management of type 2 diabetes largely takes place in 
general practice with frequent contact between GPs 
and other primary care staff and people with 
diabetes. However, few studies have tested the 
feasibility of interventions delivered in general 
practice to enhance DRS uptake. To address this gap, 
we aimed to investigate the feasibility of the IDEAs 
(Improving Diabetes Eye-screening Attendance) 
intervention to improve the uptake of DRS in Ireland’s 
national programme, RetinaScreen.  
Approach 
A cluster randomised pilot trial with an embedded 
process evaluation and cost analysis is ongoing.  
Expressions of interest were sought through 
established GP networks. Following stratification of 
interested practices by size, eight practices (clusters) 
were randomly sampled and allocated to intervention 
(n=4) or wait-list control arms (n=4). The intervention 
involves reimbursement, a practice audit of 100 
randomly selected patients with diabetes, electronic 
prompts targeting professionals, GP-endorsed 
reminders (face-to-face, phone and letter), and a 
patient information leaflet. Eligible patients had type 
1 or type 2 diabetes and not attended DRS. 
Intervention practices delivered the intervention 
between July 2019 and January 2020. The 
intervention is currently being delivered in wait-list 
control practices. Data were collected during research 
phone calls with practices, to understand intervention 
delivery (fidelity, feasibility) and research processes. 
Semi-structured interviews are ongoing with a 
purposive sample of staff and patients to examine 
intervention acceptability and feasibility.  
Findings 
Sixty practices expressed an interest in the study. 
Across intervention practices, at baseline 22-30% of 
patients had not attended DRS.  Preliminary analysis 
indicates that the intervention was feasible, albeit 
there were delays to the audit and prompts due to 
limited access to Excel, and limited experience in audit 
or adding prompts. In terms of fidelity, practices 
varied in the sequence or content of reminders: 
phone calls were conducted after letters (n=1); 
reminder letter prepared by the practice were used in 
lieu of the study template (n=1).  
Consequences 
The IDEAs intervention appears to be feasible in GP, 
though practices may need more specific training in 
the use of software to support audits. Findings will be 
used to refine the intervention and study procedures. 
A definitive trial will determine whether IDEAs is a 
cost-effective intervention to improve DRS uptake.  
Funding Acknowledgement 
Health Research Board Definitive Interventions and 
Feasibility Award 
 
I.12 
A THIN database study: What are the effects of the 
Quality and Outcomes Framework (QOF) on 
assessment, diagnoses and management of erectile 
dysfunction and testosterone deficiency in patients 
with Type 2 Diabetes Mellitus in primary care?   
Presenter: Patricia Schartau 
Co-authors:  Irwin Nazareth, Laura Horsfall, Manuj 
Sharma, Mariam Molokhia, Mike Kirby 
Institutions 
University College London (IN, LH, MS), King's College 
London (MM), University of Heartfordshire (MK) 
Abstract 
Problem 
Erectile dysfunction (ED) and testosterone deficiency 
(TD) are common and interlinked complications of 
Type 2 Diabetes Mellitus (T2DM), and independent 
predictors of cardiovascular disease. International 
guidelines recommend that men with T2DM are 
assessed and treated for ED and TD, which was 
included into the Quality and Outcomes Framework 
(QOF) from 2013–2014 only. We aimed to explore the 
effects of QOF on ED and TD diagnoses and 
management in patients with T2DM.  
Approach 
The study population included males (≥18 years) with 
T2DM and contributing to UK GP electronic health 
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records from 1999–2016. Adjusted incidence rate 
ratios (IRRs) were estimated using multivariate 
Poisson regression.  
Findings 
In total 110 423 adult males (mean age 60 years) with 
T2DM were included. During follow-up, 53 003 (48%) 
had a recorded ED assessment, 14 355 (13%) an ED 
diagnosis and of these 74% had received at least one 
phosophodiesterase-5 inhibitor (PDE5i) prescription. 
ED assessments increased from 7.7 per 1000 PYAR in 
2012 (95% confidence interval [CI] = 7.0 to 8.4) to 610 
in 2013 (95% CI = 604 to 617) when included into QOF 
but dropped to 59.4 (95% CI = 56 to 63) in 2016. 
Compared with 2012, the adjusted incidence of 
recorded ED diagnoses and PDE5i prescriptions 
doubled in 2013 (incidence rate ratio [IRR] 2.0; 95% CI 
= 1.8 to 2.1) before falling to below pre-QOF levels in 
2016 (IRR 0.89; 95% CI = 0.82 to 0.97). Of 1187 
diabetic men diagnosed with ED or receiving a PDE5i 
in 2015, 213 (18%) had a minimum of one 
testosterone measurement, of which 45 (21%) met 
biochemical criteria for hypogonadism typically 
requiring treatment (testosterone ≤ 8nmol/l). Nine 
(20%) subsequently received testosterone 
replacement therapy (TRT). The multiple regression 
analysis showed a significant effect of age on ED 
assessment, diagnosis and PDE5i prescriptions (p < 
0.001) with most assessments, diagnoses and PDE5is 
prescriptions completed in the 55-60y old age group. 
There was no effect of Townsend scores (deprivation 
index). 
Consequences 
In order to improve diagnosis and management of ED 
and TD in T2DM patients and thereby (cardiovascular 
and metabolic) health and quality of life, 
incorporation of guidelines into a GP framework 
and/or financial incentives may be required alongside 
solid GP education.  
Funding Acknowledgement 
Funded by King's College London as part of the ACF 
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How can we optimise the impact and effectiveness of 
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Abstract 
Problem 
Audit and feedback (A&F) aims to improve patient 
care by reviewing health care performance against 
explicit standards. The National Diabetes Audit (NDA) 
includes around 8,000 general practices in England. 
A&F has been shown to have significant effects on 
patient care, with the potential for substantial 
population impacts. However, the effects are variable 
and research is needed to optimise the content, 
format and delivery of feedback.  
Approach 
We conducted an innovative, fractional factorial web-
based experiment. We worked with five national 
clinical audits, including the NDA, to evaluate six ways 
of enhancing the impact of feedback: recommending 
specific actions; using comparators that reinforce 
desired behaviour change; minimizing extraneous 
cognitive load for feedback recipients; providing 
feedback in more than one way; providing short, 
actionable messages following by option detail; and 
including a patient statement. The experimental 
design meant that participants were randomised to 
one of 32 experimental combinations of these six 
components. The design permitted consideration of 
the effects of individual experimental components, as 
well as two- and three-way interactions. Collaborating 
audits shared an invitation to participate with their 
existing distribution networks. Participants completed 
the study via a specially designed online portal. After 
indicating the audit with which they were familiar, 
participants were presented with an excerpt of an 
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audit report. This was followed by a short 
questionnaire. The primary outcome was intended 
enactment of a specific clinical recommendation. 
Other outcomes assessed were comprehension, user 
experience, preferences and engagement with the 
content.  
Findings 
Analysis is underway, with the primary analysis 
drawing upon data from 638 participants, including 
204 for the NDA. We will consider the findings from 
the NDA respondents in comparison with those of the 
entire sample.  
Consequences 
The findings will have implications for the design of 
national clinical audits, with the potential to enhance 
the effectiveness of the NDA and improve the delivery 
of care for patients with diabetes in UK primary care. 
We will also highlight more general lessons for the use 
of clinical audit and feedback in primary care.  
Funding Acknowledgement 
The research was funded by the National Institute for 
Health Research (NIHR) under its Health Services & 
Delivery Research Programme (Reference Number 
16/04/13). The views expressed are those of the 
authors and not necessarily those of the NHS, the 
NIHR or the Department of Health. 
 
J.1 
Clinical Reasoning in Undergraduate Primary Care 
Medical Education: An International Systematic 
Review   
Presenter: Nur Faraheen Binti Abdul Rahman 
Co-authors:  Nathan Davies, Julia Suhaimi, Sharifah 
Najwa Syed Jamalullail, Faridah Idris, Sophie Park 
Institutions 
University College London, University of Malaya, 
Universiti Sains Islam Malaysia, Universiti Putra 
Malaysia 
 
 
 
Abstract 
Problem 
Students learn clinical reasoning for decision making 
in many settings including in the primary care 
practice. But, the implications of the primary care 
setting as an environment to teach and learning 
clinical reasoning is unclear. To our knowledge, this is 
the first study conducted on clinical reasoning 
teaching and learning in the undergraduate primary 
care practice setting. We designed a systematic 
review to identify and describe the educational 
activities, barriers to and facilitators for clinical 
reasoning teaching and learning in undergraduate 
medical education.  
Approach 
Using the BEME Systematic Review Guideline; 
empirical studies in English and Malay Languages 
were selected using a predetermined inclusion and 
exclusion criteria through searches in the MEDLINE, 
PsychINFO, EMBASE, CINAHL, ERIC databases and grey 
literature.  
Findings 
An initial scoping search using the key search terms of 
“clinical reasoning in medical education” in the 
PubMed database yielded 1583 articles of interest. 
With the help of an information specialist, a specific 
search strategy using a combination of expanded 
MESH terminologies and individual keyword resulted 
in 814 from a combination of databases i.e. EMBASE. 
MEDLINE and Psych INFO. Following deduplication, 
the numbers were reduced to 699 titles. Third scoping 
using the final consensus terminologies from MEDLINE 
yielded 313 titles. We reviewed all the abstracts and 
estimated that approximately 30% of full-text articles 
are relevant to the review questions. We anticipated 
this number will double when we include other 
databases. In the next three months, we will extract 
and analyse the findings using narrative synthesis. 
Themes are coded in the areas of clinical reasoning 
teaching and learning activities, conceptual 
framework underlying the clinical reasoning 
education, issues in implementations, facilitators and 
barriers characteristics, as well as outcomes 
particularly regarding students’ experiences and roles 
and experiences of stakeholders.  
Consequences 
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Curriculum developers and clinical teachers may 
benefit from this review from the typology of the 
clinical reasoning education practised globally. It can 
guide clinical reasoning module design and 
development in the primary care setting. Gap for 
future research recommendation will also be 
highlighted.  
Funding Acknowledgement 
This review is supported by funding from the Ministry 
of Education, Malaysia, awarded to Dr. Nur Faraheen 
Abdul Rahman. 
 
J.2 
How can we optimise medical education to support 
the development of person-centred values, beliefs 
and attitudes?   
Presenter: Dr Aarti Bansal 
Co-authors:  Professor Joanne Reeve, Dr Caroline 
Mitchell, Dr Sophie Park, Dr Katie Shearn, Sarah 
Greenley 
Institutions 
Hull York Medical School, University of Sheffield, 
University College London, Sheffield Hallam University 
Abstract 
Problem 
Person-centred care (PCC) is considered central to the 
delivery of high quality care in the context of long-
term conditions, multimorbidity and complexity 
where evidence suggests it can lead to improved 
patient outcomes. Yet current evidence points to an 
erosion of person-centredness in medical students as 
they progress through training. This is despite the 
long-established delivery of person-centred 
consultation skills training in medical medical schools; 
leading us to query whether there are gaps in our 
educational strategy in developing person-
centredness.Behaviour change theories suggest that 
values, beliefs and attitudes drive actions, so perhaps 
education strategies need to explicitly focus on these 
elements in developing professional capacity for PCC. 
However we don’t yet know how to best educate 
clinicians for person-centred values, beliefs and 
attitudes. We regard education as a complex 
intervention with multiple component parts and a 
variety of potential  outcomes depending on the 
interactions between multiple factors. A realist review 
is particularly suited to investigating complex 
interventions.  Our research question asks: How, why, 
for whom and in what circumstances educational 
programmes that aim to promote a person-centred 
approach change medical professional's values, beliefs 
and attitudes?  
Approach 
Realist review based on the published RAMESES 
guidance. With information specialist support we 
completed a search of key medical and education 
databases ( MEDLINE, ERIC, EMBASE, HMIC ) and grey 
literature sources through Boolean combinations of 
relevant free-text and subject heading terms; limited 
to papers published from 2000 and in the English 
language.  Inclusion criteria (educational 
interventions; aimed to change person-centred 
values, beliefs and attitudes) were applied with 
double screening  of 10% abstracts and full texts to 
identify final data set. An initial thematic analysis 
oriented us to the data, before moving to a detailed 
analysis of Context-Mechanism-Outcome (CMO) 
configurations to  generate our final programme 
theory.  
Findings 
2494 initial identified abstracts were screened to 
generate a final data-set of 124 papersAt this interim 
stage of analysis, we have identified three key themes 
which suggest that person-centred values, beliefs and 
attitudes may be supported by: 
1. Critical engagement with the values, 
knowledge, concepts and evidence that underpin the 
practice of PCC,  
2. Reflection on clinical practice that supports 
transformative learning and self-awareness, 
3. Clinical placements and experiences in which 
students engage with patient narratives and develop 
partnerships in their relationships with patients and 
preceptors.  
 
Consequences 
Our final output will be a refined programme theory 
which will describe the key components of an 
educational framework to optimise the development 
of person-centredness in medical students. We expect 
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the findings to have wide curricular implications and 
to be used to inform, develop and evaluate existing 
educational strategies.  
Funding Acknowledgement 
NIHR : This research is funded by an In-Practice 
Fellowship awarded to Dr Aarti Bansal 
 
J.3 
Training the Future Doctor: Evaluating General 
Practice in the HYMS MBBS Curriculum   
Presenter: James Bennett and Puja Verma 
Co-authors:  Puja Verma, Joanne Reeve, Kevin 
Anderson 
Institutions 
Academy of Primary Care, Hull York Medical School 
Abstract 
Problem 
Recruitment and retention of General Practitioners is 
in crisis.  The Wass Report highlighted the relationship 
between GP careers and undergraduate training, 
emphasising the responsibility of medical schools to 
provide experience of authentic general practice. 
HYMS is rightly proud of its primary care teaching, 
with the largest proportion of any UK medical school 
curriculum (19%) delivered by GPs and also the largest 
proportion of time (15%) that students spend learning 
in a general practice setting. What is not clear is 
whether the content and methods of delivery are in 
keeping with recent national guidance. This study 
aims to define authentic General Practice in the 
context of undergraduate medical education. It will 
evaluate if HYMS meets its duty as an educational 
institution to expose students to authentic General 
Practice, enabling them to make more informed 
career choices and potentially helping address the 
workforce crisis. As far as we know this is a new 
approach to evaluating an undergraduate curriculum.  
Approach 
We used the Wass report and RCGP-SAPC curriculum 
guidance, identifying what a curriculum should 
contain in order to deliver high quality patient-
centred community teaching. We also analysed key 
curriculum documents from comparable health care 
systems in Canada, New Zealand and Australia to 
ensure that themes identified were internationally 
recognised as crucial to the curriculum of authentic 
primary care. This structured thematic analysis 
developed seven core themes on which a novel 
framework was built to analyse the HYMS 
curriculum.Our data source included all curriculum 
documents describing learning outcomes for the 
MBBS program. We used a modified framework 
analysis approach to undertake thematic analysis of 
the data set, identifying the presence/absence of core 
concepts. For each theme, we described whether the 
coded entry was fully recognised in content/delivery 
(marked as green), partially (amber), or not 
recognised at all (red).  
Findings 
Our analysis reveals themes comprehensively 
covered, including person centred care, 
communication skills and reflective practice. It also 
highlights potential gaps such as the hidden 
curriculum, generalist medicine, and methods of 
delivery. At this point we are not clear if ‘red areas’ 
represent true curriculum gaps, or are an artefact of 
the stage 1 study design. Therefore stage 2 will 
involve semi-structured interviews and focus groups 
with key stakeholders to further evaluate potential 
gaps.  
Consequences 
Medical schools have a key role in exposing their 
students to authentic general practice during 
undergraduate training. Although HYMS delivers high 
volume of teaching in general practice, our analysis 
reveals that the medical school may not be delivering 
the recommended content. Our work systematically 
identifies potential priority areas for the school to 
address. This model of evaluation may then prove a 
transferable tool for other medical schools to follow 
suit.  
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J.4 
Learning and recommendations from Significant 
Event Analyses of Bowel Cancer cases   
Presenter: Nicola Cooper-Moss 
Co-authors:  Neil Smith, Umesh Chauhan 
Institutions 
1. School of Medicine, Faculty of Health and 
Biomedical Sciences, University of Central Lancashire, 
Preston. Lancashire and South Cumbria Cancer 
Alliance. 
Abstract 
Problem 
Bowel cancer is the second leading cause of cancer-
related mortality in the UK. Early diagnosis of bowel 
cancer provides opportunities for curative treatment 
and improved survival. Significant Event Analysis (SEA) 
is a well-established quality improvement activity and 
method for learning from new cancer diagnoses. The 
existing literature has primarily focused on learning 
from SEAs of lung cancer cases and emergency 
admissions. This project aimed to provide additional 
insights into the diagnostic processes for bowel cancer 
and to develop the use of multi-site SEA as an 
educational tool.  
Approach 
Seventy-five General Practices across Pennine 
Lancashire were invited to undertake SEAs of one or 
more bowel cancer cases from the preceding three 
years as part of an incentivised scheme. Anonymised 
data were collected on a standardised form. Practices 
provided learning outcomes and recommendations 
for the practice, hospital and local Clinical 
Commissioning Groups (CCGs). 51/75 (68%) practices 
have submitted data so far. Data collection and 
thematic analysis is currently ongoing and the 
completed results will be presented at the meeting.  
Findings 
The preliminary analysis of results has highlighted an 
increased awareness of “red flag” bowel cancer 
presentations; particularly rectal bleeding and iron 
deficiency anaemia. Caution should be exercised due 
to diagnostic overshadowing from haemorrhoids and 
presumed intentional weight loss. Rectal examination 
was considered an essential component to clinical 
assessment. Clinicians were encouraged to consider a 
lower threshold for 2-week suspected cancer referrals 
and the use of faecal immunochemical tests; 
particularly for younger patients or patients 
presenting with atypical symptoms. The diagnostic 
limitations of computed tomography scans were 
recognised, however, direct access scanning was 
advocated when endoscopic investigations were 
deemed inappropriate. Strategies for reducing missed 
diagnoses included continuity of care, pro-active 
patient follow-up and safety-netting. Both General 
Practices and CCGs were recommended to improve 
the promotion of bowel cancer screening and 
implementation of standardised systems for the 
follow-up of non-responders. Conversely, clinicians 
should not be falsely reassured by previously negative 
screening results. Commissioners were recommended 
to continue support of multi-site SEA projects; 
oversee effective communication between primary 
and secondary care; improve flexibility with suspected 
cancer referrals, and to address deficits in patient 
education on early symptom recognition.  
Consequences 
Thematic analysis of multi-site SEAs provides an 
opportunity for collaborative learning from new 
cancer cases. These findings confirm and provide 
additional insights to the existing literature on bowel 
cancer from a primary care perspective. The broad 
range of cases from multi-site SEA should be utilised 
across Primary Care Networks for peer-peer learning 
and identification of Network-wide improvements in 
cancer pathways. Further research is required 
regarding the use of SEA for improving and sustaining 
cancer outcomes.  
Funding Acknowledgement 
The analysis was undertaken as part of an academic 
fellowship from East Lancashire CCG. 
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J.5 
What do students value in their General Practice 
placements? A multi-centre evaluation.   
Presenter: William Coppola 
Co-authors:  Anthony Codd (1), Hugh Alberti (1), Kevin 
Anderson (2), Martina Kelly (3), William Coppola (4), 
Sophie Park (4). 
Institutions 
(1) Newcastle University, (2) Hull-York Medical School, 
(3) University of Calgary, (4) University College London 
Abstract 
Problem 
Medical schools are using general practice (GP) 
placements to deliver a significant proportion of the 
undergraduate medical curriculum – on average 13% 
in the UK. Whilst we are developing an understanding 
of the learning taking place in GP, we are yet to 
explore fully students’ perceptions about the value of 
their GP placements. The Wass report reminds us of 
the responsibility of medical schools to improve GP 
placements, to address the current GP recruitment 
crisis. We need to identify and understand students’ 
experience in GP placements: firstly, to improve ways 
to support students’ engagement with general 
practice learning and assessment, secondly, to inform 
integration of doctor’s training with the future needs 
of society, based on a need for more general 
practitioners and community care. We sought to 
identify what students do, and do not value in GP 
placements, and what students feel is transferable to 
their future practice.  
Approach 
Student year-groups undergoing GP placements at 
three UK medical schools were invited to provide 
feedback via an online survey at the end of their 
placements. Three additional feedback questions 
were included: 
1. What did you value about your GP placement?  
2. What did you not value about your GP placement?  
3. What did you learn that might be relevant for your 
future practice? 
Pilot studies across the individual institutions were 
used to generate initial coding themes. We identified 
similarities with the Manchester Clinical Placement 
Index (MCPI). We mapped themes to the MCPI, 
developing additional codes for items inductively 
identified within the data. A process of inductive and 
deductive thematic analysis is being used across the 
feedback cohort data, to map to identified codes, and 
iteratively develop themes. Teleconference data 
clinics are being held across the sites.  
Findings 
Preliminary data from three of the UK medical schools 
(560 respondents) show that students particularly 
value active learning, seeing a wide variety of real 
patients and receiving feedback. They value 
welcoming, supportive and well-prepared tutors and 
staff. Poor timetabling, organisation, and preparation 
of tutors, and lack of patient contact and protected 
teaching time were the most common components 
valued least. Learning for future practice was 
primarily reported as development of the consultation 
process, relationships with patients, and career 
considerations.Full findings from the three UK medical 
schools will be presented.  
Consequences 
Cross-institutional analysis highlights how GP fulfils 
many existing MCPI characteristics of good workplace 
placements. Students reported excellent relevance to 
future practice. In addition, student reference to GP-
based tutorials/seminars and assessments, 
demonstrate how GP placements can be perceived as 
holistic learning environments, potentially normalising 
GP as a ‘home’ learning context for students. These 
findings provide useful insights into the development 
of student learning, quality assurance, and teaching 
materials, as well as guidance for tutors and faculty.  
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J.6 
Can we measure participation in communities of 
practice?  Development and validation of a tool to 
measure belongingness as a proxy for participation 
in undergraduate clinical learning.   
Presenter: Rob Daniels 
Co-authors:  Professor Alex Harding, Dr Mayam 
Gomez-Cano and Dr Jane Smith 
Institutions 
University of Exeter College of Medicine and Health, 
Exeter, United Kingdom 
Abstract 
Problem 
Participation in communities of practice is postulated 
as a key mechanism for work-based learning, however 
the use of both terms in educational discourse is 
highly variable – ranging from technical to vernacular. 
Belongingness is a related single concept that is easier 
to define and measure, representing the bond that 
holds clinical teams together. As such, it is likely to 
represent an important component of effective 
communities of practice. Development of a tool that 
objectively measures belongingness may be useful in 
adding rigour to discussions regarding work-placed 
learning, with the ability to compare clinical 
placements and other learning environments.  
Approach 
After identifying relevant material from the literature 
a draft belongingness assessment tool was developed, 
based on previously published work. This was piloted 
on 181 undergraduate medical students and the 
results subjected to factor analysis. The final version 
was then used to identify whether differences exist 
between different clinical teaching environments.  
Findings 
This tool had internal and external validity, with 
Cronbach’s alpha =0.940, and detected statistically 
significant differences between primary and 
secondary care teaching environments.  
Consequences 
Statistically significant differences in student 
belongingness exist between primary and secondary 
care learning environments. The belongingness scale 
described in this study is a valid tool for the study of 
undergraduate medical students, with potential to 
investigate how varying student experiences of 
Communities of Practice influence teaching and 
learning outcomes. This has potential applications in 
the monitoring of undergraduate and postgraduate 
training placements, quantifying the strength and 
effectiveness of student- teacher relationships, in a 
way that is not currently possible.  
Funding Acknowledgement 
No funding received 
 
J.7 
Can the integration of Physician Associates into 
Primary Care Services be facilitated by curriculum 
design?   
Presenter: Claire Darling-Pomranz 
Co-authors:  Benjamin Jackson 
Institutions 
University of Sheffield - Academic Unit of Primary Care 
Abstract 
Problem 
Designing a curriculum for a new physician associate 
(PA) programme at the University of Sheffield to 
address barriers to PA integration into Primary Care 
services.  
Approach 
Grounded Theory Method research was carried out to 
understand factors affecting the integration of PAs 
into primary care services and inform curriculum 
development of a new PA programme at the 
University of Sheffield.  
Findings 
A conceptual map of the likely barriers and facilitators 
to PAs working in primary care teams in the future 
was developed and two major areas were identified 
to be addressed through targeted curriculum design 
including an adaptation of national course 
requirements. These were the ability to handle 
complexity and manage uncertainty in a first contact 
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role and a lack of general understanding of their 
professional role and competencies within the 
primary care community.  
Consequences 
Specific sessions focusing on developing clinical 
reasoning skills and the role of the PA as a generalist 
were developed.In the first year, 30hrs of additional 
consultation skills and clinical reasoning sessions were 
scheduled. First year students also complete a project 
on ‘the physician associate as a generalist in UK 
clinical care’ individually and in groups to highlighting 
the ambassadorial role they needed to adopt in an 
unfamiliar clinical role.In the second-year clinical 
placements maximise a robust exposure to patients as 
first contact providers, allowing students to develop 
these clinical reasoning skills in practice. Primary care 
placement hours were more than doubled from the 
required 180 hours to 420 hours and Emergency 
Medicine placements from 180 hours to 280 hours 
meaning that 50% were in first contact roles. 
Additionally, wherever possible General Hospital 
Medical placements were encouraged to be in 
emergency medical assessment units. To date 36 
newly qualified PAs have graduated. Their 
performance at the Faculty of Physician Associates 
(FPA) examination ranks our new course as a top 
performing programme in the UK. The 2018 FPA 
Census suggests on average 28.6% of PAs work in GP. 
At the time of writing, 34.6% of PAs employed in the 
South Yorkshire and Bassetlaw region are employed in 
GP and of the University of Sheffield PA graduates, 
16.6% went directly into GP posts. External 
engagement with primary care during our curriculum 
development has helped us to maintain strong PA 
student clinical placements with very good evaluation 
in a crowded placement setting. We are now seeing 
some practices employ more than one PA as part of 
their team and an increase in utilisation of PAs across 
primary care. The limited number of our graduates 
going directly to primary care may be limited by the 
opportunities for employment and an underlying 
anxiety of newly qualified clinicians to enter primary 
care directly. This suggests that ongoing regional 
developments of a preceptorship model for new PAs 
entering primary care would be a useful development.  
 
 
J.8 
Is it feasible for medical students, trainees and 
health professionals with little or no research 
experience to deliver high quality primary care 
research? A proof of concept study to test out the 
Primary care Academic CollaboraTive (PACT)   
Presenter: Polly Duncan 
Co-authors:  Polly Duncan, Sam Merriel, Orla 
Whitehead, Ebrahim Mulla, Victoria Silverwood, 
Rupert Payne, PACT. 
Institutions 
University of Bristol (PD, RP), Exeter University (SM), 
Newcastle University (OW), University of Nottingham 
(EM), Keele University (VS) 
Abstract 
Problem 
Primary care is seen by many undergraduate medical 
students and health professionals as a non-academic 
specialty. In other specialties, such as surgery and 
anaesthetics, collaboratives of trainee doctors are 
well established, delivering high impact research 
published in high ranking academic journals. There are 
no existing UK-wide primary care trainee 
collaboratives. PACT aims to engage medical students, 
GP trainees and primary health care professionals 
(hereinafter PACT members) in high-quality research 
by supporting them to collectively take part in 
research projects. Each project will combine data 
collected by individual PACT members from their 
practices. Data may also be used at a practice level, 
bench marked against other practices, for quality 
improvement (potentially an important buy-in for 
practices). The aim of this study is to evaluate the 
feasibility of recruiting PACT members from up to 20 
GP practices in England to take part in a proof of 
concept study focusing on home visits. This aim will be 
met by: (i) Examining the number and characteristics 
of PACT members and GP practices who express an 
interest in taking part and, of those selected, the 
proportion that collect data. (ii) Exploring the barriers 
and enablers to engaging PACT members and their GP 
practices in the project  
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Approach 
This study will take place in up to 20 GP practices in 
England recruited via the 15 Clinical Research 
Networks. Five project champions will support project 
delivery, each responsible for 4 practices in their 
geographical area. A mixed methods process 
evaluation is planned comprising serial surveys and 
semi-structured interviews with PACT members and 
(where applicable) GP trainers who are responsible 
for their general supervision. For the qualitative 
interviews, purposive sampling will be used to capture 
a range of experiences and views of PACT members 
(e.g. interested/not interested in taking part, stage of 
training, previous research experience, geographical 
region) and GP trainers (e.g. research active/inactive 
practice, interested/not interested in research).  
Findings 
This project will start in the Spring 2020. By July 2020, 
we will have data on the characteristics of PACT 
members and practices that register an interest in 
taking part; data from the first PACT member and GP 
trainer surveys; and insights from some of the early 
semi-structured interviews  
Consequences 
This study is the first England-wide study to test the 
feasibility of conducting high quality primary care 
research using a network of students, trainees and 
health professionals with little experience in research. 
PACT has the potential to increase capacity for 
primary care research in the UK and, through 
engaging medical students and early career health 
professionals in research, to change current opinion 
that primary care is a non-academic speciality. 
Conducting a thorough process evaluation of the 
project is key to understanding the barriers and 
enablers to delivering research using the PACT model.  
Funding Acknowledgement 
The study is funded by the RCGP Scientific Foundation 
Board 
 
 
 
 
J.9 
Has the Bawa-Garba case had an effect on trainee 
engagement with reflective learning?   
Presenter: Dr Laura Emery 
Co-authors:  Dr Ben Jackson 
Institutions 
The Academic Unit of Primary Care 
Abstract 
Problem 
Reflective learning is integral to postgraduate medical 
training, appraisal and revalidation. In general practice 
(GP) training it is used to evidence curriculum 
coverage and attainment of General Medical Council 
(GMC) appointed competencies for progression to 
Certificate of Completion of Training (CCT). Fears of 
exposing weakness or incompetence have long been 
identified as a barrier for engagement with reflection. 
This is likely to have been amplified following the case 
of Dr Hadiza Bawa-Garba, a paediatric trainee who 
was requested to release her ePortfolio reflective 
entries to inform a GMC investigation which later 
resulted in the loss of her licence to practice.The aim 
of this study is to identify themes of the reflections of 
GP trainees and whether their reflective practice has 
changed following the Bawa-Garba case.  
Approach 
A phenomological approach to qualitative research 
was applied. 7 trainees and 4 trainers were recruited 
from the Doncaster GP training scheme and 
underwent semi-structured interviews which were 
later transcribed for analysis. Data was assigned to a 
coding framework and analysed to identify dominant 
themes.  
Findings 
Entries describing mistakes and near misses were 
identified as most useful by trainees for developing 
their practice. This correlates with the dominant 
themes of trainee entries which were difficulty and 
challenge. All trainees reported knowledge of the 
Bawa-Garba case, describing a detrimental effect on 
their engagement with reflection as a result. Most 
notably, trainees were afraid to submit reflections on 
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mistakes and near misses for fear of jeopardising their 
careers.  
Consequences 
This study suggests that the handling of the Bawa-
Garba case by the GMC has had a detrimental impact 
not only on trainee engagement with reflective 
learning, but also on opportunities for trainee 
professional development. More research into how 
trainees might navigate their reflective practice in a 
way that manages these fears is required to maintain 
the value of reflection as a development tool.  
 
J.10 
Can medical students facilitate access to healthcare 
for a seldom heard group through service-learning?   
Presenter: Me and hopefully a student if they can 
find funding 
Co-authors:  Marina Boulton, Danielle Hartland, Louis 
Clarke, Bryony MacPherson, Anum Salam 
Institutions 
University of Manchester, Division of Medical 
Education 
Abstract 
Problem 
Medical students are altruistic, highly intelligent, 
deeply committed and well-motivated members of 
society. In clinical placements they often struggle to 
feel useful, consider themselves burdensome on the 
team and are reliant on supervisors to sign-off 
decisions. This impedes their autonomy and has 
potential for dissatisfaction.Our aim was to engage in 
a project to help asylum seekers understand their 
rights, navigate the NHS and improve health literacy 
through undertaking service-learning. This pedagogy, 
rare in UK medical schools, is recognised widely in 
North America. The work held importance for 
students, voluntary sector partners and people 
seeking asylum.  
Approach 
We undertook action research by trying out an 
educational intervention, critical reflection by multiple 
stakeholders on its success, modification of the 
intervention and repetition of the process regularly. 
The data analysed through note-taking and discussion 
included numbers of people accessing help, types of 
problems, feedback from refugees, asylum seekers 
and voluntary sector hosts, and the transformational 
impact on the students' learning and personal growth.  
Findings 
Initially passive didactic interventions were planned 
with delivery of presentations on how to access care; 
however, the students quickly realised that more 
active intervention is better for engagement. 
Participants were asking for specific advice around 
their own situations and the session was modified to 
provide more tailored service. The students were not 
indemnified for clinical care; however, felt very useful 
in facilitating GP registration, organising appointments 
through Choose and Book; filling out HC1 forms and 
explaining rights to interpretation. An anonymised log 
of problems was reviewed and the students identified 
a need for dental care and legal representation. 
Consequently, they are working up a multidisciplinary 
approach with dental and law students to widen 
signposting activities.The voluntary sector hosts were 
impressed and requested the students to teach their 
staff about healthcare charging regulations and 
managing mental health emergencies. Their 
recommendations led to invitations from a wider 
range of hosts to participate in their services.Students 
learning has been around the social determinants of 
health, inequalities and advanced communication 
skills. They have embedded themselves within 
community services where students would usually 
have limited contact and are producing a handbook 
for future students to use in the project.  
Consequences 
Owning their own project and gaining confidence in 
managing its development has led to students feeling 
they have an important role in our local community. 
The project is thriving and the students are succession 
planning. In renaming the project Students for 
Universal Health Access (SUHA) they have 
demonstrated their understanding of the value of 
advocacy in care. They plan educational sessions on 
rights to care for medical students not involved in the 
project and their passion is palpable. We report the 
service-learning model has been successful and we 
recommend this approach.  
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J.11 
Do GPs actually use online teaching resources for 
placements? Initial results from a new theme-based 
approach to clinical placements   
Presenter: Alex Harding 
Co-authors:  Susanna Hill, Shamik Agashi 
Institutions 
University of Exeter College of Medicine and Health 
Abstract 
Problem 
To what extent can a medical school curriculum 
inform placements?This work investigates uptake 
amongst tutors for a new theme-based approach to a 
placement curriculum that follows the principles set 
out in 'Teaching General Practice', the new UK GP 
curriculum guidelines.  
Approach 
Focus groups with GP tutors at 3 locations in the 
South West of EnglandA grounded theory 
interpretation of data was carried out  
Findings 
Technical problems predominateUptake of new ideas 
is slowUniversities can do much to ease the technical 
burden of GPs in busy practises by improving their 
online access  
Consequences 
Curriculum interventions that use online platforms 
may be better designed by reducing to a minimum the 
technical barriers and content should be as broad as 
possible, allowing adaptation to the variations of 
clinical practice.  
 
 
 
 
 
J.12 
The effects of small pump priming grants for GP 
tutors on innovations   
Presenter: Shamik Agashi or myself 
Co-authors:  Shamik Agashi, Tim Marwood, Jayshree 
Ramsurun, Bridget Deasey 
Institutions 
Universiry of Exeter College of Medicine and Health 
Abstract 
Problem 
Undergraduate GP tutors often feel constrained by 
medical school curricula.GP tutors were encouraged 
to apply for grants of up to £2000 to use in innovative 
ways to further education at their surgeries or 
education hubs. 
Approach 
Process evaluation of schemes introduced by 
participating surgeries  
Findings 
Given the right amount of encouragement and a 
curriculum that can be sufficiently adapted, GPs can 
be very imaginative in their use of relatively small 
amounts of money.  We report on some of these 
innovations  
Consequences 
GPs can innovate meaningfully using relatively small 
amounts of money  
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J.13 
The Medical School as Multiple Communities of 
Practice: analysis of a longitudinal GP placement   
Presenter: Me (Dr Liza Kirtchuk) 
Co-authors:  Preeti Sandhu, Dr Ann Wylie, Dr Anne 
Stephenson (co-presenter) 
Institutions 
Kings College London 
Abstract 
Problem 
In 2017, GKT School of Medical Education introduced 
a year-long, one-day-a- week longitudinal placement 
in General Practice for all 371 second-year medical 
students. This was introduced to address the need for 
early integration of clinical experience and basic 
medical science, align with shifts in healthcare 
towards community settings, and provide longitudinal 
support for students. This innovation aligns with 
international trends towards longitudinal 
undergraduate medical placements, supported by 
pedagogical benefits of continuity elements.  Such 
placements aim to develop students’ professional 
identities through becoming part of a Community of 
Practice (CoP), but research applying this theoretical 
framework to longitudinal placements is limited.  We 
sought to use CoP as a sensitising theory to further 
explore student and tutor experiences of the 
placement.  
Approach 
The programme was researched using a case study 
methodology, with student and tutor experiences 
explored through routine evaluation questionnaires, 
focus groups and field notes from a tutor training 
event. The entire student (n371) and tutor (n54) 
cohort were surveyed, with respective response rates 
of 64% and 41%. Seven tutors and 47 students 
participated in focus groups.   CoP was used as a 
sensitising theory for inductive thematic analysis of 
the qualitative data.  
Findings 
Four key themes emerged: role legitimacy, identity 
trajectories, perceived curriculum congruence and 
continuity of relationships. Student role legitimacy 
was enhanced by engaging authentically in clinical 
care and feeling welcomed into the clinical 
environment. The placement supported inbound 
professional identity trajectories, positively 
influencing conceptions of a career in General 
Practice. Tutors delivered course content with varying 
degrees of fidelity to the explicit curriculum, and 
divergence was often experienced by students and 
tutors as disallowed. Educational priorities of the 
placement were sometimes felt to conflict with those 
of Faculty, challenging student (and tutor) loyalties.   
These themes were supported and influenced by the 
continuity elements of a year-long longitudinal 
placement; with tutors, peers, learning environment 
and patients. Data sources were triangulated during 
analysis, data saturation was met across the 
modalities, and the authors were mindful of 
continually maintaining researcher reflexivity; all of 
which contributed to the trustworthiness of the 
findings.  
Consequences 
CoP theory contributes to the conceptualisation of the 
outcomes of an early years longitudinal GP placement, 
and provides a framework for understanding 
professional identity formation through legitimate 
peripheral participation. It can also elucidate tensions 
between the explicit and informal curriculum. Our 
findings support adopting the following measures: 
explicit introduction of CoP theory to students and 
tutors; supporting students to negotiate dissonance at 
the boundaries of CoPs through reflective practice 
and the development of boundary processes between 
disciplines delivering teaching; orientating CoPs 
toward clinical care to tackle interdisciplinary and 
hierarchical divides; encouraging legitimacy through 
providing students with narrow areas of clinical 
responsibility and promoting welcoming clinical 
environments.  
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J.14 
Peer-facilitated, small-group learning as a solution to 
engaging learners in interactive, reflective education 
following rapid expansion of the VTS cohort.   
Presenter: Sophie Lumley 
Co-authors:  Sophie Lumley, Mike Magill, RIchard 
Price, Nicola Roberts, Mark James, Clare Mcdermott, 
Zoe Hook 
Institutions 
Shropshire Vocational Training Scheme 
Abstract 
Problem 
Background: Trainees expressed dissatisfaction with 
learner-delivered teaching at Shropshire VTS. A new 
format was required to deliver the RCGP core 
curriculum through reflective, interactive learning for 
an expanded group of culturally diverse learners with 
mixed educational experiences. Study Aims:  
• Engagement and ownership of VTS sessions 
by trainees. 
• Explore Bloom’s higher levels of knowledge 
through small-group, peer-facilitated discussion. 
• Make efficient use of time through a “flipped 
classroom” strategy 
• Use authentic cases to explore uncertainty, 
attitudes and develop “professional artistry” and 
synthesis of new knowledge.  
Approach 
A collaborative team of trainees and TPDs developed 
a format to deliver reflective, interactive learning in 
peer-facilitated small groups (8-10 trainees). 
Volunteer peer-facilitators were trained by a 
TPD.Feedback highlighted the difficulty some 
registrars had integrating new ideas with their clinical 
practice, so cases were written by the team to provide 
authentic scenarios from which to branch out into 
allied skills and attitudes to promote ideational 
scaffolding, guided by detailed facilitator notes.Cases 
and preparatory resources were distributed in 
advance to provide foundational knowledge allowing 
group time to be dedicated to deeper exploration in a 
“flipped classroom”.  
Findings 
Feedback has demonstrated a transformation in the 
educational experience of trainees who now perceive 
ownership of the process and learning that is deeper, 
supportive and better integrated.  
Consequences 
Our experience demonstrates that peer-facilitated 
small group learning can transform reflective learning 
in a large, diverse cohort of trainees, at different 
stages of professional development. Involving learners 
in planning and facilitation promotes ownership, 
empowerment, leadership and satisfaction.  
 
J.15 
Trends in early-career general practitioners’ 
prescribing of hormone and non-hormone therapy 
for menopausal symptoms   
Presenter: Parker Magin 
Co-authors:  Jasmine De Giovanni, Amanda Tapley, 
Elizabeth Holliday, Mieke van Driel 
Institutions 
University of Newcastle (Australia), University of 
Queensland 
Abstract 
Problem 
Menopausal hormone therapy (MHT) is effective in 
managing menopausal vasomotor symptoms, but is 
not without risk. The Women’s Health Initiative (WHI) 
study in 2002 demonstrated associations between 
oestrogen plus progestin therapy and invasive breast 
cancer, coronary heart disease, stroke and pulmonary 
embolism.  With WHI’s initial publication in 2002, 
MHT prescribing reduced markedly. Recent studies, 
though, (including further WHI findings) have 
suggested that MHT is not associated with increased 
risk for all-cause, cardiovascular, or cancer 
mortality.We aimed to investigate temporal trends in 
menopausal hormone therapy (MHT) and non-MHT 
symptomatic drug prescribing by early-career general 
practitioners (GPs) for menopause-related problems 
in the eight-to-fifteen years post-WHI’s initial 2002 
publication. Specifically, we sought to establish any 
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increase in MHT prescribing (and in the ratio of MHT 
to non-MHT symptomatic prescribing) following 
publication of further findings from WHI.  
Approach 
A longitudinal analysis from the Registrar Clinical 
Encounters in Training (ReCEnT) study of GP 
registrars’ in-consultation clinical and educational 
experiences in five Australian states. In ReCEnT, 
registrars (early-career GP vocational trainees) 
document 60 consecutive general practice 
consultations, six-monthly, on three occasions. Data 
collected in ReCEnT include registrar, patient, 
practice, consultation, and educational variables.The 
outcome factor for this analysis was MHT (estrogen 
and/or progestogen) prescribed.  All menopause-
related problems were included in the primary 
analysis. The secondary analysis included only 
menopause-related problems for which MHT or non-
MHT symptomatic medicines were prescribed. 
Associations of MHT-prescribing, including year (2010-
2017), were assessed by univariate and multivariable 
logistic regression. 
Findings 
1,736 individual registrars documented 1,569 
menopause-related problems for female patients 
aged 25 years or over during data collection periods 
from 2010 to 2017. There were 756 menopause-
related problems for which patients were prescribed 
MHT or a non-MHT symptomatic drug; 626 (39.3% 
[95% CI 37.4- 42.5] of the total) were prescribed MHT 
at the index consultation. There was no linear trend in 
MHT prescription over time. 130 (17.2% [95% CI 14.6-
20.1] of the total) had a non-MHT symptomatic drug 
prescribed. For MHT prescription versus non-MHT 
symptomatic menopause medications by year, there 
was no significant time trend.  
Consequences 
Our finding of the proportion of women prescribed 
MHT for menopause-related problems by GP 
registrars remaining constant in the period eight-to-15 
years following the initial WHI publication is in the 
context of publication of follow-up studies providing 
nuance and context to the initial WHI findings.  These 
studies might be thought to encourage less restrictive 
MHT use. It may be that it is still too early to see a rise 
in MHT prescribing following the publication of these 
findings, given the generally slow uptake of evidence 
into practice. Similarly, there was no change in 
prescribing of non-hormonal medications by early-
career GP registrars. Our findings may inform the 
delivery of menopause management training for both 
early-career and established GPs.  
Funding Acknowledgement 
The ReCEnT project was funded from 2010 to 2015 by 
the participating educational organisations: General 
Practice Training Valley to Coast, the Victorian 
Metropolitan Alliance, General Practice Training 
Tasmania, Adelaide to Outback GP Training Program, 
and Tropical Medical Training, all of which were 
funded by the Australian Government Department of 
Health.  From 2016-2019, ReCEnT was funded by an 
Australian Government Department of Health 
commissioned research grant and supported by GP 
Synergy Regional Training Organisation. GP Synergy is 
funded by the Australian Government Department of 
Health.  Jasmine De Giovanni received a GP Synergy 
Medical Student Scholarship in relation to this work. 
 
J.16 
Awakening Critical Consciousness in Medical 
Education: Insights for a Critical Pedagogy in General 
Practice Teaching   
Presenter: Annalisa Manca 
Co-authors:  Nigel Hart 
Institutions 
Queen's University Belfast 
Abstract 
Problem 
As medicine’s social contract evolves, medical schools 
have a growing obligation to foster doctors who are 
conscious of social dynamics and inequality in health 
care, and willing to affect societal change. This 
approach can be nurtured via the development of a 
“critical consciousness” (i.e., awareness and 
2017). Although this discourse is increasing in medical 
education (Manca et al., 2019), applying a critical 
pedagogy within curricula in which competency-based 
orientations are dominant, is not straightforward 
because of their different philosophical and 
 110 
 
theoretical underpinnings. It requires courage 
towards change from medical educators, and a 
profound awareness of how context influences 
educational practices and dynamics. This presentation 
outlines the affordances of an undergraduate general 
practice educational context, to provide essential 
elements, for medical educators to adopt in their 
teaching, to awaken critical consciousness in their 
students.  
Approach 
This qualitative educational research adopted an 
overarching (post) critical ethnographic approach, 
informed by social constructivist theory, postmodern 
themes and critical theory. The researcher observed a 
GP undergraduate course writing extensive fieldnotes, 
and interviewed and collected audio-diaries to elicit 
participants’ viewpoints. Discourse analysis was used 
to analyse the data in order to answer the question: 
“How are the affordances for the development of 
critical consciousness enacted, in an undergraduate 
general practice learning environment?”  
Findings 
The GP teachers, while mitigating hierarchical 
relations with students, “directed” them by imparting 
a certain degree of instruction. They cultivated 
students’ understanding of general practice through 
their educational practices and through their teaching 
of values, rather than the teaching of skills for 
immediate practical purposes. Their educational 
approach acknowledged students’ “spontaneity”, 
while pursuing “conscious direction” (Gramsci, 1992). 
The educational practices guided students into 
“reading the world” (Freire & Macedo, 1987) of 
general practice and medicine in general. This 
involved the observation of the practical social 
context and the recognition of social issues, an 
exercise that entails an orientation to action. Both 
students and teachers used their own voice to 
“speak” their reading of the world. Speaking the world 
(ibid.) appeared as a foundation for practical action 
towards transformation (personal, educational, 
social): an act of power.  
Consequences 
The educational practices and relations embedded in 
the GP course foregrounded an implicit critical 
approach to education and an orientation to praxis. 
Crucially, once these spontaneous, implicit pedagogies 
were manifest, it was seen that they were 
epistemologically developed, fostered and 
intentionally adopted to support the development of 
desired attitudes, motive dispositions, and values. The 
attention to establishing pedagogically sound 
educational practices and environments is important 
not only for general practice education, but to 
improve future doctors’ attitude to care in all settings, 
primary and secondary.  
 
J.17 
Moan and Groan No More: Making It Meaningful - 
Learning from Reflective Practice to Transform the 
Teaching of Reflection   
Presenter: Dr Emma Metters 
Co-authors:   
Institutions 
St George's University of London 
Abstract 
Problem 
Reflection is an essential attribute of competent 
medical practitioners and a formal part of licencing 
and revalidation.  Consequently, teaching reflective 
practice is an important part of medical training (GMC 
2018).  Despite different definitions, theories and 
understandings of reflection, Aronson (2012) suggests 
little is known as to the best ways of teaching it.  
Driessen (2017) describes that structured reflection is 
often met with resistance from students and tutors 
alike, and highlights concerns that the 
transformational potential of reflection risks being 
lost.  This study aims to explore GP lecturers’ 
experiences of teaching reflection, drawing on their 
own experience of reflecting within professional 
practice, in order to inform how we teach reflection to 
students.  
Approach 
This was a qualitative study consisting of semi-
structured interviews with lecturers in primary care 
from two London medical schools, which were audio 
recorded, transcribed and analysed using a thematic 
analysis approach to identify themes.  An 
interpretivist stance was used to explore the 
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behaviour, perspectives and experiences of GP 
lecturers’ reflective practice and teaching.Illeris' 
(2009) theory of learning was used as a framework 
through which to consider reflective learning.  The 
educational principles of threshold concepts, social 
constructivist theory and transformative learning 
provided the lenses through which to understand the 
teaching of reflection.  
Findings 
Lecturers reported that both they and their students 
have negative perceptions of structured reflection, 
identifying it as a box-ticking exercise detached from 
meaningful reflective practice.  However, the data 
suggests that lecturers operate from a transformed 
perspective where reflection within clinical practice is 
seen as innate and recognised as valuable, whereas 
lecturers perceive that students are yet to develop 
that same transformed perspective and struggle to 
recognise its value.  For reflection to be meaningful 
lecturers felt it needs to be linked to relevant clinical 
experiences and facilitated through timely, integrated 
discussions.  
Consequences 
Identifying reflection as a threshold concept can help 
us see it as a process that occurs over time and to 
recognise the transformative learning journey the 
students are on.  In order to support students through 
the liminal state of learning to becoming reflective 
practitioners, we need to bring reflective practice 
back into view.  To do this, clinicians need to 
recognise reflection in their daily practice and role 
model it in an integrated, meaningful way that is 
evidenced for students to see.  We need to 
differentiate between documentation of learning and 
reflection, in order to remove the negative 
associations with structured reflection.  Instead 
reflection needs to be tutor facilitated rather than 
portfolio driven, through relevant, timely, clinically 
integrated discussions.  By changing the focus of how 
we teach reflection, we have the potential to change 
student perceptions of reflective learning, thereby 
supporting them as they master the necessary skills 
for becoming competent reflective practitioners.  
 
 
J.18 
Informing undergraduate medical education: A 
systematic review of international policy and mission 
documents to identify how generalism is described   
Presenter: Maddy Foster and Sophie Park 
Co-authors:  Foster, M., Kelly, M., Cheung, S., Elliott, 
J., Singh, S., Abrams, R. Park, S. 
Institutions 
UCL Medical School and Calgary University (Canada) 
Abstract 
Problem 
The need for generalist clinicians is well endorsed by 
professional bodies across the specialties, and 
educating graduates with a generalist skill base is a 
key undergraduate outcome.  Despite the large 
number of position statements on the importance of 
generalism, the pragmatics of educating for 
generalism remain unclear. For example, what core 
concepts of generalism should be integrated into 
curricula and how can these be taught and learned? 
Challenges include a plethora of definitions alongside 
tensions about how Generalism transcends or is 
located within a particular discipline. Professional 
bodies (e.g. Internal Medicine, Family Medicine, 
Surgery) advocate for increased attention to 
‘generalism’, but are the principles and nature of 
these situated practices the same or different? 
Further, physician roles in many healthcare settings 
are increasingly delegated to allied healthcare 
professionals. What might this mean for generalist 
practice and training?  
Approach 
This review aims to understand how generalism is 
described within international healthcare medical 
education mission and policy documents. It asks:  
1. How is generalism described in the policy and 
mission texts across physician clinical specialities?  
2. What facilitators and challenges are identified in 
relation to practising generalism?  
3. How might these findings inform physician training? 
Eight Health and Educational databases, and grey 
literature websites were searched. Inclusion criteria 
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included ‘physician’ and ‘generalism’ or ‘generalist’; 
1999-present; English-language only. A thematic 
analysis was used to map how and in what context, 
the terms are used.  
Findings 
Documents provide a strong imperative for 
generalism. They describe the need for generalism to 
deliver effective and efficient patient care, and the 
need to maintain and develop a workforce able to 
provide and sustain this. A number of challenges have, 
however, been identified. These include: 
a) For learning – what ‘knowledge’ and ‘skills’ 
should training focus on and provide; and how should 
generalism work across boundaries of medical 
disciplines and across multi-disciplinary teams. 
b) For culture – how to challenge a continued 
hierarchy which preferences specialised ‘expert’ work; 
and a pubic paradox which values and preferences 
specialised knowledge, while requiring generalism to 
support an effective healthcare system. 
c) For organisation structures – contending on-
going organisational change; and related shifts in 
roles, responsibilities and opportunities for 
generalism.  
Consequences 
This review highlights how policy and mission texts 
advocate educating healthcare professionals as 
Generalists, but remain ambiguous about what this 
means. The identified challenges will inform a 
subsequent review of empirical literature, as well as 
development of recommendations for future spaces 
in medical education to support generalism across 
disciplines.  
 
 
 
 
 
 
 
J.19 
Medical Student Perspectives of a community 
training experience   
Presenter: Sophie Park 
Co-authors:  Melvyn Jones, Jo Yong, Rachel Roberts, 
Gill Parsons and Will Meyer 
Institutions 
UCL, London HEE, and Barnet Community Education 
HUB. 
Abstract 
Problem 
Medical students spend most undergraduate curricula 
time in hospitals rather than community settings. This 
collaboration aimed to provide insights into how 
community, inter-professional healthcare is delivered. 
The traditional undergraduate GP placement explores 
some of this territory but contact with pharmacists, 
community nurses and other professional groups is 
often ad hoc and quite limited.  Newly forming 
Primary Care Training Hubs (formerly ‘community 
educational provider networks’) co-ordinate some 
community-based multi-disciplinary teaching. We, 
therefore collaborated, to provide undergraduate 
medical students with a one-day teaching session in 
this setting. 
Approach 
Barnet Primary Care Training Hub has collaborated 
with UCL to deliver a community-based 
multidisciplinary day to 1st year clinical students (Year 
4), complimenting an existing longitudinal general 
practice peel-out programme. The sessions are 
facilitated with a mixture of disciplines exploring how 
care is delivered to those in the community with acute 
and long-term conditions. The format is a day-long 
course with 40 students rotating round OSCE style 
interactive simulated scenarios with input from 
practice-based pharmacists, expert patients, GPs and 
practice nurses.  This was a mixed methods evaluation 
utilising content analysis of course documents, direct 
observation, & facilitator & students’ feedback.  
Findings 
The course is delivered for groups of 40 students 
(total 340 across the year). Patient educators report 
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enjoying the experience and are pleased to have their 
voice and expertise heard. The student feedback is 
largely positive. Students report gaining insights into 
the patients’ perspective, and the clinicians’ ability to 
manage patients with many illnesses in the 
community. For example, noticing the different 
resources available between primary and secondary 
care, the challenge of making sense of patient’s 
symptoms the first time they are presented and the 
challenge of identifying potentially serious illness 
within this context. Students wanted the scenarios to 
link to their “hospital firms” and struggled when they 
hadn’t acquired a working knowledge of all the 
systems e.g “not having done cardiology yet”. Travel 
gripes were only mentioned once. Not having cash for 
refreshments in a community clinic hints at students 
having a very technological, metropolitan perspective 
that such educational settings might challenge. PCT 
hub staff found resourcing the design, review and 
delivery of teaching challenging, within the available 
GP tariff.  
Consequences 
Medical students need to develop a wide view of 
what it is to be ill and how community health care 
services respond to that need. Community education 
hubs can contribute to some gaps in students’ 
knowledge and experience. Authentic experiences of 
delivering actual clinical care in the community 
(patient’s home, pharmacists etc) away from the 
familiar doctors’ clinical territory, while logistically 
complex, could be the next steps.  
Funding Acknowledgement 
This work was not formally funded. 
 
J.20 
What is the role of Massive open online courses 
(MOOC) in continuing professional development 
(CPD) of healthcare professionals?   
Presenter: Emily Player 
Co-authors:  Emily Player, Veena Rodrigues 
Institutions 
Norwich Medical School, University of East Anglia 
 
Abstract 
Problem 
Continuing professional development (CPD) is 
essential for maintenance and improvement of 
knowledge and skills of general practitioners. One 
area of CPD relevant to healthcare professionals is the 
supervision of junior colleagues. A positive 
relationship between the supervisor and trainee can 
be an important factor determining success of a 
placement. A variety of factors play into this positive 
relationship, one being a supervisor’s approach to 
constructive feedback and their preparedness to 
supervise. The general medical council (GMC) now 
recommend Clinical Supervisors are formally trained 
but face to face training is not always feasible. 
Technology enhanced learning could assist, and 
massive open online courses (MOOCs) providing a 
platform for content delivery as well as discussion 
could be a suitable option for busy GPs, however, 
little to nil is known about the impact of MOOCs on 
learning and transferral of learning into practice. This 
study aims to address this gap in understanding and 
clarify the role of MOOCs in CPD for primary care.  
Approach 
A qualitative study using an iterative approach. 
Methods will include a questionnaire and semi-
structured interviews. A questionnaire will be used to 
identify some of the learner demographics on the 
MOOC. Semi-structured interviews will be used to 
gain a learner account of their experience of using the 
MOOC and whether it has influenced their practice. 
Interviews are an appropriate form of data collection 
in this setting, as participants are likely to come from 
various geographical locations and therefore 
telephone interviews would be more practical.  
Findings 
The interim findings suggest that MOOCs are a 
valuable interface for providing GPs with CPD in the 
area of clinical supervision. Inductive thematic 
analysis is in the early stages at present but highlights 
areas positive experiences in terms of usability and 
flexibility with the mode of learning. Interviews 
suggest the role of discussion and social learning on 
the MOOC is key to enriching learning, providing 
interdisciplinary learning and a community of practice.  
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Consequences 
With increasing demands for GPs, MOOCs could be 
used as a method of delivering CPD moving forward. 
This is the first study to follow up on learners 
experience of MOOCs after a period of time from 
completion to better understand the impact on higher 
levels of learning.  
Funding Acknowledgement 
No funding to be declared 
 
J.21 
Medicine and the arts, the role of narrative medicine 
in medical education   
Presenter: Emily Player and Matthew Gerlach 
Co-authors:  Dr Emily Player, Dr Matthew Gerlach 
Institutions 
Norwich Medical School, University of East Anglia 
Abstract 
Problem 
The topic of ‘medical humanities’ is not a new area of 
medicine but it is one which is becoming increasingly 
recognised within the medical school curriculum. 
Since the 20th century there has been an increased 
recognition of the human side of medicine and a need 
to readdress the balance between this and hard 
sciences within medical schools. Historically, 
storytelling has been used as a way to enhance 
understanding of illness and the effect on the person 
as a whole, Shakespeare’s Hamlet and depressive 
illness are clear examples of this. More recently the 
movement of narrative medicine could be said to be a 
rebirth of this concept. Charon’s work discusses 
narrative medicine in two forms, that of the doctor as 
a storyteller or listener and the patient as the 
storyteller. The benefits of involving narrative 
medicine and medical humanities in the curriculum 
are suggested to include improved communication, 
empathy and possibly a more resilient well rounded 
doctor. However, there is little published on how 
medical humanities can be delivered in an already 
compact medical curriculum or the student 
experience of such teaching. This teaching evaluation 
aims to address the role of medical humanities in 
medical education and its impact on student doctors.  
Approach 
This is a teaching evaluation of a 10 week module 
delivered by a GP and trainee GP to two groups of 
second year medical students. The content included 
narrative medicine; involving experts by experience 
from marginalised groups such as those living with 
disability and medicine in the narrative; the role of 
literature in portraying and understanding medicine. 
For practical purposes the teaching evaluation 
consisted of pre and post questionnaires which were 
completed by students over two separate cohorts. 
Questionnaires were designed to produce 
quantitative data using a Likert scale for empathy and 
free text feedback for qualitative inductive thematic 
analysis of comments to better understand the 
student experience of the module.  
Findings 
Student reported empathy levels increased following 
the taught module by 2 points on the Likert scale. 
Preliminary thematic analysis of feedback comments 
identified the following themes: communication, 
empathy, medicine as an art, restorative learning. 
These themes will be further refined and re-defined in 
the coming months.  
Consequences 
The findings imply that narrative medicine and 
medical humanities have a valuable role in medical 
student education. This value can be considered from 
the student perspective; deepening their 
understanding of medicine in a different context, 
providing a restorative setting for learning and 
resilience skills as well improved communication and 
empathy towards patients, particularly those who are 
marginalised. Moreover, a structure and format for 
delivering such education has now been outlined and 
evaluated.  
Funding Acknowledgement 
No funding to declare 
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J.22 
‘What have they learnt? A mixed-methods study 
assessing for changes in knowledge, skills and 
attitudes as a result of an Out-Of-Program-
Experience (OOPE) in global health during UK 
General Practice training’   
Presenter: Aaron Poppleton 
Co-authors:  Sam Merriel, Felicity Knights, Hannah 
Fox, Rebecca Hall, Patrick Kiernan 
Institutions 
University of Manchester, University of Exeter, St 
George's (University of London), 
Abstract 
Problem 
GP Global health fellowships, a four year GP training 
programme incorporating a 12 month ‘Out Of 
Programme Experience’ (OOPE) within an 
international health setting are increasingly available 
in England and Wales. A previous survey of qualified 
UK GPs who have undertaken international work has 
shown a range of benefits, including leadership 
competencies in self-awareness, working with others, 
setting direction, managing and improving services. 
The global health fellowship programme has not yet 
been evaluated, including its influence on GP career 
trajectory and Global Health involvement, both in the 
UK and/or overseas. We undertook a mixed-methods 
exploration to understand the impact of a global 
health OOPE on practicing UK GPs.  
Approach 
We approached UK-trained GPs who have completed 
an OOPE in another country and/or a global health 
fellowship between 2009 and 2015 to undertake an 
online survey and follow-up interview. Recruitment 
was via email and social media, distributed via current 
and past global health fellowship leads within GP 
training deaneries and global health interest groups. 
Participants received a link to participate in a 
telephone interview on completion of the survey. 
Survey questions included participant demographics 
and details of the OOPE experience. Questions 
assessing for change in knowledge, skills, and/or 
attitudes (mapped to the Academy of Royal Medical 
Colleges [ARMC] ‘Global Health Capabilities for UK 
Health Professionals’) were included in the survey and 
follow-up interviews. All interviews employed a semi-
structured approach. Survey data has been analysed 
using descriptive statistics in STATA. Interview 
transcripts have been entered into NVIVO, analysed 
thematically and cross-checked by two research active 
GPs. This study received university ethical approval.  
Findings 
23 GPs completed the survey. 20 (87%) participants 
were female, and all aged between 26-45. 20 (87%) 
participants had trained in London, and all are 
currently working as GPs. 19 (86.4%) had extended 
clinical/professional roles. A minority of participants 
had undertaken global-health related work within the 
UK (5 [21.7%]) or internationally (3[13%]), however 16 
(69.9%) stated they wanted to in the future. 
Participants reported their global health OOPE had 
improved their knowledge and skills in all ARMC 
capability domains.Analysis of the GP interview 
transcripts (n=9) is ongoing. Provisional emergent 
themes include ‘Skill development through novel 
exposures’ and ‘Improved confidence within the 
diverse challenges of general practice’. The majority 
of interview participants (66%) had some ongoing 
involvement in global health, with the remainder keen 
to explore opportunities in the future.  
Consequences 
GP Global Health Fellowships may support 
development of pre-existing and novel clinical, 
governance, quality improvement and leadership 
skills, in addition to improving training confidence and 
resilience within a UK General Practice setting. Global 
health fellows show a desire to continue involvement 
in global health-related work within the UK and 
overseas after training, supporting the cross-cultural 
outlook of primary care services.  
Funding Acknowledgement 
Funding to cover interview transcription costs was 
obtained from the RCGP Severn Faculty. 
 
 
 
 
 116 
 
J.23 
The Perceived Barriers to Implementing Near- Peer, 
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Presenter: Oliver Prescott, Helen Rogers 
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Institutions 
University of Exeter Medical School, Healthcare 
Education England SouthWest 
Abstract 
Problem 
The 2016 Wass report ‘By Choice – not by Chance’ 
acknowledged the relative lack of contact 
undergraduate students have with General Practice 
trainees when contrasted to their hospital 
counterparts. It has also been seen that General 
Practice trainees are less engaged with teaching 
activities. Lack of exposure to near-peer mentors can 
affect early career choices and this lack of exposure 
can negatively influence undergraduate perceptions 
of General Practice. With an increase in the demand 
for educational experiences in community settings 
driven in part by the appreciation that General 
Practice provides a unique and ideal learning 
environment comes an opportunity to address this 
lack of contact. By utilising multi-level learning within 
community settings we could yield benefit in the 
educational experiences for all parties. We are looking 
to bridge the gap between undergraduate trainees 
and post graduate trainees in these environments.  
Approach 
The goals were three fold: 
• Understand the current landscape and 
crossover between undergraduate and postgraduate 
education in GP practices 
• Gain feedback from educators on the 
perceived benefits of multi-level learning in primary 
care 
• Understand barriers that exist to developing 
multi-level educational experiences 
We sought to obtain qualitative data in order to 
understand current practices and perceptions. Semi-
structured interviews were carried out with 
educationalists within practices to explore current 
practices and to discuss the views on involving 
postgraduate trainees in undergraduate education. 
Individual structured interviews were chosen in order 
to gain a deep understanding of local practice and to 
allow participants time to express their personal 
views, beliefs and experiences.  
Findings 
We identified a range of different approaches to 
involving GP trainees in undergraduate education 
across our region. In the environments where 
registrars encountered undergraduate trainees the 
qualitative feedback received from practices was 
positive. We identified some practices where any 
interaction was purely on an ad-hoc basis.The 
perceived positive impacts of educational programs 
within practices were felt to be multidirectional. The 
educationalists we spoke to universally felt that near-
peers could play an essential role in undergraduate 
educational experiences with many identifying social 
congruence as a positive factor.The barriers identified 
could be considered to exist as part of 3 major 
domains: organisational, individual and encultured 
attitudes.  
Consequences 
The level to which multilevel learning is utilised in 
primary care is varied; we identified multiple 
interwoven factors influencing this. Highlighting the 
benefits of multilevel learning for all participants is 
key to supporting registrars to engage in shared 
educational experiences with undergraduate students 
in community settings. Developing simple models for 
application, supporting educationalist to apply these 
models and ensuring educational support for trainees 
could yield collective benefit.  
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Educational interventions to ensure prescribing 
competence in new prescribers: a systematic review 
of quantitative and qualitative evidence   
Presenter: Patrick Redmond 
Co-authors:  Michael Naughton, Vibhore Prasad, Lisi 
Gordon 
Institutions 
King's College London, Dundee University 
Abstract 
Problem 
Prescribing competency involves the ability to 
prescribe rationally for the benefit of patients. There 
has been a sustained policy and workforce shift to 
increase uptake of prescribing in non-traditional roles. 
This changing landscape, and new evidence, suggests 
the need for an updated review of interventions to 
ensure competence in new prescribers.  
Approach 
A systematic review was undertaken according to the 
PRISMA guidelines. The review sought to characterise 
the training and its impact on knowledge,skills, and 
behaviours of learners;patient outcomes;and resource 
use. An exhaustive search strategy included all main 
databases. No restrictions were applied by date nor 
language. The MERSQI tool was used to critically 
appraise studies with the Kirkpatrick evaluation 
framework used to categorize outcomes.  
Findings 
5,758 records were screened with 38 studies meeting 
final inclusion criteria(8 RCTs, 16 quantitative 
nonrandomised, 9 quantitative descriptive, and 3 
mixed methods studies. Studies were conducted in 
the UK(n=14), the Netherlands(n=6), Turkey(n=3), 
Bahrain(n=2), Australia(n=2), USA(n=2), with one 
study in each of South Africa, Germany, Yemen, 
Canada, India, Sweden and Malaysia and two multisite 
studies. Most studies focused on medical 
students(n=32), or a mixture of nursing and medical 
students(n=1); three studies focused on nurses and 
one each included dental students or pharmacists 
only.The evaluation of interventions was heavily 
weighted towards the reaction(17) and learning(20) of 
participants with only a few evaluating their 
behaviour(3). A pharmacist facilitated interventions in 
some studies(6) with the ‘near peer’ of foundation 
doctors facilitating teaching in three studies. Some 
interventions were didactic only(2) but many had 
applied elements of learning(16).  
Consequences 
There was much heterogeneity in both study design, 
outcome choice and reporting quality. The vast 
majority of studies confined their assessment of 
learners’ competence to knowledge assessment 
neglecting the higher order of Miller’s framework of 
competency. The WHO Guide to Good Prescribing was 
the most widely evaluated tool and is now 
incorporated into many national curricula.Future 
interventions should consider more valuable 
assessments of higher order downstream competency 
assessment (e.g. OSCE, prescribing audits) as well as 
the longer-term impact of educational interventions. 
Education specific to non-medical prescribers needs 
more research.  
 
J.25 
The influence of career aspirations on medical school 
choice: a national qualitative interview study of 
applicants to UK medical schools   
Presenter: Eliot Rees 
Co-authors:  David Harrison, Karen Mattick, Katherine 
Woolf 
Institutions 
Univeristy College London, Keele University, 
University of Exeter 
Abstract 
Problem 
The NHS is critically short of doctors. The 
sustainability of the UK medical workforce depends on 
medical schools producing more future GPs who are 
able and willing to care for under-served patient 
populations. The evidence for how medical schools 
should achieve this is scarce. We know medical 
schools vary in how they attract, select, and educate 
future doctors. We know some medical schools 
produce more GPs, but it is uncertain whether those 
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school recruit more students who are interested in 
general practice or whether their curriculum 
influences career aspirations.This study sought to 
explore how applicants’ future speciality ambitions 
influenced their choice of medical school.  
Approach 
We conducted a national qualitative interview study, 
taking a critical realist perspective.  We purposively 
sampled applicants and recent entrants to eight UK 
medical schools.  Data were collected through 
individual and group interviews.  Interviews were 
audio recorded and transcribed verbatim. Transcripts 
were analysed through framework analysis by one 
researcher. A sample of 20% of transcripts were 
analysed by a second researcher.  
Findings 
Sixty-six individuals participated in 61 individual and 
one group interview. Interviews lasted a mean of 54 
minutes (range 22–113). Twelve expressed interest in 
general practice, 40 favoured other specialities, and 
14 were unsure.Three themes were identified from 
the analysis: speciality motivations, matching 
aspirations to course, medical school 
attributes.Participants described their speciality 
aspirations and what had drawn them to these 
specialities.  Many participants described becoming 
attracted to specific specialities through work 
experience, or family experience of care.  For those 
that had identified speciality aspirations prior to 
applying to medical schools, few described their 
speciality aspirations influencing their choice of 
medical school.  It appeared, rather, that there were 
other factors that drew them both to their chosen 
medical schools and their speciality of 
interest.Participants’ priorities of medical school 
attributes varied by speciality aspiration; those 
interested in general practice described favouring 
medical schools with early clinical experience and 
problem-based learning curricula, and were less 
concerned with cadaveric dissection and the prestige 
of the medical school.  
Consequences 
Many applicants do consider future speciality 
ambitions before applying to medical school. 
Participant speciality aspiration, however, doesn’t 
appear to explicitly influence choice of medical school, 
rather it appears that this is mediated by curricula 
features of these medical schools.Further longitudinal 
research exploring the influences on career 
aspirations will help us to better understand and plan 
for future workforce needs.  
Funding Acknowledgement 
Katherine Woolf is funded by a National Institute for 
Health Research (NIHR) Carrer Development 
Fellowship for this research project. 
 
J.26 
Does the Macmillan Cancer Care course for Practice 
Nurses and the Primary Care Nurse Facilitator role 
enhance nurse consultations and holistic care for 
patients and support the implementation of nurse 
led cancer care reviews in general practice?   
Presenter: Julia Roscoe 
Co-authors:  Dr Veronica Nanton, Rebecca Appleton, 
Lisa Hall, Jane Hill, Kate Day 
Institutions 
Unit of Academic Primary Care, Warwick Medical 
School, University of Warwick 
Abstract 
Problem 
With increasing numbers of people living with and 
beyond cancer, the role of primary care in the 
management of cancer patients is evolving. As new 
and alternative approaches to patient follow up, are 
being considered practice nurses have been identified 
as key professionals who could have a vital role in 
managing cancer as a long-term condition. This 
research is an evaluation of the Macmillan cancer care 
course for practice nurses and the associated role of 
the Primary Care Nurse Facilitator. The research 
investigates practice nurse’s views on the impact of 
the course, in particular; perceived benefits, applying 
new skills and transferring knowledge to clinical 
practice, increased ability and confidence to 
administer cancer care reviews, cancer related activity 
and post course follow up support.  
Approach 
A mixed methods approach was adopted, involving a 
survey for practice nurses who completed the course 
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and follow up qualitative interviews. The survey was 
designed to enable a broad understanding of the 
impact of the course and contained 20 questions plus 
2 questions for open text box responses. The survey 
was piloted with sub sample of 3 practice nurses. Six 
semi-structured interviews were conducted, lasting 
around 20 -30 minutes either face-to-face or by 
telephone. Topics for the interviews were formed 
from responses to the survey, aiming for more in 
depth exploration of key questions. The interviews 
provided greater depth in understanding the nurses’ 
experience and the variations in implementation that 
occurred.  
Findings 
Twenty-one practice nurses returned a completed 
survey, ranging in experience from 1-20+ years in a 
practice nurse role. Survey findings indicate 
enthusiasm for the course and increase in practice 
nurse confidence to start a conversation with patients 
around cancer, care and other issues such as 
emotional or psychological problems, employment 
and finances. Skills from the course were used during 
routine consultations with patients and long-term 
conditions reviews. These included signposting to 
local services and referrals to other professionals. The 
survey findings illustrate some of the challenges of 
implementing nurse led cancer care reviews in general 
practice, such as lack of time, administrative support 
and support from colleagues.  Findings from the 
interviews indicate common facilitating factors for 
overcoming challenges such as, systems for identifying 
and recalling patients with cancer, peer support and 
follow up with the Primary Care Nurse Facilitator.  
Consequences 
The Macmillan cancer care course and Primary Care 
Nurse Facilitator role are a valuable educational 
resource to upskill practice nurses to conduct nurse-
led cancer care reviews and provide holistic, 
supportive care to patients.This research identifies 
that there is a need for nurses to have time to 
establish a system for nurse-led cancer care reviews in 
their general practice and consultation time to 
conduct reviews with patients. This can be achieved 
through a policy initiative such as the LES.  
Funding Acknowledgement 
Macmillan Cancer Support, Coventry and Rugby GP 
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Influence of cognitive dissonance on clinical 
judgment of a medical student playing the role of a 
doctor in an educational program combining 
ambulatory clerkship and peer role-play: A 
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Presenter: Kazuki Sahashi 
Co-authors:  Kazuki Sahashi [1], Noriyuki Takahashi 
[2], Mina Suematsu [2], Kentarou Okazaki [2], 
Masafumi Kuzuya [2] 
Institutions 
[1]Nagoya University School of Medicine,[2]Nagoya 
University Graduate School of Medicine 
Abstract 
Problem 
In some clinical training programs, medical students 
play patients or doctors in peer role-play, providing 
opportunities for clinical judgment. Cognitive 
dissonance is considered to have important effects on 
clinical judgment. However, the situations in which 
cognitive dissonance occurs, and how it influences 
students’ clinical judgment, are currently unclear. At 
Nagoya University, an educational program combining 
ambulatory clerkship and peer role-play using 
narratives from outpatients is used for training 
medical students. The current study was conducted to 
identify the factors influencing the impact of cognitive 
dissonance on students’ clinical judgment while 
playing the role of the doctor.  
Approach 
The participant was a male student playing the role of 
the doctor. In April 2016, the participant was 
interviewed about what he thought about the training 
program, and the problem that patient was played by 
a student. The participant was recruited through 
purposive sampling. Transcripts of the interview were 
analyzed using a qualitative data analysis method 
called “Steps for Coding and Theorization”. We used 
the theory of cognitive dissonance as a framework for 
analysis. The ethical Committee of Nagoya University 
approved the study (2015-0043).  
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Findings 
We found that one of the influential factors was 
cognitive dissonance between A : a scenario involving 
a female patient, which was a recognization he 
wanted to adopt, and B : the visual recognition of a 
male student, which inhibited adopting A. Thus, two 
forms of dissonance were identified, that caused by 
sex and that caused by gender. These dissonances 
affected the student’s clinical judgment by less 
“presence” and less “particularization” of the patient’s 
information. Less “presence” meant, for example, the 
lack of visual recognition of a female patient. Less 
“particularization” meant, for example, that the 
student playing the role of the patient possessed little 
information about menstruation. Efforts to reduce 
cognitive dissonance led to a reduction in the 
dissonance caused by gender, but dissonance caused 
by sex could not be reduced. Clinical judgment was 
partially aided by reducing the cognitive dissonance 
associated with gender. But asking about sexual 
background and exhibiting an empathetic attitude 
were inhibited by the dissonance related to sex.  
Consequences 
The current findings suggested that a medical student 
recognized two kinds of cognitive dissonance caused 
by gender and sex. The student attempted to 
overcome both forms of cognitive dissonance; one 
was overcome, and the other was not. These findings 
suggested that the biological gap between the patient 
actor and the scenario could present an important 
difficulty for students playing the doctor role, 
particularly during training in clinical judgment for 
issues related to sexual background, and showing 
empathy. Because the results suggested that cognitive 
dissonance caused by gender could be overcome, 
conducting clinical judgment in consideration of 
gender may facilitate training in this educational 
program.  
Funding Acknowledgement 
This study was funded by GSK Japan Research Grant 
2014. 
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Generalist learning in specialist environments: Third 
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Abstract 
Problem 
In the UK and elsewhere, the epidemiological context 
of healthcare is changing towards an ageing society 
with greater multimorbidity. It is widely recognised 
that we need more physicians with generalist 
knowledge and skills and a patient-centred approach 
[generalist physicians] to manage these needs and 
that all undergraduate medical students, regardless of 
final career choice, need a sound generalist medical 
education to prepare for future clinical practice. With 
increasing medical specialization and shorter patient 
stays in hospital, the traditional model of students 
rotating through short speciality-based placements in 
hospitals is becoming increasingly less likely to 
support medical students to develop the generalist 
skills they will need to support the healthcare needs 
of our changing society.  
Approach 
GP facilitated teaching sessions were delivered each 
week during medical student hospital placements to 
small groups of 6-8 students for 90 minutes for six 
weeks. Students discussed and reflected on real 
patient cases that they encountered on their 
placements. The teaching focused on generalist 
clinical reasoning skills development, professional 
development and exploring the patient journey 
before and after hospital admission. Evaluation of 
learning outcomes was conducted through a student 
questionnaire using Likert scales with free text boxes 
for additional explanation. Focus groups were 
conducted to gain a more in-depth understanding of 
student perspectives.  
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Findings 
Three key aspects of the teaching emerged as 
important to the positive educational outcomes for 
students:  Patient-based learning, General Practitioner 
facilitation and Continuity of small group. Students 
expressed that patient-based learning helped them to 
develop generalist clinical reasoning skills and a 
patient-centred approach. The breadth of clinical 
expertise provided by General Practitioner facilitation 
enabled them to broaden the clinical discussion and 
to consider the patient journey across the primary and 
secondary care interface. Small group learning with 
continuity of facilitator made the learning more 
memorable, engaging and encouraged them to reflect 
on ethical and professional practice.  
Consequences 
Our findings support existing literature that 
demonstrates the educational benefits of continuity in 
the learning environment and focusing clinical 
learning around real patient-cases. Our study also 
shows how using General Practitioners as a resource 
for hospital placement teaching can maximise 
generalist learning outcomes for medical students 
during increasingly specialised hospital environments. 
The additional exposure to GPs role-modelling 
generalist clinical reasoning with a holistic approach 
may also help support students to develop career 
aspirations as GPs.  
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Abstract 
Problem 
Differential performance in medical licensing exams is 
a continuing concern for candidates, exam bodies and 
professional organisations. Previous studies 
investigating doctors' performance in medical exams 
suggest that personal, educational, cultural or 
psychological factors may be important influences 
leading to differential attainment by candidate 
attributes such as ethnicity, gender or qualification 
overseas in International Medical Graduates. The ‘Fair 
Pathways’ report suggested that poorer relationships 
between trainee doctors and their seniors, trainers or 
peers, negative expectations and sociocultural factors 
may be important sources of difficulty underlying 
differential attainment. The extent to which such 
factors contribute to differential attainment is largely 
unexplored and unknown. We aimed to examine the 
relative contribution of these factors to differential 
attainment in a national licensing clinical skills 
assessment.  
Approach 
We used a self-administered questionnaire to 
candidates which they completed immediately after 
taking the Clinical Skills Assessment (CSA) of the UK 
Membership of the Royal College General 
Practitioners (MRCGP) licensing exam. Candidates 
volunteered to participate and agreed to link their 
questionnaire, exam and demographic data for 
analysis. We analysed data using SPSS version 25 to 
produce descriptive statistics, comparisons and 
multiple regression to model factors independently 
associated with passing or failing the CSA.  
Findings 
Overall 44.6% (209 of 469) CSA candidates completed 
the questionnaire between 30 November and 6 
December 2018, and consented to data linkage. 
Multiple logistic regression showed that being older 
(odds ratio [OR] 0.86, 95% confidence interval ([CI] 
0.75 – 0.99, p=0.04), male (vs female OR 0.22, 95% CI 
0.06 - 0.79, P=0.02), of minority ethnic status (vs 
white British OR 0.04, 95% CI 0.01- 0.31, P=0.002) or 
having a negative vs positive relationship with their 
trainer (OR 0.11, 95% CI 0.01 – 0.88, p=0.04) were 
associated with a reduced chance of passing the CSA. 
There was no association with passing or failing in 
International Medical Graduates (IMG vs UK trained 
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doctors OR 0.38, 95% CI 0.08 -1.91, p=0.24), those 
who preferred the English language (vs those who 
preferred another language OR 1.20, 95% 0.13 - 
10.72, p=0.87) or candidates’ estimated score (OR 
1.07, 95% CI 0.99 - 1.16, p=0.07). Candidates who did 
not declare a specific learning difficulty vs those who 
did had a greater chance of passing the CSA (OR 
11.49, 95% CI 1.27 – 103.51, p=0.03).  
Consequences 
CSA failure was associated with older age, male sex, 
minority ethnic status, specific learning difficulty, and 
a negative relationship with the candidate’s trainer 
but not with being an International Medical Graduate, 
preferring English language or estimated score. 
Further research is needed to understand why specific 
learning difficulties and a negative relationship with a 
trainer are associated with failure, and to evaluate 
interventions designed to reduce differential CSA 
performance.  
Funding Acknowledgement 
Funded by the RCGP. 
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Abstract 
Problem 
Evidence suggests that empathy and optimism can be 
employed in healthcare consultations to improve 
outcomes for patients - however, healthcare 
practitioners (HCPs) face barriers when applying 
them. This project aimed to develop a digital 
intervention that could provide appropriate, effective 
and acceptable training in empathy and optimism to 
primary care HCPs to improve outcomes for patients 
with osteoarthritis.  
Approach 
The rigorous Person-Based Approach (PBA; Yardley et 
al. 2015), which incorporates theory, evidence and 
qualitative research, was used to develop the 
intervention. This involved: 
1. A meta-ethnography on patients’ and 
practitioners’ views on communication in 
osteoarthritis consultations to discover barriers and 
facilitators to effective consultations. 
2. Two secondary analyses to identify which 
features of empathy and optimism training were 
effective:  
• On 7 interventions  that trained HCPs 
in empathy. 
• On 22 interventions that aimed to 
increase patients’ positive outcome 
expectancies. 
3. A qualitative telephone interview study - 
twenty HCPs (including GPs, nurse practitioners, 
physiotherapists) were interviewed to explore views 
of empathy and optimism in consultations and 
training.  
Interviews were transcribed and analysed using 
inductive thematic analysis.This work informed the 
intervention’s guiding principles, behavioural analysis 
and logic model.  
Findings 
Based on this foundation, using the PBA, the 
‘Empathico’ digital intervention was iteratively 
developed. Fifteen ‘Think-aloud’ interviews were 
conducted with HCPs to help optimise acceptability, 
feasibility and likelihood of behaviour change. 
Patients (n=15) provided feedback on simulated 
videos of an ‘Empathico’ consultation versus a neutral 
consultation to ensure their concerns were addressed 
(in addition to PPI guidance). A ‘Table of Changes’ 
approach was used to modify the intervention: 
comments on each webpage were tabulated, negative 
comments and positive comments were compared, 
and solutions developed in accordance with the 
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guiding principles. For example, participants did not 
like the terms used in one of the modules, 
‘professional’ and ‘cool’, so the team changed this to 
‘attentive’ with ‘increasing expressions of empathy’, 
which conveyed our message more successfully. 
Iterative modifications like these resulted in more 
positive and fewer negative comments, resulting in a 
highly acceptable intervention.A final study was 
conducted, checking that the intervention would be 
acceptable for independent use. Five HCPs, who were 
given access to Empathico for 1-2 weeks, participated 
in a telephone interview discussing their experience. 
Feedback was mostly positive, resulting in only a few 
small final optimizations to Empathico.  
Consequences 
Using this rigorous approach, we were able to create a 
digital intervention for HCPs with strong, evidence-
based training in empathy and optimism. We 
addressed potential barriers to engagement with 
Empathico and improved its likelihood of success. The 
development phase of the project is now complete 
and entering a feasibility trial phase.Yardley, L. et al. 
(2015). The person-based approach to intervention 
development: application to digital health-related 
behavior change interventions. JMIR, 17(1), e30.  
Funding Acknowledgement 
The EMPATHICA trial is supported by a National 
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the National Institute for Health Research (NIHR) 
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Research Professorship in General Practice (NIHR-RP-
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is partly supported by the NIHR Southampton 
Biomedical Research Centre (BRC).  This paper 
presents independent research funded by the 
National Institute of Health Research (NIHR). The 
views expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR, HEE or the 
Department of Health.  The funders had no role in 
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Abstract 
Problem 
There is a growing body of evidence that medical 
students globally recognise the value of nutrition and 
dietary intervention in clinical care, and that there is 
currently an unmet need for teaching in this area in 
the majority of medical schools (Schoendorfer et al, 
2017; Kahan et al, 2017). Culinary medicine is 
particularly relevant to patient care in the primary 
healthcare setting in enabling dialogue with patients 
about lifestyle impact on chronic disease 
management and promoting and supporting healthy 
eating for well-being, disease prevention and surgical 
preparation. Evidence estimates that increasing fruit 
intake by one portion a day could reduce 
cardiovascular mortality risk by 8%, 1.6 million deaths 
per annum globally (Mozaffarian et al, 2011). Another 
study has identified dietary factors as the most 
important risk factor for disability and premature 
death (Murray et al, 2013). A learning needs 
assessment was conducted (Xie et al, in press) to 
inform the development of a Culinary medicine course 
situated within a General Practice rotation. The new 
course combines practical kitchen experience with 
motivational interviewing, case-based discussion and 
presentation of the relevant, emerging evidence-base 
in this field. In particular, the course focuses on 
enabling engagement of patients across different 
socioeconomic and cultural contexts. Our study aims 
to evaluate student learning including meeting 
students’ unmet nutritional knowledge needs; 
providing them with the skills to perform a basic 
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nutritional assessment and to adapt their advice to 
individual patients’ socioeconomic and cultural needs 
in the primary care setting.  
Approach 
Two online questionnaires evaluating students’ pre- 
and post-course knowledge were carried out 
throughout the academic year’s placements. A variety 
of Likert-type, multiple choice and free text questions 
were used. Quantitative analysis of Likert-type and 
multiple choice questions was carried out and 
qualitative thematic analysis was used to analyse free 
text and identify themes for improvements.  
Findings 
First we present quantitative data demonstrating 
improvement in medical students’ familiarity with and 
ability to take a diet history, discuss dietary changes 
and give advice appropriate to individual patients’ 
demographics after the course, compared to before 
the course. Second, we present qualitative data and 
their implementation in recommendations for course 
development within undergraduate primary care 
medical education.  
Consequences 
Our findings show the efficacy and acceptability of a 
hands-on “Culinary medicine in primary care” medical 
education course in meeting students’ nutritional 
education needs. We share reflections from students 
and the organising team about hopes for future 
improvement in the quality of dietary interventions 
and potential impact on chronic disease and complex 
multi-morbidity patient experience.  
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educational workshop of diabetes care, on its 
theatre staffs toward empowerment: a qualitative 
study   
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Abstract 
Problem 
Every choice of diabetes patient about diet, exercise, 
and pills are essential to their own care of diabetes. 
Therefore, “Empowerment approach” is considered 
one of the most suitable ways for diabetes care. In 
order to spread empowerment approach in Japan, 
“Diabetes Theatre (DT)” was developed. DT is an 
educational workshop for health care professionals 
(HCPs) who are audiences. The audiences watch plays 
about common communication problems in diabetes 
care and discuss what is the problem of that 
communication, paying attention to the relationship 
with patients. This allows each of the HCPs audiences 
to reflect their own relationship with patients and 
improve the communication. In DT, “Theatre staffs” 
are also HCPs who make scenarios, prepare for DT, 
and perform at DT. The aim of this study is to explore 
what theatre staffs learn through DT.  
Approach 
We interviewed 11 theatre staffs (3 doctors, 5 nurses, 
2 nutritionists, 1 clinical technologist) of a DT held at 
Kobe city in Japan in November 2012. Participants 
were recruited through convenience sampling and we 
obtained the approval by documents. We asked them 
what they felt about the experience of the DT and 
what kind of change happened about their daily 
communication with patients after that. The 
transcripts were analysed using a qualitative data 
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analysis method called “Steps for Coding and 
Theorization (SCAT)”.  
Findings 
Using SCAT, what the theatre staffs learned through 
DT were sorted into 3 categories:  
1) Factors leading to awareness,  
2) Awareness of the relationship with patients,  
3) Changes led by the awareness.  
We showed some concepts in each category:  
1) experience at DT putting themselves in patients’ 
shoes, experience at DT paying attention more to 
what patients think, similarity of DT to the reality,  
2) awareness of their unconsciously repeated one-
sided behaviors to patients, awareness of their 
attitude paying attention just to disease and not to 
patients themselves or patients’ background,  
3) listening to patients story more carefully, paying 
attention to patients themselves, acceptance of 
patients as a whole person, compassion for patients, 
goal setting by patients.  
Consequences 
The concepts of category 3) are true for the key 
concepts of empowerment. Thereby, the finding 
articulates the HCPs theatre staffs learn to get 
empowerment approach through DT. Like the process 
from 2) to 3), we found that HCPs’ awareness of their 
unconsciously one-sided attitude led to their 
empowerment and compassion for patients which 
would allow them to improve the quality of their 
relationship. Such awareness is only brought about 
from their own experience, and DT was the one of 
effective programs which brings those experience like 
category 1). Therefore, DT is valuable for its HCPs 
theatre staffs, and we hope such a program will 
become more widespread for better and 
compassionate communication between HCPs and 
patients.  
 
 
 
 
K.1 
Exploring the experiences people living with Guillain-
Barré Syndrome and its variants: a qualitative 
interview study   
Presenter: Dr Joseph Akanuwe 
Co-authors:  Joseph Akanuwe, Despina Laparidou, 
Ffion Curtis, Jennifer Jackson, Timothy Hodgson, 
Aloysius N Siriwardena 
Institutions 
University of Lincoln 
Abstract 
Problem 
Guillain-Barré syndrome (GBS) is a rare, usually acute, 
autoimmune disorder, affecting peripheral nerves 
within 2-4 weeks of onset and leading to paralysis and 
sometimes respiratory failure requiring ventilation. 
Variants of the condition can affect cranial nerves and 
a more chronic form, Chronic Inflammatory 
Demyelinating Polyneuropathy (CIDP), also exists. 
Some people continue to experience difficulties, even 
months or years after the acute condition. Since there 
is limited evidence describing the experiences of 
those living with the condition, we sought to explore 
the experiences of people with GBS and its variants, 
including their ongoing physical, psychological and 
social care needs, in the UK.  
Approach 
Following ethical approval, we recruited a purposive 
sample of 16 people with a previous diagnosis of GBS 
or its variants, who consented to interview. 
Recruitment was through an advert placed in the 
Guillain-Barré and Associated Inflammatory 
Neuropathies (GAIN) charity website and through 
social media. We collected data using individual semi-
structured interviews, either face-to-face or by 
telephone, based on participants’ preferences. Audio 
recorded data were transcribed verbatim and 
analysed using thematic analysis method supported 
by NVivo 11.  
Findings 
We identified six overarching themes which affected 
the recovery journey for people with GBS:  
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(1) the importance of early diagnosis to enable early 
commencement of treatment;  
(2) the importance of experience of inpatient care; 
and 
(3) the importance of active support for recovery in 
relation to healthcare, disease, psychological, prior 
health, self-care and lifestyle, social and occupational 
factors. Furthermore,  
(4) the importance of good communication 
throughout the course of the illness and its recovery; 
(5) the need for greater awareness, knowledge and 
provision of information by health care staff; and  
(6) the need to adjust to and redefine recovery, were 
also highlighted by participants as important for their 
recovery to health and function.  
Consequences 
We identified important factors that could facilitate 
improvements in the quality of care, experiences of 
illnesses and recovery of people with GBS or its 
variants. Early effective access to healthcare and 
treatment were considered important, but a positive 
experience of care together with physical, 
psychological and social support were also perceived 
to be essential for a good recovery. There is a need for 
greater knowledge and information provision from 
healthcare workers, including primary care, which has 
implications for staff training, and for the 
development of information resources for patients 
and their families. Patients identified their need to 
adapt to ongoing difficulties in function and they 
sought to redefine what recovery meant for them in 
relation to this.  
Funding Acknowledgement 
We acknowledge the GAIN Charity for funding the 
project 
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Abstract 
Problem 
Guillain-Barré Syndrome (GBS) is a rare inflammatory 
peripheral nerves disorder with variable recovery and 
variant or chronic forms. Previous qualitative studies 
have been published of GBS sufferers’ experiences but 
survey evidence on the experiences and needs of 
people with GBS or its variants particularly in a UK 
context is limited. We aimed to develop and validate a 
survey to quantify the experiences and health and 
social care needs of people with GBS and its variants 
in the UK.  
Approach 
We developed a self-administered anonymous online 
questionnaire survey to explore patients’ experiences 
of care and recovery from GBS. Questionnaire items 
were based on a systematic review and metasynthesis 
of qualitative studies and an interview study of people 
with the condition. After gaining ethical approval, the 
survey was publicised via a national GBS charity 
website and social media. Participants with a 
diagnosis of GBS consented and completed the 
questionnaire online. Question domains included 
experiences of the GBS and its care, symptom severity 
at various stages, and factors that supported or 
hindered recovery. We conducted descriptive 
statistical analyses and developed a multiple 
regression model exploring the relationship between 
experiences, demographic and disease factors.  
Findings 
Of 291 responders who completed the survey within 6 
weeks of its launch, 140 (51.9%) were male, 130 
(48.1%) female; 178 (65.9%) married or in civil 
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partnership whereas 57 (21.1%) were single; 252 
(86.6%) were from the UK. Most participants (116; 
43%) were diagnosed between 2015 and 2019.  Time 
to diagnosis was usually 1-7 days (161, 61.7%). First 
medical help was sought more often from a general 
practitioner (163; 62.2%) than from the Emergency 
Department (67; 25.6%). Improvement in symptoms 
was associated with younger age (≤ 39 years vs older), 
patients who were married (vs civil partnership or 
single), and those who presented to medical care 
early within the first 4 weeks compared with later. 
Improvement in symptoms was also better in 
responders who had a good response to 
immunoglobulins and/or plasma exchange therapy, 
those who were treated in a hospital intensive care 
unit and those who were positive about occupational 
therapy. Responders expressed a preference for 
information from health care staff compared with 
charities or social media but were more likely to 
experience better information from the latter. 
Analysis also showed high completion rates, scale 
reliabilities and construct validity in relation to 
previous studies, such as greater symptom 
improvement in younger people and those who 
received early intensive treatment.  
Consequences 
The survey showed good evidence of face and 
construct validity and internal consistency. It could be 
used to explore experiences and how these could be 
improved in a larger population of people with GBS, 
and to evaluate the effect of interventions designed 
to improve experiences.  
Funding Acknowledgement 
We acknowledge the GAIN Charity for funding the 
project 
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Abstract 
Problem 
Guillain-Barré syndrome (GBS) is an immune-
mediated polyradiculoneuropathy, with an incidence 
of 1-2/100,000 per year and variable severity. Due to 
the rarity of this condition there is limited evidence 
exploring the experiences of patients with GBS. The 
aim of this study was to review patients’ experiences 
and perceptions of GBS, by conducting a systematic 
review and thematic meta-synthesis of qualitative 
studies of patients’ experiences of GBS.  
Approach 
We searched twelve electronic databases, 
supplemented with internet searches and forward 
and backward citation tracking from the included 
studies and review articles. Data were synthesised 
thematically following the Thomas and Harden 
approach. The CASP Qualitative Checklist was used to 
assess risk of bias in included studies.  
Findings 
Our search strategy identified a total of 4,204 
citations and after removing duplicates and excluding 
citations based on title and abstract, and full-text 
screening, five studies were included in the review 
and meta-synthesis; all included studies were 
considered of acceptable quality. Through an iterative 
approach, we developed six analytical themes. The 
first theme discusses the patients’ initial symptoms, 
how they struggled to receive a diagnosis, their 
feelings of uncertainty, and how hope of recovery was 
their main motivation forward. The second theme 
summarises the effects of GBS on all aspects of 
patients’ lives, including their ongoing physical 
difficulties (e.g. pain and fatigue), their psychological 
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well-being (e.g. anxiety and fear), their family and 
social lives, as well as their ability to work. The third 
theme describes how participants were not satisfied 
with the support they received from healthcare 
services and that this was considered a key barrier 
preventing their recovery from GBS. In contrast, the 
fourth theme discussed how some participants had 
positive feelings towards the healthcare and the 
support they received from family, friends and peers. 
The final two themes discuss the participants’ path to 
recovery through achieving milestones and slowly 
accepting their situation. Their desire to go back to 
their pre-GBS selves, and the importance of re-
valuating life are also presented.Despite the variety of 
experiences, it was evident that being diagnosed with 
and surviving GBS was a life-changing experience for 
all participants.  
Consequences 
Exploring this literature has enabled us to identify 
how patients may need extra support to cope better 
with their recovery and also identify ways that 
healthcare professionals and services can help 
facilitate further such a recovery.  
Funding Acknowledgement 
The study was supported by a grant from the GAIN 
(Guillain-Barré & Associated Inflammatory 
Neuropathies) charity. 
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Abstract 
Problem 
Until relatively recently, warfarin was the drug of 
choice for stroke prevention in AF patients but the 
upward prescribing trend of DOACs for AF has 
significant consequences on NHS expenditure. DOAC 
optimisation in primary care is important to prevent 
potential adverse bleeding events  and if adherence is 
suboptimal, their efficacy may be reduced. Older 
patients with AF are often co-morbid and likely to 
experience adverse events. For example chronic 
kidney disease or acute kidney injury due to 
concurrent illness necessitates dose adjustments, and 
lack of routine monitoring and healthcare contact may 
result in poorer adherence compared to warfarin. 
Study aims:To understand patient and practitioner 
perception of DOAC optimisation for atrial fibrillation  
Approach 
Purposive sample of six practices were identified, 
stratified by practices by size, population and area 
65 years with NVAF, GPs, practice based pharmacists 
and community pharmacists were recruited. Semi-
structured, face-to-face, taped individual interviews 
undertaken. Data were organised using NVivo 
Software (V12) and analysed thematically until data 
saturation.  
Findings 
Thirty-two participants were interviewed comprising 
10 pharmacists, 6 GPs and 16 patients aged between 
67 to 89 years.  Themes identified from the patients’ 
perspectives included co-morbidities and competing 
health priorities; poor understanding of the illness and 
treatment; patients’ acceptance of illness and 
treatment as an inevitable consequence of ageing; 
and diminished risk perception of DOACs. Patients 
assumed DOACs were a safer alternative to warfarin 
and relied on their doctors’ medical decisions. Though 
patients received multiple anticoagulant leaflets, they 
could not readily re-call potential side effects of 
DOACs. There was a recognition of medication 
necessity amongst patient who took DOAC for 
secondary prevention of stroke but patients who took 
DOACs for primary stroke prevention and who had co-
morbidities expressed vagueness in illness and 
treatment coherence. Most patients gave priority to 
their co-morbid illnesses for which there was a 
physical discomfort or burden. GPs expressed 
increasing confidence and preference for DOACs over 
warfarin, and they relied on their in-house computer 
re-call systems for routine medication reviews and 
blood tests. Practice pharmacists expressed caution 
and concern for patient safety, and need for checking 
patients' understanding and adherence regularly.  
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Consequences 
Factors which hinder the optimisation of DOACs in 
older patients with AF were identified including co-
morbidities, polypharmacy, poor understanding of AF 
and anticoagulant therapy. These, and increasing 
practitioner workload has resulted in a welcome 
acceptance for alternatives to warfarin because they 
require less medication management.  However, 
diminished risk perception of DOACs, by patients and 
practitioners has implications for patient safety. It is 
the responsibility of all professionals, healthcare 
organisations and patients to ensure medicines use, 
including DOACs which are high risk drugs, is as safe 
as possible. Safe processes are required to ensure 
effective communication and meaningful reviews 
become routine practice.  
Funding Acknowledgement 
Pharmacy Research UK 
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Abstract 
Problem 
Patient-reported outcomes measures (PROM) assess a 
patient’s subjective appraisal of outcomes from their 
own perspective. Despite hypothesised benefits of 
PROM feedback supporting decision making in clinical 
practice and improving outcomes, there is uncertainty 
surrounding their effectiveness in these areas. We 
assessed the impact of PROM feedback on patient-
reported health outcomes and processes of care.  
Approach 
We registered the protocol of this systematic review 
of randomised controls trials (RCTs) in the Cochrane 
Library. We searched MEDLINE, EMBASE, CINAHL, 
clinical trial registries and five other databases, as well 
as grey literature. We included RCTs directly 
comparing the effects on outcomes and processes of 
care of feedback of PROM to clinicians and/or patients 
with the impact of not providing such feedback. We 
evaluated the impact on patient-reported outcomes 
including symptoms, functioning, health perceptions, 
and quality of life; and a range of processes of health 
care including communication, clinical management 
and health service utilisation, and patient satisfaction. 
Where possible we conducted a meta-analysis of the 
results.  
Findings 
We identified 97 randomised trials assessing the 
effectiveness of PROM feedback in improving 
processes and/or outcomes. Studies were conducted 
across diverse ambulatory primary and secondary 
care settings in North America and Europe. Certainty 
of the evidence varied between very low and 
moderate. Many studies were at risk of bias due to 
designs which increased the likelihood of allocation 
concealment and contamination.PROM feedback 
probably slightly improves quality of life (standardised 
mean difference (SMD) 0.015, 95% confidence 
interval (CI) 0.03 to 0.27; 11 studies; 1998 
participants), and probably leads to an increase in 
disease control (odds ratio (OR) 1.56, 95% CI 1.23 to 
1.97; 14 studies, 2806 participants), patient-physician 
communication (SMD 0.37, 95% CI 0.2 to 0.54; 3 
studies; 571 participants), and diagnosis and notation 
(OR 2.56, 95% CI 1.86 to 3.53; 22 studies; 7223 
participants), for which we graded the evidence as 
moderate certainty. The intervention probably makes 
little or no difference for general health perceptions, 
social functioning, and pain. We are uncertain about 
the effect of PROM feedback on physical and mental 
functioning, as well as fatigue. We did not find studies 
reporting on adverse effects.  
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Consequences 
Interventions which assess and feedback patient-
reported outcomes using PROMs can improve the 
detection of healthcare issues, leading to appropriate 
diagnosis and referral as well as increasing patient 
perception of their care and disease control. Patient 
functioning and outcomes were improved slightly in 
mental health care settings and small improvements 
to quality of life were associated with the intervention 
across all studies. There is a need for more high-
quality studies in this area, particularly cluster designs 
and techniques to maintain allocation concealment.  
 
L.1 
Causal Explanation for Patient Engagement with 
Primary Care Services in Saudi Arabia: a realist 
review   
Presenter: Alaa Alghamdi 
Co-authors:  Melvyn Jones, Paula Alves, Sophie Park 
Institutions 
UCL (University College London) 
Abstract 
Problem 
Saudi Arabia (SA) has a rapidly developing universal 
health care system and is maturing from its very 
hospital focussed origins. However, health service 
usage suggests estimates of up to 65% of the cases 
seen in secondary emergency hospitals classified as 
non-urgent that could appropriately be managed in 
primary health care (PHC). Primary healthcare 
development in Saudi has lagged behind secondary 
care, and evidence suggests that citizens are 
ambivalent or dissatisfied with these services.Previous 
research has focused on the quality and patient 
satisfaction of primary care services in Saudi Arabia. 
Yet, uncertainty still exists about causal explanations 
of patient engagement with primary care services and 
potential ways to improve thisThe aim of this review is 
to understand causal explanations of patient 
engagement with the Saudi PHC.  
Approach 
A realist approach was chosen as patient engagement 
with PHC is complex. We undertook systematic 
searches and identified data relevant to the Saudi 
primary healthcare delivery and patient engagement. 
A range of types of data such as qualitative, 
quantitative, mixed-method research and grey 
literature (incorporating related media items) were 
included as was stakeholder involvement. A realist 
review methodology has been used for the data 
synthesis where we developed an initial programme 
theory, searched for evidence as outlined, undertook 
study selection and data extraction. Through data 
synthesis the programme theory was refined.  
Findings 
We identified 33 articles. The data sources were most 
frequently cross-sectional surveys and gave us 
information on different domains in the primary care 
setting. A pathway of patient engagement was 
generated with 6 steps. Many CMOs (Context-
Mechanism-Outcome Configuration) were identified 
to produce the programme theory. Important 
contexts such as; patient's perception, patient's 
needs, healthcare type, friends/ families’ influences, 
and patient's socio-cultural factors were identified. 
The causal mechanisms included trust in, disbelief 
with or misconceptions of primary care, patients’ 
perceptions of GPs’ knowledge, GP/patient 
communication, PHC accessibility & opening hours, 
specialised care in PHC setting, and strict gatekeeping 
policies.  
Consequences 
Patient engagement with primary care services is an 
important topic in SA, particularly in the context of 
Saudi’s 2030 vision for healthcare. Patient 
engagement with PHC is a complex process, and little 
is known about patient drivers and how better 
engagement might be achieved. No previous realist 
reviews have been undertaken on this or any related 
topic in the primary care setting in SA. This review has 
extended our understanding of patient engagement 
with primary care services in SA. We will develop 
outputs to inform future interventions aiming to 
improve patient engagement with primary care 
services in SA. We believe our findings provide 
important insights for healthcare providers and 
policymakers not only in SA but in other settings 
developing primary healthcare systems.  
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Abstract 
Problem 
Attempts to address increasing demand on 
emergency departments (EDs) include the use of 
general practitioners (GPs) in or alongside the ED 
(GPED). It has been estimated that between 15% and 
40% of patients attending EDs in the United Kingdom 
could be treated in primary care, particularly those 
aged between 16–44. The 2015 ‘Keogh review’ of 
urgent and emergency care in England recommended 
co-locating primary care services alongside the ED and 
“streaming” of patients attending with primary-care 
problems to this alternative provision. At that time it 
was estimated that 43% of UK EDs already had some 
form of co-location.In March 2017 £100m of Capital 
funding was allocated by the UK Chancellor to support 
the development of GPED in England. NHS hospital 
trusts could bid for funds to support the 
implementation of GPED, which was a mandated 
healthcare policy. However, there is limited data on 
the benefits of introducing such a model; its 
effectiveness, potential risks and possible unintended 
consequences.The aim of this study was to explore 
whether NHS Trust leaders’ expectations of GPED 
were realised a year after introduction, and how the 
policy was implemented in practice.  
Approach 
Semi-structured telephone interviews were 
conducted with managerial and clinical leaders in 59 
NHS Trusts that received capital funding to support 
the implementation of GPED, to explore their 
expectations. 26 repeat interviews were conducted 
one year later to discover whether their plans have 
been realised successfully.  
Findings 
Interviewees expected that streaming to a GP in the 
ED would result in improved management of patients 
presenting with primary-care problems and a 
reduction in associated resource use. Expected 
impacts included improvements in: ED performance 
against the “four-hour standard”; waiting times; 
quality of care; patient-safety; patient satisfaction. 
The actual experience of introducing GPED for both 
system-leaders and front-line staff, including GPs, was 
varied. Success of implementation was based on 
operational, structural and organisational factors. 
Some reported the introduction of GPED had realised 
their expectations resulting in positive outcomes. 
Others reported several challenges, particularly with 
governance, recruitment and retention of staff 
(especially GPs), and little impact on patient waits or 
performance. Some abandoned GPED altogether. 
Reported concerns included the possibility that 
introducing GPED increased attendances, but such 
increases were rarely explained by GPED. The impact 
on surrounding primary and community healthcare 
providers was difficult to establish.  
Consequences 
Rapid introduction of health policy supported by the 
offer of capital funding does not always result in the 
intended outcomes. National policy is implemented 
by, and in response to, local actors and influences; the 
result can be a service that is more complex than 
anticipated. Focusing on a single area of provision 
may fail to take account of potential impacts on the 
wider health and care system.  
Funding Acknowledgement 
This study is funded by the National Institute of Health 
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Department of Health and Social Care. 
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Abstract 
Problem 
To manage increasing demand on UK emergency and 
unscheduled health care services, policy has 
promoted the streaming of patients presenting to 
emergency departments (EDs) with non-urgent 
problems to primary care services. Currently little is 
known about the different contexts in which primary 
care streaming is operated, its effectiveness in 
directing patients to the most appropriate clinician 
and the impact on flow and waiting times.  
Approach 
Using realist methods we aimed to explore the 
effectiveness of primary care streaming. We visited 13 
hospitals and conducted non-participant observations 
and semi-structured interviews with staff and 
patients. Data consisted of field notes and audio-
recorded interviews. Transcripts were coded in NVivo 
v12 and analysed to produce context, mechanism and 
outcome configurations to help explain how 
streaming works in different contexts and what 
mechanisms are perceived to lead to effectiveness 
outcomes.  
Findings 
Primary care streaming was perceived to help 
improve flow and waiting times in some settings 
because GPs saw patients with minor illness and made 
quick assessments without the need for 
investigations, enabling ED doctors to focus on more 
acutely unwell patients. In other settings where there 
was low demand from patients with primary care 
problems, there was less perceived improvement on 
flow. In more integrated services, with a shared 
governance structure and where there were good 
working relationships between ED and primary care 
clinicians, streaming was perceived to be more 
effective in terms of patients being streamed to the 
most appropriate clinician, GPs often saw a wider 
range of patients More experienced nurses working in 
a streaming or triage role were perceived to be 
effective in streaming patients to the most 
appropriate clinician because they had more skills and 
knowledge to support clinical decision-making. Nurses 
who had knowledge of primary care and of the skillset 
of primary care clinicians working in the ED were also 
perceived as more effective.  Some higher band 
nurses also improved waiting times and flow because 
they could prescribe, order X-rays, discharge patients 
or redirect them to their own GP. Clear guidance and 
training was perceived as essential in streaming 
patients to primary care clinicians and a lack of 
guidance and miss-matched governance where the 
services were provided and managed separately was 
found less effective. Less experienced nurses with less 
knowledge, skills and confidence to support streaming 
decisions were perceived as less effective in streaming 
patients to the most appropriate clinician and took 
longer in undertaking streaming assessments, 
contributing to delays in waiting times and flow.  
Consequences 
Effectiveness of streaming relies on experienced 
nurses, using clear guidance based on the local 
service, support and training. An NHS Trust managed 
service, a shared governance structure and a good 
working relationship between the ED and primary 
care clinicians improved effectiveness.  
Funding Acknowledgement 
NIHR HS&DR 
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Abstract 
Problem 
Rigorously developed clinical guidelines can play a 
pivotal role in promoting evidence-based practice and 
improving the quality and outcomes of healthcare. Yet 
the incorporation of guideline recommendations into 
routine clinical care is often inconsistent. Uptake of 
clinical guidelines may be related to their structure, 
implementation strategies and characteristics of 
targeted professionals or patients. However, 
assessment of the quality and structure of guidelines 
does not necessarily correlate with successful 
implementation. Attempts to improve uptake of 
clinical guidelines, through delivery with an 
implementation strategy, have produced inconsistent 
results. Successful implementation of clinical 
guidelines may also be related to the characteristics, 
or attributes, of the specific recommendations that 
make up the guideline.  
Approach 
This systematic review aims to identify studies that 
assess the impact of the specific attributes or 
characteristics of individual clinical recommendations 
on uptake of that recommendation. We aimed to 
include any comparative studies evaluating the 
characteristics, qualities, attributes or features of a 
clinical recommendation that assesses association 
with uptake. We also assessed studies which 
discussed attributes of recommendations, or barriers 
and enablers to uptake, but did not test this. We 
excluded studies assessing or comparing 
characteristics of individuals or organisations that use 
clinical recommendationsA database search of 
MEDLINE, EMBASE, CINAHL, EBM Reviews and HMIC 
Databases, was conducted. Screening of the titles and 
abstracts (n= 2330) was undertaken by authors 
independently to ensure that the articles satisfied the 
inclusion criteria. For included articles full text 
versions were obtained for further assessment.  
Findings 
There were nine studies which tested if the perceived 
attributes of the guideline influenced guideline uptake 
and 119 studies which discussed attributes of 
guidelines or barriers and enablers to uptake but did 
not test this. Many papers reported that clinicians 
perceive that concise, specific recommendations, 
supported by strong evidence, and guidelines which 
are testable will more likely be used and this is also 
demonstrated in the papers which tested guideline 
uptake. Clinicians also felt that guidance should be 
accessible, concern routine care and be from a 
trustworthy source, although this was shown in fewer 
papers and not shown to be important in the research 
testing guideline uptake. Overwhelmingly, clinicians 
think guidelines should suit patients and be flexible to 
their needs and preferences. However, this has no 
impact on guideline use and the most important 
factors are if the recommendation is compatible with 
current practice and does not require new skills and 
routine change.  
Consequences 
Prospective assessment of the attributes of 
recommendations that are positively or negatively 
associated with successful uptake could identify those 
guidelines that will need greater resources in an 
implementation strategy and lend further insights into 
processes of change. Greater understanding of these 
attributes could guide local and national policy on 
guideline production, dissemination and use.  
Funding Acknowledgement 
NIHR Research Capability Funding West Yorkshire CCG 
Health Education England Yorkshire & Humber Post 
CCT Fellowship 
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L.5 
Are new ways of working in primary care 
sustainable? Assessing policy interventions using 
Normalisation Process Theory   
Presenter: Louisa Harding-Edgar 
Co-authors:  Louisa Harding-Edgar, Frances Mair 
Institutions 
General Practice & Primary Care, Institute of Health & 
Wellbeing, University of Glasgow 
Abstract 
Problem 
Primary care policy in the UK continues to focus on 
the need to re-design services to address increasing 
patient complexity, increased demand and respond to 
the recruitment crisis in general practice. While there 
is much rhetoric, it is unclear to what extent new 
models of care can be embedded into routine primary 
care. We aimed to review recent primary care policies 
focused on new ways of working to assess the extent 
to which they consider sustainability and 
normalisation.  
Approach 
We conducted an analysis of English and Scottish 
health policies focused on the re-design of primary 
care services. We searched Department of Health, 
NHS England, Scottish Government and NHS Scotland 
sites from 2013 onwards, as well as key organisations 
such as the Health Foundation, the National Audit 
Office and the King’s Fund. Initial data extraction 
identified new models of care, who was involved, 
potential barriers and facilitators to implementation, 
resources and monitoring. From this, we applied 
Normalisation Process Theory (NPT) to explore: (1) if 
the policy articulated why the described models were 
‘new’; (2) if it was clear who should be involved in the 
delivery; (3) if there was consideration of the impact 
on current work or resources/training for the new 
work; (4) how implementation would be monitored 
and evaluated.  
Findings 
We identified 23 policies: 15 English, 8 Scottish. Most 
were produced by Government, NHS England or NHS 
Scotland. New models of care included Multispecialty 
providers; Integration of health and social care; New 
unscheduled care; Pharmacy-led care.  Most policies 
cited aging populations and patient complexity as 
reasons for change; some also focused on GP 
workforce shortages and inequalities. Current working 
relationships were acknowledged, and in some cases 
seen as crucial for the new intervention. However, 
linking to new stakeholder groups was also important 
e.g. local authorities and the third sector, but with no 
acknowledgement of the time this requires. 
Resources, particularly new ring-fenced monies, and 
training were outlined in the policies; however, 
timescales for implementation were often very short. 
There was little consideration of the evidence 
required to assess effectiveness nor how new ways of 
working would be monitored long-term.  
Consequences 
There is no shortage of new ways of working in recent 
primary care policy in England and Scotland. These 
are, however, high level descriptions and focus on 
initial implementation, with little consideration of 
how these models should be embedded and sustained 
in the longer term. The result is likely to be continued 
confusion for patients and additional work for primary 
care staff. The use of a theoretical framework, such as 
NPT, highlights what policymakers should focus on if 
they want to ensure the long-term sustainability of 
new ways of working.  
Funding Acknowledgement 
Unfunded study. 
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In general practice, is it possible for patients to 
participate in research before even entering the 
consultation room? The Automated Check-in Data 
Collection Study or the ‘AC DC Study’   
Presenter: Sarah A Lawton 
Co-authors:  Sarah A Lawton, Toby Helliwell, Simon 
Wathall, Christian D Mallen 
Institutions 
Keele University 
Abstract 
Problem 
Despite nine out of ten patient contacts with the NHS 
taking place in primary care settings, in 2017/18, 
participation of patients in primary care research 
studies contributed only 21.3% of total participants in 
NIHR Clinical Research Network supported research. 
Barriers to GPs delivering research include; 
consultation workload and a lack of efficient data 
collection methodologies. Choosing which data 
collection method to use when conducting research in 
the primary care setting is a predicament faced by 
many researchers. 
Approach 
When visiting a general practice for a pre-booked 
consultation, instead of patients speaking to the 
receptionist, it has now become commonplace for 
general practice waiting rooms to host an automated 
check-in screen. The basic automated check-in screen 
can be enhanced with additional software to allow the 
collection of routine data that is saved in the 
electronic patient record or to deliver patient 
messages. A research study using this automated 
process for the purposes of research, to examine 
patient acceptability for providing brief research 
information, whilst self-completing an automated 
check-in screen, prior to any general practice 
consultation, was designed. Extensive PPIE, clinician 
and user consultation was undertaken to develop and 
optimize the process. The design also included an 
assessment of the impact of check-in completion for 
general practice operationalisation.  
 
Findings 
A study response rate of 92% was achieved with brief 
research data obtained using the automated check-in 
facilities, from 9,274 participants registered at 9 
general practices within North Staffordshire. Each 
practice recruited over a three-week period. There 
were no significant differences in participation rates 
or responses across practices, age groups or genders. 
In addition, the use of the check-in facilities to collect 
brief research data also had no reported impact on 
general practice operationalisation. Results data to 
the questions asked within the study will be 
presented.  
Consequences 
Technology-based methods for data collection, 
improve accuracy, reduce costs of data processing and 
can also maximise scalability. Following this research 
to look at acceptability of the methodology, follow-up 
studies have been designed to; identify carers and to 
case find for mental health issues. The restriction 
associated with this methodology however, is that 
only brief research data is obtained as limiting the 
number of questions was identified as a priority to 
minimise the check in process time and impact on 
usual GP check in processes. Whilst brief, data can be 
obtained to provide powerful answers to 
appropriately framed research questions which could 
otherwise be cost prohibitive and take a long time to 
conduct. Next steps for this new methodology, may 
include research into specific public health issues, 
service use opinion or identification of potential study 
participants for research studies either directly or by 
registering a patient’s willingness in their health 
record.  
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How to measure the strengthening of primary care?   
Presenter: Michael  Wright 
Co-authors:  Dr Andrew Bazemore, Dr Yalda 
Jabbarpour, Professor Kees van Gool 
Institutions 
Centre for Health Economics Research and Evaluation 
(CHERE), University of Technology, Sydney, Australia, 
Robert Graham Center for Health Policy Studies, 
Washington DC, USA 
Abstract 
Problem 
The 2018 Astana Global Primary Health Care 
Conference Declaration suggests that “strengthening 
primary health care is the most inclusive, effective, 
and efficient approach to enhance physical and 
mental health.” Recent reforms in the UK and 
internationally have agreed on the importance of 
strengthening of primary care, but there is less 
agreement in how to show evidence of strengthening. 
The aim of this research is to evaluate if this can be 
observed using resource allocation methods.  
Approach 
We estimate spending on primary care as a 
proportion of health spending using Australian 
national statistics.  We compare methods to estimate 
primary care spending developed by OECD and WHO, 
with a newer methodology for estimating primary 
care spending - "PC Spend".  Using PC Spend 
methodology we categorise health spending into 3 
categories. Level A is the broadest category and 
includes all ambulatory care, and dental spending.  
Level B includes direct spending on primary care 
services, such as delivery of general practice services.  
Level C is restricted to high value primary care 
spending such as patient centred medical home 
(PCMH) payments or funding to improve care 
coordination.  We use Australian Bureau of statistics 
data, and will provide comparisons between Australia, 
USA and UK.  
Findings 
Using OECD methodology (but excluding 
pharmaceuticals), over 18% of health spending is 
categorised as being on primary health care services. 
Using PC Spend methodology we find results for PC 
Spend A, B and C at 19.6%, 6.8% and <1% respectively.  
The multiple levels of the PC Spend methodology 
provides a more granular assessment of how much of 
health budget is being spent on first contact, 
comprehensive, coordinated health services than 
OECD/WHO measures. This has the potential to better 
reflect the impact of health system reforms on 
primary care.   Further work is needed for each 
country’s health system to determine what 
components of high value primary care spending 
warrant inclusion in PC Spend Level C.  
Consequences 
These results confirm that despite calls for 
strengthening of primary care, spending on direct 
delivery of primary care services remains under 10% 
of health spending in Australia. Changes in primary 
care spending have potential use as a proxy for 
strengthening of primary care, and these methods 
require further testing and refinement.  
Funding Acknowledgement 
This project has been supported with support from an 
RACGP Foundation Grant 
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Understanding the management of common 
infections in out-of-hours primary care   
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Hayes, Lydia Holt, Paul Little, Michael Moore, Fiona 
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University of Bristol, University of Southampton, 
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Abstract 
Problem 
Despite a reduction in antibiotic consumption in 
general practice settings over the last five years, there 
is evidence that antibiotic prescribing rates in out-of-
hours primary care have remained stable. Prior 
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research has shown that communication plays a 
significant role in antibiotic prescribing decisions in-
hours; and that training promoting clear 
communication about infection symptoms and 
treatment has shown some success. Our aim is a) to 
explore the management of common infections out-
of-hours to understand factors influencing 
prescribing; and b) to develop evidence-based 
communication training to optimise prescribing 
decisions tailored to the common challenges faced in 
this setting.  
Approach 
A mixed methods approach was chosen consisting of 
three sequential phases: i) a realist-informed scoping 
review of current provider training and clinical 
guidelines for antibiotic prescribing in primary care; ii) 
three concurrent studies - one qualitative, making use 
of recorded encounters with eligible patients/carers 
and conversation analytic methods to explore the 
social context of individual prescribing decisions; two 
quantitative, involving the statistical analysis of survey 
data from participating clinicians and patients, and 
routine anonymised case records data from providers, 
to analyse the wider prescribing context; and iii) a 
mixed methods component bringing together the 
findings from phases one and two, with input from 
clinicians, patients and carers.  
Findings 
Our phase one review found existing evidence 
highlighting specific challenges faced by primary 
healthcare professionals in managing patient 
expectations out-of-hours. Some studies reported 
that antibiotics may sometimes be prescribed to avoid 
having to negotiate an alternative. A wide range of 
guidelines and training materials on antibiotic 
prescribing were found to be available. However, 
none included guidance specific to the out-of-hours 
context. Phase two (March 2019 – March 2020) 
involves two large out-of-hours providers serving 
populations in the South and West of England.  Our 
qualitative dataset will include up to 300 recordings of 
advice calls, base and home visits including GPs, 
nurses and paramedics. Eligible patients include 
community dwelling children and adults as well as 
care home residents. Over 50% of our participants are 
over 70 years old. The two main types of infections 
being managed currently are respiratory and 
urological. 60% of home visits end in an antibiotic 
prescription compared to 48% of base visits.  
Consequences 
Our interim findings show high levels of antibiotic 
prescribing in comparison to in-hours primary care. 
Our work will enable new insights into understanding 
antibiotic prescribing patterns out-of-hours. This will 
be the basis for a new e-Learning for Healthcare 
(eLfH) programme hosted by Health Education 
England, drawing on real examples to guide the 
management of common infections out-of-hours. The 
eLfH platform has over one million registered users so 
the potential to influence future outcomes is 
significant.  
Funding Acknowledgement 
This study/project is funded by the National Institute 
for Health Research (NIHR) School for Primary Care 
Research (project reference 414).  The views 
expressed are those of the author(s) and not 
necessarily those of the NIHR or the Department of 
Health and Social Care. 
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RCGP-Oxford Primary Care influenza surveillance 
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Co-authors:  Oluwafunmi Akinyemi, Manasa Tripathy, 
Rachel Byford, , Filipa Ferreira, Michael Feher, Mark 
Joy, Maria Zambon, Jamie Lopez Bernal, Simon de 
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Abstract 
Problem 
The UK general practice is highly computerised but 
there have been no codes to record COVID-19 or 
countries where people have visited. The Royal 
College of General Practitioners (RCGP) Research and 
Surveillance Centre (RSC) and Public Health England 
(PHE) system is an established national influenza 
surveillance system.  We worked with computerised 
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medical record (CMR) system suppliers to make the 
system fit for purpose for COVID-19 surveillance  
Approach 
We collaborated to create new codes to record both 
COVID-19 details and countries visited as well as 
training materials for practices.  A model was 
developed for weekly data returns and a dashboard to 
provide data quality feedback and information of 
cases. Extended virology surveillance for COVID-19 
will be undertaken in the mildly unwell, with 
additional serological surveillance of those who are 
well.  
Findings 
In less than two weeks, we created the required codes 
across all CMR systems which included clinical codes 
for recording COVID-19 specific events, local codes 
that will map 1 to 1 with the official emergency 
release of the Sytematized Nomenclature of Medicine 
Clinical Terms (SNOMED CT) and country codes of 
travel history. We have used an ontological approach 
to classify cases into confirmed cases, cases under 
investigation and those who have been under 
investigation and now excluded from having COVID-19 
infection. We have created an online network 
observatory and individual practice dashboard 
updated weekly to provide information similar to 
RCGP RSC reporting of influenza and other conditions, 
with the additional option of twice-weekly reporting.  
Consequences 
Strong relationships and collaboration between RCGP, 
PHE, and the primary care informatics community has 
enabled national deployment of the means to monitor 
the COVID-19 outbreak in under two weeks.  
Funding Acknowledgement 
The work was supported by Public Health England 
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Awareness and use of online appointment booking in 
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Co-authors:  Mayam-Gomez Cano, John Campbell, Abi 
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Abstract 
Problem 
General practices are required to provide online 
booking to patients in line with policy to digitise 
access. Online booking services offer the option of 
booking an appointment 24/7 using the internet. 
However, uptake of online booking by patients is 
currently low and there is little evidence about 
awareness and use by different patient groups.  
Approach 
As part of the OBoE study, we performed a secondary 
analysis of GP Patient Survey data (2018) making use 
of two questions, one asking about awareness of 
online booking of appointments and another asking 
about use. Multivariate logistic regression was used to 
examine associations between both awareness and 
use in relation to age, gender, ethnicity, deprivation, 
the presence of a long-term condition, long-term 
sickness and being deaf. Comparison of models 
accounting for and not accounting for clustering by 
practice was used to illustrate the extent to which 
disparities reflect the clustering of certain types of 
patients in practices where awareness and use of 
online booking is high or low for all patient groups.  
Findings 
Of 647,064 patients answering the relevant question, 
277,278 (43.3%) reported being aware of being able 
to book appointments online. In contrast, only 14% 
(93,671 /641,073) reported having actually booked an 
appointment online. There was evidence of variation 
by all factors considered. In particular, strong 
deprivation gradients in both awareness and use were 
evident (e.g. most vs. least deprived quintile OR for 
use=0.63 95%CI 0.61-0.65). There was a strong drop 
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off in both awareness and use in patients over 75 (e.g. 
85+ vs. 65-74 years OR for awareness=0.33 95%CI 
0.32-0.35). Patients with long-term conditions were 
more aware and more likely to use online booking, 
however, deaf patients were less likely to be aware, 
but more likely to use online booking (not-deaf vs 
deaf OR for awareness= 0.78, 95%CI 0.70-0.86, OR for 
use= 1.29, 95%CI 1.14-1.46). Adjustment for practice 
suggest that around a third of the deprivation 
gradient in awareness and a fifth of the deprivation 
gradient in use is attributable to deprived patients 
being clustered in practices with low awareness/use 
for all patients. 
Consequences 
Whilst over 40% of patients know that they can book 
appointment online, the number that actually do so is 
far lower. Furthermore, awareness and use of online 
appointment booking varies by patient group. Some 
of this variability is reassuring, for example that 
patients with long-term conditions are using the 
service, whilst other variability is more concerning, for 
example the strong deprivation gradient and drop off 
in old age. With the constant push for online services 
within the NHS, practices need to be aware that not 
all patient groups will book appointments online and 
that other routes of access need to be maintained to 
avoid widening health inequalities.  
Funding Acknowledgement 
This presentation presents independent research 
funded by the National Institute for Health Research 
(NIHR) under its Research for Patient Benefit (RfPB) 
Programme (Grant Reference Number PB-PG- 1217-
20033). The views expressed are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
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Abstract 
Problem 
Intended as a way to improve access and alleviate 
pressure, most general practices offer online 
appointment booking as an alternative booking via 
telephone. The UK government have invested in 
online services and recently developed an NHS 
smartphone app with an online booking feature. 
Despite such promotion, evidence shows that most 
patients continue to book appointments via phone, 
with very few using online booking services. Currently, 
evidence examining factors mediating booking 
behaviours is lacking and little is known about how 
patients use online booking and their perspectives 
about them. The Online Booking Experience (OBoE) 
study aims to examine patients’ experiences of using, 
and not using, online booking.  
Approach 
The OBoE study uses mixed methods and comprises of 
two stages. Initially data from the General Practice 
Patient Survey (GPPS) was analysed to examine 
patterns between patients’ booking behaviours and 
demographic backgrounds. This not only 
demonstrated differing levels of awareness and use 
across England, but also provided a detailed picture of 
the types of people who are more and less likely to be 
aware of, and use, online booking.This abstract 
focuses on the second stage of the study, whereby we 
carried out approximately 40 semi-structured 
qualitative telephone interviews with individuals who 
had recently booked GP appointments. During the 
interviews we explored in depth patients’ experiences 
of, and views about, booking appointments online. 
Participants were recruited from 12 practices selected 
according to demographic features, aiding maximum 
variation sampling. Initially a scoping survey was 
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distributed to collate information about participants’ 
backgrounds and their booking behaviours and 
awareness. This data enabled us to purposively 
sample interview participants according to their 
booking behaviour and awareness, as well as 
demographic background. The iterative sampling 
strategy was guided by the stage one findings, 
ongoing interview analysis and maximum variation 
sampling. Interview data was analysed by two 
researchers using framework analysis, enabling 
comparison of cases in key areas.  
Findings 
We will present the early findings from interview 
analysis (ongoing from March 2020). These qualitative 
findings will provide further exploration of the 
patterns identified in the analysis of GPPS data; 
explaining some of the reasons behind contexts when 
online booking is, and is not, appealing or feasible for 
different individuals. 
Consequences 
Examination of patients’ experiences of online 
booking will aid understanding in how to improve 
such services. As the UK government continues to 
invest in a service which has low levels of uptake, 
robust evidence identifying barriers to online booking 
for some groups is vital information needed to 
improve the quality of services and overcome any 
potential problems. This evidence will also be of 
practical use to practices when considering 
implementation of online booking services for all their 
patients effectively and efficiently.  
Funding Acknowledgement 
This abstractpresents independent research funded 
by the National Institute for Health Research (NIHR) 
under its Research for Patient Benefit (RfPB) 
Programme (Grant Reference Number PB-PG- 1217-
20033). The views expressed are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
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What patients choose and how GPs respond in 
online consultations with askmyGP   
Presenter: stephen black 
Co-authors:   
Institutions 
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Abstract 
Problem 
It is often assumed that most patients contacting their 
GP want a face to face appointment.  But what do 
they choose when their practice has an online tool 
enabling multiple modes for the GP response and they 
are given a choice? And do GPs give the patient what 
they request or something else?  
Approach 
We decided to analyse this problem by using the large 
dataset (>1m patient requests) automatically 
collected from askmyGP, an "online consultation" 
tool. Each patient is offered a preferred method for 
the GP's response (online message, phone call, video 
call, face to face appointment). askmyGP also records 
the actual response used by the GP to resolve the 
request. So we can analyse the mix of responses 
requested and whether the GP judgement matches 
the patient request.We illustrate the patterns of flow 
by extremely easy to interpret data visualisations 
using Sankey Charts.  
Findings 
The majority of patients don't wan't a face to face 
appointment when given the choice (though numbers 
vary significantly by practice).GPs do not feel bound 
by the patients' requested mode: they frequently 
judge a different response is appropriate for the 
request.Almost nobody wants a video consultation 
when given a choice of other, effective, methods.  
Consequences 
The drive to encourage video consultations appears to 
be a waste of time.GPs should not assume that 
patients will only be satisfied by a face to face 
appointment: they are often satisfied by alternatives. 
Since alternatives often require less GP time, this has 
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major implications for GP efficiency.GPs do not feel 
bound by patients' preferred method of contact and 
their judgement on how to respond frequently 
overrides patients' requests.Being flexible about how 
to respond creates more capacity for GPs to give 
patients a faster, more useful service.  
Funding Acknowledgement 
The work was funded internally by GP Access as part 
of the ongoing development of askmyGP. 
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Abstract 
Problem 
Good communication at hospital discharge is critical 
for patient safety and continuity of care. Recipient 
GPs rely almost exclusively on discharge summaries 
that are usually written by the most junior doctors; 
these are error prone and may lack insight into 
community care. Previous quality improvement 
efforts have largely focused on adherence of 
discharge summaries to standardised templates, 
which may be less suited to meet the needs of GPs, 
especially for more complex patients. 
Communication-related patient harm continues to 
occur and the limited progress of improvement has 
led to recognition of the need for a wider and deeper 
understanding of this complex issue, as the population 
becomes increasingly aged and multiply-comorbid.  
Approach 
Multiple literatures support the exploration of 
complex problems through structured qualitative 
enquiry, including Operational Research, Design, and 
Systems Engineering. Our study adopts a qualitative 
methodology situated in the ‘systems approach’ 
recently defined for healthcare by the Royal Academy 
of Engineering, Royal College of Physicians and 
Academy of Medical Sciences in their 2017 publication 
Engineering Better Care. Its set of 13 'driving 
questions' provided a framework to address the 
research question of "How can communication to GPs 
at hospital discharge be improved?". One focus group 
and twenty semi structured interviews were 
conducted with key clinical and administrative 
stakeholders across the primary-secondary care 
interface of a large tertiary hospital in England, and 
thematically analysed.  
Findings 
Data analysis suggests that the system of discharge 
communication becomes more complex, and incurs 
greater risks, as a patient’s clinical needs increases. 
This complexity was identified as a key barrier to 
communication quality, alongside others across the 
primary-secondary care interface, including time 
pressures and a lack of insight on the part of discharge 
summary authors into the nuances of recipient GP 
needs. Participants reported that system performance 
was highly variable, with significant negative 
consequences for both patients and staff attributed 
specifically to communication quality. Current 
standardised forms of communication were reported 
to hinder system performance for many patients. 
Solutions were identified that would enable GPs to 
'close the open loop' of the largely one-way system of 
communication from hospital to general practice, to 
support patient safety and continuity of care.  
Consequences 
We suggest that a far more collaborative design of 
this system may improve the quality of care at 
hospital discharge. More open lines of 
communication, shared medical records and GP-led 
teaching sessions for junior doctors are needed to 
improve stakeholders’ insights into the needs of other 
system users, facilitate a more operant improvement 
process and reinforce the shared responsibility of all 
parties in this critical and vulnerable phase of 
transition of care. Further research is required to 
verify and validate any changes before widespread 
implementation into clinical practice.  
Funding Acknowledgement 
No funding applied for or received for this study 
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Institutions 
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Abstract 
Problem 
The rapidly increasing presence of digital health 
promises to improve healthcare delivery for all. 
However, the digital health divide describes a pattern 
where socioeconomically disadvantaged patients, 
who already have poor access to traditional health, 
are now further marginalised through lower utilisation 
of digital health services. The digital health divide is 
particularly pronounced in chronic disease and 
evident in primary care. While some quantitative data 
describes an association between digital health 
exclusion and socioeconomic disadvantage, there is 
scarce qualitative and mixed methods research 
exploring the barriers and enablers of digital health 
access in this population. Our aims were to explore 
how patients with chronic disease and socioeconomic 
disadvantage experience digital health in the context 
of Australian primary care, to identify barriers and 
enablers to digital health access and benefits and to 
test these findings in a quantitative survey.  
Approach 
The study design was exploratory sequential mixed 
methods. We completed 19 semi-structured 
interviews with socioeconomically disadvantaged 
patients recruited through three general practices and 
one service organisation in Australian rural, outer-
suburban and urban regions. Two interviewers 
thematically analysed the transcripts with an 
inductive coding scheme, which was iteratively 
reviewed by the wider research team. We applied the 
final themes as the structure for a patient survey, in 
order to measure the degree and association of 
observed barriers in a wider population. The specific 
survey questions were developed out of this 
structure, using other survey questions and validated 
tools where possible, such as eHeals (a digital health 
literacy scale). Two experts and five patients 
completed pilot testing for content and face validity. 
We administered this survey among 400 patients of 
varying socioeconomic status recruited through 36 
Australian rural, outer-suburban and urban general 
practices.  
Findings 
Barriers to accessing digital health tools included 1) a 
stronger patient preference for human-based health 
services, 2) low trust of digital health services, 3) high 
financial costs of necessary tools, maintenance and 
repairs, 4) poor public internet access options, 5) 
reduced capacity to engage due to increased life 
pressures and 6) low self-efficacy and confidence in 
starting the digital health process. When patients 
engaged with digital health, we saw a positive 
feedback cycle of growing skills and confidence, 
enabled by good social support and health provider 
recommendations. Our quantitative analysis of survey 
data, including how relative socioeconomic 
disadvantage influences barriers and enablers will be 
completed by July 2020.  
Consequences 
Barriers to digital health for socioeconomically 
disadvantaged patients are more complex than 
financial costs, are often cumulative, and are 
associated with general socioeconomic determinants 
for health. Our hope is to communicate with digital 
health policymakers, practitioner and innovators to 
highlight target areas for change that will improve the 
accessibility of digital health for primary care patients.  
Funding Acknowledgement 
This project was funded by the Royal Australian 
College of General Practitioners' Foundation IPN 
Medical Centres Grant. 
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N.6 
How do you maximise acceptance of novel heath 
care technological solutions to diagnosing and 
managing health conditions such as virtual reality or 
non-invasive glucose monitors? A mixed methods 
study from GW4-Path   
Presenter: Sabrina Grant 
Co-authors:  Gemma Lasseter, Sarah Sauchelli, 
Heungjae Choi, Steffi Colyer, Sabrina Grant, Tim 
Pickles, Ben Sherlock, Alexandra Voinescu, and 
Jingjing Zhang 
Institutions 
University of Worcester, University of Bristol, Cardiff 
University, University of Exeter 
Abstract 
Problem 
An ageing population in the UK places economic 
burden on the National Health Service (NHS) and 
society in managing long term often multiple health 
conditions.  Rapid technological innovation means 
advances in the applications of common (e.g. Apps) to 
novel (e.g. virtual reality) technologies targeted to 
help patients manage their own health are often 
introduced to market without fully considering the 
needs of the end-users. Health Education England 
outlines access and acceptance of these technologies 
by users is essential to accelerate successful uptake in 
clinical practice and the optimisation of the benefits 
they can provide.  This is particularly relevant when 
new technologies can potentially add value to the 
care of the patient but are not routinely used in 
practice. This study aims to determine the prevalence 
and usage of Novel Healthcare Technologies (NHTs).  
More specifically:(i) Investigate public’s 
perceptions and attitudes towards the use of cutting-
edge NHTs to inform the development and 
introduction of future technologies(ii) Gain insight 
into how novel approaches are being introduced in 
the NHS, particularly those involved in implementing 
NHTs across the primary and secondary care interface.  
(iii) Identify how health care professionals (HCPs) 
raise awareness to patients about the availability of 
the NHTs as tools to facilitate diagnosis, prevention, 
and treatment.  
Approach 
Sequential mixed methods study of two phases Phase 
1 Semi structured interviews with primary/ secondary 
care HCPs with experience of using novel healthcare 
technologies.  Interviews explored the process of 
implementation, from conception to delivery 
exploring issues around how NHTs are introduced to 
patients, barriers and challenges faced to 
implementation in the NHS.Phase 2 Questionnaire 
survey.  National distribution of a case study-based 
questionnaire for completion by the general public.  
The design and content informed by findings from 
Phase 1 and consultation with public and patient 
involvement user groups.  The questionnaire captures 
prevalence of use of NHTs, designed activities explore 
a range of healthcare technologies.  The NHTs under 
consideration are currently being innovated by 
collaborators on this project.  
Findings 
12 interviews were conducted with HCPs.  Key themes 
emerging and feedback from user groups informed 
the design and content of the questionnaire survey 
aimed to be distributed to approximately 1350 
participants across representative regions of the UK 
Feb-March 2020.  Full results from both phases will be 
reported.  
Consequences 
Before any novel healthcare technology is introduced 
to patients in primary or secondary care, it is essential 
to identify some of the key challenges and barriers to 
implementation in real practice.   A combined 
approach of gathering insight from HCPs currently 
using innovative healthcare solutions to managing 
long term conditions in clinical practice with views 
and opinions from the general public can elucidate a 
shared learning about tailoring NHTs sensitive to the 
needs of the intended users.  
Funding Acknowledgement 
This GW4-Path (Perceptions and Attitudes of 
Technologies for Healthcare) project is funded by 
GW4 Crucible Seed Corn funding from the GW4 
Alliance, (ref: Cru_19_2) 
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N.7 
We’ve Got Your Back! A proof of concept innovative 
methodology for participant recruitment, real time 
data collection and data enrichment through the 
combination of Digital Patient Generated Data and 
linked health records   
Presenter: Toby Helliwell 
Co-authors:  Toby Helliwell, Mark Stone, Jessica 
Graysmark, Sandra Martinez de Pinillos, Matthew 
Cooper, Mick Mullane, Steph Meleck, Paul Davis, 
Jaskiran Dhanjal 
Institutions 
Keele University, CRN West Midlands, IQVIA, uMotif, 
EMIS Health 
Abstract 
Problem 
Traditional methods used to deliver clinical trials and 
observational research can be burdensome and costly 
due to the time and data collection effort required by 
clinicians, CTU’s, study teams and patients. Clinical 
trials create scientifically precise data but the 
strict/specialised environment can restrict the 
generalizability of findings. Observational research 
data can also be limited given a range of biases and 
barriers to data quality. Hence, novel study and data 
collection methods are required, to reflect as close as 
possible, real patient experience. Patient reported 
outcomes (PRO) data can also be enhanced with an 
accurate reflection of participants’ true health status 
from their electronic medical record (EMR) to create 
research outputs that are as relevant to clinicians and 
patients as possible.  
Approach 
In collaboration between IQVIA, the NIHR, CRN West 
Midlands, uMotif, EMIS Health and The University of 
Leeds, the “We’ve Got Your Back” study (WGYB) was 
developed which uses a novel recruitment and data 
capture methodology. This comprised: automated 
participant identification through the EMR and mobile 
app (uMotif) prescribed by a GP. After agreeing to 
receive an invite to the WGYB study, a text/email was 
automatically sent to the patient during consultation. 
At this referral point, the EMIS App Library creates a 
Unique Study ID, which is used to anonymously track 
patients study progress and linking the study data 
with their EMR. Patients could then download the 
uMotif WGYB app. Consent, enrolment and data 
collection (QoL, work productivity, physical/mental 
impacts of back pain) was handled by the WGYB app. 
PRO data was then combined with each patients’ 
retrospective EMR using a single patient ID to create 
an enriched dataset. IQVIA developed a live study 
dashboard where site, user and patient progress could 
be monitored by the study team and CRN to view data 
completion, patient recruitment and feedback 
progress to practices on their performance.  
Findings 
24 practices in the West Midlands took part in the 
study. 322 patients were invited and 42% downloaded 
the app, consented to participate and provided 
regular PRO data comparing favourably with other 
observational study methods. Data analysis is 
currently being completed. Further presentation and 
demonstration of GP app prescription, data 
management processes, app use demographics and 
GP critical feedback of the WGYB methodology will be 
presented.  
Consequences 
This novel method allows seamless combination of 
real-time patient PRO data through the WGYB app 
with components from the patients’ health record. It 
represents a significant step forward in the way in 
which we could utilise technology and digital methods 
to produce high quality enriched real-world data. The 
efficient utility and remote study set-up, also means 
that study set-up time can be rapidly achieved. 
Further, its use in clinical trials could be valuable, 
particularly for self-administered or on-line 
interventions.  
Funding Acknowledgement 
This study was funded by IQVIA and supported by the 
NIHR, CRN West Midlands and sponsored by Leeds 
University 
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N.8 
The impact of implementing digital health tools in 
primary care on clinician-patient communication and 
relationships: Findings from the DECODE study   
Presenter: Jeremy Horwood 
Co-authors:  Andrew Turner, Rebecca Morris, Lorraine 
McDonagh, Fiona Stevenson, Fiona Hamilton, 
Michelle Farr, Jon Banks, Helen Atherton, Sarah Blake, 
Bob Golding, John Powell, Emma Hyde, Gene Feder, 
Gemma Lasseter, Lucy Yardley, Sian Jones, Sue 
Ziebland 
Institutions 
University of Bristol, University of Manchester, 
University of Oxford, University College London, 
University of Warwick, West of England Academic 
Health Science Network 
Abstract 
Problem 
Digital health tools, such as online consultation 
systems and platforms giving patients online access to 
their medical records, are becoming commonplace. 
NHS England advocates their use as an essential part 
of a cost-effective health service to support patient 
access and care. However, their rapid development 
and adoption in primary care may lead to unintended 
consequences (positive and negative) that alter 
healthcare processes and outcomes. The DECODE 
study aims to support the adoption of digital health 
tools in primary care by understanding their 
unintended consequences. Here we focus on how 
online consultation systems and online access to 
health records provide new ways for clinicians and 
patients to interact with each other, and the 
consequences this has for clinician-patient 
communication and relationships.  
Approach 
Semi-structured individual interviews with 25 
patients, 25 general practice clinicians, managerial 
and administrative staff involved in the use of three 
types of digital health tools (online consultations, 
patient online access to health records and 
smartphone apps). Thematic analysis was used to 
analyse the data using NVivo 11 software for data 
management.  
Findings 
Our interviews highlight how these technologies can 
make clinician-patient communication more 
transactional, meaning information flows one-way, or 
only short question-and-answer exchanges take place. 
For some, this achieved the intended consequences of 
improving efficiency and access to care. For example, 
through patients being able to check test results and 
medical information online or use online consultation 
systems to update the practice or receive answers to 
simple requests. However, the unintended 
consequences of this shift included patients being 
uncertain how to interpret information in their 
medical record, increasing pressure on patients in 
relation to how they describe their issues, and 
patients being unclear who they are communicating 
with, leading to uncertainty and distress. This could be 
seen to challenge the valued element in traditional 
clinician-patient relationships; namely personal 
contact and the opportunity to explore medical 
concerns.  
Consequences 
Examining unintended consequences of digital tools 
that increase the scope and extent of transactional 
communication, shows how prioritising convenience 
and access for some, can come at the expense of 
providing holistic, patient centred care for others. 
Developing an understanding of the unintended 
consequences of digital health tools is vital to aid their 
future successful implementation in primary care.  
Funding Acknowledgement 
The DECODE study is funded by National Institute for 
Health Research (NIHR) School for Primary Care 
Research and supported by NIHR Applied Research 
Collaboration West (NIHR ARC West).  The views 
expressed are those of the authors and not 
necessarily those of the NIHR, the NHS or the 
Department of Health and Social Care 
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N.9 
Exploring the implementation and utilisation of an 
electronic pharmacy referral service at hospital 
discharge: Early findings from a qualitative 
evaluation.   
Presenter: Mark Jeffries 
Co-authors:  Hilary Belither, Richard N Keers, Fatema 
Alqenae, Kay Gallacher, Caroline Sanders, Darren M 
Ashcroft. 
Institutions 
University of Manchester, Salford Royal NHS 
Foundation Trust 
Abstract 
Problem 
It is known that the transition of patients from 
hospital to home is associated with a high risk of 
preventable medication related harm. Patients 
discharged from hospital are at risk of adverse drug 
events, errors and non-adherence. The transfer of 
information between different health professionals is 
considered important for patient safety especially 
during care transitions. Patients’ understanding of 
their medicines might be impacted a lack of 
information-giving at discharge from hospital and by 
poor explanations from health professionals. 
Information technology is increasingly being used for 
medication safety in the NHS. A NHS foundation trust 
in the North of England has introduced an electronic 
referral (e-referral) system that enables hospital 
pharmacists to electronically transfer admission and 
discharge information of patients in receipt of 
monitored dosage systems to community-based 
pharmacists. We aimed to understand the 
implementation and use of the e-referral service from 
the perspectives of health professionals and patients.  
Approach 
We used a qualitative methodology to evaluate the e-
referral service in a Clinical Commissioning Group 
(CCG) and NHS Foundation Trust in the North of 
England. Participants were purposively recruited from 
relevant stakeholder groups that included hospital 
pharmacists, hospital pharmacy technicians, 
community pharmacists, general practice based 
pharmacists, patients and carers. To explore 
perceptions of the e-referral service we conducted 
face to face semi-structured qualitative interviews. 
Preliminary analysis was thematic, iterative and 
conducted alongside data collection with themes 
developed into coding frameworks. Ethical approval 
for the study was granted by the North West - Greater 
Manchester East NHS Research Ethics Committee 
(reference 19/NW/0110).  
Findings 
Twenty-three interviews were conducted with health 
care professionals (18) and patients and carers (9). 
Early findings indicated that the implementation and 
use of the e-referral service was dependent upon a 
complex interdependent network. Patients or their 
cares took an active role in their medicines and 
initiated informal communication with health 
professionals. The service led to a building of 
relationships between different health professionals 
in secondary and primary care, including between 
general practices and community-based pharmacists. 
These relationships aided in the standardisation and 
streamlining of the exchange of information between 
hospital and community pharmacy, both at admission 
and discharge, that could lead to an increase in clinical 
time for pharmacists a reduction in administrative 
tasks and was thought to reduce errors in the 
dispensing of medicines and delays in supply.  
Consequences 
These findings suggest the introduction of an e-
referral to community-based pharmacists has the 
potential to improve communication between 
different health professionals. Participants saw the 
potential for the service to lead to greater accuracy of 
dispensed medicines for patients in receipt of 
monitored dosage systems. Further analysis of the 
data will look to unpick the impact upon patients, 
including their understanding of how the service 
might build further relationships between patients 
and health-professionals.  
Funding Acknowledgement 
This abstract summarises independent research 
funded by the NIHR Greater Manchester PSTRC. The 
views expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. 
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N.10 
Our safety blind-spots when using digital health 
interventions   
Presenter: Ciarán McInerney 
Co-authors:   
Institutions 
University of Leeds 
Abstract 
Problem 
Digital technology has revolutionised healthcare but 
the changes have not all been positive. The effect of 
digital innovations is mainly seen on processes rather 
than patient outcomes because healthcare is a large 
and complex system in which actors often only 
perceive their local environment. Consequently, the 
effects that digital innovations have on both patients’ 
health and patients’ safety outcomes are not salient 
to those who use the digital innovations. Instead, 
enlightening such effects tends to be the 
responsibility of the relatively few academic and 
clinical researchers that study healthcare as a complex 
adaptive system. Lessons learned from such study 
does not always find its way back to the actors 
conceiving, developing, implementing and using 
digital health innovations.  
Approach 
In this talk, I will speak about three blind-spots in 
current use of digital health innovations, with 
particular focus on regulation and patient safety.  
Findings 
Firstly, regulations are often ignored because those 
who write the regulations do not control the access 
and use of what they are regulating. Secondly, 
regulations will always play catch up because they are 
reactive to the unregulated evolution of digital 
innovations. Thirdly, innovation (and subsequent 
regulation) is often ineffective for the ultimate goal 
because there is a tendency to do what can be done 
rather than what needs to be done.  
Consequences 
It is hoped that an improved awareness of these blind-
spots will encourage safer design, implementation 
and use of digital health innovations.  
Funding Acknowledgement 
The research was supported by the National Institute 
for Health Research (NIHR) Yorkshire and Humber 
Patient Safety Translational Research Centre (NIHR YH 
PSTRC). The views expressed in this article are those 
of the author(s) and not necessarily those of the NHS, 
the NIHR or the Department of Health and Social Care 
 
N.11 
A qualitative exploration of patients’ needs and 
expectations regarding online access to their primary 
care record   
Presenter: Brian McMillan 
Co-authors:  Gail Davidge, Lindsay Brown, Moira 
Lyons, Helen Atherton, Rebecca Hays, Freda Mold, 
Rebecca Morris, Caroline Sanders 
Institutions 
University of Manchester, University of Warwick, 
University of Surrey 
Abstract 
Problem 
Primary care records have traditionally primarily 
served the needs and demands of clinicians rather 
than those of the patient. GP contracts in England 
state practices must now promote and offer 
registered patients online access to their primary care 
record, and research has shown benefits to both 
patients and clinicians of doing so. Despite this, we 
know little about patients’ needs and expectations 
regarding online access to their health record.  
Approach 
A community-based qualitative study of a purposive 
sample of 54 individuals who were either eligible for 
the NHS Health Check, living with more than one long 
term condition, or caring for someone. We explored 
what patients and carers want from online access to 
their electronic primary care health record, how they 
would like to interact with their record, and what 
support they may need. Focus groups and semi-
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structured interviews with individuals from a variety 
of socio-demographic backgrounds were digitally 
audio recorded, transcribed, and analysed 
thematically.  
Findings 
Participants’ needs and expectations regarding online 
access to their primary care health records centred 
around issues relating to:  
1) Privacy and security (e.g. the ability to set different 
levels of access to different individuals),  
2) Integration (with other health records, health 
services, and external systems),  
3) Self-management (e.g. access to tailored health 
information or support groups,  
4) Other features and functions (such as the ability to 
write into one’s own notes, plain English/other 
language functions, or full retrospective access), and 
5) Support from practices (such as ‘tech surgeries’ or 
demonstration iPads).  
 
In addition to these expressed needs and 
expectations, the data also illustrated important 
issues relating to personal experiences of using online 
records access, perceived benefits, and 
concerns/barriers regarding online access.  
Consequences 
Future development of primary care patient online 
records access systems should take patients and 
carers’ expressed needs and expectations into 
account. Service providers should work alongside 
patients and carers to help develop features and 
functions that address these needs. For example, 
patients could be given more control over the level of 
access they can grant to specific individuals, plain 
English/other language functions could be 
incorporated, and the online primary care record 
could be better integrated with other systems. 
Patients and carers report requiring additional 
support with accessing their primary care record and 
in interpreting the information they contain, which 
raises questions for policymakers regarding how such 
additional support will be funded.  
Funding Acknowledgement 
This work was funded by the National Institute for 
Health Research (NIHR) School for Primary Care 
Research (project reference 429). The views 
expressed are those of the authors and not 
necessarily those of the NIHR or the Department of 
Health and Social Care. 
 
N.12 
The Consultation Open and Close Study: developing a 
generic pre-consultation form for use in primary 
care.   
Presenter: Mairead Murphy 
Co-authors:  Chris Salisbury, Geoff Wong, Richard 
Morris, Jude Hancock 
Institutions 
University of Bristol, University of Oxford, Bristol 
North Somerset and South Gloucestershire CCG 
Abstract 
Problem 
Many patients leave GP consultations without having 
voiced all their concerns, especially when they want 
to discuss multiple problems, resulting with reduced 
satisfaction with the consultation. Also, patients often 
have difficulty remembering the advice given during 
consultations, which can increase their concern and 
reduce adherence to advice. The Consultation Open 
and Close (COAC) intervention is designed to address 
both these problems. It is a two-year NIHR Research 
for Patient Benefit funded study aimed at designing 
and testing an intervention to allow patients to better 
share their concerns, incorporating the use of an 
online form at consultation opening and a printed 
report at consultation closure.  These are being 
developed separately in accordance with MRC 
guidance. This abstract discusses development of the 
COAC pre-consultation form.  
Approach 
Three GP practices in the Bristol and surrounding area 
are iteratively developing the form by testing it with 
15 patients each. Patients fill in the online form before 
their appointment; this includes problems which 
might otherwise be missed, such as how worried they 
are about their health, whether they are low in mood 
or finding it difficult to adhere to their medication or 
other health advice.  After trying the form and the 
report in one practice, we will interview the GPs, 
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nurses, administrators and patients who used them 
and implement improvements before testing in the 
next practice.  
Findings 
As of 14/02/2020 two of three practices have 
recruited 15 patients each.  Eight patients and two 
GPs have been interviewed. All interviewed patients 
would use the form again. GPs demonstrating that 
they had read the form was important to patients. 
 - 
Helped them plan befo  - 
Made them feel more at ease in the consultation, 
knowing that the GP had read their information in 
 - Helped communicate their problems 
 - Uncovered problems which 
may otherwise have been missed.GPs said the form 
was not excessively time-consuming and may help 
uncover information more quickly. The forms were 
less useful for GPs when patients provided either too 
much free-text information, or none at all.Adopting an 
iterative approach resulted in improvements between 
the rounds including adding information, removing 
items, changing the colour-codes and format.  
Consequences 
The COAC pre-consultation form is a useful adjunct to 
the consultation and may have wider applicability. It is 
particularly relevant in the current context (where 
practices must offer e-consultations as standard) as 
including the COAC form in an e-consultation could 
provide GPs with more information than current 
available templates. A feasibility study, in which the 
COAC pre-consultation form and a consultation 
closure report will be combined, will be carried out 
from October 2020 – 2021.  
Funding Acknowledgement 
This study was funded by the National Institute for 
Health Research (NIHR) Research for Patient Benefit 
programme. The views expressed are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
 
 
 
N.13 
The Readability of GP Surgery Websites   
Presenter: Dr Guy Rughani 
Co-authors:  Dr Peter Hanlon, Dr Neave Corcoran, 
Professor Frances Mair 
Institutions 
General Practice & Primary Care, The University of 
Glasgow 
Abstract 
Problem 
Most GP surgeries in the UK have a website which 
they commission and update themselves.  There is an 
impetus from government to increase the provision of 
services that GPs offer online, such as appointment 
booking and the ability to order repeat prescriptions.  
The current websites’ text and design are of variable 
quality.  This matters because adult literacy levels are 
low. Similar to elsewhere in the UK, 1 in 4 Scottish 
adults experience serious challenges due to poor 
literacy, and those from the 15% most deprived 
communities are twice as likely as those in the most 
affluent group to only reach the lowest literacy level.  
Despite the rising role of GP websites as a source of 
information and point of interaction, to our 
knowledge there has been no published research into 
how understandable GP websites are to their lay 
audience, or whether practices adapt the readability 
of their websites to cater for their populations, 
knowing that affluent areas tend to have higher 
literacy levels than deprived areas.  
Approach 
Both word choice and webpage design dictate the 
ease with which online text may be scanned or read. 
Using a standardised text-difficulty score, we analysed 
the five most visited webpages of each of the 941 GP 
surgeries in Scotland.  We developed a design score 
drawing on literature about design factors that 
facilitate readability and accessibility. We then scored 
the ‘appointments’ webpage of each surgery website. 
We assessed for any correlation between the text-
difficulty score for surgery’s website, and the Scottish 
Index of Multiple Deprivation (SIMD) group to which 
the surgery’s population belonged.  
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Findings 
85% of practices in Scotland had a website, and 77% 
(2949/3822) of the webpages had a ‘reading age’ 
above that of the average UK adult.  The majority 
were also above the recommended reading level for 
public websites.  There was a spread in design scores 
despite 51% of the websites sharing a small number of 
design templates from a single website provider 
(‘MySurgeryWebsite’). There was no association 
between webpage ‘reading age’ and the measure of a 
practice population’s level of multiple deprivation 
(SIMD), suggesting that practices do not adjust their 
websites to suit the potential average literacy levels of 
their populations.  
Consequences 
This is a novel and timely piece of work as it is the first 
time that the area has been studied in this depth and 
comes at a time that government is encouraging GPs 
to conduct more interaction with their patients 
online. It highlights that most surgery websites are too 
complex for much of the population to fully 
understand, and design factors that facilitate 
accessibility and readability are not widely followed. 
We have identified simple changes that can be made 
by GP surgeries to improve the accessibility of their 
online provision.  
 
N.14 
The development and deployment of an interactive 
digital health intervention to aid diagnosis and 
management of sexual dysfunction problems and 
underlying cardiovascular disease   
Presenter: Patricia Schartau 
Co-authors:  Prof Mike Kirby 
Institutions 
University of Hertfordshire 
Abstract 
Problem 
The uptake of health screenings remains low, 
especially in men (NHS Health Check Programme, 
2017) and with stigmatised conditions. Technology is 
employed to increase uptake and improve patient 
empowerment. We aimed to create a digital health 
intervention (DHI: mobile App and web-based 
application) which acts as triage tool and allows 
(timely) detection of sexual dysfunction problems and 
potentially underlying cardiovascular disease (CVD) 
and metabolic problems, thereby providing an 
opportunity for intervention in primary care.  
Approach 
Diagnostic and management criteria for female sexual 
and erectile dysfunction, premature ejaculation, 
testosterone deficiency (low libido) and lower urinary 
tract symptoms (LUTS) were obtained from 
international guidelines to create an App/website 
where users access validated questionnaires. 
Interviews with groups of stakeholders were 
conducted to develop and refine the DHI.  
Findings 
User data (N = 21,846) from March 2016-December 
2019 suggested high levels of sexual dysfunction 
amenable to treatment. Regarding the erectile 
dysfunction (N= 6533, mean age 67y, SD = 22y) and 
the premature ejaculation tests (N= 1834, mean age 
34y, SD = 14y), 77% and 87% of participants 
respectively portrayed some dysfunction. Regarding 
testosterone levels, 47 % (N= 4214, mean age 56y, SD 
= 16y) produced a score that warranted further 
investigations. Only 33% of all participants (N= 8955, 
mean age 30y, SD = 8y) undertaking the female sexual 
dysfunction questionnaire reported normal function. 
Similarly, 33% of females (N= 190, mean age 29y, SD= 
12y) and 28% of males (N= 120, mean age 49 years, 
SD = 18y) reported normal urination.  
Consequences 
This is the first DHI supporting health screening and 
management advice for the above conditions. 
Benefits include easy access, privacy, it is cost free, 
has a triage tool function, and provides a preliminary 
diagnosis and management support. The acceptability 
and usability of the web application was higher than 
that of the App thereby allowing to draw in a wider 
age range. Given that, for example, erectile 
dysfunction is a predictor and independent risk factor 
of CVD and has recently been incorporated into 
cardiovascular risk calculators (QRisk 3; Hackett & 
Kirby, 2017), this tool may aid diagnosis of (early) CVD 
and metabolic problems, thereby providing a window 
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of opportunity for lifestyle changes/pharmacological 
management.  
Funding Acknowledgement 
Grant from Sexual Advice Association (Charity) Part of 
ACF work during the academic GP training 
 
O.1 
How do patients describe their experiences of a pre-
operative health optimisation scheme?   
Presenter: Isobel Avery-Phipps 
Co-authors:  Chirstopher Burton, Cate Hynes 
Institutions 
Academic Unit of Primary Medical Care, University of 
Sheffield 
Abstract 
Problem 
Pre-operative Health Optimisation (POHO) is the 
delaying of elective surgery to provide time for 
patients to make positive health behaviour change. 
Typically, this focuses on smoking cessation and 
weight management. Its advocates argue it reduces 
perioperative risk and may promote longer term 
change at a teachable moment. Despite criticism, 
mandatory POHO programmes have been introduced 
in several CCGs. We aimed to understand patients’ 
experience of one mandatory POHO scheme which 
introduces a delay to the elective surgery referral 
pathway for patients to stop smoking or lose weight. 
Approach 
We conducted a qualitative study involving people 
who had been referred by their GPs to a mandatory 
POHO scheme in South Yorkshire. The scheme 
introduced a delay in the referral pathway for 
smokers and people with obesity. Patients referred to 
the POHO scheme by 10 GP practices were invited to 
take part in the study by mailed invitation. Additional 
participants were recruited through weight-loss 
schemes involved in the POHO programme.   Data was 
collected from face to face interviews and transcribed 
for analysis. We used a thematic approach to analysis 
and developed themes iteratively over interviews and 
re-readings of transcripts. We used an interpretive 
phenomenological approach in analysing patients’ 
accounts. This recognised the subjectivity of both 
participant and interviewer. Finally, we considered 
accounts as examples of “resistance narratives”. 
Findings 
We invited 150 patients over 3 rounds but only 9 
agreed to be interviewed. Participants came from 
diverse socioeconomic backgrounds and had engaged 
with the programme to varying extents. We identified 
four main themes   Perceived benefit for some   Four 
of the patients we interviewed had managed to lose 
some weight during their POHO period. Two felt the 
programme was instrumental in this. The remainder 
saw no benefit from delaying surgery.   First 
impressions matter   None of the interviewees 
reported a positive introduction to the POHO 
programme by their GP. Some used their GP’s 
ambivalence to support their position of non-
engagement.   Asked the impossible   Interviewees 
saw weight loss and smoking cessation as countering 
each other and unrealistic at the same time. They felt 
this showed policymakers hadn’t considered the 
reality for patients in this situation.   What’s the link?   
While interviewees recognised a number of health 
benefits from weight loss and smoking cessation, 
getting fit before surgery wasn’t one of them. Some 
argued that delaying surgery to improve health was 
unfair and stigmatising, particularly as those with 
other behaviours were not targeted. 
Consequences   
Patients described several negative experiences of 
mandatory pre-operative health optimisation. On the 
one hand these represent points to address in 
improving delivery of POHO. On the other they 
represent narratives of resistance by which patients 
contest the unilateral imposition of POHO. Both these 
perspectives are relevant for commissioners and 
providers of POHO schemes.      
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O.2 
A change in ceiling of care at hospital discharge 
towards the end of life: the perfect storm for 
communication at the primary-secondary care 
interface   
Presenter: Nicholas Boddy 
Co-authors:  2. Barclay S, 3. Bashford T, 4. Clarkson PJ 
Institutions 
Engineering Design Centre, University of Cambridge 
(1,3,4), Primary Care Unit, University of Cambridge (2) 
Abstract 
Problem 
Despite decades of research, avoidable 
communication-related harm at hospital discharge 
persists. Discharge summaries written to GPs by time-
pressured and inexperienced junior doctors remain 
the near-exclusive format of this communication 
system. The limited success of previous interventions 
to improve quality, such as adherence of summaries 
to standardised templates, has led to recognition of 
the need for greater understanding of this complex 
problem space in order to identify high risk patient 
groups and targets for future improvement.  
Approach 
A qualitative exploration was undertaken using a 
‘systems approach’, recently redefined for the 
healthcare domain by the Royal Academy of 
Engineering, Royal College of Physicians and Academy 
of Medical Sciences in their 2017 publication 
Engineering Better Care. A systems approach is of 
particular value when addressing complex, system-
wide issues, and its set of 13 'driving questions' 
provided a framework to address the research 
question of "How can communication to GPs at 
hospital discharge be improved?" One focus group 
and twenty semi-structured interviews were 
conducted with key clinical and administrative 
stakeholders across the primary-secondary care 
interface of a large tertiary hospital in England, and 
thematically analysed.  
Findings 
Participants reported that decisions to reduce the 
ceiling of patient care made during hospital admission 
as the end of life approached, acted as the greatest 
stressors on the system of discharge communication. 
Conveying plans made to initiate a palliative care 
approach, and to avoid future treatments, 
investigations or hospital admissions, were felt to 
require a level of nuance and detail often missing 
from discharge letters. Such cases are often 
complicated by multimorbidity, polypharmacy, 
cognitive deficits, and involvement with social care 
and multidisciplinary teams. and this exponential 
complexity was felt to pose a communication 
challenge to both discharge summary authors and 
recipient GPs. Participants noted that the risk of 
subsequent suboptimal care and avoidable patient 
harm dramatically increased: discharge 
communication for patients in this period of care, 
before the community resources for the end of life 
phase are needed, was described as one of the largest 
opportunities to improve system performance and the 
quality and continuity of post-discharge care.  
Consequences 
We propose that bespoke discharge documentation is 
refined for this patient group, alongside GP-led 
teaching sessions for junior doctors, in order to 
increase system-wide awareness of this vulnerability 
in the discharge process. Quality feedback loops, 
more open lines of communication and shared 
medical records would also have significant benefits 
for this patient group, as well as for other groups 
identified at risk of communication-related harm at 
hospital discharge.  
Funding Acknowledgement 
No funding applied for or received for this study 
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O.3 
Exploring barriers and facilitators to physical activity 
experienced by young adults in socioeconomically 
deprived areas of Sheffield   
Presenter: Rachel Crothers 
Co-authors:  Dr Helen Twohig, Dr Phillip Oliver 
Institutions 
University of Sheffield Academic Unit of Primary 
Medical Care 
Abstract 
Problem 
Increasing physical activity (PA) is an evidence-based 
public health strategy for primary prevention and 
management of non-communicable diseases (NCDs). 
Complex social determinants of health mean that 
socioeconomically deprived populations experience 
higher morbidity and mortality from NCDs, and are 
less physically active. Targeting health-protective 
behaviour change in these populations has potential 
to: reduce NCD incidence; enhance healthy life 
expectancy; reduce pressure on local health services; 
and ultimately reduce health inequalities. Primary 
care has a key role in delivery of this lifestyle advice. 
Current literature shows some exploration of factors 
affecting PA uptake in deprived areas worldwide, 
uncovering multiplex barriers and facilitators to PA 
which affect individuals and communities. Our 
literature review found few studies examining these 
influences in the UK and specifically few focussing on 
young adults, who potentially have most to gain from 
long-term benefits of physical activity.  This study 
aims to explore reasons behind socioeconomic 
inequalities in PA uptake in Sheffield, by investigating 
barriers and facilitators to increasing PA for adults 
aged 18-35 living in the most deprived areas of the 
city. 
Approach 
This is a qualitative study using semi-structured 
interviews with a purposive diverse sample of 18-35 
year olds, living in areas ranked in the lowest quintile 
of English Indices of Multiple Deprivation (IMD). The 
interviews utilise a topic guide derived from the 
literature review and a PPI focus group. Participants 
are recruited through local health trainers, community 
organisations, poster advertising and snowball 
sampling.  Interviews with local health trainers are 
also being conducted to gain another perspective on 
the research question. Interviews are transcribed and 
data analysed thematically, with interviews continuing 
until data saturation.  
Findings 
Interviews and data analyses will be completed by 
June 2020. It is expected a range of barriers and 
facilitators to PA will be uncovered, encompassing 
personal, social, educational, financial and 
environmental factors.  
Consequences 
Findings will be disseminated among community 
organisations and local healthcare professionals. 
Conclusions will be used to inform the planning and 
delivery of more effective PA interventions in study 
areas, with the aim of boosting uptake of PA and 
encouraging healthy living locally.  
Funding Acknowledgement 
Many thanks to The Claire Ward Fund for supporting 
this research. 
 
O.4 
Bereavement and grief in old age – Acceptability of a 
web-based self-management intervention from the 
perspective of persons affected and health care 
experts   
Presenter: Franziska Foerster 
Co-authors:  Margrit Löbner, Franziska Welzel, Katja 
Schladitz, Janine Stein, Steffi G. Riedel-Heller 
Institutions 
Institute of Social Medicine, Occupational Health and 
Public Health (ISAP), University of Leipzig, Medical 
Faculty 
Abstract 
Problem 
The death of a close person is a highly stressful, yet 
common life event in later life. Objective of the 
present study was to assess the acceptability, possible 
access ways and barriers for implementation of a 
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web-based self-management intervention for older 
adults with prolonged grief symptoms from the 
perspectives of older persons affected and health care 
professionals.  
Approach 
The qualitative study comprised the implementation 
of two focus groups: focus group A consisted of older 
adults (60+years) with previous loss experience 
(N=12), and focus group B comprised experts of the 
medical care system (N=8). Both focus groups have 
been carried out with the help of a focus group guide 
by qualified moderators. Qualitative content analyses 
were performed based on Mayering (2015) using 
MAXQDA.  
Findings 
Participants of focus group A were on average 64.5 
years old and balanced with respect to the 
distribution of gender (50% female). Health care 
professionals of focus group B were on average 41.1 
years old and predominantly female (87.5% female). 
Participants of both focus groups supported the idea 
of a web-based self-management intervention 
focusing on prolonged grief symptoms in old age. 
According to older individuals with previous loss 
experience a web-based intervention should include 
ideas for improving self-respect and activities in 
everyday life as well as information for relatives, 
information on beliefs and spirituality and coping 
strategies for negative emotions. Participants further 
preferred a flexible use of the intervention modules 
rather than a fixed sequence. The majority of older 
individuals affirmed the usability of the web-based 
intervention. Possible access ways were seen through 
general practitioners, medical specialists, 
bereavement groups, local media and undertakers. 
Personal preferences were perceived as potential 
barriers (e.g. preferences for personal contact) by 
persons affected, while the lack of guidance was 
perceived as a potential barrier by health care 
experts.  
Consequences 
Usability and user acceptance are important aspects 
and necessary preconditions for the successful 
implementation and the effectiveness of an e-health 
intervention targeting individuals with prolonged grief 
symptoms in old age. The judgements of health care 
professionals and older persons affected showed a 
high user acceptance. Pathways for the 
implementation of such e-health interventions should 
consider the mentioned access ways and barriers.  
Funding Acknowledgement 
Bundesministerium für Bildung und Forschung 
(BMBF), Förderkennzeichen: 01GY1613. 
 
O.5 
Palliative care for children and young people: What? 
When? How? A realist inquiry   
Presenter: Sarah Mitchell 
Co-authors:  Jane Coad, Anne-Marie Slowther, Jeremy 
Dale 
Institutions 
University of Sheffield, University of Nottingham, 
University of Warwick 
Abstract 
Problem 
The World Health Organisation defines palliative care 
as “an approach to care that aims to improve the 
quality of life for people living facing the problems 
associated with life-threatening illness, through the 
prevention and relief of suffering”. The number of 
children and young people with life-limiting and life-
threatening conditions is rising. All could potentially 
benefit from palliative care, but there are significant 
inequalities in the provision of such care to children 
internationally, including the availability of specialist 
paediatric palliative care services.The aim of the 
research was to examine the delivery of healthcare, 
including palliative care, for children with life-limiting 
and life-threatening conditions and their families. A 
realist approach was taken to provide understanding 
into how palliative care is delivered most effectively, 
and when, leading to policy relevant 
recommendations.  
Approach 
There were four stages to the research: 
1. Development of a programme theory (PT) 
through systematic and realist literature reviews. 
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2. 41 serial interviews with 31 participants from 
14 families; 10 children with life-limiting or life-
threatening conditions and 21 family members.  
3. Four focus groups with children’s palliative 
care professionals. 
4. Thematic / realist analysis to describe the 
hidden mechanisms (M), triggered in certain contexts 
(C), to produce desired outcomes (O). Context-
Mechanism-Outcome configurations (CMOCs) are 
used to refine and refute the PT.  
Findings 
Children and their families are vulnerable experts, 
negotiating a healthcare system that can be rigid and 
fragmented (C). The delivery of palliative care 
depends on interpersonal relationships with 
healthcare professionals (C), who are able to bear 
witness to the child and family situation (M), 
underpinned by trust and respect (M). Important child 
and family outcomes include feeling heard and 
supported (O). In organisations, an environment that 
values these relationships and legitimises palliative 
care as an approach (C) through leadership and role 
modelling (M) as well as the development of specialist 
services (C), leads to more equitable palliative care 
(O).  
Consequences 
The realist approach provides increased 
understanding and description of important child and 
family outcomes that underpin policy goals in 
palliative care, achieved in certain contexts. Future 
service and commissioning models should propose a 
whole system approach, including primary and 
community care. Achieving this requires the 
unwavering commitment of system leaders, 
recognition of the unique situations of children and 
families, and individualised palliative care. Service 
design should place greater emphasis on the need for 
trusted relationships, should nurture and support 
professionals who have the motivation and capacity 
to provide palliative care, and should integrate 
specialist paediatric palliative care effectively into 
existing services.  
Funding Acknowledgement 
My funding was provided through a National Institute 
of Health Research Doctoral Research Fellowship, 
DRF-2014-07-065. 
O.6 
What are the experiences of young people in PPI for 
palliative care research?   
Presenter: Sarah Mitchell 
Co-authors:  Dena Khan, Jane Coad, Anne-Marie 
Slowther, Jeremy Dale 
Institutions 
University of Sheffield, NIHR CRN West Midlands 
Young People's Steering Group, University of 
Nottingham, University of Warwick 
Abstract 
Problem 
Patient and Public Involvement (PPI) is an integral part 
of research, advocated by many research funders. 
However, evaluation of the experiences of PPI group 
members and the impact of PPI work on the research 
is inconsistent and rarely reported. This abstract 
describes an evaluation of the experiences of young 
people (aged 9-25 years) who provided PPI for a 
palliative care research project.  
Approach 
PPI group members were asked to provide 
anonymous written feedback on any aspect of their 
PPI experience related to this research project, using a 
method based on “Tell Me…”, as outlined in RCPCH & 
Us Recipes for Engagement. Feedback was collected 
at two PPI sessions. An inductive thematic analysis of 
the feedback was conducted using NVivo.  
Findings 
Feedback was provided by all 16 young people who 
attended the sessions. Two overarching themes were 
identified:  
1. A desire to feel engaged in the research. 
Group members want the PPI work they are involved 
in to have an influence on the research, and for the 
research to have an impact. Young people felt 
particularly engaged through opportunities to learn 
both about the research topic and about research 
more widely, including methods and dissemination 
activities. 
2. Relationship with the researcher. The 
development of rapport over several sessions allowed 
 156 
 
the discussion of sensitive topics. Young people 
wanted the researcher to listen, respond and 
demonstrate the results of their PPI in the research.  
Consequences 
This small evaluation provided insights to guide the 
planning of PPI for future research, both in palliative 
care and with young people more widely. PPI in 
palliative care research can be a fulfilling experience 
for young people despite the potentially sensitive 
subject area. The relationship with the researcher and 
the conduct of the PPI work are important factors, 
with regular feedback provided and the development 
of rapport over time ensuring that young people have 
the opportunity to learn, to have influence on the 
research process and for them to see that the 
research to has impact.  
Funding Acknowledgement 
My funding was provided through a National Institute 
of Health Research Doctoral Research Fellowship, 
DRF-2014-07-065. 
 
O.7 
Post Sepsis Syndrome: What is it and do Primary 
Care professionals know how to treat sepsis 
survivors or are survivors slipping through the net. 
Does it even really exist?   
Presenter: Michael Porter 
Co-authors:  None 
Institutions 
University of Central Lancashire 
Abstract 
Problem 
Having spent many years teaching about sepsis, it is 
ironic that I developed sepsis in 2016.  Having been in 
a coma for 3 months, I have developed strong 
national and international links to sepsis survivor 
networks.There are conservatively 200,000 cases of 
sepsis each year in the UK.  Of those surviving 40% 
have one or more of cognitive, psychological or 
physical sequelae.The aim of this ongoing study was 
to engage both national and international networks, 
in order to define the scope of post sepsis syndrome 
(PSS), establish best practice methodologies in the 
identification and treatment of PSS and apparent 
views of Primary Care professionals to PSS, at the 
national and international level.Current research in 
this area is extremely limited and employs either 
molecular or epidemiological methodologies.  Survivor 
analysis, using both quantitative and qualitative 
methods is unavailable in the literature.  
Approach 
This preliminary and ongoing study employs a survey 
questionnaire to harvest both quantitative and 
qualitative data from sepsis survivors.  The initial 
smaller scale study proved informative and has fed 
forward into refinement of the current questionnaire.  
This updated survey is currently being rolled out to 
both UK and international sepsis survivors.Based on 
data acquisition rates during the preliminary survey, 
significant responses are expected within 30 days.  
Framework analysis is being used to assess qualitative 
data.Results of this study are being additionally 
assessed through comparison with current scientific 
research on PSS, although this field is currently 
severely understudied.  
Findings 
Initial work has identified several key components in 
both the definition and treatment of PSS.  Certain 
thematic symptom types have been identified, which 
correlate well with the limited scientific research, in 
this area.  A range of best practice methods have also 
become apparent.  There is also initial evidence of 
variation by country, although this may be the result 
of statistical anomaly or cultural variation.  
Consequences 
While sepsis research is gaining some traction, PSS 
research is extremely limited.  There are debates 
regarding its existence, variation in research 
methodologies used and even a suitable definition of 
the condition.  As a result, sepsis survivors may be 
receiving sub optimal care and perhaps also slipping 
through the net, as they return from secondary to 
primary care.This study aims to engage stakeholders, 
with particular reference to sepsis survivors, as the 
major stakeholder in their own care.  Going forward 
this work should better inform primary care 
professionals, allowing sepsis survivors with PSS to 
live well, despite any related morbidity.  
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O.8 
What would an End-of-Life Care Program at Sturgeon 
Lake First Nation look like?   
Presenter: S Bighead, N Rabbitskin, VR Ramsden 
Co-authors:  S Bighead, N Rabbitskin, C Longjohn, B 
Davis, T Smith-Windsor, S Kirychuk, N Jacobson, D 
Day, L Bill, VR Ramsden 
Institutions 
Sturgeon Lake First Nation, University of 
Saskatchewan 
Abstract 
Problem 
Lack of access to culturally responsive care has been 
identified as a barrier to health equity among 
Indigenous peoples and was addressed by the Calls to 
Action identified by the Truth and Reconciliation 
Commission of Canada. The aim of having an end-of-
life care program in the community that was co-
designed with the community and integrates Plains 
Cree practices and customs into supporting 
community members who choose to die at home 
supported by families and health care providers.  
Approach 
The overall design of the study was informed by the 
integration of community-based participatory 
research and transformative action research. Thus, 
this research endeavour has been co-created and co-
designed with the community and will be co-
implemented, co-produced and co-disseminated 
(presentations and publications) with members of the 
community as the project unfolds.    Interviews will 
begin in the near future with oral consent will be 
obtained from an individual who will be invited to 
consider questions related to the traditional end-of-
life care using Plains Cree customs and practices.  
Findings 
The community is and has been authentically engaged 
in enhancing their health and well-being. The findings 
will be analyzed and presented in a short oral 
presentation.  
 
 
Consequences 
It is hoped that the results/findings of the proposed 
project has the potential to co-design a traditional 
end-of-life program with Elders, Knowledge Keepers 
and the community which will support community 
members who choose to die at home supported by 
families, health care providers and the community.  
Funding Acknowledgement 
Saskatchewan Health Research Foundation (SHRF) & 
Saskatchewan Centre for Patient-Oriented Research 
(SCPOR) 
 
O.9 
Changes in end of life preferences for care and place 
of death in people age 75+: A population level study 
using electronic health records   
Presenter: Daniel Stow 
Co-authors:  Daniel Stow, Lucy Robinson, Fiona 
Matthews, Barbara Hanratty 
Institutions 
Population & Health Sciences Institute | Newcastle 
University 
Abstract 
Problem 
Death is now an event of later life, and primary care 
must adapt to meet the complex needs of patients 
who are dying later in life. The importance of patient 
preference in guiding end-of-life care is clear in UK 
National Guidelines. Current evidence suggests that a 
significant minority of patients change their 
preferences for place of care and place of death over 
time, but more longitudinal research is needed - 
particularly in older adults and those with non-
malignant conditions. We aimed to investigate GP 
records for evidence of preference changes for place 
of care and place of death for people age > 75  
Approach 
We collected anonymised electronic health records 
for all 13,149 people age >75 who died in England 
between 01/01/2015 and 01/01/2016 with a record in 
GP practices contributing to the ResearchOne 
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database. We investigated information on Read codes 
relating to preferences for care and place of death, 
and how these changed as people approached death.  
Findings 
A small proportion (13.0% n=1,713) of decedents had 
a code for preferred place of death, entered at a 
median of 6.6 months before death. The majority of 
people preferred to die in a care home (47.5%) or at 
home (43.9%). Of these 1,713 people, 358 (20.1%) 
were asked about their preference for place of death 
more than once before they died.  In this subset, 68 
(19.0%) people changed their preference, with the 
majority (n=25, 36.8%) changing their preference 
from home to care home. In the 290 (81%) people 
with a static preference, care home (n=172, 59.3%) 
and home (n=110, 37.9 %) death were the most 
preferred. A larger proportion (22.7%, n= 2,987) of 
decedents had recorded preference for place of care, 
entered at a median of 7.3 months before death. The 
most common preference was home (50.9%), 
followed by care home (41.5%). Of these 2,987 
people, 588 (19.7%) were asked about their 
preference for place of care more than once before 
they died.  In this subset, 115 (19.6%) people changed 
their preference, with the majority (n=38, 33.0%) 
changing their preference from home to care home. 
In the 473 (80.4%) people with a static preference, 
care home (n=231, 48.8%) and home (n=228, 48.2 %) 
care were the most preferred.  
Consequences 
In this older population, the majority of people 
preferred to be cared for and to die in a care home, or 
at home - likely reflecting their place of residence. 
However, coding of preferences occurred in a 
minority of people, and often occurred within the last 
months of life.  This study suggests that further work 
is needed to improve recording of preferences. 
Further work is also needed to understand what 
factors influence when and why preferences change.  
Funding Acknowledgement 
This project is funded by the National Institute for 
Health Research (NIHR) School for Primary Care 
Research  The views expressed are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
 
O.10 
Survey of social prescribing projects and other social 
and wellbeing approaches to health in the North 
West Coast   
Presenter: Nadja van Ginneken 
Co-authors:  Nadja van Ginneken, Katharine Abba, 
Mark Goodall, Adele Ring, Shaima Hassan, Rhiannon 
Corcoran 
Institutions 
University of Liverpool (all) 
Abstract 
Problem 
Social prescribing, the process of linking people to 
wellbeing or social activities are a way of helping 
people to change social and psychological factors that 
may be having a negative effect on their health. There 
has recently been a rapid expansion of social 
prescribing link workers in primary care (though not 
an associated expansion of social/wellbeing activities), 
in the absence of clear evidence of what works to 
make social prescribing programmes effective and 
sustainable, or how they should be evaluated. This 
presents both a need and an opportunity to learn 
from what is already happening in social prescribing, 
and to identify important gaps in knowledge where 
further research is needed. The social prescribing 
team at Liverpool consulted with members of the 
Applied Research Collaborative North West Coast 
(ARC-NWC) - a consortium of health and social 
organisations and individuals that research and apply 
interventions and evaluations to improve health 
inequalities (https://arc-nwc.nihr.ac.uk). They 
highlighted the need to conduct a survey to ascertain 
the research, evaluation and implementation needs of 
social prescribing programmes across the North West 
Coast. Findings from this survey will inform a strategy 
to develop a programme of social prescribing research 
and associated funding bids for ARC-NWC.  
Approach 
The survey will be conducted in three stages. The first 
survey conducted between February and March 2020 
will provide a baseline of social prescribing and 
wellbeing/social activities across the NWC. Two 
further surveys will be conducted midway and at the 
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end of ARC NWC in September 2024 to show 
progression and impact of social prescribing activities 
over time. The survey will be conducted electronically, 
using Google Forms.The baseline survey link has been 
sent to 61 ARC NWC partners, to Public Advisors, 
academic staff, and people who attended the ARC 
launch event. Participants have been asked to 
snowball the questionnaire to other organisations or 
programmes they know. The questionnaire includes 
questions about project components (including 
questions related to their target population and 
addressing health inequalities), referral pathways 
(including whether there is a link worker and if so 
their roles), community participation, and evaluation. 
It also asks about the challenges faced in 
implementing and evaluating their SP projects.We will 
analyse the findings using simple descriptive statistics.  
Findings 
We will present the findings from the baseline survey 
at the SAPC conference.  
Consequences 
The survey is one of three ARC action research 
initiatives (which also include an ARC knowledge 
exchange event for social prescribing in April 2020, 
and a community/ public advisor survey conducted by 
a team in Blackpool).  These will inform the creation 
of co-produced research proposals and partnership 
collaborations which will be taken forward and 
developed as several grant(s) to apply for external 
competitive funding.  
Funding Acknowledgement 
Applied Research Collaborative - North West Coast  
(ARC -NWC) 
 
O.11 
How are spiritual health and burnout associated?   
Presenter: Orla Whitehead 
Co-authors:   
Institutions 
Newcastle University 
Abstract 
Problem 
Burnout is defined by the World Health Organisation 
as an occupational phenomenon, resulting in 
exhaustion, mental distance, feelings of negativity or 
cynicism towards the job, and reduced professional 
efficacy. Burnout is thought to be contributing to the 
current workforce crisis in the UK, as well as higher 
rates of hazardous drinking and suicide among 
doctors. While burn out is not seen as an illness, it 
does appear to be associated with mental illness. 
General Practitioners (GPs) are particularly vulnerable 
to burnout, possibly because of high workloads. 
Previous authors have described a loss of meaning in 
work, and objectification of patients and their 
families, rather than engaging with their humanity. 
Christina Maslach (Maslach Burnout Inventory author) 
argued that burnout is “erosion of the soul.” Soul, 
meaning and humanity are terms associated with 
spirituality, and were used in answers GPs gave in a 
recent survey on spiritual health. Spiritual health has 
been linked with reduced risk of burn out in other 
groups.  This study aims to understand the association 
between burn out and spiritual health.  
Approach 
A systematic review of the global literature identified 
ten studies that had measured burnout in doctors, 
and made an assessment of spirituality. The quality of 
the studies does not allow conclusions to be drawn. 
Key weaknesses were sampling bias, response bias, 
and the lack of a ‘gold standard’ to assess spirituality. 
Given the flaws in the current literature on the topic, 
a robust survey of the primary healthcare team is 
planned to explore any connection between spiritual 
health and burnout. The available spiritual wellbeing 
scales are being evaluated, to identify a scale that has 
validity for measuring spiritual aspects of health and 
wellbeing, is cross-cultural, and will be accepted by 
GPs of all faiths and none, for example the Spiritual 
Health Scale 20111. Qualitative interviews are 
planned to explore the spiritual needs of the primary 
care team who have ‘burnt out’, or are at risk of 
burning out.  
Findings 
While some studies in the systematic review found an 
association between spirituality and burnout, this was 
inconsistent across the different domains of the 
burnout score, and not statistically significant on 
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meta-analysis. At the time of the SAPC meeting, 
hopefully interim findings from the survey will be 
available.  
Consequences 
As GPs seek to provide holistic care for patients, they 
also need to consider their own holistic health, and 
whether implementing policies to support the 
spiritual health of staff could reduce burnout rates. 
This also may contribute to addressing current 
recruitment and retention problems in primary care.  
Funding Acknowledgement 
Thanks to DDES CCG for funding my current post. 
 
P.1 
Do GPs and patients have differing views about the 
value of managing anxiety in primary care? A 
qualitative study   
Presenter: Charlotte Archer 
Co-authors:  David Kessler, Nicola Wiles, Katrina 
Turner 
Institutions 
Univeristy of Bristol 
Abstract 
Problem 
Anxiety disorders are common, with a 40% increase in 
generalised anxiety disorder reported in the general 
population between 2007 and 2014. GP recording of 
anxiety disorders, however, has decreased between 
1998 and 2008. It is not clear why there has been a 
decrease of GPs’ recording of anxiety, when rates in 
the general population have increased. Could it be 
due to GPs being reluctant to record anxiety and if so, 
what might the implications of this be for patients? 
The aim of this study was to understand patients’ and 
GPs’ views about recording of anxiety in primary care.  
Approach 
In-depth qualitative interviews were conducted with 
20 patients and 15 GPs, purposively sampled from GP 
practices in the South West of England. Interviews 
were held either in person or by telephone.  A topic 
guide was used to ensure consistency across the 
interviews.  The interviews were audio-recorded, 
transcribed verbatim and analysed thematically.  
Findings 
GPs described that they felt management of 
symptoms was more important than giving a diagnosis 
of anxiety.  They reported preferring to use symptom 
codes rather than diagnostic codes in order to avoid 
assigning patients potentially stigmatising labels. In 
addition, they felt diagnostic codes encouraged some 
patients to adopt a ‘sick-role’ or not help themselves. 
GPs explained that, when coding, they tended to 
reactivate previously used codes where possible, as 
this was easier and ensured continuity of codes within 
practices. The decision to use a diagnostic code 
depended on severity and chronicity of symptoms, 
and ‘anxiety state’ was mentioned as the code most 
often used. Some GPs reported that it was the role of 
a psychiatrist (not a GP) to diagnose a ‘disorder’. In 
contrast, patients commented that receiving a 
diagnosis, and how the GP communicated this, was 
just as important as the management of symptoms. 
Patients reported that understanding their diagnosis 
was beneficial in terms of acceptance and readiness 
to engage with treatment. They also stated that non-
specific codes such as ‘anxiousness’ or ‘anxiety state’ 
were unhelpful, and contributed to them not fully 
understanding their mental health.  
Consequences 
Whilst GPs appear reluctant to diagnose anxiety, 
patients think doing so would improve patient-
practitioner communication, patients’ understanding 
of their symptoms and condition, and would lead to 
more effective management of anxiety in primary 
care.  
Funding Acknowledgement 
This study/project is funded by the National Institute 
for Health Research (NIHR) School for Primary Care 
Research (project reference: CA 2017). 
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How do people of South Asian origin with long-term 
physical conditions understand, experience and seek 
help for emotional distress? A systematic review.   
Presenter: Hassan Awan 
Co-authors:  Dr Faraz Mughal, Dr Tom Kingstone, 
Professor Carolyn A. Chew-Graham, Dr Nadia Corp 
Institutions 
University of Keele 
Abstract 
Problem 
People with long-term conditions (LTCs) are twice as 
likely to suffer from depression than the general 
population. People with physical-mental comorbidity 
have a poorer quality of life, worse clinical outcomes 
and increased mortality than those with physical 
conditions alone. People from some ethnic groups are 
less likely to recognise symptoms which may 
represent mental health problems and perceive a 
need for support. Furthermore, they are an under-
served group within health services. South Asians 
(SAs) are the largest minority group in the UK, and are 
more likely to have certain LTCs such as diabetes and 
heart disease. There is limited research of the 
experience of SAs with comorbid physical and mental 
health problems in primary care. This systematic 
review seeks to synthesise studies that explore 
perceptions of emotional distress in SAs with LTCs. 
The term emotional distress encompasses distress 
which can cause significant suffering and may or may 
not be diagnosed. The systematic review will inform a 
qualitative study interviewing SA males with diabetes 
and cardiovascular conditions, to explore their 
understanding of emotional distress  and perceived 
care needs; and primary care clinicians to explore 
experiences of supporting SA males with mental-
physical comorbidity.  
Approach 
A systematic review is being undertaken to answer 
the following question: How do SAs with LTCs 
understand, experience and seek help for emotional 
distress? An ethnically appropriate PPIE group has 
been convened, and has reviewed the systematic 
review question and terms. A search strategy was 
formulated for eight databases. This included the 
population of  SAs with diabetes or coronary heart 
disease. The outcome of interest was 
conceptualisation of emotional distress. The setting 
included qualitative studies within primary and 
community care settings worldwide. 3,910 studies 
were imported into RefWorks which reduced to 2,609 
after deduplication. Two reviewers separately 
undertook title and abstract screening. Once agreed, 
27 full texts were dual screened and disagreements at 
both stages resolved through discussion or referral to 
a third reviewer. Data extraction is currently occurring 
independently and the CASP quality checklist for 
qualitative data will be used to review the quality of 
the papers. A PRISMA flow chart has been constructed 
to summarise the review process. Thematic synthesis 
will then be undertaken, based on Thomas and 
Harden’s three stages. GRADE-CERQual will be used to 
review the overall strength of evidence.  
Findings 
The systematic review is in process and the synthesis 
will be presented for the first time at SAPC 2020.  
Consequences 
The review will provide a greater understanding of 
SAs understanding and conceptualisation of 
emotional distress in the context of physical LTCs. This 
work will lead to improvement in the recognition and 
management of emotional distress in SAs with LTCs. 
The research has the potential to influence policy-
makers and commissioners about service provision for 
this patient group.  
Funding Acknowledgement 
Wellcome funded 
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Abstract 
Problem 
People with SMI die 15-20 years younger than the 
general population, principally from the same 
preventable conditions such as cardiovascular and 
respiratory disease. This is known as the mortality gap 
and is one of the biggest health inequalities of our 
time. In an effort to address the mortality gap, the 
Quality and Outcomes Framework (QOF) introduced 
financial incentives for GP practices to conduct 
physical health checks on this population with the aim 
of monitoring their cardiovascular risk. However, in 
2014/15 incentives were removed. To date research 
on the removal of QOF indicators has not focused 
specifically on people with SMI. This study aimed to 
examine the effect of removing incentives on the 
quality of care for patients with SMI.  
Approach 
Quantitative methods were used to analyse electronic 
health records data from a UK primary care database, 
the Clinical Practice Research Datalink (CPRD), linked 
to other data sources. The study design was a 
retrospective, longitudinal observational cohort 
spanning a five year period from 2011/12 to 2015/16. 
The primary research question stemmed from a 
natural experiment which arose from the removal of 
financial incentives in 2014/15 for BMI, cholesterol 
and glucose, but not for blood pressure. This enabled 
a difference-in-differences design to be used to 
examine the effect of removal of incentives on the 
proportion of eligible SMI patients who received a 
health check, compared to blood pressure which 
remained incentivised.  Multivariate logistic 
regression was used to examine the effect key 
demographic variables such as age, gender, ethnicity, 
SMI type and deprivation level had on outcomes to 
predict which demographics affected the likelihood of 
receiving different types of health check.  Data were 
analysed using Stata version 15.  
Findings 
Findings from the difference-in-difference analysis 
demonstrated that removal of financial incentives was 
followed by an immediate and significant decrease in 
the proportion of SMI patients who received a health 
check, compared to the underlying trend controlled 
for by blood pressure which remained incentivised.  
BMI had the most substantial decrease in the initial 
year post-removal of incentives. The multivariate 
logistic regression analysis indicated nuances and 
subtle variation between the different types of health 
checks relating to the likelihood of which patients 
received a check. Overall age, gender and SMI type 
had the most significant effect.  
Consequences 
This study provides new evidence about quality of 
care for SMI patients in the primary care setting. It 
demonstrates that removing financial incentives for 
health checks resulted in a significant reduction in the 
likelihood of receiving a health check. This raises 
questions about inequality and unmet need regarding 
SMI patients, at a time when the mortality gap 
appears to be widening rather than shrinking. Findings 
can inform policy about improving quality of care for 
people with SMI.  
Funding Acknowledgement 
‘This study is funded by the National Institute for 
Health Research (NIHR) Fellowship Programme 
(Katharine Bosanquet, DRF-2016-09-098) part of the 
NIHR Training Programmes. The views expressed are 
those of the author(s) and not necessarily those of the 
NIHR or the Department of Health and Social Care’. 
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Abstract 
Problem 
Postnatal depression (PND) is a common disorder with 
negative impact on mothers, infants and families. The 
World Health Organization states that globally 13% of 
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women experience a mental disorder, primarily 
depression, following childbirth, increasing to 19.8% 
in low and middle income countries. In the UK, studies 
suggest that PND is more common in British South 
Asian (BSA) women than in Caucasian women, which 
suggests that ethnic and cultural differences are 
significant risk factors for developing PND. The 
Positive Health Programme (PHP), is a culturally-
adapted group CBT intervention for PND, and is being 
tested in a multi-centred Randomised Trial.  
Approach 
A nested process evaluation is being conducted, with 
semi-structured interviews with women who have 
completed PHP, women who ‘dropped out’, and trial 
therapists, to explore acceptability of the intervention 
from the perspectives of women and therapists; 
acceptability of the training and challenges to delivery 
of the intervention from the perspectives of the 
therapists. Interviews were digitally recorded with 
consent. Interviews were transcribed verbatim, the 
transcripts forming the data for analysis. An initial 
thematic analysis was conducted within each data-set, 
followed by a framework analysis, using the 
Theoretical Framework of Acceptability (TFA) (Sekhon 
et al, 2017)  
Findings 
Nineteen women who have completed PHP were 
interviewed, along with 3 ‘drop-outs’, and 11 
therapists. Analysis will be presented from five of the 
constructs of the TFA: Affective attitudesWomen who 
had completed the group programme were positive 
about the support given in order to attend the group,  
the value of making friends with other group 
members and sense of achievement following 
completion of the course.Intervention 
coherenceWomen reported that leaving the house to 
attend the group was a positive step. Strategies 
learned in the group seemed to make sense to 
participants. Therapists felt the group programme 
made sense to them, and to their 
Community.Perceived effectivenessWomen felt the 
sessions in the group programme provided useful 
information, helping them to gain confidence, develop 
ways of managing every-day problems, and  improve 
their mood. Therapists reflected on the key features 
of the programme which were helpful to 
women.BurdenEven though transport and creche 
facilities were provided, the effort of leaving the 
house and  impact on family were too much for some 
women to manage. Self-efficacyFollowing the training, 
the therapists had confidence that that they could 
deliver the programme. Women reported that 
learning to prioritise their own needs as a key result of 
participation in ROSHNI.  
Consequences 
Using the TFA to explore acceptability of the ROSHNI 
group intervention for women with PND, from the 
perspectives of women and therapists, we have 
established that the programme is acceptable and 
valued, and has the potential to support British South 
Asian women with post-natal depression.  
Funding Acknowledgement 
This work presents independent research funded by 
the National Institute for Health Research (NIHR) HTA 
Project: 14/68/08 - Multi Centre RCT of a group 
psychOlogical intervention for poStnatal depression in 
britisH mothers of south asiaN origIn - ROSHNI-2 (The 
word Roshni means ‘light’ in Urdu/Hindi) 
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operative, Nottingham, 3 University of Oxford, 4 
Oxford Health NHS Foundation Trust, 5 University of 
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University Child Study Center 
Abstract 
Problem 
The use of antidepressants in children and 
adolescents remains controversial.  In recent years 
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antidepressant prescribing for young people has 
increased both in the UK and other countries.  
However, there is little evidence about variation in 
prescribing, particularly taking other factors into 
account.  We aimed to describe trends over time and 
variation in primary care antidepressant prescribing in 
England, using the largest cohort of children and 
young people to date.  We examined variation by 
social deprivation, region and ethnicity, and analysed 
whether the drugs prescribed reflect UK licensing and 
National Institute for Health and Care Excellence 
(NICE) guidelines.  
Approach 
The study’s open cohort was defined as all eligible 
children (aged 5-11 years) and adolescents (aged 12-
17 years) in 1998-2017 from the QResearch primary 
care database.  Incidence and prevalence rates of 
antidepressant prescriptions were calculated in each 
year overall, for four antidepressant classes (selective 
serotonin reuptake inhibitors (SSRIs), tricyclic and 
related antidepressants (TCAs), serotonin and 
norepinephrine reuptake inhibitors (SNRIs), and other 
antidepressants), and for individual drugs.  Adjusted 
trends over time and differences by social deprivation, 
region and ethnicity were examined using Poisson 
regression, taking clustering within GP practices into 
account using multilevel modelling.  
Findings 
Of the 4.3 million children and adolescents in the 
cohort, 49,434 (1.1%) were prescribed 
antidepressants for the first time during 20 million 
years of follow-up between 1998 and 2017.  Of the 
first antidepressant prescribed, 82% were TCAs in 
children, and 68% were SSRIs in adolescents.  
Antidepressant prescribing incidence rates decreased 
in children over the study period to less than 0.3 per 
1000 person-years for both sexes in 2017, but more 
than doubled in adolescents between 2005 and 2017, 
to 9.7 and 4.2 per 1000 person-years in females and 
males respectively.  Prevalence rates also more than 
doubled in adolescents in the same period to 16.4 in 
females and 7.9 in males, per 1000 person-years.  The 
lowest prescription incidence rates were in London 
and the highest were in the South East, and those 
living in more deprived areas were more likely to be 
prescribed antidepressants, for all sex and age groups.  
Prescribing rates were highest in White and lowest in 
Black adolescents.  The five most commonly first 
prescribed antidepressants representing 90% of 
prescriptions were either licensed in the UK for use in 
children and young people or included in NICE 
guidelines. 
Consequences 
Our analysis provides evidence of a continuing rise of 
antidepressant prescribing in adolescents since 2005, 
driven by SSRI prescriptions.  The variation in 
prescribing found by deprivation, region and ethnicity 
could represent inequities.  Future research should 
examine whether prescribing trends and variation are 
due to differences in need and risk factors, access to 
diagnosis or treatment, prescribing behaviour or 
young people’s help seeking behaviour.  
Funding Acknowledgement 
This research was funded by the NIHR Nottingham 
Biomedical Research Centre. 
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University of Nottingham, NIHR Nottingham 
Biomedical Research Centre and NIHR 
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Oxford,  Oxford Health NHS Foundation 
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Trust, New York University Child Study Center 
Abstract 
Problem 
Antidepressants may be used to manage a number of 
conditions in children and young people including 
depression, anxiety, and obsessive compulsive 
disorder. UK guidelines for the treatment of 
depression in children and young people recommend 
that antidepressants should only be initiated following 
assessment and diagnosis by a child and adolescent 
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psychiatrist. This study aimed to summarise visits to 
specialists and indications recorded around the time 
of antidepressant initiation in children and young 
people in UK primary care.  
Approach 
English primary care electronic health records 
provided by QResearch were linked to Hospital 
Episode Statistics (HES) secondary care data. The 
study included 5-17-year-olds first prescribed 
antidepressants between January 2006 and December 
2017. Records of visits to paediatric or psychiatric 
specialists and potential indications (from a pre-
specified list) were extracted. Events were counted if 
recorded less than 12 months before or 6 months 
after the first antidepressant prescription. Results 
were stratified by first antidepressant type (all, 
selective serotonin reuptake inhibitors (SSRIs), tricyclic 
antidepressants (TCAs)), and by age group (5-11, 12-
17 years old).  
Findings 
In total, 33,031 5-17-year-olds were included. The 
majority were aged 12-17 years (30,701, 93%) and 
were female (22,279, 67%). The first antidepressant 
prescribed was an SSRI for 22,130 (67%) patients. 
Overall, 12,149 (37%) visited a paediatric or 
psychiatric specialist in the specified time window. 
Most recorded visits (7154, 22% of the study 
population) were to paediatricians. Of those 
prescribed SSRIs, 5463/22,130 (25%) visited a child 
and adolescent psychiatrist. The proportion who 
visited a paediatrician increased steadily over the 
study window, while the proportion visiting a child 
and adolescent psychiatrist peaked in 2013, before 
starting to decline. By patient age, 1157/2239 (50%) 5-
11-year-olds and 10,992/30,701 (36%) 12-17-year-
olds had a record of visiting a paediatric or psychiatric 
specialist. Overall 17,972 (54%) patients had a record 
of at least one of the pre-specified indications. This 
proportion was higher for those prescribed SSRIs 
(15,295/22,130, 69%) than those prescribed TCAs 
(2463/10,489, 24%). Depression was recorded most 
frequently overall (12,501, 38%), followed by anxiety 
(4155, 13%). Over half of the 12-17-year-olds first 
prescribed an SSRI had a record of depression 
(11,474/21,478, 53%).  
Consequences 
These results suggest antidepressants are frequently 
prescribed to children and young people in primary 
care without the recommended involvement of 
specialists. As possible indications were identified for 
just over half of prescriptions, it is difficult to 
determine whether antidepressants were prescribed 
in children and young people for evidence-based 
indications. These findings may justify both greater 
training for GPs in child and adolescent mental health, 
and greater access to specialist care and non-
pharmacological treatments.  
Funding Acknowledgement 
This work has been funded by the National Institute 
for Health Research (NIHR). The research reported in 
this paper was conducted by the NIHR Nottingham 
Biomedical Research Centre. RM is supported by the 
NIHR MindTech MedTech and in Vitro Fertilisation 
Collaboration and the NIHR Applied Research 
Collaboration East Midlands. AC is supported by the 
NIHR Oxford Cognitive Health Clinical Research 
Facility, by an NIHR Research Professorship (grant RP-
2017-08-ST2-006) and by the NIHR Oxford Health 
Biomedical Research Centre (grant BRC-1215-20005). 
The views represented are the views of the authors 
alone and do not necessarily represent the views of 
the Department of Health in England, NHS, or the 
National Institute for Health Research. 
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Foundation Trust 
Abstract 
Problem 
Approximately 30% of the UK population have a long-
term condition (LTC). Depression is two to three times 
more likely in people with LTCs resulting in poorer 
health outcomes, reduced quality of life, and 
increased healthcare costs. Sub-threshold depression, 
a risk factor for major depression, is prevalent in 
people with LTCs, but many people remain untreated 
due to demand on services. The community pharmacy 
may be an alternative setting to offer psychological 
support for people with comorbid sub-threshold 
depression and LTCs.  
Approach 
A feasibility study and pilot randomised controlled 
trial (RCT) evaluated the feasibility of pharmacy staff 
delivering an Enhanced Support Intervention (ESI) for 
people with comorbid sub-threshold depression and 
LTCs. The ESI focussed on Behavioural Activation and 
involved up to six sessions delivered by trained 
pharmacy staff (ESI facilitators). Participants were 
identified via pharmacies or GP practice database 
searches. Participants (aged ≥18, with sub-threshold 
depression and at least one LTC) were all offered the 
ESI in the feasibility study. In the pilot RCT, 
participants were randomised to either the ESI or 
usual care. Main outcomes included recruitment and 
retention rates, ESI engagement and depression 
severity (Patient Health Questionnaire) at four 
months (primary outcome). Semi-structured 
interviews were conducted with participants, 
pharmacy staff (including ESI facilitators) and GPs.  
Findings 
Feasibility study: Twenty-four participants were 
recruited and 17 ESI facilitators were trained. 
Seventeen participants (71%) commenced the ESI; all 
completed two or more sessions and ten completed 
all six sessions. Retention at four months was 83%. 
Depressive symptoms decreased slightly at four 
months. Interview data suggested the ESI was 
acceptable to participants and ESI facilitators, and 
that the community pharmacy was an appropriate 
place to offer a psychological intervention. Learning 
generated led to refinements to study materials/ 
processes for the pilot RCT. Pilot RCT: Forty-four 
participants were recruited (out of a target of 100); 24 
randomised to the ESI and 20 to usual care. An 
additional 18 ESI facilitators were trained. Eighteen 
participants (75%) commenced the ESI with 16 
participants completing at least two sessions and nine 
completing all six sessions. Retention at four months 
was 93%. Depressive symptoms reduced slightly at 
four months, with a slightly larger reduction in the 
usual care group, although the sample size is too small 
to draw any conclusions. Interview data reported 
good acceptability of the ESI and identified barriers 
associated with implementation of recruitment and 
study processes within routine pharmacy practice.  
Consequences 
Community pharmacy represents a new setting for 
mental health research. This is the first study to 
demonstrate that pharmacy staff can be trained to 
deliver a depression prevention intervention. Despite 
good retention rates and ESI engagement, 
recruitment was a challenge and this has implications 
for conducting a definitive RCT. Further research is 
needed to address recruitment barriers.  
Funding Acknowledgement 
This work presents independent research funded by 
the National Institute for Health Research (NIHR) 
Public Health Research programme [14/186/11]. The 
views expressed in this work are those of the 
author(s) and not necessarily those of the NIHR or the 
Department of Health and Social Care. 
 
P.8 
Prognostic models for predicting relapse of 
depression: A Cochrane Prognosis Review and 
implications for primary care   
Presenter: Andrew Moriarty 
Co-authors:  Nick Meader, Simon Gilbody, Rachel 
Churchill, Bob Phillips, Shehzad Ali, Richard D Riley, 
Dean McMillan, Carolyn A Chew-Graham 
Institutions 
Hull York Medical School, University of York, Keele 
University, Western University 
 
 167 
 
Abstract 
Problem 
Most people with depression are managed in primary 
care. After a first episode, approximately half of 
patients will relapse, and this risk increases for every 
subsequent episode. Depression severity and 
treatment-resistance increase with each successive 
episode, highlighting the potential benefits of 
intervening early to prevent relapse. Factors 
associated with increased risk of relapse include 
adverse childhood events, previous episodes of 
depression and residual symptoms. Combining several 
prognostic factors within a multivariable prognostic 
model can result in improved individualised risk 
predictions. Our goal is to develop a prognostic 
model, to be implemented in primary care, to identify 
patients at increased risk of relapse and allow more 
effective allocation of relapse prevention 
interventions to those individuals.This is the first 
systematic review to set out to identify prognostic 
models for relapse of depression, a recommended 
first step in prognostic model development. The two 
main aims of this review are:To summarise the 
predictive performance of prognostic models 
developed to predict the risk of relapse and related 
outcomes in patients who meet criteria for remission. 
To summarise the value of updating an existing 
prognostic model or identify whether the 
development of a novel prognostic model is required.  
Approach 
The methodology is informed by most recent 
guidance in prognosis research. We searched a wide 
range of electronic medical databases and used the 
following eligibility criteria:Population — Adult 
patients (18 years and over) diagnosed with 
depression and meeting criteria for remission.  
Index model —Prognostic models predicting relapse 
and related outcomes in patients with depression.  
Comparator — NoneOutcomes — Relapse and related 
outcomes (recurrence, sustained remission or 
recovery) in depression.  
Timing — Start-point is the point at which a patient 
has responded to treatment and is identified as 
meeting criteria for remission.  
Setting — Primary, secondary or community care.Data 
were extracted using the Checklist for Critical 
Appraisal and Data Extraction for Systematic Reviews 
of Prediction Modelling Studies (CHARMS) and risk of 
bias assessed using the Prediction model risk of bias 
assessment tool (PROBAST).  
Findings 
The review is ongoing (full text screening stage) and 
SAPC ASM 2020 will be an early opportunity to share 
the results. 
Consequences 
The results will inform future work to improve risk 
stratification in primary care. If an existing model 
performs satisfactorily, we will update and refine this, 
with input from key stakeholders, including patients 
and the public, for implementation in a UK primary 
care setting. If no existing model has sufficient 
predictive performance or clinical acceptability, we 
will use information from this review to develop a 
novel prognostic model. The longer-term goal of this 
study is to improve clinical outcomes and quality of 
life for patients, as well as facilitating more targeted 
use of NHS resources in primary care.  
Funding Acknowledgement 
This report is independent research supported by the 
National Institute for Health Research (NIHR Doctoral 
Research Fellowship, Dr Andrew Moriarty, DRF-2018-
11-ST2-044). The views expressed in this publication 
are those of the authors and not necessarily those of 
the NHS, the National Institute for Health Research or 
the Department of Health and Social Care. 
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Abstract 
Problem 
Self-harm in young people is a major public health 
concern. Suicide is the leading cause of death in young 
people (16-25 years) in the United Kingdom, and self-
harm is the strongest risk factor for suicide. Reducing 
rates of self-harm is a key national priority. Over half 
of young people who die by suicide have a history of 
self-harm. There are estimated to be around 200,000 
young people who self-harm in the community and do 
not present to hospital. Self-harm in young people 
presenting to general practice is rising, and general 
practice is the healthcare setting young people with 
self-harm attend for help most often. There is, 
however, no published evidence on young people’s 
experiences and views of care received for self-harm 
in general practice, and on access to general practice 
services. This study aimed to explore the experiences 
and perspectives of young people (16-25 years) 
receiving care for self-harm in general practice, and 
barriers and facilitators to accessing general practice 
care.  
Approach 
Semi-structured, face-to-face or telephone interviews 
with 13 young people in England were conducted 
from April-November 2019 to attain rich insights. 
Sampling was purposive to achieve maximum 
variation in age, gender, practice location, and socio-
demographic status. Interviews were audio-recorded 
and transcribed verbatim. Transcripts formed the data 
and are being analysed by inductive thematic 
synthesis using principles of constant comparison.  
Findings 
Preliminary analysis has identified emerging themes 
including a hierarchy of self-harm behaviour, with 
method of self-harm changing over time. Young 
people report that stigma around self-harm behaviour 
hinders them from openly talking about self-harm 
with GPs, which is then further exacerbated when 
self-harm is overlooked by GPs. Young people felt GPs 
can be dismissive when self-harm is mentioned in the 
consultation. Young people describe how past 
experiences of GP care influence future help-seeking 
for self-harm. For young people who had positive 
experiences of GP care, continuity with the same GP 
was important, and acts as a facilitator for accessing 
future general practice care. Full analysis will be 
presented, and all themes agreed upon by the 
research team.  
Consequences 
This is the first study to report on young people’s 
experiences of care received for self-harm behaviour 
in general practice. These findings will be crucial for 
improving the care young people receive for self-harm 
in primary care, and help to reduce repeat self-harm 
and prevent suicide. This study will inform the 
development of integrated primary care self-harm 
models outlined in the NHS Long Term Plan and 
clinical guidelines for self-harm.  
Funding Acknowledgement 
This work is supported by FM's NIHR In-Practice 
Fellowship and a Practitioner Allowance Grant from 
the RCGP Scientific Foundation Board. 
 
P.10 
Could community pharmacy teams enhance mental 
health support through the Advancing Mental 
HeaLth Provision In PHarmacY (AMPLIPHY) service? 
A protocol and preliminary findings.   
Presenter: Lisa Riste 
Co-authors:  Hayley Gorton, Darren Ashcroft, Chris 
Armitage, Nav Kapur, Donna Littlewood, Gary 
Pickering 
Institutions 
University of Manchester, University of Huddersfield, 
Lloyds Pharmacy 
Abstract 
Problem 
The improvement of mental health support is a 
priority for the NHS, and primary care services. 
Community pharmacists and their teams are well-
placed to contribute to this agenda. Yet, a recent 
Cochrane review did not identify any formal mental 
health services which are being delivered by 
community pharmacists. (1) Given that 1.6 million 
people visit a pharmacy in England every day (2) and 
adherence to antidepressants is often poor (3), 
community pharmacies could be an underutilised 
resource.  We therefore aim to test the feasibility of 
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implementing a service that has been co-designed 
with service-users to enhance support related to 
depression and anxiety. 
Approach 
We worked with a patient and public involvement 
group, pharmacists and leadership at LloydsPharmacy 
to design a service to support people who are 
prescribed new medications for depression or anxiety, 
or have a change in medication, dose or quantity. The 
resultant programme is a series of consultations, 
beginning at the presentation of the qualifying 
prescription, after a further 1-2 weeks and then as 
further prescriptions are presented, up to 3 months. 
The participating pharmacists undertook a one-day 
training programme led by researchers from the 
Universities of Huddersfield and Manchester. This 
included review of service development, 
documentation, embedded research, suicide 
prevention, safeguarding and identification of local 
referral pathways. The service has been piloted since 
November 2019 and will continue to May 2020 in 10 
pharmacies across Greater Manchester. We will 
evaluate the service through triangulation of data 
obtained through the following methods:  
1) Monitor service uptake through audit kept by 
pharmacy teams when identifying eligible patients. 
2) Review and monitoring of anonymous 
consultations, which are recorded on 
PharmOutcomes. Descriptive statistics will be 
reported and we will use content analysis to describe 
the content of consultation.  
3) Semi-structured interviews prior to and after 
implementation of the service with the participating 
pharmacists, which we will analyse using the 
Theoretical Domains Framework. (4)  
4) Anonymous qualitative surveys of patients as they 
leave the service, which we will analyse thematically.  
 
Findings 
The first patient was recruited into the service on 
11/11/2019, to date 74 patients have been recruited 
(62% target). Patients range from age 18 to 72 (39 
median) and 45 (61%) are female. 54 (73%) entered 
the service due to a new medication, 13 (18%) due to 
a change in dose and the remainder had a change in 
medication or quantity. Female pharmacists were 
more likely to recruit female patients than male 
patients (71% vs. 29%; p<0.05). The initial qualitative 
interviews with pharmacists were undertaken in 
November/December 2019, were audio-recorded, 
and are in the process of being transcribed.  
Consequences 
By July 2020, we will be able to comment on the 
feasibility of this service as indicated from the 
methods described above. These findings will support 
potential funding applications to evaluate a wider roll-
out of the service across other community pharmacy 
providers and a wider geographical area.  
Funding Acknowledgement 
This study is funded by an Innovation award from 
NIHR Greater Manchester Patient Safety Translational 
Research Centre 
 
P.11 
Interventions for Perinatal Anxiety (PNA) in a general 
practice population: a systematic review and 
narrative synthesis   
Presenter: Victoria Silverwood 
Co-authors:  Laurna Bullock, Carolyn-Chew-Graham, 
Tom Kingstone, Katrina Turner, Joanne Jordan. 
Institutions 
VS, LB, JJ, TK, CC-G – School of Primary, Community 
and Social Care, Keele University KT – Centre of 
Academic Primary Health Care, Bristol University  TK, 
CC-G – Midlands Partnership NHS Foundation Trust  
CC-G - WM ARC 
Abstract 
Problem 
Perinatal anxiety (PNA) occurs during pregnancy or up 
to 12 months post-partum. Global prevalence of PNA 
is estimated to be >15%, at least as common as 
depression. PNA may negatively impact on pregnancy 
and neonatal outcomes, postnatal mental health, 
parenting behaviours and childhood development. 
Previous research has focused primarily on postnatal 
depression; there is limited evidence for the 
management of PNA in primary care. Studies that 
consider anxiety occurring outside of the perinatal 
period support the use of psychological therapies as 
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treatment; however, evidence for the specific 
application of these therapies for PNA seems scarce. 
There is also limited evidence published around other 
non-pharmacological interventions such as 
peer/family support.The NHS Five Year Forward View 
for Mental Health aims to improve specialist and 
community Perinatal Mental Health (PMH) support 
across England and NICE guidelines for PMH state 
there is a need for further research to specifically 
develop interventions such as psychological therapies 
to treat PNA. This study will review the current 
evidence for non-pharmacological interventions for 
PNA and highlight gaps in the current literature 
around the management of PNA.  
Approach 
A systematic review and narrative synthesis will be 
undertaken, reported in line with PRISMA guidelines 
and registered on PROSPERO. Systematic searches will 
be conducted in MEDLINE, CINAHL, AMED, EMBASE, 
Web of Science and PsycINFO. All titles and abstracts 
will be independently screened by VS; 20% will be 
screened by a second independent reviewer (LB) 
according to pre-defined eligibility criteria. 
Discrepancies will be solved by discussion or a third 
reviewer. Both researchers will undertake full paper 
screening and data extraction.The review will include 
any primary qualitative, quantitative or mixed 
methods studies. Data will be extracted about study 
participants, methodology, and intervention design 
and context. Quality assessment will be performed 
alongside data extraction using the Cochrane Risk of 
Bias tool. A grey literature scoping review will be 
conducted to identify reports from organisations 
involved in PMH care such as third sector 
organisations. A narrative synthesis will be performed 
as per the Popay guidelines to identify patterns across 
the data in order to draw informative conclusions. An 
established patient advisory group was involved in the 
concept and development of this systematic review 
and will be involved throughout.  
Findings 
Initial systematic literature searches are underway 
and results will be available for presentation at 
Conference in July.  
Consequences 
This review will identify and summarise evidence on 
the effectiveness of current non-pharmacological 
interventions used in general practice to manage PNA.  
Insights gained will be used to make 
recommendations for future research, clinical 
implications and policy changes. It forms the first part 
of a PhD looking at optimal interventions for PNA, and 
will support the co-production of an intervention for 
PNA.  
Funding Acknowledgement 
VS is a Wellcome Trust PhD Clinical Fellow – this 
systematic review forms part of a PhD. 
 
Q.1 
Exploring the relationship between post-migration 
life difficulties and mental health in asylum seekers 
and refugees: A Systematic Review   
Presenter: Alessio Albanese 
Co-authors:  Professor Catherine O'Donnell, Dr Sara 
MacDonald, Dr Barbara Nicholl 
Institutions 
University of Glasgow 
Abstract 
Problem 
Research indicates that asylum seekers and refugees 
suffer from higher rates of mental health difficulties in 
comparison to the general population of host 
countries. The available literature provides only 
partial explanations for this phenomenon, and much 
of that research utilises quantitative methods of data 
synthesis. In order to improve our understanding of 
the psycho-social context that exacerbates mental ill-
health in these populations, we are conducting a 
systematic review and Critical Interpretative Synthesis 
(CIS). The present systematic review aims to improve 
our understanding of post-migration life difficulties 
and their relationship to mental health in asylum 
seeking and refugee populations.  
Approach 
MEDLINE, Embase, Web of Science, PsychINFO, 
SocINDEX were searched using a pre-specified, 
comprehensive search strategy. The results derived 
from these searches were imported into DistillerSR 
(N=9366), and a 4-level screening was performed. All 
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papers at all levels were screened by two independent 
researchers. Quality appraisal was conducted using 
COREQ guidelines (N=35). Papers were included if 
they focussed on (1) asylum seekers/refugees; (2) 
mental health; (3) reported qualitative data; (4) 
clearly addressed post-migration issues.  
Findings 
A total of 35 papers were included and synthesis is on-
going. Most studies focus on depression, anxiety 
and/or PTSD, although only 12 include a clear 
reference to a diagnosis of at least one common 
mental health problem. Early findings indicate that 
the migration journey and experiences of the asylum 
process and related social issues, such as housing, lack 
of employment, poor access to healthcare, lack of 
social connections and family separations contribute 
to post-migration mental health difficulties. Asylum 
seekers’ and refugees’ recognition and 
conceptualisation of mental health and ill-health is 
often culturally shaped and may, therefore, differ 
from that of the health care professionals they 
encounter in high income health care systems. Access 
to mental health care may be mediated and shaped, 
amongst other factors, by these discrepancies 
between asylum seekers’ and refugees’ 
conceptualisation of mental health, and current 
service provision, which is rooted in diagnosis and 
categorisation (e.g. through the use of DSM 
categories). An additional challenge in the process of 
this review has been the different terminologies used 
to describe the migration status of participants in 
each study (e.g. asylum seekers, refugees, 
undocumented migrants, economic migrants etc.). We 
found that terms such as migrant or immigrant are, at 
times, erroneously used to refer to refugees and/or 
asylum seekers.  
Consequences 
The findings from this review can improve our 
understanding of the saliency of post-migration life 
difficulties on the mental health of asylum seekers 
and refugees resettled in high income countries. This 
has implications for general practitioners and other 
primary care and community-based mental health 
professionals, who are often the first point of contact 
for these patients.  
 
Q.2 
What is the prevalence and impact of frailty in 
minority ethnic populations?   
Presenter: Dr Hamish Foster 
Co-authors:  Dr Hamish Foster, Dr Bhautesh Jani, Prof 
Frances Mair, Dr Barbara Nicholl, Prof Catherine 
O'Donnell 
Institutions 
General Practice and Primary Care, University of 
Glasgow 
Abstract 
Problem 
Few studies have examined the prevalence and 
associated mortality of frailty among ethnic minorities 
in the UK. Better understanding of ethnic mortality 
differentials can inform policy relating to health 
inequalities. We aimed to describe the distribution 
and odds of frailty and its associated mortality across 
ethnic groups in UK Biobank.  
Approach 
A prospective cohort; 502,643 participants aged 37-73 
years; self-reported demographics/health/lifestyle 
data; linked to registries to ascertain deaths. Ethnicity 
groups: White British, Other-White background, 
White Irish, Asian/Asian British, Black/Black British, 
Other, Mixed, or Chinese. Frailty assessed by 5 criteria 
(Frailty Phenotype): grip strength/walking-
speed/exhaustion/weight-loss/physical activity. 
Participants considered ‘frail’ if they met ≥3 criteria; 
‘pre-frail’ if they met 1-2 criteria; and ‘not frail’ if no 
criteria met.Frailty prevalence was stratified by sex 
and age. Multinomial logistic regression models used 
to estimate likelihood for frailty, adjusting for 
demographics and lifestyle. Cox proportional hazards 
models used to examine associations between frailty 
and all-cause mortality.  
Findings 
485,490 participants had complete data; 17,153 
(3.4%) with missing data excluded. Minority ethnic 
groups were under-represented compared to UK 
general population: 431,416 (88.9%) White British; 
15,860 (3.3%) Other-White background; 12,767 (2.6%) 
White Irish;  9,124 (1.9%) Asian or Asian British; 7,673 
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(1.6%) Black or Black British; 4,275 (0.9%) Other 
ethnicity; 2,862 (0.6%) Mixed ethnicity; and 1,513 
(0.3%) Chinese. Compared to White British, minority 
ethnic groups had more females, were younger, more 
deprived, smoked less, and drank alcohol less often. 
After 108.2 months (IQR 17.3) median follow up there 
were 18,965 (3.9%) deaths.Frailty prevalence 
(unadjusted) was higher in most minority ethnic 
groups for nearly all age-sex groups. In those aged 56-
65, frailty prevalence was highest in Asian/Asian 
British women (15.3%) and in Asian/Asian British men 
(11.0%). Equivalent figures for White British were 
4.0% for women and 3.0% for men. White British men 
and Other-White background women had the lowest 
prevalence of frailty. Compared to White British 
participants, adjusted ORs (95%CI) for frailty were 
significantly higher for nearly all ethnic minorities: 
White Irish 1.28 (1.16-1.41); Asian/Asian British 4.40 
(4.04-4.79); Black/Black British 1.71 (1.55-1.89); 
Chinese 2.33 (1.78-3.05); Mixed 1.23 (1.01-1.48); and 
Other 2.65 (2.34-3.00). However, compared to White 
British, there were significantly lower mortality 
hazards associated with frailty in Asian/Asian British 
and Black/Black British: HR (95%CI) 0.54 (0.41-0.72); 
and 0.59 (0.40-0.87), respectively. For all other ethnic 
minorities, frailty mortality associations were not 
significantly different from those of White British.  
Consequences 
Prevalence of frailty was higher in ethnic minorities 
than in White British. After adjusting for 
sociodemographic and lifestyle factors, odds of being 
frail remained significantly higher in ethnic minorities. 
However, frailty was associated with lower or similar 
mortality compared to White British participants. 
Developing an understanding of how frailty impacts 
different ethnic groups could help improve health 
equity.  
Funding Acknowledgement 
This work was not funded. 
 
 
 
 
Q.3 
What is the prevalence and impact of multimorbidity 
in minority ethnic groups?   
Presenter: Hamish Foster 
Co-authors:  Dr Hamish Foster, Dr Bhautesh Jani, Prof 
Frances Mair, Dr Barbara Nicholl, Prof Catherine 
O'Donnell 
Institutions 
General Practice and Primary Care, University of 
Glasgow 
Abstract 
Problem 
The prevalence and impact of multimorbidity in 
minority ethnic groups is underexplored. Here we 
describe the prevalence of multimorbidity and its 
associated mortality across ethnicities in the UK 
Biobank population.  
Approach 
A prospective study of UK Biobank: 502,643 
participants aged 37-73 years; self-reported 
demographics, health, and lifestyle data; linked to 
registries to ascertain deaths. Ethnicity groups: White 
British, Other-White background, White Irish, 
Asian/Asian British, Black/Black British, Other, Mixed, 
or Chinese. Long-term condition (LTC) count at 
baseline allowed categorisation into: 0, 1, 2, 3, or ≥4 
LTCs. Multimorbidity was defined as having ≥2 
LTCs.Prevalence of LTC count was stratified by sex and 
age. Multinomial logistic regression models were used 
to estimate likelihood of having 0 (reference), 1, 2 , 3, 
or ≥4 LTCs, adjusting for demographics and lifestyle. 
Cox proportional hazards models were used to 
examine associations between LTC count and all-
cause mortality (reference group: White British).  
Findings 
493,646 had complete data; 8,997 (1.8%) with missing 
data excluded. Minority ethnic groups were under-
represented compared to UK population. Compared 
to White British they had more females, were 
younger, more socioeconomically deprived, smoked 
less, and drank alcohol less frequently. After 108.2 
months (IQR 17.4) median follow up there were 
19,665 (4.0%) deaths.Compared to White British, 
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multimorbidity (stratified by sex and age) was higher 
in most ethnic minority groups. In those aged 56-65, 
the highest prevalence of ≥2 LTCs was 45.1% in 
Black/Black British women and 46.1% in Asian/Asian 
British men. Chinese generally had the lowest 
prevalence of multimorbidity (e.g. 24.9% Chinese 
women aged 56-65 had ≥2 LTCs). This pattern was 
similar in other age groups and at higher levels of 
multimorbidity.Compared to White British, adjusted 
ORs (95%CI) for having multimorbidity (2 vs 0 LTCs) 
were significantly lower for most ethnic minority 
groups: White-Other 0.82 (0.78-0.86); Black/Black 
British 0.87 (0.81-0.93); Chinese 0.63 (0.54-0.74); and 
Other 0.80 (0.73-0.88). However, equivalent OR for 
Asian/Asian British was significantly increased: 1.10 
(1.04-1.17). There were lower hazard ratios for 
mortality for all ethnic minority groups at all levels of 
multimorbidity. Asian/Asian British, White-Other, and 
Mixed ethnicity with 2 LTCs had significantly lower 
mortality compared to White British: HR (95%CI) 0.73 
(0.57-0.94); 0.82 (0.67-0.99); and 0.53 (0.30-0.93), 
respectively.  
Consequences 
This is the first study to examine multimorbidity and 
associated mortality across ethnicities in a UK 
population. Prevalence of multimorbidity was higher 
in all ethnic minority groups but, after adjusting for 
sociodemographics and lifestyle, the odds of having 
multimorbidity was lower in ethnic minority groups. 
Multimorbidity was associated with lower mortality in 
most ethnic minority groups. Caution is warranted 
due to under-representation of minority groups in UK 
Biobank. However, multimorbidity may be a key factor 
in explaining ethnic differences in mortality.  
Funding Acknowledgement 
This work was not funded. 
 
 
 
 
 
 
Q.4 
Barriers to the use of trained interpreters in 
consultations with refugees in four resettlement 
countries: A qualitative analysis using Normalisation 
Process Theory   
Presenter: Anne MacFarlane 
Co-authors:  Susann Huschke, Kevin Pottie, Fern 
Hauck, Kim Griswold, Mark Harris. 
Institutions 
University of Limerick, Ireland, University of Ottawa, 
Canada,University of Virginia, USA, University of 
Buffalo, USA, University of New South Wales, Australia 
Abstract 
Problem 
The forced movement of people as refugees around 
the globe is increasing and reached record highs in 
recent years. Refugee resettlement has therefore 
affected increasing numbers of primary care 
practitioners. There are concerns about health equity 
in primary care for refugees. This is primarily because 
of well-documented communication challenges in 
consultations due to cultural and linguistic diversity. 
While access to trained interpreters is a priority for 
primary care practitioners and refugees alike, there 
are many barriers to the implementation of 
interpreted consultations in routine care. There is a 
lack of international, theoretically informed research 
to guide policy and practice. The purpose of this 
research is to conduct a comparative analysis of 
barriers to interpreter use in primary care 
consultations in four resettlement countries using 
Normalisation Process Theory.  
Approach 
We developed and piloted an online survey with 
closed and open questions about the use of formal 
interpreting agencies by primary care practitioners 
who work with refugees. We recruited via email 
through primary care networks in four countries: 
Australia, Canada, Ireland and US (n=314). The survey 
response rates were average rages for external 
surveys (10-15%) in all countries except Ireland: 
Australia 26%, Canada and US (networks overlapped) 
12.3%, and Ireland 5.9%. This presentation is based on 
qualitative analysis of responses to open 
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questions.We completed a two-stage qualitative 
analysis of responses about barriers to interpreter use 
(n= 178). We conducted an inductive thematic 
analysis, following the principles of framework 
analysis, and then mapped the emergent themes onto 
Normalisation Process Theory’s (NPT) construct about 
enactment. We explored whether data fell outside the 
focus of this NPT construct; there were none that did.  
Findings 
Most respondents to the open questions were over 40 
years of age (n = 122, 68.5%%), female (n = 131, 
73.6%) and were not a refugee or an immigrant (n = 
139, 78%). The majority were physicians/doctors (n = 
146, 82%) and working in a practice using formal 
interpreters (n = 11; 62.5%).In all four countries, the 
use of an interpreter presented interactional 
challenges between providers and patients (e.g. 
difficult to develop rapport in a triadic consultation). 
Primary care practitioners did not always have 
confidence in interpreted consultations and described 
poor professional practice by some interpreters (e.g. 
breaches in confidentiality). There was variation 
across countries, and inconsistency within countries, 
in the availability of trained interpreters and funding 
sources.  
Consequences 
There are shared and differential barriers to 
implementation of interpreted consultations in the 
four countries. It is necessary to identify transferrable 
interventions to address shared barriers and country 
specific interventions to address system level issues 
that are specific to the national context. Taken 
together, this will help reduce the current health 
inequities experienced by refugees in primary care.  
 
 
 
 
 
 
 
Q.5 
Engaging the multiply marginalised in Primary Care 
Research. Reflections on Involvement and 
Engagement activities within the homeless Central 
and Eastern European Community in Greater 
Manchester   
Presenter: Aaron Poppleton 
Co-authors:  Caroline Sanders, Aneez Esmael, Nusrat 
Husain 
Institutions 
University of Manchester 
Abstract 
Problem 
The UK-Central and Eastern European community 
(UK-CEE) totals around 2 million people. A range of 
barriers to effective community engagement within 
UK primary care services exist, with resultant service 
dissatisfaction. Such barriers are greater for multiply 
marginalised ‘minorities within the minority’, such as 
the UK-CEE homeless. Despite having significant 
unmet physical and mental health needs, UK-CEE 
homeless individuals are routinely absent from 
demographic data and health services research. Little 
exploration of their health beliefs and concepts for 
health utilisation has taken place. Furthermore, the 
relevance of routine Public and Patient Involvement 
(PPI) strategies to this population is unclear.  
Approach 
A series of community stakeholder, individual and 
group PPI meetings are currently being undertaken 
with UK-CEE homeless individuals within the Booth 
Centre, Manchester. Meetings are semi-structured 
and in line with UK Standards for Public Involvement 
in Research and INVOLVE PPI guidance. Field notes are 
recorded with participant permission. Discussion 
topics include: perspectives on UK primary care; 
practicalities of study recruitment, design, and 
ongoing participation; and the perceived viability of 
different methods of PPI and study/intervention co-
design.  
Findings 
Meetings are ongoing with completion due by June 
2020. Identified themes and their potential 
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implications for primary care research among the 
multiply marginalised will be presented. Direct 
comparison will be made with PPI and engagement 
activities undertaken within the wider UK-CEE and 
other UK based ethnic minority communities. 
Outcomes will inform subsequent qualitative study 
recruitment/engagement strategies in addition to co-
design of primary care service guidance.  
Consequences 
Engaging the multiply marginalised in primary care 
research is key to overcoming health inequalities and 
achieving community empowerment. Clear guidance 
on developing sustainable PPI and co-design 
strategies within the UK-CEE homeless population will 
support development of engagement strategies for 
other multiply marginalised communities.  
 
Q.6 
“I ask God for medicines and my doctors deliver 
them to me”: How do older Pakistanis living in 
London experience multi-morbidity?   
Presenter: Najia Sultan 
Co-authors:  Deborah Swinglehurst 
Institutions 
Queen Mary University of London 
Abstract 
Problem 
Multi-morbidity, or the co-existence of two or more 
medical conditions, is an escalating epidemic on a 
global scale. Living with multiple illnesses increases 
risk of mortality and decreases quality of life. The 
effects of multi-morbidity are exacerbated in 
vulnerable groups, such as those living in poverty, the 
elderly, ethnic minorities and migrants; where 
intersectional risk factors compound and result in 
poor outcomes that are blamed largely on those who 
are already disadvantaged. London is an increasingly 
super-diverse city with a South-Asian population, 
including those of Pakistani origin, who are known to 
have higher levels of multi-morbidity and an earlier 
onset of chronic illness than the native population. 
Urdu is the UK’s third most commonly spoken 
immigrant language and Urdu-speaking Pakistani 
patients form a significant ethnic group in London.  
Existing research on this population has historically 
focused on health literacy and ‘compliance’ through a 
biomedical lens. Little is known about how Pakistani 
patients experience chronic illness in its broad sense, 
within the context of their life histories and the 
migrant experience and the relationships that 
facilitate and maintain their patient-hood.  
Approach 
We interviewed 15 first-generation Pakistani migrant 
patients living with >2 chronic illnesses and on >10 
regular medications ,aged between 53 and 87, 
recruited from 7 GP practices in East London. Patients 
completed an in-depth interview with a bilingual 
researcher in Urdu at home, lasting on average 1 hour 
and 12 minutes. The interviews were designed to 
induce a narrative of patient’s experience of health in 
the context of their life story, and were subsequently 
translated into English and transcribed.  
Findings 
Through analysis we identified the central relational 
triad of family, faith and health to how these patients 
make sense of and manage their experiences of 
chronic illness. Stressful events within the family were 
identified as precipitants for ill health; whilst care 
provided by family was a crucial source of support in 
withstanding the ‘burden of treatment’. Health, good 
or bad, was seen as God’s will and to be accepted 
stoically. Narratives of being a ‘good patient’ were 
linked to gratitude to the UK healthcare system, in 
direct contrast to personal experiences in Pakistan 
where access had been restricted due to cost or 
availability of quality care.  
Consequences 
As the UK becomes progressively globalised, 
healthcare practitioners, providers and policy-makers 
need to better understand the impact of culture on 
health behaviours. This research could indicate that 
for older Pakistani patients operating within a 
collectivist culture with a wide web of concern, neo-
liberally rooted public health agendas that focus on 
individualised responsibility and self-management 
strategies maybe limited in success. More authentic 
conversations about the effects of culture on 
responses to and experiences of chronic illness are 
needed.  
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Q.7 
Registration without documentation: an exploration 
of the experiences of General Practice staff 
registering new patients unable to provide 
documentation in North East London.   
Presenter: Dr Kitty Worthing 
Co-authors:  Dr Megan Clinch, Professor Anita Berlin, 
Dr Pooja Seta, Dr Isa Ouwehand 
Institutions 
Queen Mary University 
Abstract 
Problem 
NHS England guidance states that not being able to 
provide proof of address or identification for GP 
registration cannot be used as a reason to refuse 
registration. Despite this, research has found that 
patients who are unable to produce the 
documentation requested, are refused registration by 
some practices. In response to this groups such as 
Pathway, Groundswell and Doctors of the World have 
been working to support patients to register and 
provide training to GP staff. However, GP practice 
staff's experience of new patient registration 
processes has never been explored. This on-going 
qualitative study aims to better understand the 
process by which registration is refused and factors 
that operate to influence this. It explores how non-
clinical GP staff experience of and current practice 
regarding patient registration, perceptions of patients 
without documentation and obstacles to their 
registration. Also explored is participants’ ideas of 
how to improve access for this group of patients; 
aiming to produce recommendations that are 
sustainable and acceptable.  
Approach 
Thirty-three participants across three boroughs in 
North East London have taken part in focus group 
discussions or individual interviews. A initial thematic 
analysis, utilising Pierre Bourdieu’s theory of power 
and practice has been undertaken and will be subject 
to participant checking before the analysis is 
completed.  
Findings 
Key emerging themes that engender reluctance to 
register patients without documentation include: 
perceived lack of clarity of national guidance, 
perception that this patient group represent increased 
financial, clinical and administrative burden on the 
practice, concerns regarding patient & staff safety and 
illegal activity, concerns regarding specific legal or 
statutory requirements and duties and a sense of 
‘moral’ responsibility to other patients and the wider 
NHS regarding resource distribution.  
Consequences 
Much current work around improving the inclusivity 
of registration focuses on ensuring staff are aware of 
guidance, but this study reveals a picture not just of a 
lack of knowledge of guidance, but a complex set of 
factors that work to make staff reluctant to register 
patients without documents. Specific issues that need 
to be addressed in on-going advocacy and education 
initiatives, as well as by policy makers, include: a 
perceived lack of clarity of NHS England’s registration 
guidance, perceived increased administrative and 
financial pressure specific to GP practice relating to 
the registration of certain patient groups, and 
unanswered questions about the responsibility of 
individual non-clinical staff regarding new patients. 
Beyond providing ideas of how to address challenges 
for registration for patients without documents, 
further analysis of the data using a Bourdieusian 
framework aims to contribute to an improved 
understanding of how individual interactions both 
reflect, and serve to reproduce health inequalities in 
view of access, and more broadly.  
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R.1 
What is the relationship between rheumatoid 
arthritis, multimorbidity and adverse health-related 
outcomes?   
Presenter: Jordan Canning 
Co-authors:  Stefan Siebert, Bhautesh Jani, Frances 
Mair, Barbara Nicholl 
Institutions 
University of Glasgow 
Abstract 
Problem 
Rheumatoid arthritis (RA) is a common autoimmune 
inflammatory arthropathy. Multimorbidity (the co-
existence of ≥2 long-term health conditions (LTCs)) is 
highly prevalent in people with RA however, most 
research to date has generally focussed on RA and 
comorbidity (1 other LTC) rather than multimorbidity. 
This work aims to explore the existing literature to 
determine what is known about the effect, if any, of 
multimorbidity on mortality and other health-related 
outcomes (physical functioning/well-being) in people 
with RA. 
Approach 
A systematic review was conducted following PRISMA 
guidelines. Six electronic medical databases were 
searched: CINAHL, Cochrane Library, Embase, 
Medline, PsycINFO and Scopus, using a 
comprehensive search strategy. Studies were 
screened by two reviewers to identify longitudinal 
observational studies with extractable data relating to 
multimorbidity and our outcomes of interest in adults 
with RA. Studies were restricted to English language, 
full-text articles. Quality appraisal was undertaken by 
two independent reviewers using the Cochrane-
developed, QUIPS tool, and a narrative synthesis 
conducted. 
Findings 
In total, 4,772 papers were identified by the search 
strategy, with 15 studies fulfilling the criteria for 
inclusion in our review. Of these, 6 studies had all-
cause mortality as an outcome, 8 studies reported on 
a relevant health-related outcome and 1 study 
reported on both. The number of participants ranged 
from 183 to 18,485 across studies and all studies were 
conducted in developed countries with high-income 
economies between 1985-2014 with follow-up 
periods ranging from 6 months to 23 years. The mean 
age of participants ranged from 53.5 to 66.6 years old 
with the percentage of females between 60.0-84.2% 
across studies. Six studies reported a significant 
association between multimorbidity and increased 
risk of all-cause mortality in people with RA, using Cox 
proportional hazard models and Kaplan-Meier survival 
estimates. While 9 studies reported significant 
associations between multimorbidity and reduced 
functional status (measured by the Health Assessment 
Questionnaire (HAQ)) in people with RA. Three of 
these studies also reported a further significant 
association between reduced quality of life and 
multimorbidity in people with RA. 
  Consequences   
Multimorbidity in people with RA is a significant 
predictor for increased mortality and poorer health-
related outcomes. Multimorbidity should therefore be 
taken into consideration when managing RA, with 
further research required in this area to guide future 
health service design and guidelines.  
Funding Acknowledgement 
This work is supported by the Medical Research 
Council [MR/N013166/1]. 
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Abstract 
Problem 
Painful arthritis-related conditions are long-term in 
nature and often experienced alongside other long-
term conditions (LTCs). Multimorbidity, the presence 
of ≥2 LTCs, is an urgent healthcare challenge; and 
leads to increased levels of “work” or treatment 
burden for patients and healthcare providers (HCPs). 
We know relatively little about the impact of 
multimorbidity on the healthcare experiences of 
people living with persistent musculoskeletal (MSK) 
pain or rheumatoid arthritis (RA), and their ability to 
manage their conditions. Furthermore, it is unclear 
how the presence of multimorbidity in those with 
persistent MSK pain or RA influences HCP 
management approaches. Our study uses qualitative 
methods to answer: 
• How does multimorbidity affect self-
management and the capacity to cope in those living 
with persistent musculoskeletal pain or RA? 
• What are HCPs experiences of treating and 
managing patients with persistent MSK pain or RA and 
multimorbidity?  
Approach 
This study, conducted in Scotland, is ongoing. We are 
interviewing 80 patients living with persistent MSK 
pain or RA with and without multimorbidity, and 40 
HCPs. This abstract reports preliminary findings from 
interviews with 20 patients and 17 HCPs. Analysis 
draws on two inter-related theoretical frameworks - 
Burden of Treatment Theory and Normalisation 
Process Theory which focus on the ‘work’ done by 
patients and HCPs.  
Findings 
Key points in patient interviews (5 MSK pain, 15 RA), 
which describe the onerous work that patients do to 
manage their conditions, include: 
(1) planning work needed to manage medical 
appointments and medication routinely and during 
exacerbations;  
(2) challenges faced by patients with work and family 
commitments;  
(3) monitoring work required to balance multiple 
conditions. 
 
Key points from the HCP interviews (seven GPs, a 
practice nurse, a rheumatology consultant, three pain 
medicine consultants, a pain specialist nurse, a 
psychologist, a pharmacist, and two physiotherapists) 
include:  
(1) poor and limited treatment options for MSK pain; 
(2) challenge of managing pain relief and avoiding 
analgesic addiction; 
(3) crucial importance of improving patient 
understanding, managing expectations, and 
encouraging ownership;  
(4) added complexity from multimorbidity and 
associated polypharmacy;  
(5) patients’ ability to adhere to treatment is affected 
by a multitude of factors that may be personal, 
lifestyle related, social or organisational. 
 
Consequences 
These preliminary findings highlight the challenges 
faced by patients with MSK pain or RA and their HCPs, 
including the demanding work involved in monitoring 
and managing treatment, made more difficult by 
polypharmacy, work or family commitments, and 
limited treatment options available.Our findings will 
be used to inform policy and the development of 
interventions to help patients and HCPs manage 
persistent MSK pain or RA in the context of 
multimorbidity.  
Funding Acknowledgement 
This study was funded by Versus Arthritis (grant 
number 21970).  
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Abstract 
Problem 
Chronic widespread pain (CWP) has an estimated 
prevalence of 10-15%, and is associated with 
substantial disability, psychological distress and high 
health care usage. CWP is increasingly viewed as 
occurring on spectrum, with Fibromyalgia 
representing its more severe presentation. Guidelines 
advise moving away from specialist care, placing 
primary care at the centre of CWP management. 
Medical treatment options are limited; opiates and 
gabapentinoids are associated with substantial side-
effect profiles and risk of dependence. Supporting 
those with CWP to effectively self-manage is a 
priority. Our aim is to determine the effectiveness 
multicomponent self-management interventions 
specifically targeting CWP (including fibromyalgia). 
This review will form the basis of research to develop 
novel primary care-centred, person-based self-
management interventions for CWP.  
Approach 
A systematic review and meta-analysis of randomised 
controlled trials (RCTs) including adults with a 
diagnosis of CWP or Fibromyalgia, taking part in a 
multicomponent self-management intervention. We 
drew on an established definition of self-management 
as ‘a structured, taught, or self-taught course or 
intervention programme principally aimed at patients 
with the goal of improving the participants’ health 
status or quality of life by teaching them skills to apply 
to everyday’ (Miles CL, Pincus T, Carnes D et al. 2011). 
Multicomponent refers to the intervention containing 
at least two of the following components; 
psychological, mind–body therapies, physical activity, 
lifestyle and medical education. The following 
databases were searched from their inception to 
December 2017 (All searches are currently being 
updated): The Cochrane Central Register of Controlled 
Trials, MEDLINE, Embase, PsycINFO, and the WHO 
International Clinical Trials Registry. The Cochrane 
Risk of Bias tool was used to assess risk in all trials. 
The review was prospective registered (PROSPERO ID: 
CRD42018099212).  
Findings 
Thirty-eight RCTs met our inclusion criteria and will be 
included in our analysis (n= 4489). Eleven trials limited 
to trial registry only were identified and will be 
discussed. Data has been extracted and our analysis is 
on-going; full findings will be reported at the 
conference.  
Consequences 
This systematic review will provide the current state 
of the evidence for multicomponent self-management 
interventions for CWP. We will describe the format 
and components of successful interventions, and use 
the evidence to infer critical elements for a self-
management approach targeting those with CWP 
cared for within a general practice context.  
Funding Acknowledgement 
This research was part funded by Research Capacity 
Funding from Solent NHS Trust. 
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Abstract 
Problem 
The INCLUDE (INtegrating and improving Care for 
patients with infLammatory rheUmatological 
DisordErs in the community) pilot trial aimed to 
evaluate the feasibility and acceptability of a nurse-
delivered review in primary care, for people with 
inflammatory rheumatological conditions (IRCs). The 
purpose was to identify and manage common 
comorbidities including anxiety and depression, 
cardiovascular and fracture risk. The aim of this study 
was to identify the feasibility and implementation of 
the FRAX component of the review.  
Approach 
Ethical approvals obtained. Semi-structured 
interviews were conducted to explore experiences of 
participating in INCLUDE with 20 patients, the two 
nurses delivering the intervention and three General 
Practitioners (GPs) within participating practices. 
Interviews were digitally recorded, transcribed and 
anonymised.  Additionally, 24 consenting patients had 
their INCLUDE review recorded for fidelity checking, 
and extracts relating to FRAX assessment were 
transcribed for analysis. Analysis was conducted 
utilising the Theoretical Domains Framework (TDF), 
which allows for the cognitive, affective, social and 
environmental influences on behaviour to be 
examined.  
Findings 
Fidelity checks showed that FRAX was appropriately 
calculated for 22/24 patients. Consultation data 
showed that although nurses introduced the reason 
for calculating fracture risk, explanations of the 
meaning of risk were limited, and patient’s 
understanding was not always checked. Patient 
interview findings confirmed a limited understanding 
of FRAX and the subsequent outcome of the review. 
Facilitators to implementation, as identified by TDF, 
related to the domain of beliefs about capabilities and 
skills. Nurses reported confidence in undertaking 
FRAX assessments and found the FRAX tool practical 
and straightforward.Barriers to implementation 
related to the domains of memory, attention and 
decision processes, knowledge, beliefs about 
capabilities, skills, social/professional role and 
environmental context. GPs and study nurses 
reported a lack of knowledge and skills in relation to 
the identification and management of osteoporosis. 
Reasons for this included a perceived lack of 
experience, and repeated changes in clinical guidance 
making keeping up to date difficult. Opinions differed 
about whether assessment of fracture risk in people 
with IRCs was the role of primary or secondary care. 
GPs and nurses had contrasting views about the limits 
of the nurse role in communicating risk. They 
described practical barriers to using FRAX including 
the difficulty navigating between different IT systems. 
Nurses also described uncertainty over when to refer 
to the GP within the INCLUDE trial.  
Consequences 
Screening for fracture risk in people with IRCs in a 
review consultation is feasible and nurses correctly 
calculated FRAX in 22/24 consultations. Barriers to 
routine FRAX implementation for those with IRCs 
include the lack of integration into existing IT systems 
and lack of clarity over professional roles and 
boundaries.  More work is needed to explore the 
barriers and enablers of fracture risk assessment in 
primary care in order to inform the design of targeted 
interventions.  
Funding Acknowledgement 
ZP is funded by the National Institute for Health 
Research (NIHR), Clinician Scientist Award (CS-2018-
18-ST2-010)/NIHR Academy. AH is a NIHR funded 
Academic Clinical Fellow. CJ and CCG are part funded 
by the NIHR Applied Research Collaboration (ARC) 
West Midlands.  This publication presents 
independent research funded by the NIHR. The views 
expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR, or the 
Department of Health & Social Care. 
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Abstract 
Problem 
Osteoarthritis is a major cause of disability worldwide, 
but healthcare professionals often do not have the 
right words to help patients understand the condition. 
Patients can feel that their condition is being 
trivialised or can develop negative beliefs about 
osteoarthritis as a result. Self-management strategies, 
such as exercise and weight loss (if needed), are core, 
but commonly underused, management approaches. 
Within a mixed-methods project, we are developing a 
patient explanation package for osteoarthritis (PEP-
OA) to help patients’ understanding of their condition 
and make sense of suggested management 
approaches. This abstract reports findings from the 
first work-package, to establish what patients want 
and need to know about osteoarthritis, and to identify 
appropriate language, to support self-management.  
Approach 
First a mixed expert stakeholder group (health 
professionals, researchers and patients) was 
convened to discuss initial development of candidate 
explanation statements. Informed by theory, existing 
osteoarthritis statements were divided into topics 
within 11 sets and were discussed in terms of 
completeness, accuracy and preferred wording. After 
the meeting 6 stakeholders red-amber-green (RAG) 
rated each topic (red: no clear link to supporting self-
management, green: clearly linked to self-
management). Topics unanimously RAG-rated red 
were removed. Remaining topics were discussed by a 
separate patient advisory group (PAG, n=6) for further 
feedback, exclusion and refinement. Using feedback, 
the topics were developed into statements to be 
prioritised within a two-round nominal group 
technique (NGT), consensus was defined as 80% 
agreement among participants. If no consensus was 
achieved, prioritised statements were identified by 
applying a numerical weighting to ranking.  
Findings 
Ten people attended the stakeholder group. The word 
‘degeneration’ was rejected and PAG members 
rejected ‘wear and tear’, ‘loss’, ‘not inflammatory 
arthritis/osteoporosis’, ‘normal’ and technical 
descriptions involving changes in joint anatomy. The 
words ‘condition’ or ‘disorder’ and ‘movement’ or 
‘activity’ were preferred over ‘disease’ and ‘exercise’ 
respectively. Both groups conceptualised 
osteoarthritis as: not inevitably progressive; 
modifiable, and being variable between people, joints 
and over time. NGT participants (n=5) prioritised 
myth-busting statements and opposed being told 
what they already know (e.g. osteoarthritis causes 
pain). Throughout, patients and stakeholders liked 
positive statements portraying hope and the benefits 
of simple self-management strategies.  
Consequences 
These findings outline what patients want and need to 
know to understand osteoarthritis and its core 
management. Stakeholders preferred simple 
explanations which conceptualise osteoarthritis as a 
manageable and/or modifiable long-term condition. A 
conjoint analysis survey will now identify patients' 
preferences for the statements that are most helpful 
for self-management, before a core patient 
explanation of osteoarthritis for use in consultations is 
finalised.  
Funding Acknowledgement 
Acknowledgments: This abstract presents 
independent research funded by the National 
Institute for Health Research (NIHR) under its 
Research for Patient Benefit (RfPB) Programme (Grant 
Reference Number PB-PG-0817-20031). CJ is part 
supported by NIHR Applied Research Collaboration 
(ARC) West Midlands. ZP is funded by the National 
Institute for Health Research (NIHR), Clinician Scientist 
Award (CS-2018-18-ST2-010)/NIHR Academy. The 
views expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. 
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Abstract 
Problem 
Osteoarthritis (OA), a common primary care 
presentation, causes pain and can significantly impact  
quality of life. Clinical research shows that an 
empathic consultation approach can improve patient 
quality of life and satisfaction with care. Experimental 
studies have also demonstrated optimistic 
communication which conveys a positive message 
about treatment effects, can reduce patient 
experience of pain. However, there is limited 
understanding about patients’ views on these 
approaches. Empathica is an SPCR project developing 
a digital intervention to enhance practitioner skills in 
communicating empathy and realistic optimism.  
Associated with this, we sought to explore patients’ 
views on empathy and realistic optimism in primary 
care consultations. 
Approach 
Thirty-three purposively sampled patients, aged 45+ 
with hip or knee OA from primary care practices in 
Wessex participated in a semi-structured interviews, 
using  stimuli to elicit patients’ perspectives on 
Empathica-style consultations.  Fifteen participants 
watched two filmed consultations in randomised 
order, one enacting the ‘Empathica-trained’ approach 
incorporating evidence-based verbal and non-verbal 
behaviours, and the other a ‘neutral’ consultation. 
They rated each one in turn on a modified 
Consultation and Relational Empathy (CARE) scale and 
then answered a series of open-ended questions 
about the films. Eighteen participants read two 
written vignettes in a randomised order. One used 
positive messages and phrases whilst the other used 
neutral messages and phrases. Participants then 
answered a series of open-ended questions about the 
vignettes and positive messaging in primary care 
consultations more broadly.  Questionnaire data were 
analysed descriptively. Interviews were transcribed 
verbatim and analysed using thematic analysis.  
Findings 
Participants rated the Empathica-style consultation 
video more highly (mean CARE 43 vs 17) 
demonstrating enhance empathy compared to the 
neutral consultation. Participants felt the following GP 
behaviours enhanced the interaction;  showing care 
and respect, demonstrating knowledge of the patient, 
active listening, open body language and good eye 
contact. Participants identified important components 
of the positive communication approach, which 
included providing a clear rationale for management 
advice using evidence and reinforcement of the 
message. They felt effective delivery of a positive 
message in the consultation required the GP to 
communication with empathy in order to reassure the 
patient that the positive message was credible and 
trustworthy.  There was, however, some scepticism as 
to whether this approach is achievable in the time and 
resource constrained environment of NHS primary 
care. 
Consequences 
These findings highlight components of verbal and 
non-verbal empathic and optimistic communication 
that are acceptable to patients and could enhance the 
primary care consultation for OA. It is important to 
identify key elements that primary care practitioners 
could include without adding time to the consultation. 
These results have informed development of the 
Empathica intervention which aims to enhance 
practitioner empathic communication, and ultimately 
improve levels of OA pain and quality of life for 
patients.  
Funding Acknowledgement 
The EMPATHICA trial is supported by a National 
Institute for Health Research (NIHR) School for 
Primary Care Research grant (project number 389). 
The Primary Care Department is a member of the 
NIHR School for Primary Care Research and supported 
by NIHR Research funds.  HDM is funded through an 
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Abstract 
Problem 
Rheumatoid arthritis (RA) is a chronic autoimmune 
disease, resulting in painful joint pathology.  Despite 
high levels of multimorbidity (≥2 long-term conditions 
(LTCs)) in RA, most work has focused on comorbidity 
(+1 LTC) and little is known about how multimorbidity 
in RA impacts health outcomes, including 
hospitalisations.  This work aims to analyse the risk of 
and reasons for hospitalisations in those with RA and 
multimorbidity using two datasets- population-based 
and clinical.  
Approach 
We used data from UK Biobank (N=502,533 
participants) and the Scottish Early Rheumatoid 
Arthritis (SERA; N=1095) cohort to study RA and a 
count of up to 42 other LTCs at baseline. Both 
datasets were linked to Hospital Episodes Statistics 
data.  Negative binomial regression models were used 
to ascertain risk of hospitalisation (controlled for both 
lifestyle factors (smoking status, frequency of alcohol 
intake, and body mass index (BMI)) and demographic 
factors (sex, age and socioeconomic status)).  Most 
common reasons for hospitalisation were calculated 
using primary ICD-10 codes.  
Findings 
N=5658 (1.1%) of participants in UK Biobank self-
reported RA (mean age (SD), %F), whilst N=901 SERA 
(82.3%) SERA patients (mean age (SD), %F) had 
clinician diagnosed RA. In UK Biobank, of the N=5625 
RA participants with complete LTC data, N=1424 
(25.3%) reported having 0 LTCs, N=1694 (30.1%) 1 
LTC, and N=2507 (44.6%) ≥2LTCs. In SERA, N=226 
(25.1%) of participants had 0 LTCs, N=252 (28.0%) 1 
LTC, and N=423 (46.9%) ≥2LTCs.  When examining risk 
of hospitalisation, UK Biobank data showed that those 
with ≥2 LTCs and RA had a 68% increased risk of 
hospitalisation compared to those with RA alone 
(relative risk ratio (RRR) 1.68, 95% confidence 
intervals (CI) 1.55-1.80). In SERA, those with RA and 
≥2LTCs had a 31% increased risk of hospitalisation 
(RRR 1.31, 95% CI 1.07-1.63) compared to those with 
RA alone. When examining reasons for hospitalisation, 
UK Biobank participants with RA and ≥2 LTCs were 
predominantly admitted due to RA (“M06” ICD-10 
codes) and chronic kidney diseases (“N18” codes), 
whilst those with RA alone were admitted 
predominantly for RA and cancer (“C” codes). In SERA, 
those with RA and ≥2LTCs were predominantly 
admitted for respiratory disease (“J” codes), 
myocardial infarction (“I21” codes) and throat and 
chest pains (“R07” codes), whilst those with RA alone 
were predominantly admitted for myocardial 
infarction, cancer and RA.  
Consequences 
These findings suggest that multimorbidity should be 
taken into account in the management of patients 
with RA. In both the population based/clinical 
datasets, participants living with RA and ≥2 other LTCs 
were at increased risk of hospitalisation after 
controlling for demographic/lifestyle factors, although 
the risk was higher in the population-based cohort. 
There was overlap in the commonest reasons for 
hospitalisation, however cancer only featured for 
those with RA alone.  
Funding Acknowledgement 
This work was funded by a Versus Arthritis research 
grant (grant number 21970) 
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Abstract 
Problem 
Musculoskeletal (MSK) conditions are common and 
can have a significant impact on individuals and 
society. Many MSK problems are managed 
predominantly in primary care, and in the UK, these 
account for 14% of all general practice (GP) 
consultations. Evidence shows that 43-61% of the 
English population have low health literacy (HL) and 
those individuals have a significantly higher 
prevalence of osteoarthritis. Furthermore, patients 
with low HL and MSK conditions are more likely to 
have a poor prognosis, with more persistent and 
disabling pain, compared to those with adequate HL. 
Supported self-management can be effective yet it 
appears that current interventions are not meeting 
the needs of all patients. Identifying the components 
of innovative interventions designed to address this 
gap is complex. The EASIER study has drawn on a 
number of methods to identify and reach consensus 
on intervention components suitable for individuals 
with MSK conditions and varying levels of HL.  
Approach 
This is a mixed-methods concurrent-sequential study 
design consisting of four work packages (WPs). 
Findings from WP1 (secondary analysis of existing 
data to identify potential components for 
intervention(s)), WP2 (evidence synthesis of existing 
interventions) and WP3 (the views of community 
members and professionals) were synthesised and 
evidence tables produced. A stakeholder group 
meeting is planned where a Nominal Group Technique 
(NGT) will be employed to discuss the evidence tables 
and reach consensus on which intervention 
components are most suitable to form the basis of an 
evidence-based logic model for supported self-
management intervention(s) (WP4). The stakeholder 
group meeting will consist of a multi-disciplinary 
group of health care professionals (HCPs) and third-
sector workers (n=8-10), who have the expertise or 
special interest in HL and experience in dealing with a 
range of individuals with MSK conditions.  
Findings 
The data from the WPs will be synthesized coherently 
and concisely such that they are accessible and 
understandable as tables of evidence. The NGT will 
enable diverse HCPs and third sector workers to reach 
consensus on the components of interventions and 
allow for the generation of a logic model for 
supported self-management interventions.  
Consequences 
Developing interventions that are acceptable to all 
users is essential to improving patient outcomes. 
Strategies that enable conversations amongst key 
stakeholders at the design stage is critical to 
identifying and developing robust research. The key 
output of the EASIER study will be the development of 
an evidence-based logic model for self-management 
intervention(s) that will be taken forward for testing 
in subsequent work.  
Funding Acknowledgement 
The EASIER project is funded by Versus Arthritis 
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Abstract 
Problem 
First Contact Physiotherapy (FCP) is a rapidly evolving 
primary care model where expert musculoskeletal 
(MSK) physiotherapists undertake the first patient 
consultation, to enhance and expedite care and free-
up GP capacity. A three-phased evaluation of NHS 
England’s pilot of the FCP model has been undertaken 
(2018/2020). We report Phase 3, which evaluates the 
FCP model against five predefined service aims and 
twelve success criteria.  
Approach 
Phase 3 comprises a mixed-methods 24-month service 
evaluation involving 40 FCP sites across England. 
Using an online platform, patient reported experience 
and outcomes were collected immediately following 
the FCP consultation and at 1, 2 and 3-months. These 
included the Keele STarT MSK Tool, pain intensity (0-
10 NRS scale), overall MSK health (Musculoskeletal 
Health Questionnaire (MSK-HQ)), and patient 
experience measures (Friends-and-Family Test). A 
two-stage qualitative evaluation (focus groups, 
interviews and observation diaries) involved case 
studies of eight FCP services to explore views and 
experiences of FCPs, GPs, patients and practice staff.  
Findings 
Over 13 months, 2825 patients were registered as 
eligible and 24% (n=680) completed their initial 
questionnaire. Their mean age was 56.2 (14.9 SD), 
61% were female, ethnicity was 97% white, mean pain 
intensity was 6.1 (2.13 SD) and mean MSK-HQ score 
was 33.8 (9.5 SD). Duration of MSK problem (≤3 
months) was 47%, with 25% having pain >1 body 
region and 49% reporting ≥1 co-morbidity. The STarT 
MSK tool classified 29% low-risk, 58% medium-risk, 
and 13% at high-risk of persistent disabling pain. On 
data to date, two success criteria are met: 95% of 
patients receiving sufficient information on self-care, 
94% recommending the FCP to friends-and-family. 
One success criteria is not met: 29% of those in 
employment (n=388) receiving work advice (target 
75%). Currently follow-up rates at 1, 2 and 3 months 
are 62%, 62% and 57%. Interim analysis of 295 
patients at 3-month follow-up shows a 2.8 (CI 2.5,3.1) 
mean reduction in pain intensity from baseline, a 
mean 6.9 (5.7, 8.2) score improvement in MSK-HQ 
and 63% reporting overall improvement (much 
better/better) since seeing the FCP. Five themes are 
identified as important in the success of the FCP 
model from the qualitative evaluation: 
Communication (identifying important communicative 
strategies and considerations); Patient understanding 
of FCP (lack of awareness/understanding of FCP as a 
barrier to access); Embeddedness of the FCP service 
(factors which promote cultural adaptation); 
Contribution of FCP (patient and staff satisfaction, 
recognition of MSK expertise); Reconceptualising 
physiotherapy (extended skills and new models of 
care).Data collection is ongoing with full results 
available at the conference.  
Consequences 
Ahead of the UK wide FCP model scale-up, this 
evaluation shows who accesses this service, their 
short-term clinical outcomes and which success 
criteria are being met to add to the body of evidence 
to optimise FCP service design and delivery.  
Funding Acknowledgement 
We wish to acknowledge our funders: The Chartered 
Society of Physiotherapy and The Joint Work and 
Health Unit, Department for Work and Pensions. 
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R.10 
Characterising flare-ups of knee osteoarthritis in 
community-dwelling adults: who gets them and how 
long do they last?   
Presenter: Martin J Thomas 
Co-authors:  Martin J Thomas, Trishna Rathod-Mistry, 
Emma L Parry, Christopher Pope, Tuhina Neogi, 
George Peat 
Institutions 
Primary Care Centre Versus Arthritis, School of 
Primary, Community and Social Care, Keele University, 
Midlands Partnership NHS Foundation Trust, Keele 
Clinical Trials Unit, Keele University, Boston University 
School of Medicine 
Abstract 
Problem 
Acute flare-ups are experienced by a substantial 
proportion of adults with osteoarthritis (OA), but 
these events remain poorly understood. As part of a 
wider programme of research, the current study 
aimed to (i) identify participant or knee symptom 
characteristics associated with higher risk of flare-ups, 
(ii) describe the time course and consequences of 
flare-ups of knee OA to provide better information for 
healthcare professionals and patients on the likely 
short-term prognosis.  
Approach 
The ACT-FLARE study (ACuTe FLAREs in knee OA) is a 
13-week web-based case-crossover study of knee pain 
in people aged ≥40 years resident in England, with or 
without a recorded diagnosis of knee OA, and no 
inflammatory arthropathy. Participants were recruited 
from 15 general practice registers, and from the 
community via distributed flyers/posters and online 
social media advertisement. After completing a 
baseline questionnaire, participants were encouraged 
to self-report a flare-up at any time during the study 
period via the website. A flare-up was defined as the 
sudden onset of worsening signs and symptoms, 
sustained for ≥24 hours. After characterising their 
flare-up, from notification date through to flare-up 
resolution participants completed four daily questions 
about the last 24 hours: i) average pain (0-10 NRS), ii) 
level of bothersomeness, iii) pain medication use, and 
iv) whether the flare-up had resolved. Associations 
between selected participant and knee symptom 
characteristics at baseline and the occurrence of flare-
ups were estimated using Poisson regression and 
expressed as unadjusted incidence rate ratios (IRR; 
95%CI). Flare-up characteristics, course and 
consequences were analysed descriptively.  
Findings 
Of 744 participants recruited between July 2018 and 
February 2019 (mean age (SD) 62.1 (10.2) years; 60% 
female, body mass index 29.2 (5.7) kg/m2), 493 
participants reported 714 flare-ups. Among 
participants who engaged throughout study follow-
up, 242 (51%) reported ≥1 flare-up. Flare-ups were 
more common in younger ages (IRR 0.98: 95%CI 0.97, 
0.99), females (1.85: 1.43, 2.39), and those with 
severe frequent knee pain at baseline (2.06: 1.17, 
3.63). Associations with prior knee injury/surgery and 
socioeconomic status were weak or absent. Among 
those whose end dates were known, number of flare-
ups per participant ranged between 1 and 6 (mean 
(SD) 1.32 (0.64)) and median (IQR) flare-up duration 
was 5 (3, 8) days. Knee changes noticed since flare-up 
onset included: stiffness (64%), limping (58%), 
increased difficulty with everyday activities (57%), 
sleep disturbance (48%) and swelling (33%). Levels of 
pain, bothersomeness and medication usage reduced 
over the period between flare-up onset and 
resolution.  
Consequences 
Knee OA flare-ups are most commonly reported by 
working age adults, females and those with more 
persistent pain patterns. Most flare-ups appear to last 
between 3 and 8 days.  
Funding Acknowledgement 
MJT is joint-funded by a Health Education England 
(HEE) and National Institute for Health Research 
(NIHR) Integrated Clinical Academic Programme 
Clinical Lectureship (ICA-CL-2016-02-014) for this 
research project. ELP received funding from an NIHR 
In-Practice Fellowship (IPF-2014-08-03) and an NIHR 
Academic Clinical Fellowship and is currently 
supported by an NIHR School for Primary Care 
Research GP Progression Fellowship. TN is funded by 
NIH K24 AR070892, R01 AG066010 and P30 
AR072571. This conference abstract presents 
independent research funded by the NIHR. The views 
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expressed are those of the authors and not 
necessarily those of the NHS, the NIHR, HEE or the 
Department of Health and Social Care. 
 
R.11 
Psychometric evaluation of the Polymyalgia 
Rheumatica-Impact Scale (PMR-IS); a new patient-
reported outcome measure to assess quality of life in 
polymyalgia rheumatica   
Presenter: Helen Twohig 
Co-authors:  Sara Muller, Caroline Mitchell, Christian 
Mallen 
Institutions 
Keele University, University of Sheffield 
Abstract 
Problem 
Polymyalgia rheumatica (PMR) causes pain, stiffness 
and disability in older adults. It usually has a sub-acute 
onset and responds rapidly to treatment with steroid 
medication, although the initial large improvement in 
health is typically followed by longer periods of lower 
level symptoms and episodes of relapse. Steroids 
themselves cause significant morbidity and adverse 
effects have to be balanced against PMR symptoms. 
Therefore, measuring the impact of PMR and its 
associated treatments from the patient’s perspective 
is of high importance, yet there are currently no 
validated outcome measures to support patient and 
clinician decision making. We have developed a 
patient-reported outcome measure (PROM) to assess 
PMR-related quality of life. The development process 
involved qualitative interviews, iterative item 
development and application of classical and modern 
measurement theory methods. The resultant PROM, 
the polymyalgia rheumatica-impact scale (PMR-IS), 
assesses key symptoms, function, psychological well-
being and steroid side effects.  Here we present 
assessment of the construct validity, test-retest 
reliability and responsiveness of the PMR-IS.  
Approach 
People diagnosed with PMR within the last 2 years 
were identified through GP practices (and one 
secondary care site) and invited to take part. 
Participants were asked to complete the PMR-IS, the 
modified Health Assessment Questionnaire (mHAQ) 
and the Short Form-36 (SF-36) at baseline and then 
the PMR-IS, the mHAQ and a series of anchor 
questions 2-6 weeks later. Questionnaire booklets 
were sent out via a secure mailing service (CFH 
Docmail) and returned directly to the research team. 
Construct validity will be assessed by testing 
hypotheses about relationships between domains of 
the PMR-IS and the other questionnaires. Test re-test 
reliability of each domain will be assessed in the 
sample of participants who report they ‘stayed the 
same’ between the two time points on that domain in 
the anchor questions.Responsiveness will be assessed 
by testing hypotheses about relationships between 
change in scores on the PMR-IS and change responses 
on the anchor questions.  
Findings 
Data collection is underway, and we will be able to 
present results of the analysis at the meeting.  
Consequences 
The PMR-IS is a newly developed PROM to assess 
PMR-related quality of life. Evaluation of its 
measurement properties is essential prior to being 
able to promote it as a reliable, valid, responsive 
measure for use in clinical research studies and in 
clinical practice.  The availability of such a measure 
will enable the assessment of what truly matters to 
people with PMR to be incorporated into research 
into the condition and ultimately improve person-
centred care for PMR.  
Funding Acknowledgement 
This work was funded by a Wellcome Trust Doctoral 
Fellowship awarded to Helen Twohig 
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S.1 
Impact of the frequency of advice to quit smoking 
and experience of care in general practice   
Presenter: Chris Barton 
Co-authors:  Johnson George, Liz Sturgiss, Melis 
Selamoglu, Sanduni Madawala, Ron Borland 
Institutions 
Monash University, University of Melbourne 
Abstract 
Problem 
General Practitioners (GPs) have an important role in 
motivating and supporting patients who smoke to 
quit. Qualitative studies suggest that GPs hold 
concerns that conversations about smoking cessation 
may negatively influence doctor-patient relationship 
and experience of care. We conducted an online 
survey to determine if experience of care differed 
between smokers and ex-smokers and the influence 
of advice to quit smoking on experience of care and 
patient ratings of care received from GPs.  
Approach 
Current and ex-smokers (quit within the past 5 years) 
were invited to complete an online survey about 
experience of care in general practice in the past 12 
months. The survey was advertised online through 
social media across all Australian states and 
territories. Validated questions were used to assess 
patient experience of care and anticipated stigma. 
Care received from GPs was rated on a 10 point scale 
(higher scores indicated higher rating of care). 
Smokers were asked how important it was for them to 
quit, how often GPs had advised them to quit in the 
past 12 months, if they were advised in a way that 
motivated them to quit, and if they had tried to quit.  
Findings 
Respondents included n=611 current and n=275 ex-
smokers. Respondents’ ages ranged from 35-83 years 
(mean 60 ± 9.5). Relational experiences of care did not 
differ between smokers and ex-smokers (feeling 
listened to, being shown respect, having enough time 
with GP), however, smokers reported poorer access 
(p=0.042) and were more likely to delay seeking care 
from GPs (p=0.006). Smokers were more likely to 
anticipate stigma in GP clinics (p<0.001), but overall 
rating of care received from GPs did not differ 
between smokers and ex-smokers. Nearly all (85.2%) 
smokers reported that quitting was ‘important’ or 
‘very important’ to them and 64% had tried to quit in 
the past 12 months. Almost half (48.8%) reported 
‘usually’ or ‘always’ being advised to quit and 43% 
reported being advised in a way that made them feel 
motivated to try. Smokers who ‘always’ or ‘usually’ 
were advised to quit rated care from GPs more highly 
(8.1 vs 7.7/10, p=0.016). Despite this, they were more 
likely to report delaying seeking care (71.6% vs 60.3%; 
p=0.005) and higher anticipated stigma (10.4 (3.7) vs 
9.6 (3.8); p=0.004).  
Consequences 
Consistent with other studies, smokers who were 
more frequently advised to stop smoking reported 
better health care experiences and rated GPs more 
highly. Conversely, these patients were more likely to 
delay seeing their GP and anticipation of stigma was 
higher. Frequent advice to quit smoking appears 
acceptable to patients and may reflect better quality 
care more generally, however GPs should endeavour 
to provide advice and support that motivates and 
does not exacerbate feelings of shame, guilt or 
stigma.  
Funding Acknowledgement 
Shepherd Foundation, Victoria Australia. 
 
S.2 
Impact of persistent physical symptoms on the self: 
qualitative analysis of consultations and patient 
interviews.   
Presenter: Dr Kate Fryer 
Co-authors:  Kate Fryer 
Institutions 
University of Sheffield 
Abstract 
Problem 
Living well with persistent physical symptoms (PPS), 
sometimes referred to as “medically unexplained 
symptoms”, poses several challenges. In addition to 
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the symptoms themselves, the uncertain and 
contested nature of PPS means that the relationship 
between illness and identity for patient is often 
difficult. Recent research described the ‘constant 
identity negotiation’ involved in being ‘illegitimately 
ill’. Attributing PPS to psychosomatic causes or 
dysfunctional cognitions may be particularly 
threatening to self-identity.  
Approach 
Multiple Symptoms Study 3 is a multi-centre trial of an 
Extended-Role GP intervention for patients with PPS. 
It includes embedded qualitative research to 
understand how the intervention works in practice. 
This uses data from both consultation transcripts and 
participant interviews; with triangulation used to 
combine findings from these complementary data 
sources. Analysis takes an inductive approach drawing 
on phenomenology and grounded theory. Coding is 
iterative and emergent themes and 
conceptualisations are discussed in regular analysis 
meetings.Here we describe an analysis of how 
patients describe symptoms in relation to their self-
identity, which emerged from an open coding of 
consultation transcripts and participant interviews.  
Findings 
We identified three different types of relationship 
between symptoms and patient’s self-identity within 
the data. Each may have different implications for 
treatment: this is being examined in ongoing 
analysis.Symptoms with intact selfPatients describe 
their symptoms as things that happen to them, which 
have implications and make them feel a particular 
way, but without substantially affecting self-identity. 
Approaches aimed at challenging and adapting to 
symptoms (as in CBT) may be appropriate.Losing trust 
in the bodySymptoms are beyond the patient’s 
control, and the person no longer trusts their body. 
This has implications for how they feel and act, and is 
further complicated by their symptoms being 
contestable by others. Challenging beliefs and 
behaviours may further threaten the uncertain self. 
Approaches to validate the person and make sense of 
PPS may be appropriate before challenge and 
adaptation.The changed selfThe patient feels 
transformed by their illness, but the new self is not 
their “true” self or “real me”. Approaches which help 
the person re-find aspects of their “true” self may be 
an important foundation for work to adapt to and 
manage symptoms.These three relationships between 
symptoms and self appear to form a hierarchy, with 
potential implications for the content and delivery of 
care. Applying a mismatched approach may result in 
rejection of treatment by the patient.  
Consequences 
Patients indicate, through the way they speak about 
symptoms, the relationship between their symptoms 
and their self. We suggest that the patterns described 
here can help understand those relationships and has 
implications for the delivery of care to these patients.  
Funding Acknowledgement 
Multiple Symptoms Study 3 is funded by the NIHR 
Health Services & Delivery Research scheme. 
 
S.3 
How do transgender people experience their 
relationships with their GPs?   
Presenter: Adam Shepherd 
Co-authors:  Andy Guise, Benjamin Hanckel 
Institutions 
King's College London, University of Tasmania 
Abstract 
Problem 
Transgender people face well documented 
discrimination from healthcare staff which causes 
them to delay or avoid seeking healthcare in the 
future. Primary care is often the first entry into the 
healthcare system, and as a result the relationships 
people have with their general practitioner (GP) can 
impact health outcomes. Trans people, on average, 
have been found to experience greater health 
inequalities than lesbian, gay, and bisexual people. 
The Royal College of General Practitioners’ position 
statement on transgender care in June 2019 
highlighted some key issues with the current National 
Health Service (NHS) system for transgender people. 
However, there is a lack of research into trans 
peoples’ experiences of primary care, much less 
within the NHS setting. This study aimed to explore 
how transgender people experience their relationship 
with their GP and what factors contribute to this.  
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Approach 
In this exploratory study eight semi-structured, in-
depth interviews were completed face to face or over 
Skype. In-depth interviews are beneficial in 
exploratory research for understanding the contexts 
in which people live whilst their versatility enables 
participants to talk about what is important to them. 
A purposive sampling methodology was used to select 
participants registered with a GP in England, and a 
thematic analysis was carried out on verbatim 
transcripts.  
Findings 
Three main themes emerged from the interviews.  
(1) All participants had one or more long term 
conditions, but none described the care they received 
from their GPs for these as a contributing factor to 
having a meaningful relationship with their GP.  
(2) Communication was central to how participants 
experienced their relationships with their GPs. It was a 
facilitator where GPs engaged personally with 
participants and provided space for the participants to 
negotiate their needs and wants. Where there was a 
breakdown in communication due to GP’s exercising 
their professional dominance over participants, this 
became an interpersonal barrier.  
(3) Participants faced structural barriers within the GP 
practice and the wider NHS system which impacted on 
how they related to their GPs.  
A perceived lack of administrative staff training 
resulted in five participants viewing their GP practice 
as a whole more negatively, whilst the computer 
system’s inability to communicate the anatomy of 
participants’ bodies impeded care delivery.  
Consequences 
These results provide a new insight into an area 
where there is limited previous research available. 
The implications for GP practice is relate to the 
significance of communication, and the need for 
having an awareness of the structural barriers 
transgender people have to overcome when seeing 
their GP. However, as an exploratory study, these 
implications are subject to further research. With 
further research, a deeper understanding of the 
underlying processes which impact the healthcare 
experiences of transgender people can help to 
promote better health outcomes.  
S.4 
To what extent do patients and GPs have a shared 
understanding of blood testing in primary care?   
Presenter: Jessica Watson 
Co-authors:  Chris Salisbury, Willie Hamilton, Penny 
Whiting, Jonathan Banks 
Institutions 
University of Bristol, University of Exeter 
Abstract 
Problem 
Rates of blood testing are increasing in primary care, 
with significant implications for NHS costs and GPs 
workload. Increased testing rates are not mirrored by 
increased rates of disease, suggesting non-medical 
reasons such as patient or GP expectations may be 
important. There is increasing awareness about the 
importance of shared decision making in medicine, 
but most research focuses on treatment decisions 
rather than investigations. The aim of this research is 
to compare patients’ and GPs’ experience, 
expectation and understanding of testing, in order to 
improve communication and promote patient 
engagement.  
Approach 
Six general practices were recruited, reflecting a range 
of socioeconomic and demographic characteristics. 
Patients were recruited at the time of blood testing by 
phlebotomists or GPs. Qualitative interviews were 
undertaken with patients at two time points: (a) at or 
soon after their blood test and (b) after they had 
received their test results. We also undertook 
interviews with the patients’ GPs who requested the 
tests. This gave us paired data which enabled to us to 
examine areas of congruence and dissonance 
between GPs’ and patients’ expectations, experience 
and understanding of testing.  
Findings 
27 patient and 26 GP interviews have been either 
booked or completed, out of a target of 30 patients 
and 30 GPs. Early findings indicate a lack of shared 
understanding and a mismatch between patients’ and 
doctors’ expectations of testing. Patients are 
frequently unaware which tests have been done and 
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why. Patients have high expectations of tests; 
expecting them to provide diagnostic certainty 
without mistakes, whereas doctors expectations are 
more modest. Whilst doctors tend to be reassured by 
normal results, patients with ongoing symptoms may 
find normal results unhelpful. Patients’ expectations 
that tests will provide answers can be frustrated by a 
lack of communication about test results.  
Consequences 
The results have implications, not just for shared 
decision making, but more fundamentally, informed 
consent. Misunderstanding and a lack of 
communication around testing and test results can 
lead to uncertainty, anxiety and frustration for 
patients. Promoting a shared understanding and 
shared decision making could help rationalise testing, 
potentially reducing unnecessary investigations and 
improving patient-centred care.  
Funding Acknowledgement 
This report is independent research arising from 
Jessica Watson’s doctoral research fellowship 
(reference number: DRF-2016-09-034) supported by 
the National Institute for Health Research (NIHR). The 
views expressed in this article are those of the authors 
and not necessarily those of the NHS, NIHR, Health 
Education England, or the Department of Health and 
Social Care. 
 
T.1 
What do patients want to improve in their own 
general practice? Adapting discrete choice 
experiments for local use.   
Presenter: Jessica Drinkwater 
Co-authors:  David Meads, Maureen Twiddy, Anne 
MacFarlane, Ruth H Chadwick, Ailsa Donnelly, Phil 
Gleeson, Amir Hannan, Nick Hayward, Michael Kelly, 
Robina Mir, Graham Prestwich, Martin Rathfelder, 
Robbie Foy. 
Institutions 
University of Leeds, Patient Participation in Improving 
General practice (PPIG) co-research group University 
of Leeds, University of Hull, University of Limerick. 
 
Abstract 
Problem 
Patient experience data is increasingly used as a proxy 
for public voice in health care design and delivery. 
However, experience data may not reflect patient 
values, and raises questions about democratic validity: 
who decides how data are interpreted and used. An 
alternative is to ask the public about their priorities 
directly, using a discrete choice experiment (DCE). 
DCEs are commonly used to influence regional or 
national decision making. We tested the feasibility 
and acceptability of co-designing and delivering a 
locally contextualised DCE to strengthen patient voice 
when planning individual general practice service 
improvement.  
Approach 
A template DCE was co-designed as part of a 
participatory action research study. Two general 
practices and their patient participation groups (PPGs) 
agreed to adapt the DCE template (Practice 1=P1 and 
Practice 2=P2). PPG members (P1=12, P2=5) and staff 
(P1=23, P2=14) met separately to shortlist, and then 
together to vote on 24 pre-designed attributes 
(covering access, personalisation, continuity, co-
ordination, equity, and quality of care). Observational 
notes were taken at each meeting. Two DCEs were 
produced, each in three formats; online, paper, and a 
ballot box. All formats included an introduction, a 
number of choice tasks (five online, three paper, and 
one ballot box), demographic questions, a free text 
box, and an advertisement for the PPG. Choice tasks 
had five attributes and three or four levels. The online 
DCE was distributed to practice patients via text 
message. The paper and ballot box DCEs were 
distributed in the waiting room by the PPG. Data was 
analysed using mixed logit regression analysis.  
Findings 
Initially, PPG members and staff prioritised different 
attributes. After discussion and voting there was clear 
consensus on the final five attributes to use, in both 
practices.P1 attributes were listening skills; shared 
decision making; comprehensive services; 
receptionists; and complaints. 333 people completed 
the survey: 160 online (8.4% response rate (RR)); 115 
paper (83.3% RR); 58 ballot box (RR unknown). The 
most valued attribute was being listened to. P2 
attributes were clinician choice; information 
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continuity; self-management support; social 
prescribing; and appointment length. 342 people 
completed the survey: 153 online (3.8% RR); 116 
paper (85.2% RR); 74 ballot box (RR unknown). The 
most valued attributes were information continuity, 
and appointment length. Free text responses included 
both preference and experience data. In both 
practices the most frequent comments were about 
attributes not included in the DCE.  
Consequences 
It is feasible for patients and staff to co-design and 
deliver a DCE contextualised to local service 
improvement priorities that is acceptable to most 
patients. There is evidence from the free text 
comments that the choice task still lacked democratic 
validity. Further evidence is needed about whether 
preference data are more accurate or influential than 
experience data in producing patient-centred service 
improvement.  
Funding Acknowledgement 
Jess Drinkwater is funded by a National Institute for 
Health Research (NIHR), Doctoral Research Fellowship 
for this research project. This abstract presents 
independent research funded by the National 
Institute for Health Research (NIHR), UK. The views 
expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. 
 
T.2 
Participatory evaluation of a co-designed 
intervention to strengthen patient involvement in 
improving general practice.   
Presenter: Jessica Drinkwater 
Co-authors:  David Meads, Maureen Twiddy, Anne 
MacFarlane, Ruth H Chadwick, Ailsa Donnelly, Phil 
Gleeson, Amir Hannan, Nick Hayward, Michael Kelly, 
Robina Mir, Graham Prestwich, Martin Rathfelder, 
Robbie Foy. 
Institutions 
University of Leeds, Patient Participation in Improving 
General practice (PPIG) co-research group University 
of Leeds, University of Hull, University of Limerick. 
Abstract 
Problem 
Patient and public involvement in health care design 
and delivery is recognised as important 
internationally. Health policy cites the moral rationale 
for involving patients, but also claims involvement will 
result in more patient centred services, despite little 
evidence of the mechanism to achieve this. In 
England, this policy is enacted through contractual 
requirements for every general practice to involve 
patients in service improvement through Patient 
Participation Groups (PPGs). However, there are 
problems with making this routine and meaningful for 
all stakeholders. To address this policy-practice gap 
we co-designed an intervention to strengthen patient 
involvement in general practice.  
Approach 
A participatory action research study, working with a 
co-research group involving ten patients (seven core 
members), six general practitioners (two core 
members), one receptionist, and a PhD researcher, to 
evaluate a co-designed intervention. The intervention 
consists of a series of four facilitated meetings, using 
participatory methods to address power; a bespoke 
survey to address demographic legitimacy; PPG 
training focused on representational legitimacy; and a 
further facilitated meeting to develop a credible 
action plan. The intervention is being evaluated by the 
co-research group in two general practices in the 
North of England. The dataset includes two sets (PhD 
and patient co-researcher) of observational notes of 
intervention meetings and four to six follow up 
meetings (total meeting time per practice: 15 hours 
over 1 year); and semi-structured interviews with 
patients (four completed, six outstanding) and staff 
members (three completed, four outstanding) 
involved in the intervention. Data co-analysis uses 
both an inductive and deductive approach drawing on 
normalisation process theory.  
Findings 
This work is in progress. Interim analysis suggests that 
patients and staff valued working together during the 
intervention, and one practice rebranded as ‘the 
listening practice’. However, there is little evidence of 
longer term change in working relationships between 
patients and staff. Patients and staff were motivated 
by the opportunity to make patient centred services 
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changes. Unlike staff, patients were also motivated by 
the concept of working together. Both patients and 
staff lacked skills to engage with each other. Where 
individuals possessed these skills, barriers to enacting 
them included hierarchal practice structures, 
institutional norms, and societal expectations about 
the role of patients. External facilitation and 
participatory methods helped to address some of 
these barriers. A lack of reflective space during 
implementation resulted in missed opportunities to 
consolidate new long term working relationships.  
Consequences 
The intervention resulted in actions consistent with 
patient priorities for service change. However, several 
barriers have been identified that warrant further 
attention to support implementation and the scope 
for long term change in how patients and staff work 
together. The policy of mandatory patient 
involvement is unlikely to be successful unless patient 
involvement work is recognised as a separate skill set 
and adequately resourced.  
Funding Acknowledgement 
Jess Drinkwater is funded by a National Institute for 
Health Research (NIHR), Doctoral Research Fellowship 
for this research project. This abstract presents 
independent research funded by the National 
Institute for Health Research (NIHR), UK. The views 
expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. 
 
T.3 
How do lay people experience their involvement in 
research?   
Presenter: Emma Scott 
Co-authors:  Jeremy Dale, Veronica Nanton, Joelle 
Loew 
Institutions 
University of Warwick 
 
 
 
Abstract 
Problem 
Caring is an increasingly vital role in society. There are 
approx. 6.8m informal carers in the UK, providing care 
worth £130bn.  Carers face numerous challenges 
including responding to changing complex physical, 
social and psychological needs of the cared for 
person; finding and verifying relevant information and 
support; loneliness and isolation; and managing their 
own health and social needs.  Carers need access to 
support 24/7 and lack of support for carers 
contributes to unplanned hospital admissions, 
prolonged hospital stays and delays in discharging 
patients.Interventions need to meet the users needs 
in an efficient and effective manner.  Patient and 
public involvement in the development of both 
interventions and academic research is now 
considered essential to ensure that work remains 
relevant and acceptable to the intended beneficiaries. 
Understanding how non-academic, non-clinical 
partners experience this process is, however, 
relatively unexplored territory.  
Approach 
Care Companion is novel and simple to use online 
support platform for carers, which aims to strengthen 
carer resilience and sustain caring by providing 
personalised online support.  It has been co-produced 
by a panel of carers, university academics, 
representatives from local health & social care 
providers, third sector organisations and a digital 
media company.  The Carers Panel is made up of 
people with first-hand experience of providing 
informal care for a loved one and a wide range of IT 
competency.  They have been at the heart of the 
development process, ensuring that Care Companion 
meets the needs of informal carers and contains the 
features that they find relevant.Members of the 
Carers Panel, content developments and a 
representative of the digital media company took part 
in semi-structured interviews exploring their 
experience of working together to develop Care 
Companion.  
Findings 
Interviews have been completed and transcribed.  
Thematic analysis is currently underway.  
Consequences 
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A greater understanding of how non-academic, non-
clinical partners experience their involvement in 
research will enable us, as a research community, to 
better support them during this process and to 
maximise the benefits of this engagement.  
Funding Acknowledgement 
The development of Care Companion was jointly 
funded by Coventry & Rugby CCG, South 
Warwickshire CCG, Warwickshire County Council, and 
the Global Initiative Innovation Fund. 
 
U.1 
The CHIPPS study: a cluster randomised controlled 
trial to determine the effectiveness and cost-
effectiveness of independent pharmacist prescribing 
in care homes   
Presenter: Christine Bond 
Co-authors:  David Wright, Richard Holland, David 
Alldred, Carmel Hughes, Fiona Poland on behalf of the 
CHIPPS team 
Institutions 
Universities of Aberdeen, East Anglia, Leicester, Leeds, 
Belfast 
Abstract 
Problem 
Prescribing, monitoring and administration of 
medicines in care homes could be significantly 
improved. Research has identified the need for one 
person to assume overall responsibility for the 
management of medicines within each care home. 
The advent of pharmacist independent prescribers 
(PIPs) provides an opportunity for pharmacists to 
assume this role. Although this approach is being 
implemented in practice there has been no 
randomised controlled trial demonstrating its 
effectiveness.  
Approach 
The approach was to conduct a three nation 
randomised controlled trial, with internal pilot, to 
determine the effectiveness and cost-effectiveness of 
pharmacist independent prescribing in care homes 
compared to usual GP led care. The trial was designed 
following a programme of developmental and 
feasibility work conducted in accordance with the 
Medical Research Council framework for developing 
and evaluating a complex intervention. The unit of 
randomisation is a triad (a pharmacist-independent 
prescriber (PIP), a GP practice and a care home(s)). In 
the intervention group, the PIP will, for 6 months, 
collaborating with the GP: assume responsibility for 
prescribing and managing residents’ medicines 
(medication review, pharmaceutical care planning, 
prescribing and deprescribing); support the care home 
and optimise communication between the GP, care 
home, and supplying community pharmacy. The 
primary outcome is resident falls at 6 months. 
Secondary outcomes include resident health-related 
quality of life, falls at 3 months, medication burden, 
mortality and hospitalisations. A full health economic 
analysis is being undertaken. The target sample size is 
880 residents (440) in each arm) from 44 triads. This 
number is sufficient to detect a decrease in fall rate 
from 1.5 per individual to 1.178 (relative reduction of 
21%) with 80% power and an ICC of 0.05 or less. There 
is a parallel process evaluation including in depth 
qualitative interviews with stakeholders.  
Findings 
The trial has recruited to target and will complete in 
March 2020. The internal pilot study confirmed   
feasibility of the RCT and no safety concerns. Baseline 
data showed intervention and control groups are well 
matched. Characteristics of all residents recruited are: 
mean age 85 years; 30% male,;13% had capacity to 
consent; median number  medications 7; fall rate 
0.55; mean drug burden index 0.64; Charlson 
Morbidity Index 5.98; proxy EQ 5D utility score 0.32; 
Barthel index 7.51. Full trial results will be available, 
for the first time, at the ASM. Preliminary analysis of 
qualitative stakeholder interviews suggest changing 
professional roles need to be acknowledged and 
actively managed and effective communication 
systems implemented.  
Consequences 
We do not currently know the trial outcome, but 
whether or not we demonstrate a ‘positive’ finding 
based on the primary outcome, we will report new 
information on working practices, PIP roles in care 
homes and barriers and enablers to placing PIPs into 
care homes.  
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Funding Acknowledgement 
This abstract reports independent research funded by 
the National Institute for Health Research 
(Programme Grants for Applied Research, Care Homes 
Independent Pharmacist Prescribing Service (CHIPPS): 
Development and delivery of a cluster randomised 
controlled trial to determine both its effectiveness 
and cost-effectiveness, RP-PG-0613-20007). 
 
U.2 
Patient acceptability of a proposed clinical 
pharmacist-led review for persistent pain in primary 
care (PROMPPT study)   
Presenter: Nicola Cornwall 
Co-authors:  Charlotte Woodcock, Clare Jinks, Lisa 
Dikomitis, Sarah A Harrisson, Alison Buttery, Christian 
D Mallen, Julie Ashworth (on behalf of PROMPPT 
team) 
Institutions 
School of Primary Community and Social Care Keele 
University 
Abstract 
Problem 
Randomised controlled trials of complex interventions 
often fail to show an intervention effect. This could be 
due to suboptimal intervention design if the 
intervention it is not acceptable to participants 
receiving it or those delivering it. This is a problem for 
researchers and funders as it leads to poor uptake of 
interventions and high attrition rates resulting in bias 
and reduced internal validity. “Acceptability” as a 
concept is often not defined. We draw on a new 
Theoretical Framework of Acceptability (TFA) of 
health care interventions to inform development of a 
clinical pharmacist-led primary care review for 
patients prescribed opioids for persistent pain.  
Approach 
Patients in the West Midlands living with persistent 
pain (> 6 months) and taking regular opioids were 
invited to participate in face-to-face semi-structured 
interviews (n=15) to investigate acceptability of a 
proposed PROMPPT review led by clinical 
pharmacists. An online qualitative study (n=69), using 
a dedicated discussion forum which was live for 11 
weeks, was conducted  to capture the views of people 
beyond the West Midlands, and those unable or 
unwilling to participate in person.  The interview topic 
guide and online discussion questions were informed 
by TFA constructs of affective attitude, burden, 
ethicality, intervention coherence, opportunity costs, 
perceived effectiveness, and self-efficacy. Interviews 
were transcribed verbatim and online discussions 
downloaded and analysed in Nvivo12. Data were 
deductively coded onto constructs of the TFA. 
Members of the qualitative research team met 
regularly to discuss analysis decisions.  
Findings 
Data coded into all TFA constructs targeting two areas 
of intervention acceptability, namely (i) acceptability 
of seeing a clinical pharmacist for a pain review, and 
(ii) acceptability of reducing opioid medicines. For 
example, patients perceived being offered a regular 
review for persistent pain as valuable (ethicality), 
however anticipated feeling anxious about attending a 
review as they expected opioid medicines to be 
reduced or taken away (affective attitude). When 
attending the review, patients reported the need for 
clinical pharmacists to show empathy, compassion, 
and understanding (perceived effectiveness) and 
shared ways to support belief in ability to live better 
with pain (self-efficacy).  
Consequences 
Overall findings indicate elements of the proposed 
PROMPPT review to be acceptable. Pertinent for the 
developmental phase, findings also point to areas for 
improvement in order to enhance levels of 
acceptability for patients ahead of a feasibility study. 
Findings have informed PROMPPT review’s iterative 
design and illustrate the importance of evaluating 
acceptability during the earliest stages of intervention 
development.  
Funding Acknowledgement 
This research is funded by the National Institute for 
Health Research (NIHR) under its Programme Grants 
for Applied Research Programme (Reference Number 
RP-PG-0617-20005). CJ and CDM are part funded by 
the National Institute for Health Research (NIHR) 
Applied Research Collaboration (ARC) West Midlands. 
The views expressed are those of the author(s) and 
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not necessarily those of the NIHR or the Department 
of Health and Social Care. 
 
U.3 
Co-prescription of gabapentinoid and opioid 
analgesia in a general practice: evaluation of a brief 
quality improvement exercise.   
Presenter: Melissa Nagar 
Co-authors:  Melissa Nagar, Elizabeth Cottrell, John J. 
Edwards 
Institutions 
Keele University School of Medicine, Wolstanton 
Medical Centre ST5 8BN 
Abstract 
Problem 
Chronic pain is common in the UK, affecting one-third 
to one-half of the population. Patients with chronic 
pain present to their general practitioner around five 
times as often as those without. Primary care pain 
management needs to be of a high-quality to address 
this population burden. Given contact frequency, 
primary healthcare professionals are well-placed to 
deliver this. The National Institute for Health and Care 
Excellence (NICE) are producing a clinical guideline on 
chronic pain; presently there are some 
recommendations listed in the NICE Clinical 
Knowledge Summaries (CKS).We aimed to assess 
current practice of prescription of gabapentinoids 
with opioids in a single general practice against the 
NICE CKS recommendations and the impact of a brief 
practice-level quality improvement intervention.  
Approach 
We reviewed co-prescription of opioid analgesia and 
gabapentinoids in patients without active cancer 
(defined as a consultation including a Read code for 
cancer in the previous 15 months, or inclusion on the 
palliative care register). We determined the number 
of patients at 01.01.2019 who had been prescribed 
both opioids and gabapentinoids within the previous 
three months and then stratified by strong opioids 
[(dia)morphine, oxycodone, (al)fentanyl, 
hydromorphone], or tramadol, or weak opioids 
(including compound analgesics). The data were 
presented at a practice quality improvement meeting.  
It was agreed to try to stop initiating patients on 
opioid plus gabapentinoid repeat therapy without 
review and demonstration of clear functional benefit. 
Tools for non-pharmacological management were 
highlighted. Data were collected on 01.01.2020 for 
new patients (those not included in the 2019 cycle) 
only to assess whether practice had been modified 
between the time points.  
Findings 
On 01.01.2019, 127 patients were eligible for inclusion 
(without active cancer and recorded as having been 
prescribed both opioids and gabapentinoids in the 
previous three months). Of these, 18 (14%) had been 
prescribed a strong opioid, 34 (27%) tramadol (but not 
a strong opioid) and 75 (59%) other opioids. On 
01.01.2020, 111 patients in total were potentially 
eligible for inclusion, 14 (11%) of the original group 
having left the practice and 72 (56%) no longer 
receiving opioids plus gabapentinoids within the three 
months to 01.01.2020. 41 were newly eligible 
patients. Of these, five (12%) had been prescribed 
strong opioids, three (7%) tramadol, and 33 (80%) 
other opioids.  
Consequences 
Through a brief intervention, highlighting the 
problems associated with co-prescription of opioids 
and gabapentinoids and practice-based discussion of 
potential solutions, improvements in prescribing have 
been attained. Further work is needed to determine if 
these improvements can be maintained and are 
generalisable.  
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U.4 
What do the public, patients and health 
professionals think about the design of an 
intervention trial to reduce anticholinergic burden?   
Presenter: Yvonne Cunningham 
Co-authors:  Frances S Mair, Katie Gallacher, Terry 
Quinn, Karen Wood, Richard Lowrie, Graham Ellis, 
Christine Bond, Phyo Myint 
Institutions 
University of Glasgow, NHS Lanarkshire, University of 
Aberdeen 
Abstract 
Problem 
Medications with anticholinergic properties are 
prescribed in 20-30% of older people despite their 
known association with negative health-related 
outcomes. The risk varies greatly between 
medications, and accumulates with polypharmacy to 
create an anticholinergic burden (ACB). NICE 
highlights that increased ACB is associated with 
cognitive impairment and should be reduced in those 
with dementia. Here we explore stakeholder 
(patients/public/health professionals) perspectives of 
barriers and facilitators to reducing ACB. The work 
reported here is preparatory research for a proposed 
ACB deprescribing trial which aims to reduce ACB in 
an at-risk population (older people with 
multimorbidity and polypharmacy) in a primary care 
setting.  
Approach 
We undertook three focus groups and ten individual 
semi-structured qualitative interviews with 22 older 
adults with polypharmacy, as well as two focus groups 
and seven semi-structured qualitative interviews with 
a range of health care professionals (HCPs) including 
GPs, geriatricians, and pharmacists (n=16).We 
explored views about barriers and facilitators to ACB 
reduction and the design of any future ACB reduction 
trial.All focus groups and qualitative interviews were 
digitally recorded and transcribed verbatim and the 
transcripts served as the data for qualitative analysis. 
Data analysis was underpinned by Normalization 
Process Theory (NPT). NPT explains how the work of 
enacting an ensemble of tasks or practices is 
accomplished through the operation of four 
mechanisms: ‘coherence’ (sense-making work); 
‘cognitive participation’ (relationship work); ‘collective 
action’ (enacting work); and ‘reflexive monitoring’ 
(appraisal work).  
Findings 
Key “take home” messages for any future ACB 
reduction trial in the community were: (1) The public, 
patients and health professionals were generally 
positive about the possibility of running a trial of 
deprescribing (sense-making work); (2) Ensure patient 
engagement from the outset to enable concerns and 
potential pitfalls to be addressed (relationship work); 
(3) Clear communication is essential so that patients 
involved in any trial have a very clear understanding 
of the rationale and to minimise the potential for 
misconceptions about the reasons for ACB reduction 
(relationship work); (4) It would be important to 
provide access to a point of contact for patients 
throughout the life of a trial to address queries or 
concerns (enacting work); (5) Minimise the workload 
implications of any trial and use IT systems, if this 
would make the enacting work of practitioners easier 
(enacting work); (6) Pharmacists are best placed to 
carry out ACB reviews, though overall responsibility 
for patient medication should remain with the GP 
(appraisal work).  
Consequences 
These findings, together with other preliminary work 
carried out by the team provide key insights which will 
be crucial in planning and developing a large-scale RCT 
of deprescribing or medication switching that aims to 
reduce ACB in the older general population.  
Funding Acknowledgement 
This study was funded by CSO Catalyst Fund, grant 
number: CGA/18/47. 
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U.5 
Prescribing at 95+: findings from the Newcastle 85+ 
Study   
Presenter: Laurie Davies 
Co-authors:  Andrew Kingston, Adam Todd, Barbara 
Hanratty, Newcastle 85+ Study Team 
Institutions 
Newcastle University, Population Health Sciences 
Institute 
Abstract 
Problem 
Previous research has described prescribing amongst 
nonagenarians but little is known about their 
prescribing within the UK, despite those aged 90+ 
being a rapidly growing subpopulation. This study 
aims to characterise prescribing amongst 95-year olds 
using data from the Newcastle 85+ Study.  
Approach 
The Newcastle 85+ Study is a prospective cohort of 
people living in north east England, who were born in 
1921.  Amongst its participants surviving to 95 years 
of age, the prevalence of polypharmacy and individual 
medications will be analysed cross-sectionally using R-
3.5.0.  
Findings 
The prevalence of polypharmacy, and the most 
commonly prescribed medications, will be presented 
through tables.  
Consequences 
Examining medication patterns and features in a 
cohort of 95-year olds may help to identify 
inappropriate prescribing. This will support avoidance 
of adverse outcomes, and inform future investigation 
of clinical data sets to better understand how we can 
optimise medical intervention in the very old.  
Funding Acknowledgement 
This work presents independent research funded by 
the National Institute for Health Research School for 
Primary Care Research (NIHR SPCR). The views 
expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the 
Department of Health. The Newcastle 85+ Study has 
been funded by the Medical Research Council, 
Biotechnology and Biological Sciences Research 
Council, the Dunhill Medical Trust and the National 
Institute for Health Research School for Primary Care 
Research. Parts of the work have also been funded by 
the British Heart Foundation, Unilever Corporate 
Research, Newcastle University, NHS North of Tyne 
(Newcastle Primary Care Trust).  Mortality data were 
obtained from NHS Digital.  We acknowledge the 
operational support of the North of England 
Commissioning Support Unit, the National Institute of 
Health Research Clinical Research Network North East 
and North Cumbria, local general practitioners and 
their staff. We thank the research nurses, laboratory 
technicians, data management and clerical team for 
their work throughout, as well as many colleagues for 
their expert advice. Thanks are due especially to the 
study participants and, where appropriate, their 
families and carers. 
 
U.6 
Should clomifene citrate be prescribed in primary 
care: an in-depth interview study.   
Presenter: Heather Garthwaite 
Co-authors:  Scott Wilkes, Jane Stewart 
Institutions 
University of Sunderland 
Abstract 
Problem 
Clomifene citrate has long been considered the first-
line medical treatment for fertility issues associated 
with polycystic ovary syndrome (PCOS).  Twenty years 
ago, it was commonly prescribed in primary care.   
Currently, only 250 prescriptions are issued by GPs in 
England each month.  Guidelines do not specifically 
say where clomifene should be prescribed.  NICE 
CG156 does advise follicular tracking using 
transvaginal ultrasound (TVUS) during the first cycle of 
treatment, suggesting that management in specialist 
care may be more suitable.  However, follicular 
tracking is often not practised by fertility specialists, 
and so the management of patients treated with 
clomifene may not differ much between primary care 
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and specialist services.The aim of this study was to 
explore the preferences of patients, GPs and fertility 
specialists in terms of where clomifene is prescribed.  
Approach 
We conducted in-depth interviews with three cohorts: 
patients (n=10), fertility specialists (n=7) and GPs 
(n=9).  Recruitment was an iterative process, guided 
by ongoing thematic analysis.  
Findings 
While all three cohorts acknowledged that receiving 
clomifene from the GP might be quicker and easier, 
there was an overall preference for an expert input 
and support from a fertility clinic.  There was also 
emphasis on optimising communication and timely 
referral between primary and specialist care.None of 
the GP participants had recent experience of 
prescribing clomifene.  Several said they would 
consider prescribing if robust guidelines and 
education were in place, however they recognised 
their limited exposure to fertility issues and expressed 
concerns about increasing workload and restricted 
time in consultations.  
Consequences 
The value of a specialist input was a common theme 
that resonated throughout the three cohorts.  Current 
guidelines should be modified to standardise practice 
in terms of where clomifene is prescribed and how it 
is monitored, and to streamline the referral process 
from primary to specialist care for patients with PCOS-
related subfertility.  
Funding Acknowledgement 
Health Education England (North East) 
 
 
 
 
 
 
 
U.7 
What are the risks of adverse outcomes associated 
with polypharmacy?   
Presenter: Peter Hanlon 
Co-authors:  Peter Hanlon, Bhautesh Jani, Guy 
Rughani, Barbara Nicholl, David McAllister, Frances 
Mair 
Institutions 
University of Glasgow 
Abstract 
Problem 
Polypharmacy, the use of multiple medications, is 
increasing in prevalence. Many drug treatments, 
indicated for individual conditions, carry similar 
potential risks and are often used in combination. The 
degree of risk associated with these combinations is 
often unclear. This study aims to assess risk associated 
with taking multiple medications with similar adverse 
side effect profiles.  
Approach 
We used data from SAIL databank (n = 1,175,826 aged 
≥40, using primary care records) and UK Biobank (n = 
502,533, age 37-73, using baseline assessment data). 
The Scottish Polypharmacy Guideline was used to 
identify medications associated with six potential 
adverse outcomes (fall or fracture, constipation, 
urinary retention, CNS depression, bleeding, and 
acute kidney injury (AKI)). Outcomes were identified 
using Hospital events, identified using ICD-10 codes 
from linked Hospital Episode Statistics. For each 
individual, we then calculated the number and type of 
medications associated with each adverse side effect 
taken at baseline. Cause specific Cox-Proportional 
Hazards models were used to assess the risk of each 
outcome associated with number of medications with 
similar adverse side effect profiles (0, 1, 2, ≥3). We 
also tested each combination of 2 medications taken 
by >100 people. Multi-state Weibull models used to 
predict 5-year risk associated with number of 
medications across a range of ages. All models 
adjusted for age, sex, deprivation and multimorbidity 
count.  
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Findings 
Increasing numbers of medications with similar 
adverse side effect profiles was associated with falls 
(hazard ratio 1.13 (1.11-1.16) for ≥3 medications 
compared to 0 in SAIL), faecal impaction (1.17 (1.13-
1.21)), urinary retention (2.21 (2.05-2.38)), delirium 
(1.86 (1.81-2.07)), bleeding (1.93 (1.81-2.07)) and AKI 
(2.97 (2.86-3.09)). Effect sizes were similar for UK 
Biobank. For each outcome, the risk increased with 
age, meaning that the difference in absolute risk 
associated with medications was higher for older 
people. For example, at age 50 the 5-year AKI risk 
associated with 1 and 3 or more medications linked 
with AKI was 1.2% (1.0-1.4) and 3.6% (3.4-3.8), 
respectively. At age 80 the risk was 6.8% (6.5-7.0) for 
1 medication and 12.9% (12.4-13.5) for 3 or more 
medications. When comparing pairs of medication 
with similar adverse outcomes, the range of risk 
associated with different combinations of medications 
was wide (e.g. HR 4.17 (2.93-5.93) for delirium with 
opiates and benzodiazepines in combination, while 
many other combinations had null effect).  
Consequences 
Taking multiple medications with similar adverse side 
effect profiles is associated with higher risk of related 
outcomes. However, in absolute terms, this risk is far 
greater in older people. Different combinations of 
medication are also associated with markedly 
different levels of risk. These is therefore potential for 
alerts within electronic healthcare systems to 
incorporate data on magnitude of risk and better 
inform prescribing decisions.  
Funding Acknowledgement 
Peter Hanlon is funded by a Medical Research Council 
Clinical Research Training Fellowship 
 
 
 
 
 
 
U.8 
What is the Prevalence of Potentially Inappropriate 
Prescribing (PIP) in Middle-Aged Adults in South 
London?   
Presenter: Aman Khatter 
Co-authors:  Patrick, Redmond 
Institutions 
King's College London 
Abstract 
Problem 
PIP refers to prescribing medications which may be 
non-evidence-based, have a higher chance of risk to 
patients than benefit or may not be cost-effective 
(Mahony and Gallagher, 2008). Research has primarily 
focused on PIP in older adults (≥65 years) and has 
consistently found that a substantial number of 
prescriptions in primary care may be potentially 
inappropriate. Polypharmacy, strongly associated with 
multimorbidity, is a key determinant of PIP in older 
adults. Research suggests that both polypharmacy and 
multimorbidity are also prevalent in middle-aged 
adults (45-64 years), yet there is a paucity of research 
on the prevalence of PIP within this age group 
(Barnett et al., 2012; Cassell et al., 2018). The 
PRescribing Optimally in Middle-Aged People’s 
Treatment (PROMPT) criteria were developed for this 
purpose (Cooper et al., 2014) The primary aim of this 
study was to calculate the prevalence of the top three 
PROMPT criteria (as per Cooper et al. (2016)) in South 
London, an area not yet studied:- Strong 
opioids should not be prescribed without the co-
prescribing of at least one laxative- Proton pump 
inhibitors (PPIs) should not be prescribed at doses 
above the recommended maintenance dosage for 
greater than eight weeks- Benzodiazepines 
should not be used for greater than four weeksThe 
secondary aim is to to examine which patient and 
practice factors are associated with PIP.  
Approach 
A retrospective cross-sectional study was conducted 
using data from Lambeth DataNet (LDN) in South 
London (42 general practices, N=342,046). 
Prescribing, demographic and coding data were 
extracted for all those aged between 45-64 years who 
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were also administered one or more prescriptions 
during the study period of January 1st to December 
31st 2017. Descriptive analysis of the data, including 
calculation of the percentage prevalence of the three 
PROMPT criteria, are reported. Adjusted logistic 
regression will be performed to investigate the 
association between PIP and polypharmacy, 
multimorbidity, deprivation, practice variation, gender 
and age group.  
Findings 
This study included 47,775 patients. 17.3% of the 
study population have been exposed to at least one 
PIP, the most common criterion being PPIs (12.1%), 
followed by strong opioids (5.9%) and 
benzodiazepines (2.6%). Logistic regression analysis 
and adjustment for covariates is underway.  
Consequences 
The prevalence of PIP calculated is similar to other 
studies internationally (Cooper et al., 2016; Moriarty 
et al., 2016). PIP has been associated with adverse 
drug events and increased costs from subsequent 
hospitalisation. Given the prevalence of PIP in middle-
aged adults, there may be a significant number of 
patients exposed to avoidable, costly adverse drug 
events. It also implies that prescribing quality may be 
an issue in South London. Efforts should be made to 
reduce and ultimately prevent PIP in middle-aged 
adults.  
Funding Acknowledgement 
No Funding 
 
U.9 
Can a proposed risk assessment and communication 
tool help New Zealand general practitioners and 
patients?   
Presenter: Sharon Leitch 
Co-authors:  Tim Stokes, Alesha Smith 
Institutions 
University of Otago, Centre for Health Systems and 
Technology 
 
Abstract 
Problem 
Participating in shared decision-making, 
understanding the rationale for treatment, and being 
able to identify potential side effects can maximise 
wellness for patients across the life course. However 
these tasks are difficult due to structural barriers, 
language, cultural barriers, bias, and limited resources 
appropriately tailored for the health literacy of most 
patients. These factors contribute to health inequity 
based on ethnicity and socioeconomic disadvantage, 
which is widespread in Aotearoa New Zealand (NZ). 
Decision support tools can address these issues. A 
novel decision support tool was proposed to alert 
prescribers of patients at risk of medication harm and 
provide tailored risk information for patients. It aims 
to facilitate discussion about medications and support 
informed decision-making with patients and their 
whānau (family). This early phase co-design research 
aims to determine what GPs and patients think about 
the proposed tool, what factors they felt would 
increase its utility and avoid increasing health 
inequity.  
Approach 
Fifteen patients (five Māori, five Pasifika and five NZ 
European) and nine GPs (two Māori and seven 
European) prospectively evaluated the proposed tool. 
Semi-structured interviews were based on a topic 
guide informed by Normalisation Process Theory 
(NPT). A deductive thematic analysis was conducted 
into the relevant NPT domains.  
Findings 
Three themes were identified. Theme 1 investigated 
participants’ understanding of prescribing safety, 
medication harm and risk; this is based on experience. 
Patients want comprehensive information about their 
medications and potential risk, but doctors find it 
difficult to communicate that information.  Patient 
participants were keen to actively participate in 
shared decision making about their healthcare, 
whereas doctors described a wider range of interest in 
patient participation. Theme 2 explored what 
participants thought about a prescribing decision 
support tool; they were cautiously optimistic, but 
worried about potential harm arising from its use. 
Participants identified both requirements for the tool 
and features to avoid. Theme 3 describes the 
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collective action required for successful 
implementation of the tool; namely, culturally safe 
and trustworthy doctor-patient relationships. Use of 
Māori and Pacific languages in the proposed tool may 
enhance engagement and understanding. Patients 
and general practitioners provided different 
perspectives when prospectively evaluating the 
proposed risk assessment and communication tool. 
NPT provided a comprehensive theoretical framework 
to conduct this evaluation. This co-design research 
identified important pre-requisites for the tool and 
features to avoid, as well as several novel ideas for the 
proposed tool.  
Consequences 
Co-designing interventions tailored for the needs of 
different groups may reduce barriers to receiving 
healthcare and may reduce inequities arising from use 
of technological interventions. A multidimensional 
approach is required to reduce health inequities, 
founded on culturally safe and trustworthy 
relationships.  
Funding Acknowledgement 
Health Research Council of New Zealand 
 
U.10 
Prescribing of Long-term Antibiotic to Adolescents in 
Primary Care: a Retrospective Cohort Study   
Presenter: Mark Lown 
Co-authors:  Sam McKeown, Beth Stuart, Nick Francis, 
Miriam Santer, George Lewith, Fhanzhong Su, Michael 
Moore, Paul Little 
Institutions 
Primary Care & Population Sciences, Faculty of 
Medicine, University of Southampton, Aldermoor 
Health Centre, Southampton SO16 5ST, Cardiology 
and Electrophysiology, Southampton General 
Hospital, Tremona Road, Southampton 
Abstract 
Problem 
Antimicrobial resistance (AMR) is a major threat to 
global health as new resistance mechanisms emerge 
and spread globally. Unnecessary and inappropriate 
use of antibiotics promotes the emergence and 
spread of resistant bacteria. Lower doses and longer 
durations of antibiotic therapy are linked with 
increased risk of AMR. Long-term antibiotics are 
commonly used for the treatment of acne and 
prophylaxis of urinary tract infection. As acne is 
common in adolescence and oral antibiotics are the 
most common acne-related medication prescribed, 
we chose to determine the rates and trends and 
overall burden of long-term antibiotic prescriptions in 
an adolescent cohort in primary care in Hampshire 
UK.  
Approach 
To describe the prescribing of long-term (28 days or 
more) antibiotics in a cohort of 11-18 year olds, 
including trends over time and comparisons with 
acute antibiotic prescribing using primary care data 
for participants born between 1979 and 1996 who 
attended one of the GP surgeries included in the Care 
and Health Information Analytics database at least 
once during adolescence (11-18 years).  
Findings 
We identified 1,703,786 antibiotic prescriptions for 
320,722 participants. Total antibiotic prescriptions 
increased from around 212 per 1000 person years in 
1998 to just under 420 in 2012 and declined to around 
361 in 2017. More than 15% of prescriptions were for 
long-term antibiotics (≥28 days). Long-term antibiotic 
prescribing resulted in a similar magnitude of 
antibiotic exposure (days of use) as acute antibiotic 
prescribing in this cohort.  
Consequences 
Adolescents’ and young adults’ exposure to antibiotics 
comes just as much from prescribing of long-term 
antibiotics as it does from prescribing of acute 
antibiotics. Urgent action is needed by to curtail the 
use of long-term antibiotics, and promote alternative 
management strategies.  
Funding Acknowledgement 
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Abstract 
Problem 
Increasing numbers of older people are taking many 
different medications. The number of older people on 
five plus medications has increased from 12 to nearly 
50% over 20 years. Managing complex regimens can 
be very challenging for older people, family carers and 
primary care clinicians. There are key gaps in 
understanding how, why and for whom complex 
medication management works and from this, how 
best to improve practice and outcomes. MEMORABLE 
(MEdication Management in Older people: Realist 
Approaches Based on Literature and Evaluation) was 
funded by the NIHR and aimed to address these gaps 
(PROSPERO registration: 2016:CRD42016043506). Key 
aims were:1. To understand causal paths relating to 
medication management. 2. To develop a framework 
for an intervention(s) to optimise medication.  
Approach 
Realism analyses and interprets multiple sources of 
evidence to understand what works, for whom in 
what circumstances. As such it is ideal to understand 
how complex interventions work, or not. Following 
RAMESES (Realist And Meta-narrative Evidence 
Syntheses: Evolving Standards) guidelines, 
MEMORABLE involved three work packages:  
1. Realist review: focused on 24 articles on 
medication management that explore causality;  
2. Realist evaluation: 50 realist-informed 
interviews with older people, family carers and 
practitioners, exploring and explaining their 
experiences; and  
3. Synthesis and theorising the outputs from 1 
and 2.  
 
Findings 
Medication management is a complex 
implementation process that can be mapped onto five 
separate but linked stages: 
• Three individual stages where the older 
person, sometimes with help from a family carer, fits 
medication into their daily lives, balancing routines, 
risk and coping with any burden; and 
• Two interpersonal stages where the older 
person engages with a practitioner, again sometimes 
with a family carer, sharing decisions about diagnoses 
and medications.  
Using Normalisation Process Theory as an explanatory 
‘lens’ we identified four key steps in each stage:  
1. Making sense: information, clarification.  
2. Taking action: shared decision making.  
3. Reflection and monitoring. 
4. Building enduring collaborative relationships 
underpinned by trust.  
 
To deepen our understanding of what it means for an 
older person to take medications, a detailed analysis 
of the Reviewing/reconciling medications stage was 
conducted and five burdens that needed addressing 
identified: ambiguity, fragmentation, unfamiliarity, 
concealment, exclusion. MEMORABLE established a 
burden-focused, transferable theoretical framework 
to explore and explain the complexity of medication 
management, directly applicable to the experiences of 
older people, family carers and primary care staff.  
Consequences 
Older people find managing complex medication 
regimens a burden. Primary care staff need to work 
with older people and family carers to reduce the 
burden from medication. Two interventions that 
might potentially optimise medication management 
were identified: a tool to identify older people 
struggling and individualised information.  
Funding Acknowledgement 
NIHR (HS&DR) 
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Abstract 
Problem 
NICE define medication review as a “structured, 
critical examination of a patient’s medicines with the 
objective of reaching an agreement with the patient 
about treatment, optimising the impact of medicines, 
minimising the number of medication related 
problems and reducing waste”. Within NICE guidance 
for medicines optimisation, regular medication review 
is recommended as a key priority for implementation 
and a mechanism for making medicines optimisation 
part of routine practice. Despite the guidance, there is 
still a lack of understanding about what constitutes a 
clinical medication review. Practical and detailed 
descriptions for what a clinical medication review 
should involve and how it should be delivered in 
clinical practice are lacking. The aim of this study was 
to; i) identify the ‘active ingredients’ of a medication 
review, described in trials aimed at improving 
medication safety and efficacy, when compared with 
usual care; and ii) develop a model of medication 
review for use in clinical practice.  
Approach 
The starting point was a systematic review published 
in 2017 (Huiskes VJ. BMC Fam Pract) summarising the 
evidence for medication review as an isolated short-
term intervention (as performed in clinical practice). 
An updated literature search, using the same search 
data sources and strategy was performed. Selection 
criteria included RCTs with adult participants (≥18 
years), involving a medication review intervention 
operationalised as a single, short-term intervention, 
delivered by a healthcare professional and involving 
the patient, within which all medicines used by the 
patient were considered. Trials in a palliative care 
setting were excluded. Titles and abstracts were 
screened, and full-text articles were considered by 
two reviewers independently. Data related to the 
characteristics of the intervention were extracted and 
analysed thematically to develop a framework to 
classify the components and functions (i.e. the 
ingredients) of the medication review strategies used. 
Outcomes investigated in each trial were also 
extracted.  
Findings 
Overall, 1498 papers were identified and 31 were 
included. The ingredients of the medication review 
strategies of included trials have been classified. 
Outcomes have been organised into the six categories 
(drug efficacy, treatment safety, service use, cost, 
patient experience, mortality). Cross tabulation 
analysis of ingredients per trial according to each 
outcome is being conducted. A development group 
comprising the investigators and external advisers 
representing a range of stakeholder perspectives will 
be convened to review and synthesise the findings of 
the systematic review and develop a comprehensive 
and systematic approach to medication review.  
Consequences 
A medication review model for use in a routine clinical 
practice setting will be of use to healthcare 
professionals who have roles in medicines 
optimisation; help to improve the consistency, 
transparency and quality of the medication review 
process; and encourage routine and improved 
dialogue between patients and prescribers around the 
use of medicines.  
Funding Acknowledgement 
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Abstract 
Problem 
Routine identification of older people living with 
frailty has become integral to primary care medicines 
management strategies, driven by the NHS Long Term 
Plan. Primary Care Networks (PCNs) will use existing 
tools to stratify patients by frailty severity, proactively 
targeting the most severe for medication reviews. A 
priority area is the review of anticholinergics (ACs); 
medicines which block the neurotransmitter 
acetylcholine in the brain and peripheral nervous 
system. They are commonly prescribed and are 
indicated for a range of conditions, and although they 
can have positive outcomes in older people, growing 
evidence suggests associations with cognitive and 
physical dysfunction, falls, hospitalisation and even 
death. Older people living with frailty are likely to be 
more susceptible to the adverse effects of AC 
medicines, however this has been understudied, and 
little is known about the extent of these associations 
in this syndrome. Similarly, it is unknown whether 
frailty severity modifies risks of outcomes when 
exposed to ACs. The aim of this systematic review is to 
identify, appraise and synthesise existing literature in 
this field, with a view to answering the following 
research question: what are the associations between 
AC medication exposure and adverse health outcomes 
in older people living with frailty?  
Approach 
MEDLINE, CINAHL, Embase, Web of Science, PsycINFO 
and The Cochrane Database of Systematic Reviews 
were searched, from inception to July 2019. Search 
terms represented three domains: 1) aged 
participants 2) AC medicines and 3) observational 
studies. Studies were selected if participants were 65 
and over and exposed to ACs, deemed to be living 
with pre-frailty/frailty, and where clinical outcomes 
were measured. Screening of papers, data extraction 
and quality appraisal were performed by two 
independent reviewers. Disagreements were resolved 
by a third reviewer or consensus-based discussion. 
Citation analysis was conducted using Publish or 
Perish software and Web of Science.  
Findings 
Titles and abstracts of 12,070 unique papers were 
screened, identifying 61 papers for full-text review. 12 
papers met the inclusion criteria and were subject to a 
narrative synthesis. Interim findings are that AC 
exposure can be associated with adverse outcomes in 
older people living with frailty; particularly falls, 
physical dysfunction and mortality, however, the risk 
modifying role of frailty is unclear. Inconsistencies in 
how studies measure AC exposure and frailty, and the 
lack of studies designed specifically for frail 
populations, impairs the generalisability of the 
findings.  
Consequences 
Although early findings show some associations, there 
are deficiencies in research which can support reliable 
and clinically meaningful conclusions in this area. As 
frailty stratification is now embedded within 
medicines management strategies, it is essential that 
the use of ACs in this syndrome is better understood, 
particularly with regards to whether stratifying by 
frailty severity for targeted medication reviews is a 
clinically useful approach.  
Funding Acknowledgement 
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Abstract 
Problem 
Antimicrobial resistance is recognised as a global 
threat to public health, and there is a need for 
improved stewardship of existing medicines. One 
approach to reducing antibiotic consumption in 
primary care is delayed (or ‘back-up’) prescription. 
The clinician prescribes antibiotics, but the patient is 
advised to delay initiating treatment. This has shown 
to be effective in reducing consumption without 
increasing complication rates. However, despite its 
inclusion in guidelines since 2008, this strategy is not 
widely used in the UK. Although the prescribing 
decision is made by the GP, the expectations of the 
patient may influence that decision. Our work aimed 
to identify factors influencing preferences among the 
UK public for delayed prescription, and understand 
their relative importance, to help improve 
implementation of this prescribing option.  
Approach 
We conducted an online choice experiment in two UK 
general population samples: adults, and parents of 
children under 18. We used the example of a 
respiratory tract infection (RTI) - a common reason for 
GP consultations and a major contributor to antibiotic 
prescribing. Respondents were presented with twelve 
scenarios in which they, or their child, might need 
antibiotics for an RTI, and asked to choose either 
immediate or delayed prescription. Scenarios were 
described by seven attributes (including symptoms, 
duration, and the format of the delayed prescription), 
allowing exploration of trade-offs between them. 
Preferences were modelled using mixed-effects 
logistic regression.  
Findings 
The survey was completed by 802 adults and 801 
parents. In the adult sample the probability of 
choosing delayed prescription was 0.53 (95% CI 0.50-
0.56) for a chesty cough and runny nose, compared to 
0.30 (0.28-0.33) for a chesty cough with fever, 0.47 
(0.44-0.50) for sore throat with swollen glands and 
0.37 (0.34-0.39) for sore throat, swollen glands and 
fever. Probabilities were similar for parents 
considering treatment for a child.The most important 
determinant of choice was symptom severity, 
especially for cough-related symptoms. Respondents 
were less likely to choose delayed prescription with 
increasing duration of illness, and if they had to return 
to the practice to pick up the prescription. Parents 
differed from the adult sample in giving higher 
weighting to the duration of illness. Females were 
more likely to choose a delayed prescription than 
males, and were particularly likely to do so for minor 
cough symptoms. Older people, those with a good 
understanding of antibiotics, and those who had not 
used antibiotics recently, showed similar patterns of 
preferences.  
Consequences 
Delayed prescription appears to be acceptable to 
patients. Certain groups appear to be more amenable 
to delayed prescription, suggesting opportunities for 
increased use of this strategy. Prescribing choices for 
sore throat may need additional explanation to 
ensure patient acceptance, and parents in particular 
may benefit from reassurance about the usual 
duration of these illnesses.  
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Abstract 
Problem 
Adverse drug reactions (ADRs) are associated with 
adverse outcomes for patients including emergency 
admissions. Older people are vulnerable to ADRs due 
to ageing-related physiological changes and increasing 
multimorbidity and polypharmacy. While some ADRs 
can be prevented, identifying those most at risk is 
challenging and there is limited primary care research 
to support this. This study aimed to examine patient 
characteristics associated with ADRs in a prospective 
cohort of older community-dwelling adults.  
Approach 
Study design and participants: Prospective cohort 
study (2010-2016), 904 community-dwelling adults 
aged ≥70 years taking ≥1 regular medication recruited 
from 15 general practices. Outcome measures: review 
of GP medical record, detailed patient questionnaire, 
and linked dispensed medications from a national 
pharmacy claims database. Baseline patient 
characteristics: age, sex, deprivation, health 
insurance, marital status, number of drug classes, 
medication adherence (Medication Possession Ratio) 
and multimorbidity (Charlson Comorbidity Index). 
Primary outcome: ADRs, measured by GP medical 
record review for the six-year follow-up period. ADR 
severity: mild-no treatment required, moderate-
required treatment or resulted in non-permanent 
disability, severe-resulting in permanent 
disability/death. Statistical analysis: Descriptive 
statistics and logistic regression (Odds Ratios [OR], 
95% Confidence Intervals [CIs]) are presented.  
Findings 
Of 904 study participants, median age was 78 years 
(Interquartile Range [IQR] 73, 81), 489 (54%) were 
female with a median of 6 regular drugs (IQR 3, 8). A 
total of 205 (23%) participants experienced ≥1 ADR 
with 61 (7%) experiencing ≥2 ADRs. Of 266 ADRs 
identified, 236 (88%) were mild, 28 (11%) moderate 
and 2 were severe. A total of 26 ADRs (10%) resulted 
in an emergency admission. Cardiovascular system 
drugs resulted in 30% of all ADRs. In multivariable 
analysis, female sex (OR 1.7, 95% CI 1.2-2.5 p 0.003) 
and being in receipt of 5-10 drug classes (compared to 
<5) (OR 1.8, 95% CI 1.2-7.4 p 0.003) and >10 drug 
classes (OR 2.0, 95% CI 1.1-3.7 p 0.017) were 
associated with ADRs.  
Consequences 
ADRs are common in older people attending general 
practice with one in four study participants 
experiencing at least one ADR. One in 10 identified 
ADRs resulted in an emergency admission. 
Cardiovascular drugs were most commonly 
implicated, while females and those with 
polypharmacy were more likely to experience an ADR. 
This study highlights the importance of proactive 
medication review for older people taking multiple 
medications to reduce their risk of ADRs. Future 
research could examine risk stratification to identify 
those older people at highest risk of experiencing an 
ADR and consider strategies to reduce the overall 
drug burden including dose reduction and 
deprescribing.  
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Abstract 
Problem 
Over 23 million opioid prescription items were 
prescribed in English primary care in 2018-2019 and 
the levels of prescribing are not distributed equally 
across regions and populations. A greater 
understanding of the geographical differences and 
social drivers of opioid prescribing is needed to guide 
policy responses and interventions. The aim of this 
study is to explore regional variations in opioid 
prescribing in England and the role of socio-economic 
deprivation in driving inequalities in opioid 
prescribing.  
Approach 
Cross-sectional study using national prescription data 
from primary care settings. The prescribing of opioids 
in each general practice was quantified by Defined 
Daily Doses (DDDs) and then attributed to 32,844 
Lower Layer Super Output Areas (LSOAs), the 
geographical units representing approximately 1,500 
people. Linear regression was used to model the 
effect of socio-economic deprivation, measured using 
the Index of Multiple Deprivation (IMD) 2019 
quantiles, on levels of prescribing, measured by 
DDDs/1,000 populations/day. The model accounted 
for the proportion of females and people over 65-
year-old, rurality/urbanity classification of the area, 
and prevalence of cancer, palliative care, depression, 
severe mental illness (SMI), rheumatoid arthritis, and 
obesity. Within higher organisational areas (Clinical 
Commissioning Groups, CCG), adjusted DDD estimates 
were obtained and compared at each deprivation 
level. 
 
Findings 
In total, 5,350,151,699 DDD of opioids were 
prescribed. Prescribing of opioids was not distributed 
randomly between LSOAs and varied between 4 and 
1,905 DDD/1000 population/day. On average, 93.77 
(SD: 1.90, p < 0.001) more DDD/1000 population/day 
were prescribed in the most deprived areas compared 
to the least deprived areas. Prevalence of cancer and 
SMI were negatively associated with opioid 
prescribing, and the remaining conditions had a 
positive association. Smaller LSOAs and LSOAs with 
smaller proportion of females prescribed fewer 
opioids. A higher proportion of population over 65 
was associated with higher prescribing. On average, 
opioid prescribing was 33.6 DDD/1000 
populations/day (SD: 2.16, p < 0.001) higher in urban 
compared to rural areas. Within individual CCGs, the 
difference between prescribing in the least and most 
deprived areas varied by up to 200%.  
Consequences 
Even after adjusting for differences in population 
structure, opioid prescribing practices differ 
significantly across the country, and geospatial 
deprivation is a key prescribing driver. Future policies 
and interventions should focus on high-prescribing 
low-geography areas and tackling deprivation driven 
inequalities.  
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Abstract 
Problem 
When children present with cough in primary care, 
prognostic uncertainty can lead to defensive antibiotic 
prescribing (“treat, just in case”). To combat this, a 
clinical prediction rule called “STARWAVe” was 
developed and validated. STARWAVe uses seven 
clinical factors (Short illness duration, Temperature, 
Age, Recession, Wheeze, Asthma, Vomiting) to 
estimate a child’s risk of deterioration (“very low” if 
≤1 factor is present, “normal” if 2-3 are present, 
“high” if ≥4 are present). In so doing, it aims to reduce 
prognostic uncertainty and unnecessary prescribing in 
non-high risk cases.  Providing STARWAVe as a 
decision aid to General Practitioners (GPs) could 
improve risk assessment and prescribing decisions. 
However, a risk score is merely a probability and could 
be ignored, especially if it contradicts the decision 
maker's intuitive assessment of risk. We aimed to 
compare GPs’ intuitive risk assessments and 
prescribing decisions to those of STARWAVe.  
Approach 
252 UK GPs were randomly assigned to view four (out 
of a possible eight) clinical vignettes online. Each 
vignette depicted a child presenting with cough, who 
was described in terms of the seven STARWAVe 
factors. Sytematically, we varied patient age (20 
months vs. 5 years), illness duration (3 vs. 6 days), and 
the presence (vs. absence) of vomiting and wheeze, 
holding the remaining STARWAVe factors constant. 
Per vignette, GPs selected between “very low (e.g. 1 
in 300)”, “medium (e.g. 1 in 70)” and “high (e.g. 1 in 
8)” risk of deterioration. GPs also indicated whether 
they would prescribe antibiotics. We compared GPs’ 
risk classifications and prescribing decisions to those 
of STARWAVe, and assessed the influence of the 
manipulated factors using mixed-effects logistic 
regression.  
Findings 
GPs underestimated risk of deterioration in almost 
half of instances (46%, 459/1008) and 
overerestimated it in 9% (88/1008). Despite 
underestimating risk, they overprescribed: 78% of 
prescriptions were unnecessary relative to GPs’ own 
risk classification (121/156), and 83% relative to 
STARWAVe’s risk classification (130/156). In 
accordance with STARWAVe, GPs classified risk as 
higher for patients of 20 months vs. 5 years (OR=1.49 
[1.14-1.95], p=0.003), though this did not influence 
prescribing (OR=0.92 [0.69-1.23], p=0.569). In contrast 
to STARWAVe, a shorter illness duration (3 vs. 6 days) 
decreased both risk classification (OR=0.54 [0.42-
0.69], p<0.001) and prescribing odds (OR=0.34 [0.24-
0.49], p<0.001). Vomiting and wheeze increased both 
risk classification and prescribing odds, in accordance 
with STARWAVe (OR_vomiting_risk=1.92 [1.57-2.36], 
OR_vomiting_prescribe=1.49 [1.24-1.80], 
OR_wheeze_risk=3.33 [2.66-4.16], 
OR_wheeze_prescribe=3.89 [2.66-5.69], all ps<0.001).  
Consequences 
Relative to the STARWAVe rule, GPs underestimated 
risk of deterioration. This was mainly because they 
assigned lower risk to a short (vs. long) illness 
duration. Still, they overprescribed, which suggests 
that risk classifications (as measured in this study) and 
prescribing decisions were not well-linked. Providing 
STARWAVe as a decision aid necessitates that GPs are 
aware of and agree with its assessment of clinical 
factors.  
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Abstract 
Problem 
The national ePACT2 polypharmacy prescribing 
indicators were introduced in 2017, and use patient-
level primary care electronic dispensing data to 
identify patients taking multiple medicines or certain 
potentially high-risk combinations of medicines. The 
indicators can be used to facilitate the identification 
of patients in individual GP practices, but it is unclear 
whether they might have a role in comparing 
prescribing across practices.  
Approach 
We used practice-level ePACT2 data from all GP 
surgeries in England from June 2019. Five key 
indicators were studied, applied to patients 
prescribed at least one drug during the study month: 
mean number of drugs per patient, and percentage of 
patients per practice receiving ≥10 drugs, exposed to 
an anticholinergic burden score (ABS) ≥9, receiving ≥3 
anticoagulant or antiplatelet drugs, and receiving ≥2 
unique medications likely to cause kidney injury. 
Indicators were based on prescribing for all ages, and 
for patients ≥75 years. Basic descriptive statistics were 
calculated describing variation (mean and standard 
deviation) across all practices for each indicator and 
age group. We calculated inter-unit (Spearman-
Brown) reliability to determine how reliably practices 
can be distinguished (classified) from each other for a 
particular indicator, using mixed-effects Poisson 
(mean drug number) or logistic (other indicators) 
regression.  
Findings 
Across practices (n=6974) and all age groups, the 
mean (±SD) number of drugs prescribed was 3.5±0.5, 
with 5.2±2.5% of patients receiving ≥10 medicines, 
0.08±0.10% with ABS≥9, 0.09±0.24% taking multiple 
anticoagulants/antiplatelets, and 31±5.8% taking 
drugs likely to cause kidney injury. Polypharmacy was 
considerably higher in patients ≥75 years (mean 
number drugs 5.1±0.8, 10.7±5.8% on ≥10 medicines), 
but other indicators had similar prevalence. For 
prescribing for people of any age, reliability was 
excellent for indicators looking at mean number of 
drugs (0.98±0.08) and percentage patients taking ≥10 
medicines (0.93±0.08). Reliability of the kidney injury 
prescribing indicator was lower although still 
acceptable (0.82±0.13). Reliability of indicators 
measuring high ABS or high risk of bleeding was poor 
(0.39±0.16, 0.17±0.06 respectively). For patients ≥75 
years, reliability remained high for mean number of 
drugs (0.95±0.10), but was notably lower for 
percentage patients taking ≥10 drugs (0.85±0.12) and 
kidney injury prescribing (0.61±0.18).  
Consequences 
Polypharmacy is common in primary care, and use of 
multiple drugs likely to cause kidney injury is 
widespread. However other measures of potentially 
inappropriate prescribing are relatively uncommon. 
Further research is required to determine to what 
extent prescribing variation reflects differences in 
practice demographics. Indicators may have utility for 
individual practices for identifying patients receiving 
potentially problematic medication regimens. 
Although the basic polypharmacy indicators may have 
utility in distinguishing practices with varying levels of 
multiple drug use, including potentially in high-stakes 
applications, the other indicators cannot be reliably 
used to assess differences in potentially inappropriate 
prescribing between practices and their use as quality 
indicators is inadvisable.  
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Abstract 
Problem 
Older people with frailty are frequently prescribed 
multiple medicines for co-morbidities resulting in 
polypharmacy (the concurrent use of five or more 
medicines). Polypharmacy can be beneficial; however, 
inappropriate polypharmacy is common and can lead 
to adverse health outcomes, particularly in this 
population. The National Health Service (NHS) 
recognises this issue in its Long Term Plan (2019), with 
Primary Care Networks (PCNs) responsible for 
implementing structured medicine reviews to stop 
unnecessary or harmful medicines (deprescribing). 
However, little is understood from the patient’s 
perspective, particularly around the barriers older 
people with frailty face when reducing or stopping 
their medicines. The aim of this research was to 
investigate the barriers older people with frailty and 
their supporting peers (i.e. SPs, those who help 
patients manage their medicines at home) experience 
when stopping medicines. This is part of a wider 
programme of work investigating how deprescribing 
can be safely implemented in primary care using a 
behaviour change approach.  
Approach 
A qualitative design was adopted. Patients (n=9) 65 
years and older, who were taking five or more 
medicines, and had received an invitation from their 
GP to discuss stopping a medicine, were recruited 
across four GP practices in Yorkshire and Humber. If 
patients managed their medicines with the help of a 
SP, these were also invited to an interview (n=3). 
Semi-structured interviews were conducted with 
participants immediately after their deprescribing 
consultation, and again five to six weeks later (n=24). 
This enabled the elicitation of the patients' 
experiences of the initial consultation, and their 
experiences of stopping medicines in the follow-up 
period. Interviews lasted approximately 30 minutes, 
were audio-recorded and analysed using Framework 
Analysis and underpinned by the Theoretical Domains 
Framework (TDF - a behaviour change framework).  
Findings 
Several barriers were identified, such as habitual and 
emotional attachments to medicines, inadequate 
support and guidance, and a lack of involvement from 
clinicians throughout the deprescribing process. 
Patients and their SPs expressed a lack of knowledge 
and understanding as to the reasons behind reducing 
their medication, and the benefits for doing so. Post-
appointment, patients and their SPs conveyed a sense 
of abandonment due to the absence of a clear plan or 
follow-up support conveyed in the following quote 
“...I’m left alone now. Yes. I’m left alone now...”.  
Consequences 
The exploratory nature of this research provides 
insight into the barriers older people with frailty and 
their SPs face when reducing or stopping their 
medicines. It is part of a wider body of research on 
deprescribing that will inform the development and 
design of interventions aimed at safely implementing 
deprescribing within primary care. This research is 
particularly timely, given both the global and national 
aim to improve medicines safety outlined in the World 
Health Organisation’s ‘Medicines Without Harm’ 
Programme (2017).  
Funding Acknowledgement 
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U.20 
Determinants of Inappropriate opioid prescribing: A 
cross sectional study in a South London population   
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Institutions 
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Abstract 
Problem 
Opioid prescribing in the UK has been increasing in 
recent years. While opioids are known to be effective 
for treating cancer related pain, their role in non-
cancer pain is less clear.  There is emerging evidence 
that long-term use of opioids for non-cancer pain can 
lead to adverse health outcomes, including 
dependency, falls and premature mortality.Opioid 
prescribing has been noted to be more likely in 
deprived groups; this may be due to confounding by 
other health factors. The aim of this study was to 
examine determinants of opioid PIP, and the relation 
to deprivation, adjusted for potential confounders.  
Approach 
Study design: Retrospective cross-sectional study of 
patients reported according to the RECORD-PE 
criteria.  Prescribing and clinical records for all 
patients aged ≥18 years registered at a Lambeth GP 
for the period 03/06/19-30/11/19 were extracted 
(N=323,980; Practices N=41). Exclusions: Cancer 
diagnoses, substance abuse disorders prescribed oral 
methadone or buprenorphine. Potentially 
inappropriate prescribing (PIP) of opioids was defined 
using the Guidelines of the Faculty of Pain Medicine;  
PIP being greater than 90 days of continuous opioid 
use for non-cancer pain or a morphine daily dose 
equivalent of >120mg.  Both partially and fully 
adjusted multilevel (adjusted for practice) logistic 
regression models were developed to analyse the 
association between PIP and patient deprivation 
(Indices of Multiple Deprivation), as well as other 
relevant covariates (age, sex and co-morbidities).  
Findings 
Opioid prescribing rates were 2% in Lambeth, of those 
patients prescribed an opioid in the last 3 months, 
more than half met the criteria for PIP. Determinants 
of inappropriate prescribing in the fully adjusted 
model were, increasing multi-morbidity, increasing 
age, relative deprivation and female sex.  Following 
adjustment, relative deprivation was associated with 
inappropriate prescribing of an opioid with those in 
the most deprived quintile in Lambeth at increased 
risk of being inappropriately prescribed an opioid 
compared with the least (AOR 1.59 , 95%CI 1.41-
1.79,p<0.001).Patients also had increasing odds of 
being inappropriately prescribed opioids if female 
(AOR 1.33, 95%CI 1.24-1.43,p<0.001), increasing age 
(p<0.001) and increasing multi-morbidity (p<0.001).  
Consequences 
We found lower prescribing rates of opioids in 
Lambeth significantly lower than national figures.  This 
would be in line with previous studies that have 
shown lower prescribing rates for opioids in London.  
Key determinants of inappropriate opioid prescribing 
were multi-morbidity, increasing age, relative 
deprivation and female sex. This study has identified 
inequalities in opioid prescribing, with potential for 
avoidable drug dependencies and undesirable side 
effects. Identifying and addressing reasons for this 
variation will help improve prescribing quality. I think 
this would be worthy of further exploration looking at 
PIP trends overtime and validating these findings in a 
national database.  
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Abstract 
Problem 
PINCER is a proven pharmacist-led IT-based 
intervention to reduce clinically important medication 
errors in primary care.  Having demonstrated its 
effectiveness in a randomised controlled trial, we then 
assessed whether PINCER could be ‘scaled up’ with 
the same effect. Findings from this further project 
showed that large scale rollout to 370 general 
practices was effective and demonstrated statistically 
significant reductions in hazardous prescribing 
(particularly for preventing gastrointestinal (GI) 
bleed). Our objective was to develop a replication 
model for the further scale and spread of PINCER 
using a social franchising approach and to use this 
model to roll PINCER out to at least 60% of GP 
practices in England over a five year period to make 
primary care prescribing even safer for patients.  
Approach 
Social franchising involves enabling another team or 
organisation to deliver a proven intervention to 
agreed standards under a franchise agreement, with 
the primary aim of maximising social benefit. Over the 
last two years, we have been funded by the Health 
Foundation to work with Spring Impact, a non-profit 
global leader in social replication, to implement their 
systematic five-stage process to design a replication 
model for the scale and spread of PINCER.  
Findings 
We have designed a replication model for the national 
rollout of PINCER using a social franchise approach, 
and are working with Medicines Optimisation Leads 
from all 15 Academic Health Science Networks to roll 
PINCER out to GP practices across England. As of 
February 2020, 4,318 (62%) GP practices in England 
across 126 (66%) Clinical Commissioning Groups have 
engaged in the PINCER rollout. Of these, 2,264 (55%) 
practices have uploaded baseline data to the national 
PINCER comparative analysis service showing that a 
minimum of 21.9 million patient records have been 
searched to identify instances of potentially 
hazardous prescribing using 13 evidence-based 
prescribing safety indicators. Almost 176,000 at-risk 
patients have been identified in at least one 
prescribing safety indicator at baseline. Early findings 
from analysis of follow-up data from 816 practices 
show overall reductions in numbers of at-risk patients 
(12.3%) with greatest reductions for those indicators 
associated with GI bleed (23.1%). Over 1,100 
pharmacists (of a total 1,579 individuals) have been 
trained to deliver the PINCER intervention and further 
training sessions are planned as the rollout 
progresses.  
Consequences 
We have used the concept of social franchising to 
develop a replication model for the national rollout of 
PINCER. Early findings have demonstrated that this 
approach has been successful in terms of both reach 
and impact. There is potential for this approach to be 
used for the scale and spread of other proven 
interventions in healthcare.  
Funding Acknowledgement 
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Abstract 
Problem 
Antibiotics are still frequently prescribed for 
respiratory tract infections (RTIs), most of which are 
self-limiting and for which symptomatic benefit from 
antibiotics is modest at best.  Delayed prescribing can 
be a useful strategy to reduce antibiotic prescribing.  
Whilst in some situations delayed antibiotic 
prescribing is appropriate, for other patients it may be 
unsuitable.  It is important to understand which 
subgroups of patients may require immediate 
antibiotics and which patients might benefit from a 
delayed or no prescribing strategy.  
Approach 
This study undertook a systematic review in Cochrane 
Central Register of Controlled Trials, Ovid MEDLINE, 
Ovid Embase, EBSCO CINAHL Plus and Web of Science 
to identify all randomised controlled trials (RCTs) and 
observational cohort studies of delayed prescribing.  
The primary outcome of interest was symptom 
severity scores.  Secondary outcomes include duration 
of illness and reconsultation.  Interaction terms for 
differential effects in subgroups were explored in the 
following pre-defined groups: shorter prior duration 
of illness, age, fever at baseline consultation, 
comorbid lung condition and severity of symptoms at 
baseline consultation. IPD meta-analysis was 
conducted using a one-stage approach, using 
generalised linear mixed modelling with a random 
effect for study. All models controlled for baseline 
severity of illness and diagnosis.  Propensity scores 
were used as inverse probability weights to control for 
confounding in observational studies.  
Findings 
We obtained data from 4 observational studies and 9 
RCTs, totalling 56,301 patients.  For the primary 
outcome, there was no statistically significant 
difference in symptom scores between delayed and 
immediate antibiotics (mean difference 0.04;95% CI -
0.05,0.13) nor between delayed and no antibiotics 
(MD 0.03;95% CI -0.13,-0.19).  The symptom duration 
was slightly shorter in those given immediate 
antibiotics (RR 1.07;95% CI 1.00, 1.14).  
Reconsultation was significantly less likely in those 
given a delayed prescription compared to those given 
no prescription (OR 0.69;95% CI 0.56,0.84).  Subgroup 
analyses showed a statistically significant interaction 
term for those under 16 years.  Compared to those 
aged 16-64, those aged under 16 were more likely to 
have improved symptom scores with delayed 
prescribing compared to none and slightly poorer 
symptom scores with delayed compared to 
immediate. However, the difference did not represent 
a clinically meaningful difference.  There were no 
statistically significant interactions in any of the other 
subgroups.  
Consequences 
Delayed prescribing appears to be a safe and effective 
strategy for most patients, with no clinically significant 
increase in symptom severity in any of the pre-defined 
subgroups.  Encouraging delayed prescribing as a tool 
in consultations may reduce reconsultation and is 
unlikely to be associated with an increase in 
symptoms or illness duration.  
Funding Acknowledgement 
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Abstract 
Problem 
Antibiotic resistance is a worldwide public health 
priority. Interventions are required to reduce 
unnecessary antibiotic use. Several types of 
interventions are effective at reducing antibiotic 
prescribing by primary care clinicians and antibiotic 
use by patients. Three are: training in use of C-
reactive protein point-of-care testing (CRP POCT), 
communication skills training for clinicians and use of 
delayed prescriptions (DP). However, these 
interventions appear to be rarely used in UK general 
practice. We sought to develop support materials to 
increase engagement and adoption of these three 
interventions in general practice.  
Approach 
We used the Person-Based Approach to inform the 
development of support materials. This approach 
combines theory, evidence and person-based 
approaches. We used intervention content from 
previous interventions shown to be effective and 
drew on relevant theories of change. We sought 
clinicians’ views and experiences to make decisions 
about the content and delivery of materials in three 
stages: 
• Focus groups with clinicians in 9 high-
antibiotic prescribing practices discussing use of the 
three interventions. 
• Four workshops, two with clinicians and two 
with citizens, discussing initial ideas for, and drafts of, 
support materials. 
• Think-aloud interviews (22) with clinicians to 
feedback on draft support materials.  
Findings 
Focus group data indicated that clinicians struggled to 
identify scenarios for which interventions would be 
most useful and often had contradicting views. 
Clinicians had no access to POCT CRP, mainly due to 
cost, but varied in whether, and how, they thought 
tests would be helpful. Training in communication 
skills and use of DP were sometimes seen as 
unnecessary but some were open to the idea of 
refining their existing skills for “difficult patients”.In 
workshops, clinicians wanted brief materials that 
covered multiple scenarios. They suggested one 
patient booklet which would “suit all ages and cover 
all infections” and communication skills on “one A4 
sheet”. Preference for type of CRP POCT was based on 
cost and time to result. Clinicians felt that a 
‘champion’ within each practice could help adoption 
of interventions. Citizens initially struggled with the 
concept of a DP but identified communication 
strategies which could be better understood by 
patients.In think aloud interviews clinicians requested 
minimal content, clear links to evidence, examples of 
other clinicians’ experience and easily accessible 
summary sheets. Some particularly liked examples of 
alternative explanations for patients when not giving a 
prescription or when giving a DP. Some terminology 
needed to be adapted to better resonate with 
clinicians.  
Consequences 
There appeared to be a clash between the format and 
length of support materials which clinicians 
considered ideal and the breadth and detail of 
content which was thought to be useful. With detailed 
input from clinicians we developed support materials 
for practices which are currently being evaluated in an 
implementation study with 9 high-antibiotic 
prescribing general practices.  
Funding Acknowledgement 
The study was funded by the Economic and Social 
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Abstract 
Problem 
Problematic polypharmacy, the concurrent use of 
multiple medicines in a single person, on a long term 
basis when the intended benefit is not achieved, is a 
significant problem in Primary Care. Polypharmacy can 
be appropriate, extending life expectancy and 
improving quality of life. However ~40% of people 
taking 5 or more medicines a day report feeling 
significantly burdened by their medication. 
Discontinuing long-term-medicines can cause anxiety 
and concern for clinicians and patients. Despite 
guidelines on stopping inappropriate medicines, 
clinicians report a broader problem of knowing how 
and when to stop medication that may be clinically 
‘appropriate’ but not right for individual patients. 
Balancing clinical and patient and theory carers needs 
and priorities is increasingly recognised as a research 
and policy imperative.. To help clinicians and patients 
make these often challenging decisions on optimising 
medications, we are conducting a realist review. It will 
unpack and understand optimisation of medicines to 
answer the broad question “what works, for whom, in 
what circumstances, to what extent, how and why?”  
Approach 
The Tailor Medication synthesis is a 21 month NIHR 
funded project comprising of a parallel scoping review 
and realist review. Here we report the realist review 
component. The realist reviews are a theory-driven 
approach to synthesising qualitative, quantitative and 
mixed-methods literature. Our review followed 
established steps and the RAMESES quality standards 
for realist reviews (http://www.ramesesproject.org). 
Briefly, after initial programme theory development 
we systematically search electronic databases, articles 
were screened, data extracted and analysed to 
explore issues surrounding the patient-centred 
management of polypharmacy. Relevant sections of 
text were analysed both inductively, retroductively 
and deductively and used to critically challenge, 
examine and refine the programme theory.  
Findings 
Early findings highlight complex social, professional 
and system-level dynamics underlying patient-centred 
medication management. Prescribing is influenced by 
a range of social norms. For example the symbolic 
value of medicines for both prescribers and patients 
and their families shape the ways in which medicines 
are prescribed, deprescribed and managed in general. 
Furthermore the presence of multiple prescribers and 
transitions between primary and secondary care make 
it difficult to keep track of medication-related decision 
making. This is compounded by the absence of unified 
electronic systems. Clinicians also report they lack the 
skills necessary to manage polypharmacy and 
multimorbidity making them reluctant to challenge 
the decisions made by clinicians in other specialties.  
Consequences 
Optimising medication is a complex process and whilst 
primary care clinicians can be skilled up to do so, any 
training must consider the important influences of 
societal and professional norms and practices on this 
process and create an enabling environment.  
Funding Acknowledgement 
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Abstract 
Problem 
The recruitment and retention of primary care doctors 
have been one of the prominent dilemmas 
internationally. Kuwait has also been suffering from 
this problem, in which a high number of doctors have 
left clinical practice for administrative positions, and 
others have resigned from the Ministry of Health in 
Kuwait. As part of a wider study of recruitment and 
retention, this study aimed is to explore the career 
intentions of primary care doctors in Kuwait.  
Approach 
A cross-sectional survey of medical doctors working in 
primary care services in Kuwait was conducted. All 
primary care doctors working in a sample of primary 
are medical centres were included, with no limitations 
to the physicians’ age, nationality, or qualification. 
However, doctors working in specialised clinics, such 
as surgery, were excluded from the study and doctors 
currently in the family medicine training programme 
were excluded. The survey was distributed in 25 
centres broadly representative of size and 
geographical location (urban vs less urban), 
representing more than >25% of the primary care 
centres in Kuwait. The survey instrument, which was 
designed for the UK, was adapted to fit the Kuwaiti 
health care system and piloted before distribution. 
Analyses included Chi-square tests and regression 
analysis.  
Findings 
One hundred ninety-one surveys were returned with 
80.9% response rate. The majority of the participants 
were female, aged 35 to 44 years, and non-Kuwaitis. 
Approximately one-third of the participants were 
senior registrars and the majority, 27%, hold the 
qualification of medical degree only. Most were 
working in centres which operated 17 hours per day 
and covered a population of up to 25000. The most 
common five-year career plan was to increase 
teaching and research activities followed by increasing 
management responsibilities. However, 23.6% of 
participants stated their desire to leave primary care. 
Several factors were identified as important in 
contributing to participants’ decision to leave: 
workload, working hours, job satisfaction, and family 
commitments. Factors which would encourage them 
to stay in primary care were reduction in workload 
and working hours, increasing clinical autonomy and 
annual leave, providing protected time for education 
and increasing payment. An intention to leave primary 
care was associated with working for less than ten 
years, being currently dissatisfied, and being less 
satisfied with work in the last two years. Workload, 
working hours, and spending time on unimportant 
tasks were identified as important drivers by those 
intending to quit primary care. Reducing workload, 
reducing administrative tasks, and shorter clinic hours 
were significant encouraging factors for remaining in 
primary care.  
Consequences 
Work-related factors and job satisfaction were the 
leading influencers on primary care doctors decisions 
to leave practice in the next five years. Policies are 
required to address primary care physicians’ working 
conditions and create a more supportive environment 
to improve their retention.  
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Abstract 
Problem 
The recruitment and retention of primary care doctors 
have been one of the prominent dilemmas 
internationally. Kuwait is also suffering from the same 
problem, in which a high number of doctors left 
clinical practice for administrative positions, and 
others have resigned from the Ministry of  Health. 
Using a qualitative approach, this study aimed to 
explore the main factors influencing the decision to 
quit among primary care doctors in Kuwait.  
Approach 
Qualitative semi-structured interviews were 
conducted with twenty primary care doctors working 
in Kuwait. Participants were recruited during a 
previous cross-sectional study, in which participants 
asked if they wish to be involved in this interview 
study. Purposeful selection from those willing to 
participate was carried out to ensure representation 
by gender, age, and nationality (Kuwaiti vs non-
Kuwaiti). Interviews were transcribed by professional 
transcribers, and thematic analysis was conducted.  
Findings 
Eleven interviews were done with males, of which 
three were Kuwaitis and eight were from other 
nationalities; nine interviews were conducted with 
female doctors, seven Kuwaitis, and two were from 
other nationalities. Participants age ranged from 29 to 
68, although most were in their thirties. Although 
some participants had replied in the survey that they 
did not wish to quit their primary care job, during the 
interview they indicated that they would quit if the 
circumstances were right. Most participants felt that 
the ideal of primary care is not applied in Kuwait, with 
a lack of clinical autonomy frequently cited as an 
issue. Work-related factors, such as workload and 
working hours, were among the leading influencers to 
quit. Other issues related to health system 
organisation, e.g. the lack of appointment systems.. 
Although relationships with patients were cited as a 
positive factor, the increase in patient demand for 
documentation relating to sick leave was viewed as a 
particularly negative aspect of primary care work in 
Kuwait. Participants also talked about the shortage of 
doctors, and the discrepancy between governorates in 
the allocation of doctors and resources.Promotion 
systems were criticised as there is no formalised 
career development or promotions system, this was a 
particular difficulty for non-Kuwaitis. Introducing the 
concept of primary care doctors with a special interest  
was viewed as a positive way of supporting doctors’ 
retention in primary care. Increasing  opportunities 
for Continuous Professional Development and medical 
education activities, with dedicated time allocated for 
such activities, were also suggested as key retention 
strategies.  
Consequences 
Work-related factors, clinical autonomy, and rules and 
regulations were the main issues influencing primary 
care doctors’ decisions to leave. Primary care reform 
policies, especially establishing appointment systems 
and primary care doctors with special interest might 
increase doctor’s retention. Increasing the 
recruitment of primary care doctors and decreasing 
the discrepancy of doctors and resources might also 
improve doctor’s retention.  
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Abstract 
Problem 
The workload crisis in primary care is one of the most 
urgent and important issues facing the delivery of 
primary care in the UK. The increased use of nurses 
and allied health professionals to perform some roles 
instead of GPs is now widespread. A scoping review of 
reviews identified qualitative and economic evidence 
gaps in the literature. Based on this, the aims of this 
study were to explore the advantages, disadvantages 
and consequences of role substitution in primary care.  
Approach 
A mixed methods design was chosen to respond to 
the breadth of the study aims.  Two systematic 
reviews were conducted to uncover the economic and 
qualitative evidence on role substitution in primary 
care. A survey of twenty primary care cluster leads 
was run to assess the current use of role substitution 
within primary care practices in Wales.  Qualitative 
interviews were conducted with twenty-one 
purposively sampled patients and healthcare 
professionals and analysed using Framework to 
explore the barriers and facilitators to role 
substitution. A health economic analysis (case study of 
two practices) was used to explore the budget impact 
of role substitution in primary care.  
Findings 
The systematic review identified six economic 
evaluation studies. There was some evidence that 
substituting GPs with nurses to treat common minor 
health problems is cost-effective. A separate 
qualitative systematic review focusing on pharmacists, 
physiotherapists and occupational therapists 
identified eleven qualitative studies; highlighting a 
number of barriers and facilitators to pharmacists and 
physician associates providing general medical 
services instead of GPs.    The primary care cluster 
leads who completed the survey reported that on 
average, 96.6% of practices across these clusters were 
using role substitution. Respondents offered a variety 
of strategies to increase the uptake of role 
substitution including ongoing support to employ and 
train allied health professionals and increase 
independent prescribing by nurses and pharmacists.    
The budget impact analysis indicated a reduction in 
GP appointments, and a rise in nurse and allied health 
professional consultations across the two practices. 
The qualitative analysis is ongoing and includes 
findings on allied health professional and care 
navigator roles, patient factors and factors relating to 
the primary care team and wider healthcare system.  
Consequences 
This PhD study has suggested a need for information, 
guidance or standards on role substitution to help the 
development of this model of care.  Despite the 
growing prevalence of role substitution, a lack 
information for practices was identified on how best 
to implement role substitution successfully and how 
best to enhance service delivery under this model. 
The fact that these standards do not yet exist could 
have significant implications on service delivery as 
well as patient care and satisfaction.  
Funding Acknowledgement 
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Abstract 
Problem 
Primary care services in England are at saturation 
point. Integrating community paramedics into primary 
care teams is advocated as an innovative way to build 
resilience in the primary care workforce. However, 
there is little evidence for the effectiveness of 
community paramedics working in primary care, or an 
understanding of how paramedics and GPs might 
develop interdisciplinary working. The aim of this 
project is to explore experiences and acceptability of 
an acute primary care home visiting service delivered 
by paramedics.  
Approach 
Three practices in a rural area of north east England, 
with a combined patient population of approximately 
20,000 patients, piloted a paramedic acute home 
visiting service, between October 2018 and March 
2019. Four focus groups were conducted, three with 
each primary healthcare team (14 participants) and 
one with five community paramedics, and nine 
individual patient interviews from across the three 
practices. Data were analysed using a modified 
thematic framework approach.  
Findings 
Community paramedics integrated successfully into 
primary care teams, to deliver an acute home visiting 
service. They relieved some of the workload pressures 
faced by GPs, providing increased time for care 
planning and other duties. Role perception and 
professional boundaries dominated the discourse 
within focus groups. Initially, GPs were apprehensive 
because of their preconceptions about the paramedic 
role and skillset, stemming from traditional 
professional identities. Collaboration was a key factor 
in mitigating this uncertainty and supporting 
interdisciplinary working. Paramedics had 
opportunities to discuss their clinical decisions with 
GPs, allowing the two professional groups to learn 
from each other. By the end of the pilot phase, GPs 
and paramedics were working together to define their 
roles and re-shape their professional boundaries. 
Patients held traditional perceptions of the paramedic 
role. Some feared a visit from a paramedic would 
result in hospital admission, or were concerned that 
paramedics were being taken away from their 
emergency response role. These fears were overcome 
as patients appreciated the interpersonal skills and 
thoroughness of paramedics. However, patients’ 
confidence in the paramedics was based on an 
awareness that they were working collaboratively 
with GPs.  
Consequences 
The introduction of paramedics into the primary care 
skill-mix provides an important opportunity to future-
proof the primary care workforce. Practice teams 
need time to find a way of working with paramedics 
that fits their local context. Further research is 
required to assess the impact on healthcare outcomes 
such as conveyance to hospital, and to explore the 
potential of paramedics to take on other aspects of 
primary care, such as consultations in GP practices.  
Funding Acknowledgement 
Funding: NECS (North of England Commissioning 
Support Unit) Primary Care NIHR Research Capability 
Funding. 
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V.5 
GP burnout, patient safety, and the importance of 
connecting with colleagues.   
Presenter: Louise Hall 
Co-authors:  D.B. O'Connor, I. Watt, J. Johnson 
Institutions 
University of Leeds, Bradford Institute for Health 
Research, University of York, Hull York Medical School 
Abstract 
Problem 
Levels of burnout in general practitioners (GPs) are 
consistently higher than the mean across physicians 
specialties. A recent UK survey found that 73% of GPs 
reported severe exhaustion and 49% severe 
disengagement. Burnout is linked with a range of 
negative personal and organisational outcomes, 
including suicidality and reduced patient safety. 
Potential interventions for burnout have often not 
been investigated within primary care settings. 
Furthermore, existing research has primarily focused 
on reducing burnout, without also investigating 
whether patient safety has improved. One potential 
low cost and pragmatic intervention could be the 
introduction of scheduled, shared breaks: these could 
reduce isolation through providing opportunities for 
positive social interactions with colleagues, whilst also 
allowing time for physical needs to be met. However, 
there is a lack of evidence exploring this.This study 
aimed to examine whether: 1) on days when 
physicians took a break at work, their levels of 
burnout improved, along with their ability to provide 
safe care; 2) effects of taking a break only impacted 
on burnout/safety that same day, or whether effects 
carried over onto the following day; 3) taking a break 
per-se was associated with lower burnout/improved 
safety, or whether positive interactions with 
colleagues were the central aspect of the break.  
Approach 
A within-subjects, interval contingent, daily-diary 
design was used. Fifty-eight GPs in the UK completed 
short online questionnaires before and after work, for 
seven consecutive days. Burnout, patient safety 
incidents, safety perceptions, and work breaks, were 
measured. Hierarchical linear modelling was 
conducted. 
Findings 
Taking at least one break during the working day was 
associated with lower disengagement that day, and 
lower exhaustion the following day. Having a positive 
interaction during the break was important: GPs who 
had at least one break with at least one positive 
interaction reported significantly lower overall 
burnout, disengagement, and exhaustion that day, 
and higher perceived patient safety that day, as well 
as lower exhaustion and improved perceptions of 
patient safety the following day.  
Consequences 
Having a break during the work day where GPs can 
interact with colleagues may be one path to alleviate 
and prevent burnout, and improve patient safety. 
Whilst it may not be the ultimate solution to the 
current GP shortages, it is practical, feasible, and 
could be implemented with relative ease compared to 
alternative solutions (e.g. recruiting more staff to 
reduce workload burdens and other job-stress 
causes). These findings have relevance for healthcare 
managers; the finding that the opportunity for 
positive social interactions was of key importance, 
suggests that breaks need organising at the 
organisation level, so physicians can take these 
together. GPs who are able to carve out time to take 
breaks, as a personal intervention, are unlikely to gain 
the full benefit of these, if they are not coordinated 
with their colleagues' breaks.  
Funding Acknowledgement 
This study was undertaken as part of a PhD 
studentship, awarded jointly by the University of 
Leeds, and Bradford Institute for Health Research 
(funded by the National Institute for Health Research 
Collaboration for Leadership in Applied Health 
Research and Care Yorkshire and Humber). 
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V.6 
Helping us grow generations of GPs in Derbyshire 
(HUGG- GP Derbyshire). A longitudinal support 
network (LSN) pilot study   
Presenter: Shehla Imtiaz-Umer 
Co-authors:  Shehla Imtiaz-Umer1, Anjla Sharman2, 
Jaspal Taggar3, Gail Allsopp3 
Institutions 
1GP Task Force 2Health Education East Midlands 
3University of Nottingham – GP Academy 
Abstract 
Problem 
These are unprecedented times in the GP workforce 
with a reported a 1.2% reduction in GPs up to 
September 2019.  In Derbyshire, work is being 
undertaken to address the recruitment & retention 
crisis. The Derbyshire GP academy applied the Waas 
report recommendation by bringing GP trainees into 
the medical school to teach students. The project 
showed the expected benefits from near-peer 
teaching, but also showed increased resilience and 
desire in the GP trainees to stay working in the region. 
Focus groups showed linking GP trainees, students 
and academic GPs made them feel part of a 
supportive team. To evaluate the impact of 
longitudinal support, we took those interested in 
primary care from medical school, through GP 
training, and all stages of the GP career, including 
retired GPs; joining them together in networks to 
enable us to evaluate the feasibility, barriers and 
benefits of this approach. We aim to determine if it’s 
feasible to set up a LSN in Derbyshire covering all 
stages of general practice from medical school to 
retirement, reviewing the benefits and barriers of this 
approach when building resilience, promoting 
recruitment and retention locally.  
Approach 
42 participants were randomly split into 5 LSN’s with 
all stages of GP represented in each. Each month 
(n=6), a different method of communication (e.g. 
social media, face to face meeting) are given to the 
LSNs to encourage group communication. A mixed 
method approach, using focus groups and surveys, 
comprising 5-point Likert scale, (1=low; 5=high) and 
free text open questions are undertaken at the 
beginning and end of the study, to ascertain 
information about the experience and views of 
participants. Each month, the number and type of 
contact within each LSN are measured. Quantitative 
analyses and thematic analyses are to be conducted 
for closed and open questions, respectively.  
Findings 
The initial survey and focus group have been 
completed. Monthly data continues to be collected. 
Once the final focus group has been completed, 
formal analysis of the results will be undertaken. The 
mixed method nature of the study with regular 
collection of data and paired (beginning and end) 
surveys and focus group ensures the data we collect is 
robust and trustworthy, although the small number of 
participants could add bias.  
Consequences 
Building on the soft data collated with the GP 
academy regarding the impact of LSNs on GPs in 
Derbyshire; we aim to determine the best approach to 
setting up and sustaining these networks, the best 
method of communication within the LSN and ideal 
frequency of contacts. By establishing the benefits 
and barriers of using such schemes, our aim is to then 
run a larger project starting in September 2020 based 
on these findings. HUGG-GP would be easily 
transferable to other areas once this data is available 
and shared.  
Funding Acknowledgement 
GP Task Force 
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V.7 
Have Primary Care Networks Increased Practice-
Level Workforce Inequalities?   
Presenter: Claire Nussbaum 
Co-authors:  Marcello Morciano, Rebecca Fisher, 
Efthalia Massou, John Ford 
Institutions 
Institute of Public Health, University of Cambridge; 
Health Organisation, Policy and Economics, University 
of Manchester; Health Foundation; Department of 
Public Health and Primary Care, University of 
Cambridge 
Abstract 
Problem 
In June 2019 Primary Care Networks (PCNs) were 
established to bring together practices covering 
30,000 to 50,000 patients. The Long Term Plan set out 
to expand primary care recruitment of additional roles 
including pharmacists, social prescribing link workers, 
physiotherapists, physician associates, and 
paramedics. With limited staff in these specific roles 
available, workforce shortages may disproportionately 
affect practices and PCNs in more deprived areas. The 
overall aim of this research is to assess the impact of 
PCNs on practice-level workforce inequalities and 
determine which types of PCNs are best or least able 
to recruit.  
Approach 
We will assess the trends in practice-level workforce 
inequalities over time. The Slope Index of Inequality 
(SII) and Relative Index of Inequality (RII) for GPs, 
nurses, other clinical staff, and each additional role 
will be calculated at each quarter from September 
2015 to March 2020, with and without adjustment for 
patient need using the Carr Hill formula. This will 
allow for an evaluation of whether the introduction of 
PCNs in 2019 changed or exacerbated these inequality 
indices. We will then identify broad types of PCNs 
using Latent Class Analysis (LCA) based on deprivation, 
rural/urban classification, patient age structure, 
patient satisfaction and care quality ratings. Finally, 
each LCA group will be evaluated on the basis of its 
ability to recruit additional roles throughout the first 
fiscal year of PCN rollout, from March 2019 to March 
2020.  
Findings 
As the practice-level workforce data for December 
2019 and March 2020 have yet to be released, data 
analysis is still in progress and specifically findings 
regarding additional roles recruitment is still 
preliminary. However, emerging findings suggest that, 
after adjustment, there is an inverse relationship 
between deprivation and number of paramedics per 
10,000 patients, with fewer paramedics employed in 
more deprived deciles. This trend in inequality 
appears to be increasing from September 2015 to 
September 2019. Moreover, for GPs and for clinical 
staff excluding GPs and nurses, there is similarly an 
inverse relationship between deprivation decile and 
workforce. On the contrary, the number of physician 
associates employed in more deprived areas is 
relatively higher than in less deprived areas, especially 
in recent quarters. The inequality indices and trends 
over time for physiotherapists, pharmacists, social 
prescribing link workers and nurses are less clear with 
the workforce data available thus far. Evaluation of 
the recruitment ability of certain types of PCNs is still 
in progress as it is dependent on December 2019 and 
March 2020 workforce data.  
Consequences 
Policies regarding PCNs should work to limit both 
workforce and health inequalities, with funding and 
resources allocated proportionate to need. Reducing 
health inequalities is a long-term goal of the NHS, but 
if workforce inequalities continue to increase so will 
health inequalities.  
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V.8 
Operational failures and how they influence the 
work of general practitioners: A qualitative study in 
primary care   
Presenter: Carol Sinnott 
Co-authors:  Alexandros Georgiadis, Mary Dixon-
Woods 
Institutions 
THIS Institute (The Healthcare Improvement Studies 
Institute), University of Cambridge; ICON Plc, The 
Translation & Innovation Hub Building, Imperial 
College London 
Abstract 
Problem 
General practice faces a workforce recruitment and 
retention crisis. While the pressures experienced by 
General Practitioners (GPs), including unmanageable 
workloads, the complexity of patients’ needs and 
policy expectations to move more care from hospitals 
to the community have been well documented, there 
has been less focus on whether the wider health 
system facilitates the work of GPs by supporting an 
efficient primary care work environment.This study 
aims to understand what and how system-level 
operational failures in the primary care work 
environment interfere with and influence GPs’ work, 
with a view to identifying failures that may be 
tractable to improvement.  
Approach 
We conducted a qualitative interview study, using 
“operational failures”- defined as disruptions, 
inadequacies or errors in the information, supplies, or 
equipment needed for patient care - as a sensitising 
concept. Twenty-one GPs were recruited via the East 
of England Clinical Research Network, using criteria of 
length of time since qualification, location, and 
practice size. The technique of chart-stimulated recall 
was utilised during interviews. Analysis was based on 
the constant comparative method.  
Findings 
Operational failures experienced by GPs arose mainly 
from inadequate channels of communication external 
to their own practices, but also related to problems in 
practice technology and suboptimal distribution of 
work within practices. GPs were obliged to undertake 
compensatory labour to fulfil their duties of 
overseeing, coordinating and safeguarding patients’ 
care. Though individual operational failures often took 
only minutes to resolve, the additional strain they 
imposed in the context of already stretched daily 
schedules, threatened job satisfaction, patient safety 
and the quality of care. Though GPs often believed 
that working around these problems was the simplest 
solution, compensatory labour may be 
counterproductive in the longer term by keeping 
problems obscured as learning opportunities.  
Consequences 
Operational failures within general practices and the 
wider healthcare system interfere with and configure 
GPs’ work and signal system-level weaknesses that 
cause pressure within the primary care work 
environment. Using failure occurrence as a trigger for 
improvement efforts at a local and collective level will 
be critical to making the primary care work 
environment more attractive and efficient.  
Funding Acknowledgement 
This work has been supported by an NIHR (UK) Clinical 
Lectureship, an Academy for Medical Sciences (UK) 
Starter Grant (SGL018\1023) and Mary Dixon-Woods’ 
Wellcome Trust Senior Investigator Award (WT09789). 
MDW is supported by the Health Foundation's grant 
to the University of Cambridge for The Healthcare 
Improvement Studies Institute. The Health 
Foundation is an independent charity committed to 
bringing about better health and healthcare for 
people in the United Kingdom. MDW is a National 
Institute for Health Research (NIHR) Senior 
Investigator (NF-SI-0617-10026. The views expressed 
in this article are those of the authors and not 
necessarily those of the NHS, the National Institute for 
Health Research, the Department of Health and Social 
Care, the Health Foundation, the Academy for 
Medical Sciences or the Wellcome Trust. 
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W.1 
Do school students want to be General Practitioners?   
Presenter: Magdy Abdalla 
Co-authors:  Blanchard, D., Beddows, J., Hammond, E., 
Hay, F., Jensen, K., Panesar, A., Smithson, S, Webb, M. 
Protheroe, J., 
Institutions 
School of Medicine. Keele University 
Abstract 
Problem 
General practice is currently facing a recruitment 
crisis. One possible solution suggested is to raise 
awareness in high school students of general practice 
and the role of General Practitioners (GPs).  
Approach 
For the past two years, we have organised a “My day 
in General Practice” for year 12 college and school 
students who were participating in Keele’s widening 
participation program “Steps 2 Medicine”. They were 
offered the opportunity to spend a full day in a local 
GP surgery. The students were briefed about the 
visits, especially regarding confidentiality, behavior 
and dress code. Each student completed a pre-visit 
questionnaire to explore their views of general 
practice and the role of GPs. The practice visit was 
organised using a simple observation and activity log 
sheet entitled “My day in General Practice”.Following 
the visits, students gave written and verbal feedback 
and their attitude toward general practice was 
reassessed.  
Findings  
Exposure of college and school students to the 
authentic learning environment of general practice 
can change their attitude towards the role of GPs and 
the attractiveness of general practice as a future 
career.  
Consequences 
This will likely impact on applications to medical 
school and improve diversity of future health 
professionals.  
 
W.2 
Rapid and cost-efficient recruitment of focus group 
participants using Instagram   
Presenter: Richard Ma 
Co-authors:  Ms Rebecca Blaylock, Dr Lorna Hobbs, 
Professor Helen Ward, Professor Sonia Saxena 
Institutions 
Imperial College London, British Pregnancy Advisory 
Service (BPAS), Tavistock and Portman NHS 
Foundation Trust 
Abstract 
Problem 
Recruiting individuals into studies such as trials, focus 
groups and interviews can be difficult. Often this 
process can be time consuming, resource intensive 
and particularly for participants who might be “hard 
to reach”.Our research project includes focus group 
study of young women between ages of 16 to 24 
years on their experiences on using contraception. We 
aimed to recruit between 8 to 12 people for each of 
16-19 and 20-24 age-based focus groups.  
Approach 
Following advice from our patient and public 
involvement group, we designed a poster for social 
media format (including a £50 Amazon voucher) and 
posted on Twitter account of one of the authors. After 
a period of poor response, we chose another platform 
– Instagram – and used their promotions 
feature.There are guidelines for promoting content on 
Instagram (which is owned by Facebook). This 
includes subtle differences in wording that do not 
inadvertently disclose personal information for 
anyone who interacts with the advertisement.The 
Instagram feature allows targeted promotion 
according to gender, age, location and content. The 
cost of promotion was a product of the number of 
days of promotion and the intensity of exposure each 
day, i.e. the same budget could pay for a longer, less 
intense promotion or vice versa. We had a budget of 
£60 for recruitment and planned to run the promotion 
for a week.  
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Findings 
At the time of the promotion, the Instagram account 
used by one of the authors had a small following of 
fewer than 20 people. We had just over 30 enquiries 
within three days and had to stop the promotion due 
to high demand. We had 30 participants who 
responded and requested study information; nine 
participants confirmed and attend the focus group for 
16 to 19 years and ten attend focus group for 20 to 24 
years. There was a total of 217 promotion clicks and 
284 profile visits, 76% of which were from the 
promotion alone. The promotion reached 3860 
accounts, with 5629 impressions, 77% were from the 
promotion alone. The total spend for the promotion 
was £18.48 or 31% of the £60 budget. The 
recruitment cost was less than £1 per participant.  
Consequences 
Instagram can be a rapid and cost-efficient way of 
recruiting participants especially young women. This 
and other social media platforms might be useful 
ways to target recruitment for research depending on 
the demographic.However, there are ethical 
considerations when using social media to recruit 
participants for research studies. Researchers need to 
consider how to protect potential participants from 
privacy breaches or inadvertently sharing potentially 
identifying information about themselves.  
Funding Acknowledgement 
RM was funded by an NIHR Doctoral Research 
Fellowship SS and HW have received funds from NIHR 
School for Public Health Research 
 
W.3 
Views and experiences of managing eczema: 
systematic review and thematic synthesis of 
qualitative studies   
Presenter: Emma Teasdale 
Co-authors:  E Teasdale, I Muller, K Sivyer, D Ghio, K 
Greenwell, S Wilczynska, A Roberts, MJ Ridd, N 
Francis, L Yardley, KS Thomas, M Santer 
Institutions 
University of Southampton, University of Bristol, 
University of Nottingham 
Abstract 
Problem 
Eczema is a common skin condition that has a 
substantial impact on quality of life. Increasingly, 
qualitative approaches have been adopted to explore 
people’s perceptions of eczema and eczema 
treatment. Synthesising qualitative studies can 
provide a comprehensive overview of existing 
literature, greater understanding of people’s 
perspectives and experiences and can inform clinical 
practice. We sought to synthesise existing qualitative 
studies exploring the views and experiences of people 
with eczema and parents/carers of children with 
eczema about the condition and its treatment.  
Approach 
We systematically searched four databases (MEDLINE, 
PsycINFO, CINAHL and EMBASE) from the earliest date 
available to February 2019. Papers were selected that 
primarily focused on views and experiences of eczema 
and eczema treatments, and barriers / facilitators to 
eczema self-management. We excluded papers that 
focused solely on models of health service provision 
or the views and experiences of health professionals. 
No language restrictions or date limits were placed on 
the search. Reference lists of selected papers were 
searched for additional relevant papers. Two authors 
and two additional research assistants performed 
assessment of study quality and data extraction. A 
thematic synthesis approach was used to synthesise 
the findings. 
Findings 
We identified and synthesised 39 papers (reporting 32 
studies) from 13 countries exploring the views and 
experiences of 1,007 participants. Four key themes 
were identified 1) Eczema not viewed as a long-term 
condition, 2) Significant psychosocial impact of 
eczema not acknowledged by others, 3) Hesitancy 
(patient uncertainty) about eczema treatments and 4) 
Insufficient eczema information and advice. Our 
findings suggest that people with eczema and parents 
of children with eczema experience frustration at 
having to manage a condition that is seen by others as 
mundane but has significant psychosocial impact and 
treatment burden and concerns. This frustration 
appears to be exacerbated by experiences of 
conflicting and inconsistent information and advice, 
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from both health professionals or friends, family and 
others.  
Consequences 
Our synthesis suggests that effective self-
management of eczema could be supported by 
addressing beliefs and concerns about treatments and 
seeking positive ways to promote a ‘control not cure’ 
message. Acknowledging the significant psychosocial 
impacts of eczema and burdensome nature of 
treatment as well as providing clear consistent 
information and advice or signposting towards 
reliable information, may address people’s concerns 
that distress caused by the condition is not taken 
seriously.  
Funding Acknowledgement 
This study presents independent research funded by 
the National Institute for Health Research (NIHR) 
under its Programme Grants for Applied Research 
programme (grant ref No RP-PG-0216-20007). The 
views expressed are those of the author(s) and not 
necessarily those of the NHS, the NIHR or the 
Department of Health and Social Care. 
 
W.4 
Examining the impact of an innovative online 
qualitative study (netnography) in developing a 
clinical pharmacist-led review for persistent pain 
patients in primary care (PROMPPT study)   
Presenter: Charlotte Woodcock 
Co-authors:  Julie Ashworth, Nicola Cornwall, Sarah A 
Harrisson, Alison Buttery, Clare Jinks, Christian Mallen, 
Lisa Dikomitis 
Institutions 
School of Primary, Community, & Social Care, Keele 
University 
Abstract 
Problem 
Qualitative methods are central to adopting a person-
centred approach to intervention development in 
order to maximise intervention effectiveness. Face-to-
face interviews and focus groups are often used, but 
risk omitting views of those unable or unwilling to 
participate in person, a barrier more likely to affect 
those living with a chronic illness or stigmatized 
condition. Online methods have the potential to 
extend participant inclusivity and contribute towards 
a comprehensive assessment of an intervention’s 
acceptability and inform its development. To further 
understand the value of online methods, we 
compared findings from face-to-face interviews with 
those from an online discussion forum used in the 
iterative development of a clinical pharmacist-led 
primary care review for patients prescribed opioid 
medicines for persistent pain.  
Approach 
An online discussion forum was available for 11 
weeks, with a new discussion topic posted 
approximately weekly. In this time 69 participants 
joined the forum, with 31 of these posting 160 
comments ranging in length from 19 to 2,143 words. 
The discussion topics (n=10) and semi-structured 
interviews (n=15) were informed by behaviour change 
theories, and explored patient experiences of living 
with persistent non-cancer pain, pain management 
and taking opioid medicines, to identify facilitators of 
and barriers to delivering a pain review in primary 
care. All interviews were carried out by one 
researcher, whilst the forum was moderated by a 
team of six researchers specialising in behaviour 
change, psychology, applied health research and 
clinical pain management. A framework approach to 
data analysis was used, and findings between the two 
methodological approaches were compared in terms 
of thematic codes.  
Findings 
Preliminary findings indicate thematic overlap 
between interview and forum data including provision 
of multidisciplinary care, importance of clinical 
pharmacist consultation skills, and development of 
individualised plans for patients’ pain self-care. The 
discussion forum attracted participants who had 
experience of reducing off opioids and led to 
additional themes concerning patient support when 
reducing opioid medicines, and alternative ways to 
help manage pain and self-care strategies. Findings 
fed into refining the content of the PROMPPT 
intervention and training programme ahead of a 
formal feasibility study.  
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Consequences 
The present study highlights the contribution of online 
qualitative methods in maximising intervention 
development. Inclusion of a discussion forum allowed 
participants with different experiences of using and 
changing pain medicines, from a wider geographical 
region to engage in research at a personally 
convenient time and location. Initial findings suggest 
research targeting patient populations involving 
chronic and/or stigmatized conditions could benefit 
from including online methods as an accessible 
alternative to face-to-face approaches when 
evaluating facilitators of and barriers to intervention 
implementation and delivery.  
Funding Acknowledgement 
This research is funded by the National Institute for 
Health Research (NIHR) under its Programme Grants 
for Applied Research Programme (Reference Number 
RP-PG-0617-20005). CJ and CDM are part funded by 
the National Institute for Health Research (NIHR) 
Applied Research Collaboration (ARC) West Midlands. 
The views expressed are those of the author(s) and 
not necessarily those of the NIHR or the Department 
of Health and Social Care. The views expressed are 
those of the authors and not necessarily those of the 
NIHR or the Department of Health and Social Care. 
 
X.1 
International Primary Care Respiratory Group 
(IPCRG) Research Prioritisation Exercise: A 
Qualitative Analysis of the Most Important 
Respiratory Research Themes Relevant to Primary 
Care as Viewed by Clinicians Worldwide   
Presenter: Dr Arwa Abdel-Aal 
Co-authors:  Dr Arwa Abdel-Aal: Clinical Research 
Fellow in Primary Care, HYMS. Dr Rachel Jordan: 
Reader in Epidemiology and Primary Care, University 
of Birmingham 
Institutions 
For a full lis of authors and their affiliations, please 
follow this link: 
https://www.theipcrg.org/display/DoResearch/Resear
ch+Prioritisation+2020  
Abstract 
Problem 
Respiratory diseases impose a substantial burden on 
global health where over 1 billion people worldwide 
suffer from respiratory conditions. Primary care has a 
fundamental role in identifying, diagnosing and 
managing respiratory diseases and good quality 
evidence is needed to effectively manage respiratory 
conditions worldwide. In 2010, the International 
Primary Care Respiratory Group (IPCRG) published its 
Research Needs Statement which was followed by an 
e-Delphi prioritisation exercise in 2012 to identify the 
most important respiratory research questions that 
are relevant to primary care. An updated IPCRG 
research prioritisation exercise that considers a wider 
range of clinical conditions and embodies global 
perspectives is currently due.  Aim: To identify the 
most important respiratory research themes from the 
perspective of primary care clinicians in low-, middle- 
and high-income countries.  
Approach 
An online e-Delphi was conducted to prioritise the 
most important research questions for respiratory 
primary care. Clinicians who manage people with 
respiratory conditions in the community were 
recruited via the IPCRG network of 34 member 
countries. An initial open questionnaire elicited 
participants’ views on the most common and 
important respiratory conditions seen in their daily 
practice. In addition, they were asked to suggest 5-10 
research questions that are relevant to primary care. 
Here we report a qualitative analysis of participants’ 
responses to identify the main cross-cutting 
respiratory research themes relevant to primary care 
practitioners. Thematic analysis (Using the Braun and 
Clarke 6-step approach) was conducted using NVIVO 
software. 
Findings 
112 participants from 27 countries responded to the 
open questionnaire and 608 research questions were 
suggested. The most common and important 
conditions reported were COPD, asthma and 
respiratory infections. For common conditions, 
asthma was the most frequently mentioned single 
condition (17.2%), followed by COPD (15.2%) and 
upper respiratory tract infections (URTI) (7.1%). 
Asthma was the most clinically important condition 
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mentioned (25.7%) followed by COPD (24.5%) and 
URTI (5.8%). Five main themes emerged from the 
thematic analysis: uncertainties about the best way to 
diagnose and treat respiratory conditions in primary 
care; need for locally relevant and accessible 
guidance; need to explore methods to better 
empower patients to manage their own conditions; 
the role of the wider healthcare team, and the need 
for simple point-of-care tests in the diagnosis, 
monitoring and management of respiratory conditions 
in primary care. 
Consequences 
Participants suggested a broad range of questions 
within 5 themes, some of which reflected a basic lack 
of knowledge of evidence-based guidelines. These 
results emphasise the need for better methods of 
educating practitioners to provide evidence-based 
practice and the development/evaluation of locally 
relevant approaches accessible and affordable for 
primary care in all settings. The next stage of the e-
Delphi will provide a refined list of relevant research 
questions for prioritisation.  
 
X.2 
Self-management interventions to reduce healthcare 
utilisation and improve quality of life among patients 
with asthma: a systematic review and network meta-
analysis   
Presenter: Alex Hodkinson 
Co-authors:  Peter Bower, Christos Grigoroglou, Salwa 
S Zghebi, Hilary Pinnock, Evangelos Kontopantelis and 
Maria Panagioti 
Institutions 
University of Manchester 
Abstract 
Problem 
Asthma is one of the most common chronic conditions 
worldwide. Guidelines for treating asthma 
recommend the use of self-management 
interventions. However, it is unclear which self-
management models are most effective at reducing 
healthcare utilisation and improving quality of life 
(QoL).  
Approach 
A systematic review and network meta-analysis 
(NMA) of randomised controlled trials to compare the 
effects of three different Self-management 
intervention models (multi-disciplinary case-
management, regularly-supported self-management 
and minimally-supported self-management) and self-
monitoring models, against usual care and education. 
The primary outcomes include healthcare utilisation 
(i.e. hospitalisation or emergency visit) and QoL. 
Summary standardised mean differences (SMDs) and 
95% credible intervals (95%CrI) were estimated using 
Bayesian NMA with random-effects. Heterogeneity, 
inconstancy and publication bias were assessed.  
Findings 
From 1,178 citations we included 105 trials comprising 
27,767 participants. In terms of healthcare utilisation, 
both multi-disciplinary case-management (SMD=-0.18, 
95%CrI: -0.32 to -0.05) and regularly-supported self-
management (SMD=-0.30, 95%CrI: -0.46 to -0.15) 
were significantly better than usual care. For QoL, 
only regularly-supported self-management (SMD = 
0.54, 95% CrI: 0.11 to 0.96) showed a statistically 
significant increase when compared to usual care. For 
trials including adolescents/children (aged 5-18 years), 
only regularly-supported self-management showed 
statistically significant benefits (healthcare utilisation: 
SMD=-0.21, 95%CrI: -0.40 to -0.03; QoL: SMD=0.23, 
95% CrI: 0.03 to 0.48). Multi-disciplinary case-
management (SMD=-0.32, 95%CrI: -0.50 to -0.16) and 
regularly-supported-self-management (SMD=-0.32, 
95%CrI: -0.53, -0.11) were most effective at reducing 
healthcare utilisation in patients with symptoms of 
severe asthma at baseline.  
Consequences 
This is the largest study to use NMA to assess the 
relative merits of different models of self-
management in the treatment of asthma. We 
conclude that regularly-supported self-management is 
the most optimal intervention model for improving 
healthcare utilisation and QoL. Future research and 
policy investments need to focus on implementing 
regularly supported self-management, targeting 
multi-disciplinary case management on those with 
complex disease.  
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Abstract 
Problem 
Asthma is one of the most common chronic conditions 
worldwide. Guidelines for treating asthma 
recommend the use of self-management 
interventions. However, it is unclear which self-
management models are most effective at reducing 
healthcare utilization and improving quality of life 
(QoL).  
Approach 
We performed a systematic review and network 
meta-analysis (NMA) of randomised controlled trials 
to compare the effects of three different Self-
management intervention models (multi-disciplinary 
case-management, regularly-supported self-
management and minimally-supported self-
management) and self-monitoring models, against 
usual care and education. We searched MEDLINE, the 
Cochrane library, CINAHL, EconLit, EMBASE, Health 
Economics Evaluations Database, NHS Economic 
Evaluation Database, PsycINFO and ClinicalTrials.gov 
for published and unpublished trials from January 
2000 to April 2019. We assessed risk of bias in 
accordance to the Cochrane Handbook and certainty 
of evidence using the Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) 
framework. The primary outcomes include healthcare 
utilization (i.e. hospitalisation or emergency visit) and 
QoL. Summary standardised mean differences (SMDs) 
and 95% credible intervals (95%CrI) were estimated 
using Bayesian NMA with random-effects. 
Heterogeneity was quantified with heterogeneity-
variance (τ2) and through inconsistency analysis. 
Publication bias was assessed with funnel plots. This 
study is registered with PROSPERO, number 
CRD42019121350.  
Findings 
From 1,178 citations we included 105 trials comprising 
27,767 participants. In terms of healthcare utilization, 
both multi-disciplinary case-management (SMD=-0.18, 
95%CrI: -0.32 to -0.05) and regularly-supported self-
management (SMD=-0.30, 95%CrI: -0.46 to -0.15) 
were significantly better than usual care. For QoL, 
only regularly-supported self-management (SMD = 
0.54, 95% CrI: 0.11 to 0.96) showed a statistically 
significant increase when compared to usual care. For 
trials including adolescents/children (aged 5-18 years), 
only regularly-supported self-management showed 
statistically significant benefits (healthcare utilization: 
SMD=-0.21, 95%CrI: -0.40 to -0.03; QoL: SMD=0.23, 
95% CrI: 0.03 to 0.48). Multi-disciplinary case-
management (SMD=-0.32, 95%CrI: -0.50 to -0.16) and 
regularly-supported-self-management (SMD=-0.32, 
95%CrI: -0.53, -0.11) were most effective at reducing 
healthcare utilization in patients with symptoms of 
severe asthma at baseline.  
Consequences 
This is the largest study to use NMA to assess the 
relative merits of different models of self-
management in the treatment of asthma. We 
conclude that regularly-supported self-management is 
the most optimal intervention model for improving 
healthcare utilisation and QoL.  
Funding Acknowledgement 
Work was funded by the NIHR Evidence Synthesis 
Working Group 
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Abstract 
Problem 
There is an increased risk of psychological co-
morbidities for people with chronic obstructive 
pulmonary disease (COPD), which often go unnoticed 
and untreated. The TANDEM trial developed a 
tailored, cognitive behavioural approach (CBA) 
intervention for patients with COPD and anxiety 
and/or depression. The aims were to improve mood in 
patients with anxiety and/or depression and increase 
uptake of pulmonary rehabilitation (PR). Respiratory 
healthcare professionals (facilitators) were recruited 
and received tailored training in CBA. Supported by 
telephone supervision from a clinical psychologist, the 
facilitators saw trial patients for six to eight sessions, 
usually in the patient’s home.  
Approach 
ObjectivesTo explore  
• The experiences of health care professionals 
working as CBA facilitators with patients living with 
COPD.  
• The facilitators’ views regarding the 
implementation of the TANDEM model in usual 
care.MethodsAs part of the process evaluation, 
qualitative interviews were conducted via telephone 
with facilitators who consented to participate.   
Interviews, conducted by two researchers, addressed 
the core objectives. Sampling was purposive, aiming 
to achieve a maximum variation sample. Thematic 
analysis (assisted by NVivo) was iterative using a small 
team approach, to aid interpretation.  
Findings 
Interviews were conducted with ten facilitators, 
including three nurses, three occupational therapists 
and four physiotherapists. Facilitators considered the 
CBA skills they had learnt enabled them to improve 
the quality of care they provide patients. Using CBA 
opened up a broader view of patients’ lives and 
facilitatorsto ‘show more empathy to these patients’ 
and appreciate that some patients were often dealing 
with co-morbities.  Facilitators were ‘struck at how 
complicated everyone’s lives are’ with concerns other 
than their COPD which could be overlooked in a time-
limited clinical setting. Though the time to be able to 
commit to these participants with complex lives was 
valued, facilitators also mentioned that it wasn’t 
always easy to manage. Most facilitators said that 
they found it difficult to adapt from their problem-
solving approach to the patient-centred CBA, 
describing the training as having ‘massively changed 
my approach with patients’. Facilitators gave 
examples of how they would use the CBA skills in their 
professional roles outside of TANDEM ‘because it 
would make us all better at actually supporting our 
patients’.  Supervision from a clinical psychologist was 
new to all facilitators and valued. Most facilitators 
believed that a major obstacle for implementing the 
TANDEM intervention in usual care would be time and 
that this time is focusing on a holistic approach rather 
than simply addressing the physical symptom(s).  
Consequences 
The CBA training was valued by facilitators in the 
context of the TANDEM trial, and also for the 
transferable skills that could be applied in their 
routine work. The patient-centred approach was time-
consuming but considered worthwhile, albeit raising 
concerns about implementation in a time-limited NHS.  
Funding Acknowledgement 
The study is funded by the NIHR Health Technology 
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Abstract 
Problem 
Severe Asthma (SA) is asthma that does not respond 
to standard treatment and is characterized by one or 
more exacerbations in the previous year despite high 
dose inhaled or oral corticosteroids. This patient 
subgroup is difficult to diagnose and associated with 
significant morbidity and preventable premature 
mortality. There is evidence of improved clinical 
outcomes if these patients can be identified and 
offered specialist assessment and management 
including novel monoclonal antibody treatment. 
However, there is significant inequality in access to 
specialist asthma care across the United Kingdom, 
with unacceptable variation in prevalence, frequency 
of exacerbations, and health outcomes across 
geography, age, ethnicity and socio-economic groups. 
Data linkage presents a unique opportunity to identify 
this high-risk subgroup. Asthma patients have 
healthcare records held in various databases 
throughout the Health and Social Care system. 
Primary Care healthcare records have many unique 
properties which make them essential to gain an 
accurate picture of SA clinical burden. These include 
the representativeness of the entire asthma 
population and the high quality of clinical data coding, 
in particular for Quality and Outcome Framework 
(QOF) data. An unrealised opportunity may exist via 
data linkage with a variety of other datasets (including 
those from secondary care) to identify those likely to 
have SA.  
Approach 
The General Practice Intelligence Platform (GPIP) is 
being established to extract primary care data from all 
GP practices in Northern Ireland under agreed 
governance processes. Data will be extracted and de-
identified at source. A secured data governance and 
linkage framework is being developed to incorporate 
primary healthcare data into established systems for 
linkage of secondary care records.We plan to use this 
process to link primary healthcare record data from 
the Northern Ireland asthma population including 
QOF, prescribing and laboratory data to secondary 
healthcare record datasets including admissions and 
emergency department attendances.  We aim to use 
this linked dataset to determine the prevalence, 
characteristics and clinical outcomes of patients with 
SA in Northern Ireland and identify potential 
candidates for monoclonal antibody treatment. 
Linkage of these records into a single anonymised 
dataset presents a unique opportunity to better 
understand this high-risk subgroup and to shed light 
on how inequalities in care and outcomes might be 
mitigated.  
Findings 
In  preparation for this study we have conducted a 
scoping review on how primary care records linked to 
secondary and administrative data can help identify 
the prevalence and characteristics of SA. Results from 
this review have been used to guide the design of our 
study.  
Consequences 
This novel proof of concept study, which plans to link 
primary and secondary healthcare records of an entire 
asthma patient population, could lead to improved 
clinical outcomes and pave the way for similar linkage 
studies for other conditions.  
Funding Acknowledgement 
Queen's University Belfast HSC Research and 
Development Northern Ireland 
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Are persistent physical symptoms associated with 
low socioeconomic status: a meta-epidemiologic 
study?   
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Rooney 
Institutions 
University of Sheffield 
Abstract 
Problem 
Persistent (“medically unexplained”) physical 
symptoms reduce quality of life. Risk factors for these 
disorders include early live adversity. However, there 
has been no systematic study of the relationship 
between socioeconomic factors and the prevalence of 
persistent physical symptoms or related functional 
symptom syndromes. Reflecting the “deep-end” 
approach to the most deprived sections of the 
population, we were particularly interested in 
comparing the most deprived 10-20% with the 
remainder of the population.  
Approach 
We carried out a meta-epidemiologic study in which 
we systematically identified studies describing one or 
more of the following: multiple “medically 
unexplained” symptoms (including somatoform 
disorders); chronic widespread musculoskeletal pain 
(including fibromyalgia); fatigue (including chronic 
fatigue syndrome); functional GI disorders (including 
IBS); chronic pelvic / genitourinary pain; and 
functional neurological disorders.We searched 
Medline and Embase from 1980 to the present for 
papers including one or more of the symptoms / 
syndromes along with terms relating to epidemiology 
or socioeconomic status. Data extraction is complete 
for multiple symptoms and for other symptoms 
/syndromes since 2017. Full data extraction and 
analysis will be completed by May 2020.We are 
conducting meta-analysis of the results of case-
control studies with meta regression to examine the 
influence of study variables.  
 
Findings 
To date, we have identified 9420 titles with 1126 
abstracts identified for full text searching. So far, we 
have extracted data from 25 studies with case and 
control data from 426 full text papers.To date the 
pooled odds ratio for the prevalence of multiple 
symptoms in the most deprived sector of the 
population is 1.7 (95%CI 1.5 to 1.9) and for prevalence 
of fibromyalgia is 1.6 (1.1 to 2.5).We will report full 
study findings across all symptoms/ syndromes in July.  
Consequences 
This is the first study to systematically show that at 
least some persistent physical symptoms and 
functional syndromes have an adverse socioeconomic 
gradient. Symptom disorders contribute to the excess 
burden of ill-health in poorer people. As this 
demographic group may be least likely to engage with 
programmes such as IAPT symptom management 
programmes, interventions are needed to enable 
people living in, or close to, poverty to live well 
despite persistent physical symptoms.  
Funding Acknowledgement 
Funded by NIHR through Research Capability Funding 
to NHS Sheffield CCG. 
 
Y.2 
Do GP's practices which employ Social Prescribing 
exhibit similar patterns in the prescription of pain 
and antidepressant medication?   
Presenter: Lawrence Dawson 
Co-authors:   
Institutions 
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Abstract 
Problem 
One of the goals of the NHS 'Long Term Plan', is to 
greatly increase the access to social prescribing 
schemes through 'link workers' working within GP's 
practices. It is hoped that through the increased 
uptake of such programmes problems such as over-
medication can be addressed. To date, the trends of 
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prescription rates for pain and anti-depressant 
medications, within practices employing social 
prescribing, have not been compared and contrasted. 
This study aims to inform further research into the 
role of social prescribing in the treatment of chronic 
musculoskeletal conditions.  
Approach 
This study took three NHS locations with award-
winning social prescribing programmes and compared 
their opioid, non-opioid, anti-inflammatory, and anti-
depressant medication rates, both with each other 
and the NHS means over a five-year period. These 
medications were selected as they are relatively 
common and they can possibly be seen as surrogate 
indicators for chronic musculoskeletal health 
conditions. The prescription data was taken from the 
University of Oxford's DataLab, and the practice 
patient numbers from NHS Digital. Linear regression 
analyses were performed for each medication type, at 
each of the three locations and the NHS England 
mean figures for the same period.  
Findings 
In all but one medication type, in one location, the 
prescription rates of opioid, non-opioid, anti-
depressant, and anti-inflammatory medication 
decreased over the study period in comparison with 
NHS means. However, the actual prescription rates 
varied considerably between locations with, as an 
example, prescription rates of opioids and anti-
depressants being over twice as great within a 
Somerset market town, compared to those from a 
deprived inner-city CCG.  
Consequences 
Although the three study groups showed a greater 
decrease in prescription rates, in almost every case, 
compared to NHS means, it cannot be ascertained 
whether the improvements are representative of 
improvements from patients actually involved in 
social prescribing schemes. It could be that these 
improvements are due to a general change in culture 
within these health locations. However, from these 
findings, it would appear important to consider also 
the clinical and financial change which could be 
achieved if the individual, health culture or 
community factors behind the disparity in prescription 
rates could be identified and changes made 
accordingly.  
Y.3 
Understanding the interactions between lifestyle and 
deprivation to support policy and intervention 
development: an overview of a mixed methods PhD.   
Presenter: Hamish Foster 
Co-authors:  Fellow: Dr Hamish Foster; Supervisors: 
Prof Catherine O'Donnell, Prof Frances Mair, Prof 
Jason Gill, Prof Duncan Lee 
Institutions 
General Practice and Primary Care, University of 
Glasgow 
Abstract 
Problem 
Lifestyle factors are the strongest modifiable risk 
factors for non-communicable diseases (NCDs). 
Deprived populations have the highest clustering of 
unhealthy lifestyle factors and disproportionately high 
lifestyle-associated morality. How combinations of 
‘old’ (e.g. smoking) and ‘new’ (e.g. sleep) lifestyle 
factors interact with each other and with 
socioeconomic status is largely unknown. This mixed 
methods PhD aims to improve understanding of the 
risks associated with combinations of lifestyle factors 
across the socioeconomic spectrum to inform policy 
and interventions.  
Approach 
There will be four work-packages (WPs):WP1) 
Systematic review of the literature to collate evidence 
for lifestyle factor combinations associated with 
adverse health outcomes (mortality; cardiovascular 
and cancer incidence) and for interactions between 
lifestyle factor combinations and deprivation. We will 
include prospective observational studies which 
examine the adverse health risk associated with a 
combination of at least three lifestyle factors. The 
main aim will be to identify candidate lifestyle factors 
to be examined in WP2. WP2) Statistical analysis of UK 
Biobank (>500,000 participants with self-reported 
lifestyle data linked to routine health outcomes) to 
examine how lifestyle factor combinations are 
associated with adverse health outcomes and how 
deprivation modifies those associations. Use of Cox 
proportional hazard models to examine risk; variable 
selection algorithms to identify the highest risk 
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lifestyle factor combinations in deprived groups.  WP 
3) Perform similar analysis using HUNT Databank, 
Norway (>50,000 participants in each of 3 survey 
waves with detailed self-reported lifestyle and 
socioeconomic data linked to routine health 
outcomes), to assess generalisability of findings.WP 4) 
Evaluate how public and professionals view lifestyle 
factor combinations in the context of deprivation. 
Qualitative approach combining focus groups of 
members of the public from areas of deprivation and 
interviews with primary care nurses/physicians and 
public health professionals/policy makers, analysis 
guided by Normalisation Process Theory. This will 
identify the work required by individuals and groups 
to incorporate new evidence into policy and practice 
to support healthy living in deprived areas.  
Findings 
This PhD programme has just started. Previous work 
from our group has shown the disproportionate all-
cause and CVD mortality from the interaction 
between a wide combination of unhealthy lifestyle 
factors and lower socioeconomic status. This 
highlighted the need to identify the highest risk 
lifestyle factor combinations. Preliminary scoping of 
the literature suggests there is a large body of 
evidence for the adverse health associated with 
traditional/old lifestyle factor combinations. However, 
there appears to be a lack both of studies that include 
‘new’ lifestyle factors and of studies that assess the 
impact of deprivation.  
Consequences 
This mixed methods PhD will provide new quantitative 
and qualitative evidence that will develop practice 
and policy to support healthier living in areas of 
deprivation. 
Funding Acknowledgement 
This is a Medical Research Council (UK) Clinical 
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Abstract 
Problem 
Multimorbidity, defined as two or more chronic 
conditions, is increasing in prevalence and affects 
66.2% of patients over 50 attending primary care in 
Ireland (1). It is associated with increased health care 
use, fragmented care and poorer health outcomes (2). 
There is a link between social deprivation and 
multimorbidity (3). Link workers are non-health or 
social care professionals based in primary care who 
support people to develop and achieve a personalised 
set of health and social goals by engaging with 
community resources. Link workers have been piloted 
in areas of deprivation (4), but there remains 
insufficient evidence to support their effectiveness 
(5). This study aims to test the effectiveness of link 
workers based in General Practices in deprived areas 
in improving health outcomes for people with 
multimorbidity.  
Approach 
This will be a randomised controlled trial involving a 
total of 10 GP practices and 600 patients, serving 
areas of deprivation in four Irish cities.  Eligible 
participants will be community dwelling adults with 
multimorbidity suitable for referral to a practice based 
link worker. Baseline data will be collected, followed 
by randomisation to intervention or control groups. 
The intervention group will meet with a link worker 
based in the GP practice and receive support over 
three months to develop and achieve a personalised 
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set of health and social goals. The ‘wait list’ control 
group will receive usual care from their GP during this 
time. Primary outcomes will be health related quality 
of life as assessed by EQ5D5L and mental health 
assessed by HADS. Secondary outcomes will be based 
on the core outcome for multimorbidity (6) and 
include a range of patient reported outcome and 
healthcare utilisation measures.Data will be collected 
at baseline and on RCT completion at 3 months using 
questionnaires self-completed by participants. Health 
care utilisation will be extracted from GP records by 
researchers. The final protocol was informed by an 
uncontrolled pilot study in single practice to test 
feasability and acceptability of the intervention and 
trial processes.  
Findings 
The pilot demonstrated that the intervention was 
received positively. Adjustments were made to the 
selection process to allow inclusion of GP 
identification of patients they felt could benefit fron a 
linkworker intervention. This was felt to reflect real 
world practice. Additional time was built into the 
recruitment stages. Recruitment and baseline data for 
the main trial will be complete by June 2020.  
Consequences 
This will be the largest trial of link workers with 
individual randomisation that we are aware of and will 
provide some of the most robust evidence to date in 
this area.  This will help to inform policy makers in 
Ireland who are currently actively considering ways to 
move care into the community and of providing 
holisitic care for people with multimorbidity.  
Funding Acknowledgement 
This trial is jointly funded by the Health Research 
Board Ireland and the Health Service Executive 
Slaintecare Integration Fund. The funders did not have 
any role in the design of this study. 
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Abstract 
Problem 
Pelvic Inflammatory Disease (PID) comprises a range 
of inflammatory disorders of the upper female genital 
tract and can lead to reproductive complications. 
Sexually transmissible infections (STIs) are often 
implicated as a cause. Diagnosing PID is challenging 
due to the wide variety of symptoms and severity. 
This can lead to under-diagnosis. Speculum and 
bimanual examinations are recommended to support 
PID diagnosis in women considered at risk and who 
report recent onset pelvic pain. There is limited 
evidence regarding general practitioner (GP) PID 
diagnosis practices. We investigated the PID diagnosis 
practices of GPs in Australia.  
Approach 
An online survey about chlamydia management was 
distributed in 2019 to GPs in Australia. It included 
Likert scale questions pertaining to investigating PID 
symptoms in women diagnosed with chlamydia, the 
frequency GPs conduct pelvic examinations for 
women reporting pelvic pain or dyspareunia, and a 
free-text question about barriers to performing pelvic 
examinations. From 323 respondents, 85.8% (n=277) 
responded to quantitative questions about PID and 
74.6% (n=241) provided 452 comments regarding 
pelvic examination barriers. Adjusting for gender, age 
and additional sexual health training/education we 
used multivariable logistic regression to analyse 
factors associated with the frequency that GPs 
conducted pelvic examinations. Barriers to performing 
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pelvic examinations were explored using thematic 
analysis. 
Findings 
Most GPs reported they frequently asked patients 
with an STI about symptoms suggestive of PID, 
including pelvic pain (86.2%), abnormal vaginal 
discharge (95.3%), dyspareunia (79.6%), and abnormal 
vaginal bleeding (89.5%). Over half reported they 
would frequently conduct speculum (69.0%) or 
bimanual (55.3%) examinations for women reporting 
pelvic pain.  Multivariable analysis found female GPs 
were more likely to frequently perform speculum 
(adjusted odds ratio, AOR: 4.6, 95% CI 2.6-8.2) and 
bimanual examinations (AOR: 3.7, 95% CI 2.1-6.5). GPs 
with additional sexual health training/education were 
more likely to perform speculum (AOR: 2.2, 95% CI 
1.1-4.2) and bimanual examinations (AOR: 2.1, 95% CI 
1.2-3.7).Of the free-text comments, the most 
common barrier focused on was a lack of patient 
consent or desire to proceed with a pelvic 
examination, highlighting the need for further 
research into patient perspectives and expectations of 
pelvic examinations outside of cervical screening. 
Other barriers included GP gender, concerns about 
patient health, time pressures, and GP reluctance to 
perform examinations due to inexperience and/or a 
lack of certainty that an examination would add value 
to their assessment. This experience was not 
universal, however, with several GPs reporting that 
they did not face barriers to performing pelvic 
examinations.  
Consequences 
Under-diagnosis of PID is a global issue, and results in 
reproductive complications including chronic pain and 
infertility. While GPs typically ask about PID symptoms 
when managing patients with chlamydia, they are not 
consistently able or willing to perform pelvic 
examinations to support a diagnosis, potentially 
reducing capacity to diagnose PID.  
Funding Acknowledgement 
National Health and Medical Research Partnership 
Project (Application ID: APP1150014) 
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traumatic stress disorder in postnatal women? A 
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Abstract 
Problem 
Up to a third of women describe their experience of 
giving birth as psychologically traumatic, and post-
traumatic stress disorder (PTSD) following childbirth is 
common, affecting 3-4% of women who give birth. 
Evidence-based treatments for PTSD are available, 
however UK women presenting to NHS services in the 
postnatal period with mental health problems are 
often underdiagnosed and report feeling dismissed. 
Especially little is known about women’s pathway into 
NHS services when they are experiencing postnatal 
PTSD. Thus far, no studies have investigated GPs’ and 
psychiatrists’ perceptions of PTSD in a postnatal 
population following a traumatic birth, to help us 
understand women's experiences  of seeking a 
diagnosis and appropriate care for this condition.  
Approach 
This qualitative study, making use of a vignette case 
study, aimed to investigate whether GPs and 
psychiatrists perceive PTSD symptoms after birth to 
be indicative of a disorder and what diagnosis and 
management options they would give a postnatal 
patient with a classic presentation of PTSD symptoms. 
Semi-structured interviews were conducted with 6 
GPs and 7 psychiatrists based around a fictional 
vignette featuring a diagnostic case of PTSD in a 
postnatal woman, based on DSM-5 criteria. Interview 
transcripts were analysed using thematic analysis and 
a framework approach.  
Findings 
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None of the six GP participants acknowledged that the 
woman in the vignette was experiencing PTSD, 
instead GPs sought to normalise traumatic symptoms 
or made a postnatal depression diagnosis. GPs said 
they would offer a combination of antidepressants, 
referral for psychological therapy, debriefing services 
and referral to specialist perinatal mental health 
teams to help manage the presentation. GPs 
distrusted the timeliness of the referral process both 
to psychological therapy and secondary psychiatry 
services. The psychiatrists who took part clearly 
identified the vignette to be a presentation of PTSD 
however, like the GPs, the majority were keen to refer 
this patient to the specialist perinatal mental health 
team.  
Consequences 
GPs did not recognise the case study as PTSD and 
diagnosed distress as postnatal depression. 
Psychiatrists recognized PTSD but felt specialist 
treatment in perinatal women was beyond their 
remit. There is a clear demand from clinicians for 
specialist perinatal mental health services, which may 
still be unmet in some geographical areas due to high 
thresholds for accepting referrals. More research is 
required to understand the challenges facing GPs 
caring for such patients, including whether targeted 
professional education and specialist care ultimately 
improve outcomes.  
Funding Acknowledgement 
Royal College of Psychiatrists Pathfinder Fellowship 
(awarded to Haniah Habash-Bailey). 
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Co-authors:  Saran Shantikumar, Jeremy Dale 
Institutions 
Unit of Academic Primary Care, Communicable 
Disease Control Evidence & Epidemiology, Warwick 
Medical School 
 
Abstract 
Problem 
Prescribing rates of various drugs in general practice 
are associated with socioeconomic deprivation, but 
until now evidence has been lacking around its 
relationship with rates of hormone replace therapy 
(HRT) prescribing in women. Concerns have been 
raised that women from more deprived backgrounds 
are less likely to be receiving HRT treatment and its 
associated benefits.We aimed to investigate the 
association between general practice HRT prescription 
rates and socioeconomic deprivation in England.  
Approach 
In this cross-sectional study, monthly primary care 
prescribing data for 2018, as well as practice age and 
sex profiles, were downloaded from NHS digital. 
Practice-level Index of Multiple Deprivation (IMD) 
scores – a marker of socioeconomic deprivation – 
were obtained from Public Health England. Quality 
Outcomes Framework (QOF) data for 2017/18 were 
obtained for the proportions of patients of each 
practice with a diagnosis or risk factor that may 
influence decisions around HRT prescribing. Practice-
level prescribing rate was defined as the number of 
items of HRT prescribed per 1000 registered female 
patients over the age of 40 years. The association 
between IMD score and HRT prescribing rate was 
tested using univariate and multivariate Poisson 
regression. Multivariate analyses adjusted for the 
practice proportions of obesity, smoking, 
hypertension, diabetes, coronary heart disease and 
cerebrovascular disease, as well as practice list size. 
The analysis was repeated for (1) only oral and (2) 
only transdermal preparations.  
Findings 
The overall rate of HRT prescribing was 29% lower in 
practices from the most deprived quintile compared 
with the most affluent (Incidence rate ratio [IRR] 0.71, 
95% CI 0.68-0.73). After adjusting for all 
cardiovascular disease outcomes and risk factors, the 
prescribing rate in the most deprived quintile was still 
18% lower than in the least deprived quintile 
(adjusted IRR 0.82, 95% CI 0.77-0.86). In more 
deprived practices, there was a significantly higher 
tendency to prescribe oral HRT over transdermal 
preparations (p < 0.001).  
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Consequences 
This study has highlighted inequalities associated with 
HRT prescription. This may reflect a large unmet need 
in terms of post-menopause care in areas of 
deprivation. Further research is needed to confirm 
these results with individual-level patient datasets, 
and to identify the underlying factors from patient 
and GP perspectives that may explain this.  
 
Z.4 
Understanding primary care usage, treatment and 
referral patterns for women with common menstrual 
disorders   
Presenter: Hannah Knight 
Co-authors:  Professor Christina Pagel, Dr Ipek Gurol-
Urganci 
Institutions 
University College London, London School of Hygiene 
and Tropical Medicine 
Abstract 
Problem 
Menstrual disorders have an adverse impact on 
women’s physical, social, emotional and material 
quality of life. It is estimated that among women of 
reproductive age, one in four suffers from 
menorrhagia, one in five from severe dysmenorrhea, 
and one in ten from endometriosis. In the United 
States, dysmenorrhea alone has been estimated to 
cause an annual loss of nearly 140 million working 
hours. Recent studies highlight concerns about how 
effectively menstrual disorders are being managed 
and treated in primary care. However, the number of 
women seeking help from GPs for heavy and/or 
painful periods is not well understood and neither are 
their healthcare needs. Most studies that report the 
prevalence of these conditions in the UK are surveys 
carried out in the 1960s to early 1990s. In this study, 
we use a nationally representative sample of 
electronic primary care records to estimate the 
prevalence of common menstrual disorders and to 
understand primary care use, treatment and referral 
patterns among women affected by these conditions.  
Approach 
We are conducting a retrospective cohort study using 
a random sample of 500,000 patients drawn from the 
Clinical Practice Research Datalink (CPRD) linked to 
Hospital Episode Statistics (HES). Our sample is 
restricted to female patients aged 8 to 60 years in 
2013 who meet acceptable data quality criteria. Code 
lists for common menstrual disorders are being 
developed following best practice guidelines. We will 
use an expert panel of clinicians to reach consensus 
on inclusion and exclusion of codes and allow 
sensitivity analysis to explore the impact of 
uncertainty in coding.  
Findings 
Based on preliminary code lists, of the 500,000 
women in the cohort 117,873 (23.6%) have one or 
more codes to indicate a menstrual disorder during 
the study period. We will describe the incidence and 
point prevalence of menstrual disorders (overall and 
by sub-condition) in 2013 and primary care utilisation 
over a 5-year follow-up period, exploring associations 
with age, ethnicity and deprivation status. We also 
show sensitivity analysis on the impact of coding 
uncertainty on estimates.  
Consequences 
The code list development and analysis will be 
complete by June 2020 and will inform a grant 
application for a larger, mixed-methods programme of 
work to explore which aspects of care are particularly 
important to women with menstrual disorders and 
how they can be improved or better integrated in the 
services that are already available. The study aims to 
support GPs, gynaecologists and commissioners to 
understand the health service needs of patients with 
menstrual disorders, to identify opportunities to 
improve access to existing treatments and to highlight 
any disparities that exist in the care that they are 
given.  
Funding Acknowledgement 
The Health Foundation 
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Z.5 
Shame, bluffs and drug mules – experiences of young 
women obtaining contraception   
Presenter: Dr Richard Ma 
Co-authors:  Ms Rebecca Blaylock, Dr Lorna Hobbs, 
Professor Helen Ward, Professor Sonia Saxena 
Institutions 
Imperial College London, British Pregnancy Advisory 
Service (BPAS), Tavistock and Portman NHS 
Foundation Trust 
Abstract 
Problem 
Despite a wide range of available contraceptive 
methods, clinical guidelines and national policies, 
young women continue to be at highest risk of 
unplanned and unwanted pregnancies. We aimed to 
explore the experiences of young women about 
information and access to contraception.  
Approach 
We recruited young women from Instagram and 
allocated them into: 16 to 19 and 20 to 24 age groups 
to reflect the different life stages, experiences and 
policy focus. Focus group discussions lasted 90 
minutes and were facilitated by two researchers. 
These were recorded digitally and sent to commercial 
transcription service; transcripts were validated with 
the participants. We used a topic guide and a range of 
contraceptive methods out on display to stimulate 
discussions about experiences and access from 
healthcare settings.Three researchers analysed the 
transcripts through discussions of categories from 
initial reading, further thematic analysis, comparing 
and agreeing on coding. We used NVivo to organise 
the data. 
Findings 
10 women aged 16 to 19 years and 11 aged 20 to 24 
years participated in their respective focus groups. 
They were ethnically diverse, and most were from 
London. Contraceptive pills and patches were often a 
default and only choice that was discussed and made 
available to them. Hormonal side effects were 
recognised as a common trade off of these 
methods.Condom use was encouraged from an early 
age, particularly from school. Some chose to purchase 
condoms as “free” condoms incurred other costs such 
as efforts to get on a "condom card scheme", time to 
attend a venue, and condoms were often limited in 
quantity and variety. Female condoms were neither 
popular or acceptable.Women reported they assumed 
responsibility for contraception and sexual health 
within a relationship no matter how brief, and men 
were seen as complacent. Some women had to bluff 
to test out their trust in partners’ attitudes to 
contraception and sexual health.Sex was shameful 
and disapproved by family and cultural norms. 
Women felt judged obtaining contraception and some 
resorted to asking peers to obtain on their behalf. In 
addition to confidentiality and accessibility, women 
want services that recognise their maturity and 
responsibility, as well as being holistic, empathic and 
non-judgemental. Parents (particularly mums) were 
viewed as overprotective and controlling, often 
restricting what young women were allowed to use. 
However, they also wanted a degree of "mothering"; 
for example, they reminisced about support school 
nurse offered them.Women also found it liberating 
and informative discussing sex and contraception in 
the focus groups setting.The data from focus group 
are still being analysed and further themes will be 
presented at the conference in July.  
Consequences 
Young women face challenges obtaining 
contraception they need. Although individual services 
can make changes to improve individual experiences, 
more needs to be done to change societal attitudes to 
gender roles and sexuality.  
Funding Acknowledgement 
RM was funded by NIHR Doctoral Research Fellowship 
SS and HW have received funding from NIHR School 
for Public Health Research 
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Z.6 
Barriers and facilitators for General Practitioner 
Doctors to report domestic violence cases to the 
authorities   
Presenter: Diana Nadine Moreira 
Co-authors:  Mariana Pinto da Costa 
Institutions 
Portuguese Northern Region Health Administration, 
Institute of Biomedical Sciences Abel Salazar, 
University of London 
Abstract 
Problem 
Domestic Violence (DV) is a serious, prevalent and yet 
preventable public health problem. The  Portuguese 
law defines it as ‘actual or threaten physical, 
psychological or sexual harm perpetrated by a current 
or former partner or against someone of particular 
vulnerability with which the aggressor co-habits’. 
Since 2000 in Portugal DV is a public crime, which 
means that everyone that is aware of it has the duty 
to report it. Although the number of reports has been 
growing in the last few years there are anecdotal 
impressions that only a small number of cases are 
denounced to the authorities.Evidence shows that DV 
has a considerable heath impact, in short and long 
term physical and mental health of the victims. When 
it comes to provide assistance to potential victims and 
their family, general practitioners (GPs) are in a 
particularly central position to detect and report cases 
of DV to authorities. However, they may be faced with 
a complex decision-making position.  In fact, little is 
known about what drives  doctors to present, or not, 
an official report.  
Approach 
To address this question, a national qualitative study 
has been conducted in Portugal, to further 
understand what leads GPs to present or not, a report 
of DV when they  become aware of such cases in their 
clinical practice.  Semi-structured interviews were 
conducted to GPs of each of the five Heath Regional 
Administrations of continental Portugal and Madeira 
and Azores Regional Offices. The interviews were 
transcribed, coded and analyzed using thematic 
analysis.  
Findings 
The preliminary results show as common themes: 
concerns about breaking doctors-patient 
confidentiality, the victims safety before and after 
making a report and doctors personal safety. Doctors 
have also expressed many doubts about the right 
procedures and availability of means.  
Consequences 
The  presentation of these preliminary results is key to 
further discuss and reflect from the ongoing analysis. 
Hopefully with a better understanding in this matter 
we can define new strategies to guide GPs when 
dealing with patients suffering from DV.  
 
Z.7 
What do primary care providers need in a prescriber 
checklist for mifepristone medication abortion?   
Presenter: Wendy V. Norman 
Co-authors:  Sarah Munro, Kate Wahl, Sheila Dunn, 
Edith Guilbert. 
Institutions 
University of British Columbia, London School of 
Hygiene & Tropical Medicine, University of Toronto, 
Laval University. 
Abstract 
Problem 
Primary care providers are challenged to bridge the 
gap between medical abortion guidelines and a 
comprehensive approach to prescribing and follow up 
within a primary care visit. We aimed to develop and 
implement a charting checklist and quick reference 
guide to support the adoption of medication abortion 
among Canadian primary care providers.  
Approach 
The preliminary checklist and reference guide were 
adapted from 7 clinical exemplars using the 2016 
Society of Obstetricians & Gynecologists of Canada 
guidelines on medical abortion. Materials were 
subjected to expert review (n=6). Front-line providers 
(n=5) gave feedback on the revised materials in ‘think-
aloud’ interviews and rated the materials using the 
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System Usability Scale (SUS). Final materials were 
approved by expert reviewers; English and French 
versions were shared with providers through 
communities of practice convened online and in 
person.  
Findings 
Expert reviewers were 4 clinician-researchers, 1 
community stakeholder, and 1 knowledge translation 
scientist. Front-line participants were 2 family 
physicians, 1 obstetrician-gynecologist, 1 family 
medicine resident, and 1 registered nurse. Front-line 
participants had between 2 and 20+ years in practice; 
3 had previous experience with medication abortion 
and 2 did not. Changes to the materials focused on 
alignment with clinical guidelines and best practices as 
well as suitability for the clinical context. The median 
SUS was 86.25 (69.4-97.5), indicating good-to-
excellent usability. Between April 2018 and October 
2019, the checklist was downloaded or distributed 
1423 times (1354 English, 69 French) and the 
reference guide was downloaded 912 times (841 
English, 71 French).  
Consequences 
Primary health care providers are starting to add 
medication abortion to their scope of practice for the 
first time, particularly in Canada where this innovation 
has been recently approved. The tools described 
above have been optimized to support the 
implementation of medical abortion services in the 
primary care context.  
Funding Acknowledgement 
The authors have no competing interests to declare. 
This study was supported by a Canadian Institutes of 
Health Research Partnership for Health System 
Improvement Grant (PHE148161), in partnership with 
the Michael Smith Foundation for Health Research 
(16743), and by a research grant from the Society of 
Family Planning (SFPRF11-19). SM was supported as a 
Trainee and a Scholar of the Michael Smith 
Foundation for Health Research (16603, 18270). WVN 
was supported as a Scholar of the Michael Smith 
Foundation for Health Research (2012-5139 (HSR)), 
and as an Applied Public Health Research Chair by the 
Canadian Institutes of Health Research (CPP-329455-
107837). In kind support was contributed by the 
Women’s Health Research Institute of British 
Columbia Women’s Hospital and Health Centre of the 
Provincial Health Services Authority of British 
Columbia. Planned Parenthood Ottawa supported this 
project in many ways including contributions of staff 
time, recruiting and coordination. 
 
Z.8 
Just Walk It! Encouraging use of the Active10 app to 
promote brisk walking after a hypertensive 
pregnancy: pilot study   
Presenter: Dr Mohammad Sharif Razai 
Co-authors:  Professor Pippa Oakeshott 
Institutions 
St George's Univeristy 
Abstract 
Problem 
Each year in England, 70,000 women have high blood 
pressure during pregnancy (known as hypertensive 
disorders of pregnancy or HDP). Women who have 
high blood pressure during pregnancy are at increased 
long-term risk of cardiovascular disease. Regular brisk 
walking at 3-4mph starting in the postnatal period 
might reduce this risk. The Free Active 10 app, 
developed by Public Health England, encourages at 
least 10 minutes brisk walking every day. It has never 
been evaluated in a trial.Aims:To conduct a pilot study 
over 3 months of giving postnatal women who had 
HDP a ‘Just walk it’ leaflet encouraging use of the 
Active 10 app.We will assess:1. How many women 
downloaded the Active 10 app2. How many women 
used it to monitor their brisk walking3. How many 
achieved 10 minutes brisk walking in a day as 
recorded on the app  
Approach 
We will recruit 20 women with HDP from hospital 
postnatal wards. Two months after delivery a 
researcher (MR) will visit them at home and measure 
BP, height, weight and waist circumference and 
administer a health questionnaire.A week later the 
women will be posted a “Just walk it” leaflet providing 
information on possible benefits of brisk walking after 
HDP and encouraging them to download and use 
Active 10.MR will telephone them after 2 weeks to 
see how they are getting on with brisk walking and 
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Active10. If they have not downloaded or used the 
app he will encourage them to try it and arrange a 
further call after 2 weeks.Outcomes at 3 months by 
telephone questionnaire to patient backed by GP 
medical record search:1. How many women 
downloaded the Active10 app2. How many women 
used it to monitor their brisk walking3. How many 
achieved 10 minutes brisk walking in a day – from a 
screenshot of participants’ Active 10 record.4. 
Exploratory data on any change in BP, weight, waist 
circumference from patient questionnaire/GP records  
Findings 
The pilot study was designed with the help of 17 
postnatal mothers (including four with HDP) in two 
general practices. All welcomed the advice and were 
keen to do brisk walking.Comments included:."I've 
downloaded the app and I am more aware of my 
walking briskly now. I didn't know whether my 
walking was good enough or not but now I look at the 
app and it tells me if I am walking fast.""I will continue 
to use the app.""I think it is good to know how fast I 
am walking. I try to be active but it's difficult with a 
baby."  
Consequences 
Promoting Active 10 could be a simple, cheap way of 
increasing long-term brisk walking after HDP. If 
beneficial, it could be offered routinely by GPs/health-
visitors during postnatal reviews.  
Funding Acknowledgement 
St George's University of London 
 
Z.9 
Factors associated with postpartum return to 
smoking in two UK cohorts   
Presenter: Lauren Taylor 
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Cooper 1, Katharine Bowker 1, Lucy Phillips 1, Sarah 
Lewis 1, Michael Ussher 2,3, Tim Coleman 1 
Institutions 
1 University of Nottingham, 2 St George's University 
of London, 3 University of Stirling 
Abstract 
Problem 
Helping women quit smoking in pregnancy and remain 
abstinent postpartum is an important public health 
target. Approximately half of UK women who smoke 
will attempt to quit in pregnancy but, despite wishing 
to remain abstinent, up to 76% return to smoking 
within two years. Since the introduction of e-
cigarettes, the methods people use to attempt to stop 
smoking have changed substantially. To investigate 
factors which influence postpartum return to smoking 
(PPRS) and whether these have changed since e-
cigarettes became popular, we present findings from 
analyses of two longitudinal pregnancy cohorts 
conducted in 2011-2012, when e-cigarettes were not 
widely used, and in 2017, when they were, comparing 
the prevalence of and factors associated with PPRS.  
Approach 
The 2011-2012 cohort ‘PLS Nottingham’ recruited 
participants from antenatal clinics in two Nottingham 
hospitals. The 2017 cohort ‘PLS National’ was 
multicentre, recruiting from 17 hospitals in England 
and Scotland. In both cohorts, questionnaires were 
completed by pregnant women at baseline (8-26 
weeks gestation), in late pregnancy (34-36 weeks) and 
at 12 weeks postpartum. These asked about women’s 
characteristics, smoking behaviours and, in PLS 
National, e-cigarette use. For each cohort, we 
calculated the prevalence of postpartum relapse in a 
subgroup of women that were abstinent in late 
pregnancy. In both subgroups, we conducted 
exploratory, multiple logistic regressions to identify 
factors significantly associated with PPRS.  
Findings 
From 850 women in the PLS Nottingham cohort, we 
identified a subgroup of 255 who reported having quit 
smoking at the late pregnancy questionnaire. In PLS 
National from 750 women we identified 162 women 
who had quit. Baseline characteristics for the groups 
were similar. The postpartum questionnaire response 
rate for women who had quit in late pregnancy in PLS 
Nottingham was 81.6% (n=208) and in PLS National 
84.6% (n=137). Prevalence of PPRS was 25.2% (95% CI 
0.20-0.32) in PLS Nottingham and 35.8% (95% CI 0.28-
0.44) in PLS National. Factors independently and 
significantly associated with a change in relapse rates 
in PLS Nottingham were education at GCSE level or 
above (adjusted OR 0.25, 95% CI 0.07-0.91), 
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breastfeeding at 12 weeks postpartum (adjusted OR 
0.39, 95% CI 0.17-0.89) and reporting, in the 
postpartum, living with someone who smoked 
(adjusted OR 3.27, 95% CI 1.07-9.98). In PLS National, 
both breastfeeding at 12 weeks postpartum (adjusted 
OR 0.12, 95% CI 0.04-0.35) and having used an e-
cigarette in pregnancy (adjusted OR 0.41, 95% CI 0.17-
0.99) were associated with reduced PPRS rates.  
Consequences 
Both before and after e-cigarettes became widely 
available, breastfeeding at 12 weeks postpartum was 
associated with lower PPRS rates. In the survey that 
measured it, e-cigarette use during pregnancy was 
also associated with a lower rate. Further qualitative 
work is required to understand why these associations 
are noted, and help design future interventions aimed 
at relapse prevention.  
Funding Acknowledgement 
NIHR School for Primary Care Research (Personal 
fellowship – Sophie Orton) 
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